<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D2AF99C9-67A3-4AAF-8F96-E79F107852AD"><gtr:id>D2AF99C9-67A3-4AAF-8F96-E79F107852AD</gtr:id><gtr:name>United States Agency for International Development</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/73528ABC-EFA1-4B0A-AA35-D6F649729E83"><gtr:id>73528ABC-EFA1-4B0A-AA35-D6F649729E83</gtr:id><gtr:name>Global Fund to Fight AIDS, Tuberculosis and Malaria</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89B67BA0-D9B9-44D8-A2FA-580E970CD20D"><gtr:id>89B67BA0-D9B9-44D8-A2FA-580E970CD20D</gtr:id><gtr:name>Michigan State University</gtr:name><gtr:address><gtr:line1>301 Administration Building</gtr:line1><gtr:line4>East Lansing</gtr:line4><gtr:line5>Michigan 48823-1046</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EC177B1F-35EE-4B74-981D-E8382EE3D18C"><gtr:id>EC177B1F-35EE-4B74-981D-E8382EE3D18C</gtr:id><gtr:name>London School of Economics &amp; Pol Sci</gtr:name><gtr:address><gtr:line1>Houghton Street</gtr:line1><gtr:line2>Aldwych</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>WC2A 2AE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/28DF10CD-6250-442A-804C-A8710CF218D1"><gtr:id>28DF10CD-6250-442A-804C-A8710CF218D1</gtr:id><gtr:name>University of Bern</gtr:name><gtr:address><gtr:line1>Universitat Bern</gtr:line1><gtr:line2>Sidlerstrasse 5</gtr:line2><gtr:line4>Bern</gtr:line4><gtr:line5>CH-3012</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9F19673B-7D22-421A-A058-CFC1F3E932C1"><gtr:id>9F19673B-7D22-421A-A058-CFC1F3E932C1</gtr:id><gtr:name>National Institute of Health, Pakistan</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9DE33998-C1C9-4C48-9B4B-039FC2802CA1"><gtr:id>9DE33998-C1C9-4C48-9B4B-039FC2802CA1</gtr:id><gtr:name>Healthsites.io</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D70D374-4644-48AF-8B76-D8F2856D9290"><gtr:id>5D70D374-4644-48AF-8B76-D8F2856D9290</gtr:id><gtr:name>FIND Diagnostics (India)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/430ABEF3-2F94-4B47-A8DB-E521642AA1E5"><gtr:id>430ABEF3-2F94-4B47-A8DB-E521642AA1E5</gtr:id><gtr:name>University of Wisconsin Madison</gtr:name><gtr:address><gtr:line1>University of Wisconsin</gtr:line1><gtr:line4>Madison</gtr:line4><gtr:line5>Wisconsin</gtr:line5><gtr:postCode>WI 53706</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/88382C36-9EC3-426D-933F-F6BA945BFF1B"><gtr:id>88382C36-9EC3-426D-933F-F6BA945BFF1B</gtr:id><gtr:name>Tan Tock Seng Hospital</gtr:name><gtr:address><gtr:line1>Tan Tock Seng Hospital</gtr:line1><gtr:line2>11 Jalan Tan Tock Seng</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B2EE12FB-8E49-4F6A-8073-DF35FAF50581"><gtr:id>B2EE12FB-8E49-4F6A-8073-DF35FAF50581</gtr:id><gtr:name>Emory University</gtr:name><gtr:address><gtr:line1>201 Dowman Drive</gtr:line1><gtr:line4>Atlanta</gtr:line4><gtr:line5>Ga 30322</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68F78F03-B2B0-4B8E-AB8D-02362018AD72"><gtr:id>68F78F03-B2B0-4B8E-AB8D-02362018AD72</gtr:id><gtr:name>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F14141B5-3C0D-41D1-BD24-130CF9F18423"><gtr:id>F14141B5-3C0D-41D1-BD24-130CF9F18423</gtr:id><gtr:name>Antigen Discovery Inc</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D120E762-DC0F-488D-B1F4-EC68BCF6573A"><gtr:id>D120E762-DC0F-488D-B1F4-EC68BCF6573A</gtr:id><gtr:name>Jinan University</gtr:name><gtr:address><gtr:line1>Tianhe District</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/150CE820-6372-414E-9F7F-524E27034E23"><gtr:id>150CE820-6372-414E-9F7F-524E27034E23</gtr:id><gtr:name>University of Colorado at Boulder</gtr:name><gtr:address><gtr:line1>Boulder</gtr:line1><gtr:line4>Colorado</gtr:line4><gtr:line5>80309-0425</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0CF6353C-24C9-4866-99CF-FB1DB633AF6F"><gtr:id>0CF6353C-24C9-4866-99CF-FB1DB633AF6F</gtr:id><gtr:name>University of North Carolina at Chapel Hill</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D339D78-760B-4FD1-9B8C-437494DA87CF"><gtr:id>4D339D78-760B-4FD1-9B8C-437494DA87CF</gtr:id><gtr:name>M?decins Sans Fronti?res (MSF)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D2B8776-4478-4DDB-A4DE-748C90B8EBAE"><gtr:id>5D2B8776-4478-4DDB-A4DE-748C90B8EBAE</gtr:id><gtr:name>Makerere University</gtr:name><gtr:address><gtr:line1>PO Box 7062</gtr:line1><gtr:line4>Kampala</gtr:line4><gtr:postCode>+256</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F5F667B-3844-49DF-948F-FCA983560AF9"><gtr:id>6F5F667B-3844-49DF-948F-FCA983560AF9</gtr:id><gtr:name>Hannover Medical School</gtr:name><gtr:address><gtr:line1>Carl-Neuberg-Str. 1</gtr:line1><gtr:postCode>D-30625</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8484BD99-7BD1-4B14-95B1-A3F33315CC68"><gtr:id>8484BD99-7BD1-4B14-95B1-A3F33315CC68</gtr:id><gtr:name>Chinese Center for Disease Control and Prevention (China CDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF94AA14-BBB6-40D1-8FBC-94CF531FE138"><gtr:id>BF94AA14-BBB6-40D1-8FBC-94CF531FE138</gtr:id><gtr:name>Intellectual Ventures</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD4A20F9-F2EF-4DF2-965F-44704CCC3BF1"><gtr:id>DD4A20F9-F2EF-4DF2-965F-44704CCC3BF1</gtr:id><gtr:name>John Hopkins Centre for Global Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/51A54576-82D8-4D2A-9C33-CDE03E7072AC"><gtr:id>51A54576-82D8-4D2A-9C33-CDE03E7072AC</gtr:id><gtr:name>Guangzhou No. 12 People's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CC092EB8-FCC2-42C2-9E65-F6368A54E233"><gtr:id>CC092EB8-FCC2-42C2-9E65-F6368A54E233</gtr:id><gtr:name>Clinton Health Access Initiative (CHAI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1594AF38-7652-4453-83A4-113012910DD3"><gtr:id>1594AF38-7652-4453-83A4-113012910DD3</gtr:id><gtr:name>National Institute of Health</gtr:name><gtr:address><gtr:line1>National Institute of Health</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9943714C-1C41-47FC-85BF-FFB8DF2BA118"><gtr:id>9943714C-1C41-47FC-85BF-FFB8DF2BA118</gtr:id><gtr:name>Christian Medical College Vellore</gtr:name><gtr:address><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77E9B390-B130-406F-9C5D-130AB9383F54"><gtr:id>77E9B390-B130-406F-9C5D-130AB9383F54</gtr:id><gtr:name>Government of the Swiss Confederation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/990FEC22-C988-4943-AA62-01322D61942A"><gtr:id>990FEC22-C988-4943-AA62-01322D61942A</gtr:id><gtr:name>Medicines for Malaria Venture (MMV)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F"><gtr:id>FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F</gtr:id><gtr:name>Baylor College of Medicine</gtr:name><gtr:address><gtr:line1>Baylor College of Medicine</gtr:line1><gtr:line2>Texas Medical Center</gtr:line2><gtr:line4>Houston</gtr:line4><gtr:line5>Texas</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D6FFCBB4-4A07-4C06-AEC3-5A7F5AAB0CFC"><gtr:id>D6FFCBB4-4A07-4C06-AEC3-5A7F5AAB0CFC</gtr:id><gtr:name>Brown University</gtr:name><gtr:address><gtr:line1>Brown University</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BCD05341-5D48-43F1-A505-C169496883A1"><gtr:id>BCD05341-5D48-43F1-A505-C169496883A1</gtr:id><gtr:name>University of Hong Kong</gtr:name><gtr:address><gtr:line1>Pok Fu Lam Road</gtr:line1><gtr:line4>Hong Kong</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Hong Kong</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/36DBCFDF-CF45-4282-8FEF-9503E5C57B00"><gtr:id>36DBCFDF-CF45-4282-8FEF-9503E5C57B00</gtr:id><gtr:name>Government of Saudi Arabia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D82F94EC-9E43-4133-AAC5-FB34D0074719"><gtr:id>D82F94EC-9E43-4133-AAC5-FB34D0074719</gtr:id><gtr:name>Government of the UK</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FF9D180E-7AAF-479F-8D6A-91239520D6C2"><gtr:id>FF9D180E-7AAF-479F-8D6A-91239520D6C2</gtr:id><gtr:name>Zoology Ecology and Plant Science</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FDA3FC4C-8E75-4C67-9DA6-3482A4A94186"><gtr:id>FDA3FC4C-8E75-4C67-9DA6-3482A4A94186</gtr:id><gtr:name>Drugs for Neglected Diseases initiative (DNDi)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D532438-F73F-4B0F-9AEF-67E34576B20C"><gtr:id>1D532438-F73F-4B0F-9AEF-67E34576B20C</gtr:id><gtr:name>National Environment Agency</gtr:name><gtr:address><gtr:line1>11 Biopolis Way</gtr:line1><gtr:line2>Helios Block</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2856B134-C51C-4260-A8A7-FB687E6C76D8"><gtr:id>2856B134-C51C-4260-A8A7-FB687E6C76D8</gtr:id><gtr:name>Indiana University</gtr:name><gtr:address><gtr:line1>Indiana University</gtr:line1><gtr:line2>PO Box 1847</gtr:line2><gtr:line4>Bloomington</gtr:line4><gtr:line5>IN 47404</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5A393419-8F67-4FB5-9D17-B9A04A7B3CA9"><gtr:id>5A393419-8F67-4FB5-9D17-B9A04A7B3CA9</gtr:id><gtr:name>University of New South Wales</gtr:name><gtr:address><gtr:line1>Gate 9 High St</gtr:line1><gtr:line2>Kensington</gtr:line2><gtr:line4>Sydney</gtr:line4><gtr:line5>NSW 2052</gtr:line5><gtr:postCode>2052</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/24A1EE66-AE01-4E27-9C73-48C3A1C90C77"><gtr:id>24A1EE66-AE01-4E27-9C73-48C3A1C90C77</gtr:id><gtr:name>PATH</gtr:name><gtr:address><gtr:line1>PATH</gtr:line1><gtr:line2>2201 Westlake Avenue, Suite 200</gtr:line2><gtr:line3>PO Box 900922</gtr:line3><gtr:postCode>98109</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AB307619-D4FA-427E-A042-09DBEBA84669"><gtr:id>AB307619-D4FA-427E-A042-09DBEBA84669</gtr:id><gtr:name>Swansea University</gtr:name><gtr:address><gtr:line1>Singleton Park</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BECA2763-0902-40AA-8DB2-836A5731CF58"><gtr:id>BECA2763-0902-40AA-8DB2-836A5731CF58</gtr:id><gtr:name>Brunel University</gtr:name><gtr:address><gtr:line1>Brunel University</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:line5>Middlesex</gtr:line5><gtr:postCode>UB8 3PH</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4FD94DB2-6E9A-4B09-B0BC-7B57E5E320E4"><gtr:id>4FD94DB2-6E9A-4B09-B0BC-7B57E5E320E4</gtr:id><gtr:name>PANGEA Consortium</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4EE61FCC-E1FF-4A18-851F-CBEA61340EAD"><gtr:id>4EE61FCC-E1FF-4A18-851F-CBEA61340EAD</gtr:id><gtr:name>Oxitec Ltd</gtr:name><gtr:address><gtr:line1>71 Milton Park</gtr:line1><gtr:postCode>OX14 4RX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A558502F-01F8-4075-B4B4-DA175DD39376"><gtr:id>A558502F-01F8-4075-B4B4-DA175DD39376</gtr:id><gtr:name>European Vaccine Initiative (EVI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ACB5DBCD-F829-402F-AE06-8E61E5EB71D4"><gtr:id>ACB5DBCD-F829-402F-AE06-8E61E5EB71D4</gtr:id><gtr:name>Worldwide Antimalarial Resistance Networkn WWARN</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1C702039-D041-41C7-97E6-22CA228D3CC0"><gtr:id>1C702039-D041-41C7-97E6-22CA228D3CC0</gtr:id><gtr:name>International Epidemiologic Databases to Evaluate AIDS (IeDEA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1EF3E051-4E49-4163-BC0B-1EBDD3A3F9E6"><gtr:id>1EF3E051-4E49-4163-BC0B-1EBDD3A3F9E6</gtr:id><gtr:name>Industrial University of Santander</gtr:name><gtr:address><gtr:line1>Carrera 27 Calle 9</gtr:line1><gtr:line2>Ciudad Universitana</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2FABEB48-DF0E-4217-8145-76C31F17D153"><gtr:id>2FABEB48-DF0E-4217-8145-76C31F17D153</gtr:id><gtr:name>Malaria in Pregnancy Consortium</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CE43EBFA-3FC9-44BC-B6FF-001F11664C46"><gtr:id>CE43EBFA-3FC9-44BC-B6FF-001F11664C46</gtr:id><gtr:name>Aarhus University</gtr:name><gtr:address><gtr:line1>Nordre Ringgade 1</gtr:line1><gtr:line4>Aarhus C</gtr:line4><gtr:line5>DK-8000</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/749D2949-C2AC-42A3-A2E6-387EFD274E99"><gtr:id>749D2949-C2AC-42A3-A2E6-387EFD274E99</gtr:id><gtr:name>Colombian Institute of Family Welfare</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B71DAB15-F1C8-4390-83FE-32E90E74FE79"><gtr:id>B71DAB15-F1C8-4390-83FE-32E90E74FE79</gtr:id><gtr:name>Ministry of Defence (MOD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/15F14F70-1F3B-4A46-94EB-A0CA7755035F"><gtr:id>15F14F70-1F3B-4A46-94EB-A0CA7755035F</gtr:id><gtr:name>University of Trento</gtr:name><gtr:address><gtr:line1>via Calepina 14</gtr:line1><gtr:postCode>I-38122</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2A697884-94B9-4CC4-AE04-04206CD18D86"><gtr:id>2A697884-94B9-4CC4-AE04-04206CD18D86</gtr:id><gtr:name>Istituto Zooprofilattico Sperimentale Delle Venezie (IZSVe)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179"><gtr:id>FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179</gtr:id><gtr:name>University of Florida</gtr:name><gtr:address><gtr:line1>University of Florida</gtr:line1><gtr:line4>Gainesville</gtr:line4><gtr:line5>Florida FL 32611</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FB1BEB9F-319E-4C83-BCDB-A80D16EB2399"><gtr:id>FB1BEB9F-319E-4C83-BCDB-A80D16EB2399</gtr:id><gtr:name>University of Wisconsin, Milwaukee</gtr:name><gtr:address><gtr:line1>PO Box 413</gtr:line1><gtr:line2>2200 East Kenwood Boulevard</gtr:line2><gtr:line3>Milwaukee, Wisconsin</gtr:line3><gtr:line4>WI 53201-0413</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DE956CB8-1DF4-49EB-BC34-78BD6095649A"><gtr:id>DE956CB8-1DF4-49EB-BC34-78BD6095649A</gtr:id><gtr:name>University of KwaZulu-Natal</gtr:name><gtr:address><gtr:line1>Govan Mbeki Centre</gtr:line1><gtr:line2>Westville Campus</gtr:line2><gtr:line3>Private Bag X54001</gtr:line3><gtr:postCode>4000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DF930BA1-5D36-4AE0-AE42-08B4B2D37BFA"><gtr:id>DF930BA1-5D36-4AE0-AE42-08B4B2D37BFA</gtr:id><gtr:name>Pasteur Merieux Serums</gtr:name><gtr:address><gtr:line1>Mallards Reach</gtr:line1><gtr:line2>Bridge Avenue</gtr:line2><gtr:postCode>SL6 1QP</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F18FBDC7-B9EA-44B2-BCD8-3DA8B6B51D8B"><gtr:id>F18FBDC7-B9EA-44B2-BCD8-3DA8B6B51D8B</gtr:id><gtr:name>National Tuberculosis Institute (India)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1A515510-3DD6-448D-B145-2D02C4D53A7D"><gtr:id>1A515510-3DD6-448D-B145-2D02C4D53A7D</gtr:id><gtr:name>Murdoch University</gtr:name><gtr:address><gtr:line1>Murdoch University</gtr:line1><gtr:line2>South Street</gtr:line2><gtr:postCode>6150</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2B6203E6-6A8B-4FF7-9977-A4ED47B2CCDD"><gtr:id>2B6203E6-6A8B-4FF7-9977-A4ED47B2CCDD</gtr:id><gtr:name>China Centre for Disease Control</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F1E8BD4-7DC3-4D05-81E4-DDF7ED63665A"><gtr:id>6F1E8BD4-7DC3-4D05-81E4-DDF7ED63665A</gtr:id><gtr:name>PoPART Consortium</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A7D5F0-2767-4BED-A50A-595CA7E4B688"><gtr:id>A0A7D5F0-2767-4BED-A50A-595CA7E4B688</gtr:id><gtr:name>Department of Health (DH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E27575EF-ABFB-484B-BEEF-53343150A49E"><gtr:id>E27575EF-ABFB-484B-BEEF-53343150A49E</gtr:id><gtr:name>Bill and Melinda Gates Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/54F9413B-19F2-46DE-AFD4-245E4FB19B79"><gtr:id>54F9413B-19F2-46DE-AFD4-245E4FB19B79</gtr:id><gtr:name>Stellenbosch University</gtr:name><gtr:address><gtr:line1>Private Bag X1</gtr:line1><gtr:line2>19 Jonkershoek Road</gtr:line2><gtr:line3>Matieland</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/546582A9-ECD9-4857-ACDF-772746AC8508"><gtr:id>546582A9-ECD9-4857-ACDF-772746AC8508</gtr:id><gtr:name>Department for Environment, Food and Rural Affairs (Defra)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5BBA8EF7-8C5F-4BF2-96CB-6A66D0CBD157"><gtr:id>5BBA8EF7-8C5F-4BF2-96CB-6A66D0CBD157</gtr:id><gtr:name>University of Illinois at Urbana-Champaign</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A5CC1180-2386-42BD-B1A9-14DC84D52ED1"><gtr:id>A5CC1180-2386-42BD-B1A9-14DC84D52ED1</gtr:id><gtr:name>European Centre for Disease Prevention and Control (ECDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A861D5B4-C006-49D3-8DF9-5C184B00E4AC"><gtr:id>A861D5B4-C006-49D3-8DF9-5C184B00E4AC</gtr:id><gtr:name>Kenyan Institute for Medical Research (KEMRI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/108667A5-CE28-407B-B451-EF1190E0CD9A"><gtr:id>108667A5-CE28-407B-B451-EF1190E0CD9A</gtr:id><gtr:name>HIV Monitoring Foundation (SHM)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>School of Public Health</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D2AF99C9-67A3-4AAF-8F96-E79F107852AD"><gtr:id>D2AF99C9-67A3-4AAF-8F96-E79F107852AD</gtr:id><gtr:name>United States Agency for International Development</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/73528ABC-EFA1-4B0A-AA35-D6F649729E83"><gtr:id>73528ABC-EFA1-4B0A-AA35-D6F649729E83</gtr:id><gtr:name>Global Fund to Fight AIDS, Tuberculosis and Malaria</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89B67BA0-D9B9-44D8-A2FA-580E970CD20D"><gtr:id>89B67BA0-D9B9-44D8-A2FA-580E970CD20D</gtr:id><gtr:name>Michigan State University</gtr:name><gtr:address><gtr:line1>301 Administration Building</gtr:line1><gtr:line4>East Lansing</gtr:line4><gtr:line5>Michigan 48823-1046</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC177B1F-35EE-4B74-981D-E8382EE3D18C"><gtr:id>EC177B1F-35EE-4B74-981D-E8382EE3D18C</gtr:id><gtr:name>London School of Economics &amp; Pol Sci</gtr:name><gtr:address><gtr:line1>Houghton Street</gtr:line1><gtr:line2>Aldwych</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>WC2A 2AE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/28DF10CD-6250-442A-804C-A8710CF218D1"><gtr:id>28DF10CD-6250-442A-804C-A8710CF218D1</gtr:id><gtr:name>University of Bern</gtr:name><gtr:address><gtr:line1>Universitat Bern</gtr:line1><gtr:line2>Sidlerstrasse 5</gtr:line2><gtr:line4>Bern</gtr:line4><gtr:line5>CH-3012</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9F19673B-7D22-421A-A058-CFC1F3E932C1"><gtr:id>9F19673B-7D22-421A-A058-CFC1F3E932C1</gtr:id><gtr:name>National Institute of Health, Pakistan</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9DE33998-C1C9-4C48-9B4B-039FC2802CA1"><gtr:id>9DE33998-C1C9-4C48-9B4B-039FC2802CA1</gtr:id><gtr:name>Healthsites.io</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D70D374-4644-48AF-8B76-D8F2856D9290"><gtr:id>5D70D374-4644-48AF-8B76-D8F2856D9290</gtr:id><gtr:name>FIND Diagnostics (India)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/430ABEF3-2F94-4B47-A8DB-E521642AA1E5"><gtr:id>430ABEF3-2F94-4B47-A8DB-E521642AA1E5</gtr:id><gtr:name>University of Wisconsin Madison</gtr:name><gtr:address><gtr:line1>University of Wisconsin</gtr:line1><gtr:line4>Madison</gtr:line4><gtr:line5>Wisconsin</gtr:line5><gtr:postCode>WI 53706</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88382C36-9EC3-426D-933F-F6BA945BFF1B"><gtr:id>88382C36-9EC3-426D-933F-F6BA945BFF1B</gtr:id><gtr:name>Tan Tock Seng Hospital</gtr:name><gtr:address><gtr:line1>Tan Tock Seng Hospital</gtr:line1><gtr:line2>11 Jalan Tan Tock Seng</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B2EE12FB-8E49-4F6A-8073-DF35FAF50581"><gtr:id>B2EE12FB-8E49-4F6A-8073-DF35FAF50581</gtr:id><gtr:name>Emory University</gtr:name><gtr:address><gtr:line1>201 Dowman Drive</gtr:line1><gtr:line4>Atlanta</gtr:line4><gtr:line5>Ga 30322</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68F78F03-B2B0-4B8E-AB8D-02362018AD72"><gtr:id>68F78F03-B2B0-4B8E-AB8D-02362018AD72</gtr:id><gtr:name>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F14141B5-3C0D-41D1-BD24-130CF9F18423"><gtr:id>F14141B5-3C0D-41D1-BD24-130CF9F18423</gtr:id><gtr:name>Antigen Discovery Inc</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D120E762-DC0F-488D-B1F4-EC68BCF6573A"><gtr:id>D120E762-DC0F-488D-B1F4-EC68BCF6573A</gtr:id><gtr:name>Jinan University</gtr:name><gtr:address><gtr:line1>Tianhe District</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/150CE820-6372-414E-9F7F-524E27034E23"><gtr:id>150CE820-6372-414E-9F7F-524E27034E23</gtr:id><gtr:name>University of Colorado at Boulder</gtr:name><gtr:address><gtr:line1>Boulder</gtr:line1><gtr:line4>Colorado</gtr:line4><gtr:line5>80309-0425</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0CF6353C-24C9-4866-99CF-FB1DB633AF6F"><gtr:id>0CF6353C-24C9-4866-99CF-FB1DB633AF6F</gtr:id><gtr:name>University of North Carolina at Chapel Hill</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D339D78-760B-4FD1-9B8C-437494DA87CF"><gtr:id>4D339D78-760B-4FD1-9B8C-437494DA87CF</gtr:id><gtr:name>M?decins Sans Fronti?res (MSF)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D2B8776-4478-4DDB-A4DE-748C90B8EBAE"><gtr:id>5D2B8776-4478-4DDB-A4DE-748C90B8EBAE</gtr:id><gtr:name>Makerere University</gtr:name><gtr:address><gtr:line1>PO Box 7062</gtr:line1><gtr:line4>Kampala</gtr:line4><gtr:postCode>+256</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F5F667B-3844-49DF-948F-FCA983560AF9"><gtr:id>6F5F667B-3844-49DF-948F-FCA983560AF9</gtr:id><gtr:name>Hannover Medical School</gtr:name><gtr:address><gtr:line1>Carl-Neuberg-Str. 1</gtr:line1><gtr:postCode>D-30625</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8484BD99-7BD1-4B14-95B1-A3F33315CC68"><gtr:id>8484BD99-7BD1-4B14-95B1-A3F33315CC68</gtr:id><gtr:name>Chinese Center for Disease Control and Prevention (China CDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF94AA14-BBB6-40D1-8FBC-94CF531FE138"><gtr:id>BF94AA14-BBB6-40D1-8FBC-94CF531FE138</gtr:id><gtr:name>Intellectual Ventures</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD4A20F9-F2EF-4DF2-965F-44704CCC3BF1"><gtr:id>DD4A20F9-F2EF-4DF2-965F-44704CCC3BF1</gtr:id><gtr:name>John Hopkins Centre for Global Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/51A54576-82D8-4D2A-9C33-CDE03E7072AC"><gtr:id>51A54576-82D8-4D2A-9C33-CDE03E7072AC</gtr:id><gtr:name>Guangzhou No. 12 People's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CC092EB8-FCC2-42C2-9E65-F6368A54E233"><gtr:id>CC092EB8-FCC2-42C2-9E65-F6368A54E233</gtr:id><gtr:name>Clinton Health Access Initiative (CHAI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1594AF38-7652-4453-83A4-113012910DD3"><gtr:id>1594AF38-7652-4453-83A4-113012910DD3</gtr:id><gtr:name>National Institute of Health</gtr:name><gtr:address><gtr:line1>National Institute of Health</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9943714C-1C41-47FC-85BF-FFB8DF2BA118"><gtr:id>9943714C-1C41-47FC-85BF-FFB8DF2BA118</gtr:id><gtr:name>Christian Medical College Vellore</gtr:name><gtr:address><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77E9B390-B130-406F-9C5D-130AB9383F54"><gtr:id>77E9B390-B130-406F-9C5D-130AB9383F54</gtr:id><gtr:name>Government of the Swiss Confederation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/990FEC22-C988-4943-AA62-01322D61942A"><gtr:id>990FEC22-C988-4943-AA62-01322D61942A</gtr:id><gtr:name>Medicines for Malaria Venture (MMV)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F"><gtr:id>FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F</gtr:id><gtr:name>Baylor College of Medicine</gtr:name><gtr:address><gtr:line1>Baylor College of Medicine</gtr:line1><gtr:line2>Texas Medical Center</gtr:line2><gtr:line4>Houston</gtr:line4><gtr:line5>Texas</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D6FFCBB4-4A07-4C06-AEC3-5A7F5AAB0CFC"><gtr:id>D6FFCBB4-4A07-4C06-AEC3-5A7F5AAB0CFC</gtr:id><gtr:name>Brown University</gtr:name><gtr:address><gtr:line1>Brown University</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BCD05341-5D48-43F1-A505-C169496883A1"><gtr:id>BCD05341-5D48-43F1-A505-C169496883A1</gtr:id><gtr:name>University of Hong Kong</gtr:name><gtr:address><gtr:line1>Pok Fu Lam Road</gtr:line1><gtr:line4>Hong Kong</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Hong Kong</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/36DBCFDF-CF45-4282-8FEF-9503E5C57B00"><gtr:id>36DBCFDF-CF45-4282-8FEF-9503E5C57B00</gtr:id><gtr:name>Government of Saudi Arabia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D82F94EC-9E43-4133-AAC5-FB34D0074719"><gtr:id>D82F94EC-9E43-4133-AAC5-FB34D0074719</gtr:id><gtr:name>Government of the UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FF9D180E-7AAF-479F-8D6A-91239520D6C2"><gtr:id>FF9D180E-7AAF-479F-8D6A-91239520D6C2</gtr:id><gtr:name>Zoology Ecology and Plant Science</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FDA3FC4C-8E75-4C67-9DA6-3482A4A94186"><gtr:id>FDA3FC4C-8E75-4C67-9DA6-3482A4A94186</gtr:id><gtr:name>Drugs for Neglected Diseases initiative (DNDi)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D532438-F73F-4B0F-9AEF-67E34576B20C"><gtr:id>1D532438-F73F-4B0F-9AEF-67E34576B20C</gtr:id><gtr:name>National Environment Agency</gtr:name><gtr:address><gtr:line1>11 Biopolis Way</gtr:line1><gtr:line2>Helios Block</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2856B134-C51C-4260-A8A7-FB687E6C76D8"><gtr:id>2856B134-C51C-4260-A8A7-FB687E6C76D8</gtr:id><gtr:name>Indiana University</gtr:name><gtr:address><gtr:line1>Indiana University</gtr:line1><gtr:line2>PO Box 1847</gtr:line2><gtr:line4>Bloomington</gtr:line4><gtr:line5>IN 47404</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5A393419-8F67-4FB5-9D17-B9A04A7B3CA9"><gtr:id>5A393419-8F67-4FB5-9D17-B9A04A7B3CA9</gtr:id><gtr:name>University of New South Wales</gtr:name><gtr:address><gtr:line1>Gate 9 High St</gtr:line1><gtr:line2>Kensington</gtr:line2><gtr:line4>Sydney</gtr:line4><gtr:line5>NSW 2052</gtr:line5><gtr:postCode>2052</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/24A1EE66-AE01-4E27-9C73-48C3A1C90C77"><gtr:id>24A1EE66-AE01-4E27-9C73-48C3A1C90C77</gtr:id><gtr:name>PATH</gtr:name><gtr:address><gtr:line1>PATH</gtr:line1><gtr:line2>2201 Westlake Avenue, Suite 200</gtr:line2><gtr:line3>PO Box 900922</gtr:line3><gtr:postCode>98109</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB307619-D4FA-427E-A042-09DBEBA84669"><gtr:id>AB307619-D4FA-427E-A042-09DBEBA84669</gtr:id><gtr:name>Swansea University</gtr:name><gtr:address><gtr:line1>Singleton Park</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BECA2763-0902-40AA-8DB2-836A5731CF58"><gtr:id>BECA2763-0902-40AA-8DB2-836A5731CF58</gtr:id><gtr:name>Brunel University</gtr:name><gtr:address><gtr:line1>Brunel University</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:line5>Middlesex</gtr:line5><gtr:postCode>UB8 3PH</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4FD94DB2-6E9A-4B09-B0BC-7B57E5E320E4"><gtr:id>4FD94DB2-6E9A-4B09-B0BC-7B57E5E320E4</gtr:id><gtr:name>PANGEA Consortium</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4EE61FCC-E1FF-4A18-851F-CBEA61340EAD"><gtr:id>4EE61FCC-E1FF-4A18-851F-CBEA61340EAD</gtr:id><gtr:name>Oxitec Ltd</gtr:name><gtr:address><gtr:line1>71 Milton Park</gtr:line1><gtr:postCode>OX14 4RX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A558502F-01F8-4075-B4B4-DA175DD39376"><gtr:id>A558502F-01F8-4075-B4B4-DA175DD39376</gtr:id><gtr:name>European Vaccine Initiative (EVI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ACB5DBCD-F829-402F-AE06-8E61E5EB71D4"><gtr:id>ACB5DBCD-F829-402F-AE06-8E61E5EB71D4</gtr:id><gtr:name>Worldwide Antimalarial Resistance Networkn WWARN</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1C702039-D041-41C7-97E6-22CA228D3CC0"><gtr:id>1C702039-D041-41C7-97E6-22CA228D3CC0</gtr:id><gtr:name>International Epidemiologic Databases to Evaluate AIDS (IeDEA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1EF3E051-4E49-4163-BC0B-1EBDD3A3F9E6"><gtr:id>1EF3E051-4E49-4163-BC0B-1EBDD3A3F9E6</gtr:id><gtr:name>Industrial University of Santander</gtr:name><gtr:address><gtr:line1>Carrera 27 Calle 9</gtr:line1><gtr:line2>Ciudad Universitana</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2FABEB48-DF0E-4217-8145-76C31F17D153"><gtr:id>2FABEB48-DF0E-4217-8145-76C31F17D153</gtr:id><gtr:name>Malaria in Pregnancy Consortium</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE43EBFA-3FC9-44BC-B6FF-001F11664C46"><gtr:id>CE43EBFA-3FC9-44BC-B6FF-001F11664C46</gtr:id><gtr:name>Aarhus University</gtr:name><gtr:address><gtr:line1>Nordre Ringgade 1</gtr:line1><gtr:line4>Aarhus C</gtr:line4><gtr:line5>DK-8000</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/749D2949-C2AC-42A3-A2E6-387EFD274E99"><gtr:id>749D2949-C2AC-42A3-A2E6-387EFD274E99</gtr:id><gtr:name>Colombian Institute of Family Welfare</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B71DAB15-F1C8-4390-83FE-32E90E74FE79"><gtr:id>B71DAB15-F1C8-4390-83FE-32E90E74FE79</gtr:id><gtr:name>Ministry of Defence (MOD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/15F14F70-1F3B-4A46-94EB-A0CA7755035F"><gtr:id>15F14F70-1F3B-4A46-94EB-A0CA7755035F</gtr:id><gtr:name>University of Trento</gtr:name><gtr:address><gtr:line1>via Calepina 14</gtr:line1><gtr:postCode>I-38122</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2A697884-94B9-4CC4-AE04-04206CD18D86"><gtr:id>2A697884-94B9-4CC4-AE04-04206CD18D86</gtr:id><gtr:name>Istituto Zooprofilattico Sperimentale Delle Venezie (IZSVe)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179"><gtr:id>FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179</gtr:id><gtr:name>University of Florida</gtr:name><gtr:address><gtr:line1>University of Florida</gtr:line1><gtr:line4>Gainesville</gtr:line4><gtr:line5>Florida FL 32611</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FB1BEB9F-319E-4C83-BCDB-A80D16EB2399"><gtr:id>FB1BEB9F-319E-4C83-BCDB-A80D16EB2399</gtr:id><gtr:name>University of Wisconsin, Milwaukee</gtr:name><gtr:address><gtr:line1>PO Box 413</gtr:line1><gtr:line2>2200 East Kenwood Boulevard</gtr:line2><gtr:line3>Milwaukee, Wisconsin</gtr:line3><gtr:line4>WI 53201-0413</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DE956CB8-1DF4-49EB-BC34-78BD6095649A"><gtr:id>DE956CB8-1DF4-49EB-BC34-78BD6095649A</gtr:id><gtr:name>University of KwaZulu-Natal</gtr:name><gtr:address><gtr:line1>Govan Mbeki Centre</gtr:line1><gtr:line2>Westville Campus</gtr:line2><gtr:line3>Private Bag X54001</gtr:line3><gtr:postCode>4000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DF930BA1-5D36-4AE0-AE42-08B4B2D37BFA"><gtr:id>DF930BA1-5D36-4AE0-AE42-08B4B2D37BFA</gtr:id><gtr:name>Pasteur Merieux Serums</gtr:name><gtr:address><gtr:line1>Mallards Reach</gtr:line1><gtr:line2>Bridge Avenue</gtr:line2><gtr:postCode>SL6 1QP</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F18FBDC7-B9EA-44B2-BCD8-3DA8B6B51D8B"><gtr:id>F18FBDC7-B9EA-44B2-BCD8-3DA8B6B51D8B</gtr:id><gtr:name>National Tuberculosis Institute (India)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1A515510-3DD6-448D-B145-2D02C4D53A7D"><gtr:id>1A515510-3DD6-448D-B145-2D02C4D53A7D</gtr:id><gtr:name>Murdoch University</gtr:name><gtr:address><gtr:line1>Murdoch University</gtr:line1><gtr:line2>South Street</gtr:line2><gtr:postCode>6150</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2B6203E6-6A8B-4FF7-9977-A4ED47B2CCDD"><gtr:id>2B6203E6-6A8B-4FF7-9977-A4ED47B2CCDD</gtr:id><gtr:name>China Centre for Disease Control</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F1E8BD4-7DC3-4D05-81E4-DDF7ED63665A"><gtr:id>6F1E8BD4-7DC3-4D05-81E4-DDF7ED63665A</gtr:id><gtr:name>PoPART Consortium</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A7D5F0-2767-4BED-A50A-595CA7E4B688"><gtr:id>A0A7D5F0-2767-4BED-A50A-595CA7E4B688</gtr:id><gtr:name>Department of Health (DH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E27575EF-ABFB-484B-BEEF-53343150A49E"><gtr:id>E27575EF-ABFB-484B-BEEF-53343150A49E</gtr:id><gtr:name>Bill and Melinda Gates Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/54F9413B-19F2-46DE-AFD4-245E4FB19B79"><gtr:id>54F9413B-19F2-46DE-AFD4-245E4FB19B79</gtr:id><gtr:name>Stellenbosch University</gtr:name><gtr:address><gtr:line1>Private Bag X1</gtr:line1><gtr:line2>19 Jonkershoek Road</gtr:line2><gtr:line3>Matieland</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/546582A9-ECD9-4857-ACDF-772746AC8508"><gtr:id>546582A9-ECD9-4857-ACDF-772746AC8508</gtr:id><gtr:name>Department for Environment, Food and Rural Affairs (Defra)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BBA8EF7-8C5F-4BF2-96CB-6A66D0CBD157"><gtr:id>5BBA8EF7-8C5F-4BF2-96CB-6A66D0CBD157</gtr:id><gtr:name>University of Illinois at Urbana-Champaign</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5CC1180-2386-42BD-B1A9-14DC84D52ED1"><gtr:id>A5CC1180-2386-42BD-B1A9-14DC84D52ED1</gtr:id><gtr:name>European Centre for Disease Prevention and Control (ECDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A861D5B4-C006-49D3-8DF9-5C184B00E4AC"><gtr:id>A861D5B4-C006-49D3-8DF9-5C184B00E4AC</gtr:id><gtr:name>Kenyan Institute for Medical Research (KEMRI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/108667A5-CE28-407B-B451-EF1190E0CD9A"><gtr:id>108667A5-CE28-407B-B451-EF1190E0CD9A</gtr:id><gtr:name>HIV Monitoring Foundation (SHM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/046201DF-773B-4DBE-99E4-089E1DF6C554"><gtr:id>046201DF-773B-4DBE-99E4-089E1DF6C554</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Ferguson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7DAC6F34-AE2C-4199-8C84-D230E91CC37C"><gtr:id>7DAC6F34-AE2C-4199-8C84-D230E91CC37C</gtr:id><gtr:firstName>Wes</gtr:firstName><gtr:surname>Hinsley</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7B10F328-E8EA-4F83-B462-FB23117BCF8F"><gtr:id>7B10F328-E8EA-4F83-B462-FB23117BCF8F</gtr:id><gtr:firstName>Maria</gtr:firstName><gtr:surname>Van Kerkhove</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK010174%2F1"><gtr:id>1C0BAE9C-FFEF-4C4D-B24A-1AD58E93658F</gtr:id><gtr:title>MRC Centre for Outbreak Analysis and Modelling Renewal</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K010174/1</gtr:grantReference><gtr:abstractText>The threat from new infectious diseases has been highlighted in recent years by the 2003 SARS epidemic, H5N1 'bird flu' and the 2009 H1N1 flu pandemic. Preparing for such eventualities is a priority for public health agencies and governments worldwide. Also, as scientific research delivers new approaches to controlling existing infectious diseases such as malaria, HIV and polio, there is a need to determine what interventions are likely to work best to limit the disease and illness caused by a specific disease in a particular setting.

In this context, computer modelling of the spread of diseases in populations coupled with scientifically rigorous data analysis have proven themselves as powerful tools for giving insight into how diseases spread and what can be done to limit that control that spread. The Centre for Outbreak Analysis and Modelling undertakes research on these scientific methods and applies them to disease threats of concern. 

A key feature of the Centre is the close links it has made with with public health agencies - such as the UK Health Protection Agency, the Centers for Disease Control and Prevention in the US (CDC), and the World Health Organization (WHO) - organisations which have to formulate and implement strategies to control infectious diseases. 

The senior scientists in the Centre are world-leaders in infectious disease modelling and analysis. They have broad experience in responding to real epidemics (e.g. BSE/vCJD, SARS, H5N1 bird flu and the 2009 flu pandemic), and undertaking epidemiological research on endemic diseases (such as malaria, HIV and polio). Their work directly influences disease control policy through the many interactions the Centre has with public health organisations and governments. 

The funding provided by MRC and Imperial College have allowed dedicated investment into the development of close collaborative partnerships with HPA, CDC and WHO - as well as with other important organisations who work on improving health in developing countries (notably the Bill and Melinda Gates Foundation). With each, we are working on a large number of research projects which have both scientific interest to Centre researchers and are contributing to the evidence base needed for public health decisions. Centre funding supports a core technical capacity available to all projects, and pays for dedicated postdoctoral research staff who spend substantial time at WHO (Geneva) and CDC (Atlanta) undertaking epidemiological research with the staff of those agencies and facilitating collaboration with other Centre staff. 

MRC funding has also facilitated a greater focus on collaboration, training and career development within the Centre - training the next generation of quantitative infectious disease epidemiologists. We are also involved in increasing knowledge of advanced modelling methods in public health institutions and the wider infectious disease research community, and so have run a number of introductory vocational short courses, both at Imperial College, but also on partner sites in Geneva and London.

All of this applied activity depends on the more fundamental research undertaken in the Centre on the epidemic dynamics of different diseases, how diseases evolve genetically over time, and on analysing new approaches to control or treat diseases. Much of this research is multidisciplinary, involving Centre researchers working with leading clinical and experimental scientists around the world.

Continued funding for the Centre will allow the collaborative partnerships established in the last 4 years to be sustained and enhanced, and new collaborations with researchers and health agencies in countries such as China and India to be developed. It will also fund new priority research areas, including work to implement the analysis and modelling methods developed by Centre staff as user-friendly computer programs that can be used by public health professionals around the world.</gtr:abstractText><gtr:technicalSummary>The threat to human populations from new and re-emerging pathogens has been highlighted in recent years by the 2003 SARS epidemic, the pandemic potential of the highly pathogenic H5N1 avian influenza strain and the 2009 H1N1 pandemic. Preparedness is therefore a key policy priority for public health agencies and governments worldwide. In addition, as novel vaccines, antimicrobials and other interventions are developed for endemic diseases, there is a need to extrapolate from clinical trial results to determine which combination of interventions gives the optimal (or most cost-effective) control strategy for a specific disease in a particular setting.

In this context, modern epidemiological modelling and analysis methods have proven themselves increasingly powerful tools for giving insight into the patterns of emergence of novel outbreaks, the transmission dynamics of endemic diseases and the options available for the control of both. In the last 4 years, the Centre for Outbreak Analysis and Modelling has facilitated the exploitation of cutting-edge quantitative epidemiological research by public health agencies and policy makers tasked with delivering response strategies to infectious disease threats.

Before the founding of the Centre, much of the interaction between the (world leading) researchers at the Centre and public health agencies (such as HPA, CDC or WHO) was sporadic and unsystematic, being difficult to fund from traditional project grants. Centre funding allows dedicated investment into the development and maintenance of close collaborative partnerships with HPA, CDC, WHO and BMGF. Centre funding supports a core technical capacity available to all projects, and pays for dedicated 'liaison' staff - postdocs who spend substantial time at WHO and CDC. Internally, Centre funding supports capacity-building, enhanced collaboration and an enhanced focus on career development - as well as vocational training of staff in public/global health agencies.</gtr:technicalSummary><gtr:potentialImpactText>As a translational research Centre, a key aspect of our primary mission is wider impact. Our goal is to improve public and global health decision making in relation to infectious disease control through the use of advanced statistical and mathematical modelling methods, with a particular emphasis on novel emerging infections or rapidly spreading disease outbreaks. We believe the only effective way of delivering on this goal is to form long-term collaborative partnerships with the leading public and global health organisations world-wide, providing analytical support and capacity building for those partners. 

The 2009 H1N1 pandemic provided a concrete test of this vision. In the first few weeks of the pandemic, the Centre's response team rapidly scaled to involve over 30 staff, with individual components being led by Centre PIs, coordinated by the Director.
From the translational perspective, some of the most critical roles were the staff who acted as liaisons with our key public health partners (especially WHO and CDC), spending much of 2009 embedded in those organisations. 

The success of this approach in 2009 has led us to formalise and extended this 'embedding' model of building collaborative partnerships. Following the pandemic, the Centre became the WHO Collaborating Centre for Infectious Disease Modelling, with a senior research fellow acting as our primary liaison with WHO. We have adopted a similar model with US CDC, with another senior postdoctoral researcher from the Centre is based in Atlanta for the majority of his time. 

HPA has considerable modelling capacity itself (two groups, in Colindale and Porton Down), so the nature of its relationship with the Centre is rather different. The Colindale modelling unit is now headed by Dr Peter White, who splits his time between HPA (80%) and the MRC Centre at Imperial (20%), providing a natural bridge between us. Collaborative work with the Colindale group has increased dramatically over the last few years. The Centre also collaborates with and advises the Microbial Risk Assessment group at Porton Down, most notably on bioterrorism related topics. 

A second important aspect of the relationship is coordination of parallel research efforts: the UK Dept of Health (DH) often calls upon HPA for quantitative analysis, and increasingly the MRC Centre is being called upon to either peer review this work or provide alternative independent analyses. As HPA evolves to become Public Health England, we expect this role to become more important. 

Over the first term of the Centre we have also built close relationships with a number of other key global/public health bodies: BMGF, UNAIDS, European CDC, China CDC (on pandemic influenza) being just a few. Our relationship with BMGF is of particular strategic importance - both as a funder of Centre research, but more importantly as a key stakeholder in global health decision-making. The Centre's work on polio, malaria, HIV, dengue and influenza has been influential in shaping BMGF investment decisions. 

In addition to formal research outputs, often the most important value we give to these organisations is advice provided from a dynamical modelling perspective. This analytical advisory role is multifaceted: from improving situational awareness in crises, advising on likely impact of interventions, undertaking rapid assessments of severity and disease burden, and advising on improving surveillance, study design and data capture systems. 

Capacity building within our partner organisation is another priority, through informal skills transfer and formal training. The former occurs as a natural result of the degree of interaction, and for the latter we have run short (2-3 day) short courses on infectious disease modelling for WHO in Geneva (in 2010) and for CDC in Atlanta (in 2011, in collaboration with Harvard). 

Attached letters of support from HPA, CDC, WHO and BMGF highlight the public health impact of the Centre.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2325409</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Tuberculosis Institute (India)</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>NTI India - 2015</gtr:description><gtr:id>325510F0-1A50-4692-AF34-EF03CA0F2CE5</gtr:id><gtr:impact>One paper in review, one paper to be submitted.</gtr:impact><gtr:outcomeId>56d6e152a1bb91.20142153-1</gtr:outcomeId><gtr:partnerContribution>Co-authored papers under review</gtr:partnerContribution><gtr:piContribution>Hosted Dr.Vineet Chadha (leading TB epidemiologist in India) over a series of discussion meetings in Delhi, from which one manuscript is now in review and another in preparation.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>China Centre for Disease Control</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>China CDC</gtr:description><gtr:id>3ECDF52F-4ACD-4215-AA64-1FDE200EBEF5</gtr:id><gtr:impact>Publication submitted to The Lancet</gtr:impact><gtr:outcomeId>fVkPkFggYhX-1</gtr:outcomeId><gtr:partnerContribution>We were provided access to data on the H1N1 pandemic in China and were able to gain an understanding of disease spread in this area of the world.</gtr:partnerContribution><gtr:piContribution>Statistical description of the H1N1 pandemic in China</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>John Hopkins Centre for Global Health</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>China Flu Studies-2013</gtr:description><gtr:id>80948EF9-22ED-4CA3-B4FA-49C745864A22</gtr:id><gtr:impact>not yet</gtr:impact><gtr:outcomeId>taH3tBrEMLo-1</gtr:outcomeId><gtr:partnerContribution>Data has been collected by Justin Lessler (of JHU) in China.</gtr:partnerContribution><gtr:piContribution>Analysis of JHU-collected China data.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Tuberculosis Institute (India)</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>National Institute for Research on TB in India (NIRT)</gtr:description><gtr:id>2CBF116D-8E58-47C1-8E36-AB14D673F1E9</gtr:id><gtr:impact>none to date</gtr:impact><gtr:outcomeId>58c812c095c7c1.68641983-1</gtr:outcomeId><gtr:partnerContribution>Data analysis and model design</gtr:partnerContribution><gtr:piContribution>Project relates to TB control in Chennai and the collaboration is about modelling impact of interventions</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>The cost effectiveness of genetic markers for antibiotic resistance in tuberculosis PW</gtr:description><gtr:id>1259467E-084A-4CFB-BFB5-884B5CB8CD3E</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine</gtr:impact><gtr:outcomeId>c1SyGHu4uGT-3</gtr:outcomeId><gtr:partnerContribution>Systematic review
Statistical analysis
Health economics</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Baylor College of Medicine</gtr:description><gtr:id>102E1059-1E49-4781-A9F9-18C5211EFD68</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58aadea5de6f02.41092852-2</gtr:outcomeId><gtr:partnerContribution>Rotavirus virology; mass spectrometry for breast milk study</gtr:partnerContribution><gtr:piContribution>Lead coordinator on a study and design of clinical study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College Cork</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:department>Environmental Research Institute</gtr:department><gtr:description>Achtman XD 2012</gtr:description><gtr:id>E7D3E76E-3928-4394-8FC7-E81B965B9F9E</gtr:id><gtr:impact>PMID 21951486, 21829375, 20935094, 20661309, 22737074.</gtr:impact><gtr:outcomeId>fokorwm2dGS-1</gtr:outcomeId><gtr:partnerContribution>Sampling of bacterial isolates, multi-locus sequence typing and whole-genome sequencing.</gtr:partnerContribution><gtr:piContribution>Statistical analysis of genetic data from Salmonella enterica, Helicobacter pylori, Yersinia pseudotuberculosis, Vibrio cholerae.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>What are the public health outcomes, costs and cost-effectiveness of GUM and primary care based STI services, and how should these be planned in order to maximise STI control and cost-effectiveness for a population? PW 2012</gtr:description><gtr:id>226D680E-BF81-4136-AC5D-DF2986A5A315</gtr:id><gtr:impact>Mercer et al Sexually Transmitted Infections 2012; 88: 9-15</gtr:impact><gtr:outcomeId>dr3sUCUKB8T-1</gtr:outcomeId><gtr:partnerContribution>Study design
Survey implementation
Statistical analysis
Transmission-dynamic modelling</gtr:partnerContribution><gtr:piContribution>Advice on transmission-dynamic modelling and survey design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>WHO - Vaccines for public health emergencies (FWC/IVB/IVR/IMR)</gtr:description><gtr:id>2520FD6E-DBFF-43B3-9268-E4F6E76FD206</gtr:id><gtr:impact>no impact yet</gtr:impact><gtr:outcomeId>58c70828204352.59920298-1</gtr:outcomeId><gtr:partnerContribution>Contributions to the design and plan for analyis of vaccine studies during public health emergencies</gtr:partnerContribution><gtr:piContribution>To produce a WHO blueprint</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Biostatistics</gtr:department><gtr:description>Dengue Modelling Consortium UoW-2013</gtr:description><gtr:id>5354F7ED-9F68-4D63-911B-DD8FC0F7D446</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>NjapB9kgmgK-1</gtr:outcomeId><gtr:partnerContribution>Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate.</gtr:partnerContribution><gtr:piContribution>Founder. Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Monitoring the epidemic potential of swine-origin H3N2v influenza SC</gtr:description><gtr:id>A7AA0952-1891-4B95-ACB8-3921B3AB0E52</gtr:id><gtr:impact>1 paper in revisions. Work presented to the director of CDC</gtr:impact><gtr:outcomeId>bVt8hapgEAE-1</gtr:outcomeId><gtr:partnerContribution>Provide data</gtr:partnerContribution><gtr:piContribution>New method to estimate the epidemic of zoonoses</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>Vietnam, Socialist Republic of</gtr:country><gtr:department>Oxford University Clinical Research Unit Vietnam (OUCRU)</gtr:department><gtr:description>Interpretation of flu serology SC</gtr:description><gtr:id>D3450D27-046B-49FC-BE17-4B23B0AF1C3E</gtr:id><gtr:impact>1 paper in press in plos pathogens</gtr:impact><gtr:outcomeId>jELXagJ6iCR-1</gtr:outcomeId><gtr:partnerContribution>Provide data</gtr:partnerContribution><gtr:piContribution>New method to interprete influenza serological data. Better quantify measurement errors and assess their impact on estimates of influenza attack rates.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxitec Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Oxitec (Luke Alphey and Andy McKemey) - 2015</gtr:description><gtr:id>221782B5-0170-4EEE-88F8-8B15C8C10E5A</gtr:id><gtr:impact>PMID: 26554922</gtr:impact><gtr:outcomeId>56d6d8f5c6c9e8.87880083-1</gtr:outcomeId><gtr:partnerContribution>Ongoing collaboration on the evaluation of genetically modified insects for use in the control of disease risks (including transmission of dengue virus)</gtr:partnerContribution><gtr:piContribution>Experimental design, statistical analysis and dynamical modelling</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute For Global Health</gtr:department><gtr:description>UCL - Andrew Phillips , Tim Colborne</gtr:description><gtr:id>C694A8CB-314A-4BBA-B611-C1DB81D46AEE</gtr:id><gtr:impact>Submitted several joint grant applications (awaiting results)</gtr:impact><gtr:outcomeId>58a2db3c22e747.95039497-1</gtr:outcomeId><gtr:partnerContribution>Statistics expertise</gtr:partnerContribution><gtr:piContribution>Modelling expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Measuring the impact of school closure and illness on social contact patterns PW</gtr:description><gtr:id>528507EF-1B5F-4768-8C06-1285FD6F7F94</gtr:id><gtr:impact>Paper in Health Technology Assessment: Eames et al. 2010</gtr:impact><gtr:outcomeId>V5K4X6DQ6o9-2</gtr:outcomeId><gtr:partnerContribution>Study design: survey instrument &amp;amp; sampling strategy
Survey implementation</gtr:partnerContribution><gtr:piContribution>Study design: survey instrument &amp;amp; sampling strategy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hong Kong</gtr:collaboratingOrganisation><gtr:country>Hong Kong, Special Administrative Region of China</gtr:country><gtr:description>fluscape SR</gtr:description><gtr:id>B033F843-806C-4995-A6F7-396BB37919F9</gtr:id><gtr:impact>pmids 22829765, 22687447</gtr:impact><gtr:outcomeId>e9A5A72PTZo-1</gtr:outcomeId><gtr:partnerContribution>as above plus implement field work and implement lab testing.</gtr:partnerContribution><gtr:piContribution>designed field work, managed field work, co ducted analyses, designed analyses. drafted manuscripts, edited ,manuscripts. interpreted results</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Aarhus University</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>University of Aarhus - Thomas Bataillon</gtr:description><gtr:id>38DC21BB-31B9-4D97-A173-1966D4B758F7</gtr:id><gtr:impact>DOI:&amp;nbsp;10.1002/bies.201600176</gtr:impact><gtr:outcomeId>589334f807e6b8.85369624-1</gtr:outcomeId><gtr:partnerContribution>Modelling parallel evolution in bacteria</gtr:partnerContribution><gtr:piContribution>Modelling parallel evolution in bacteria</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of the Swiss Confederation</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Department of Public Health</gtr:department><gtr:description>Mathematical models for the Swiss resurgent HIV epidemic</gtr:description><gtr:id>10611281-9B81-4704-B989-9AC4B4926D34</gtr:id><gtr:impact>Increased understanding of the resurgence of HIV in Switzerland</gtr:impact><gtr:outcomeId>9366FEE67DC-1</gtr:outcomeId><gtr:partnerContribution>intellectual input</gtr:partnerContribution><gtr:piContribution>Development and fitting of models to inform policy</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>BEEHIVE: Bridging the Evolution and Epidemiology of HIV in Europe (2014)</gtr:description><gtr:id>BCE9AD73-4874-4B22-9640-4D97172C12F4</gtr:id><gtr:impact>More cohorts involved than anticipated, but too early to report scientific impacts.</gtr:impact><gtr:outcomeId>5460c1ce61c0d7.92999745-1</gtr:outcomeId><gtr:partnerContribution>Scientific collaboration; providing data, samples &amp;amp; laboratory analysis/work.</gtr:partnerContribution><gtr:piContribution>Leadership &amp;amp; scientific coordination</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Environment Agency</gtr:collaboratingOrganisation><gtr:country>Singapore, Republic of</gtr:country><gtr:description>Singapore Wolbachia Project</gtr:description><gtr:id>76122609-F3D2-4189-A9BF-86F37088A187</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58c03463bc3b28.56869071-1</gtr:outcomeId><gtr:partnerContribution>Data provision</gtr:partnerContribution><gtr:piContribution>Data analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physics</gtr:department><gtr:description>Marisa Miraldo - 2016</gtr:description><gtr:id>9F547830-DDE5-47AB-9489-F361B1AAC5C8</gtr:id><gtr:impact>Data from final survey awaited. Likelihood check. Then apply for grant in the future to expand detail and scale of experiment (including lab experiments)</gtr:impact><gtr:outcomeId>58c7f7ed125b39.13976072-1</gtr:outcomeId><gtr:partnerContribution>Expertise in behavioral econ in designing and conducting flu vaccination study (PHE Porton Down)</gtr:partnerContribution><gtr:piContribution>Managed the collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>What are the public health outcomes, costs and cost-effectiveness of GUM and primary care based STI services, and how should these be planned in order to maximise STI control and cost-effectiveness for a population? PW 2012</gtr:description><gtr:id>DC5F6DB1-D3E0-44D9-98A6-D143323A6F67</gtr:id><gtr:impact>Mercer et al Sexually Transmitted Infections 2012; 88: 9-15</gtr:impact><gtr:outcomeId>dr3sUCUKB8T-3</gtr:outcomeId><gtr:partnerContribution>Study design
Survey implementation
Statistical analysis
Transmission-dynamic modelling</gtr:partnerContribution><gtr:piContribution>Advice on transmission-dynamic modelling and survey design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brunel University London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Interferon gamma tests for the rapid identification of active tuberculosis disease PW</gtr:description><gtr:id>3FF5A987-7B76-41B9-868E-692E4ADBCD04</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>Kf6WWBBmVaC-5</gtr:outcomeId><gtr:partnerContribution>Clinical research
Statistical analysis
Health economics</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of New South Wales</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Efficacy of masks to prevent influenza transmission - 2012</gtr:description><gtr:id>D4D85DD9-03B1-45F1-A2D7-D68024D57E82</gtr:id><gtr:impact>19193267</gtr:impact><gtr:outcomeId>ACCB215D7F4-1</gtr:outcomeId><gtr:partnerContribution>provision of data and intellectual input</gtr:partnerContribution><gtr:piContribution>statistical analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medicines for Malaria Venture (MMV)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Medicines for Malaria Venture - 2015</gtr:description><gtr:id>E9932A09-CD4C-4A45-B969-7D3F70498FB4</gtr:id><gtr:impact>PMID: 25425081</gtr:impact><gtr:outcomeId>56d6fa9dddd999.78000315-1</gtr:outcomeId><gtr:partnerContribution>Provide scientific advice and data, and funding</gtr:partnerContribution><gtr:piContribution>Mathematical modelling of impact of different anti-malerial drugs on transmission</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Health Economics Research Centre</gtr:department><gtr:description>Oxford University, Centre for Tropical Medicine and Global Health - Paul Turner</gtr:description><gtr:id>3003AD47-1E8C-4BDC-BC73-5F82E8DA149E</gtr:id><gtr:impact>DOI: 10.1073/pnas.1617849114</gtr:impact><gtr:outcomeId>589334ad9608c0.81799752-1</gtr:outcomeId><gtr:partnerContribution>Provide data</gtr:partnerContribution><gtr:piContribution>Data analysis and modelling to examine the evolution of resistance in pneumococcus</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard T.H. Chan School of Public Health</gtr:department><gtr:description>Methods for modelling transmission in households</gtr:description><gtr:id>957B5ACE-77DA-44EF-AE51-ECE044F7C8F8</gtr:id><gtr:impact>data sharing and intellectual discourse</gtr:impact><gtr:outcomeId>AD535C77879-1</gtr:outcomeId><gtr:partnerContribution>data sharing and intellectual input</gtr:partnerContribution><gtr:piContribution>Development &amp;amp; fitting of mathematical models to inform policy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Healthsites.io</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Healthsites.io</gtr:description><gtr:id>666DF76B-600F-4B68-9494-5F370797A76D</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58a2d6458b5453.97608543-1</gtr:outcomeId><gtr:partnerContribution>Collect and provide data on healthcare facilities</gtr:partnerContribution><gtr:piContribution>Gather data from various sources and build a model to estimate a risk of transmission of a pathogen from one country to another</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Industrial University of Santander</gtr:collaboratingOrganisation><gtr:country>Colombia, Republic of</gtr:country><gtr:description>Zika - University of Santander</gtr:description><gtr:id>21474708-0A19-435A-AAC9-26F0A9A1ABF8</gtr:id><gtr:impact>Too early to report</gtr:impact><gtr:outcomeId>58c7058d462d17.76186212-1</gtr:outcomeId><gtr:partnerContribution>Serological surveys, fieldwork, and testing.</gtr:partnerContribution><gtr:piContribution>Investigators from the MRC Centre for Outbreak Analysis and Modelling designed the collaboration and are now overseeing it.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Clinton Health Access Initiative (CHAI)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>CHAI - Taryn Barker</gtr:description><gtr:id>7E3BF7F0-F58E-4F9C-B099-3C86617E54F6</gtr:id><gtr:impact>In process</gtr:impact><gtr:outcomeId>58a2db70adbc30.55455202-1</gtr:outcomeId><gtr:partnerContribution>Provide data</gtr:partnerContribution><gtr:piContribution>Data analysis, guidance for programme operation</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NIHR HPRU in Modelling Methodology at Imperial College London (2014)</gtr:description><gtr:id>36640618-5912-4011-B400-328D8CC3B998</gtr:id><gtr:impact>Too early to report scientific impacts.</gtr:impact><gtr:outcomeId>5460c4e8401df1.56937959-1</gtr:outcomeId><gtr:partnerContribution>Scientifc collaboration &amp;amp; data collection.</gtr:partnerContribution><gtr:piContribution>Theme Leader on HIV &amp;amp; STIs Theme in NIHR HPRU in Modelling Methodology</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Clinical and cost-effectiveness of technologies for testing and treating sexual partners of people with sexually transmitted infections: Evidence synthesis and mathematical modelling study PW 2012</gtr:description><gtr:id>AC85111D-B03F-4814-904E-20D0072B4423</gtr:id><gtr:impact>Report for NIHR
Paper submitted

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>ijyk8pxxz9G-5</gtr:outcomeId><gtr:partnerContribution>Systematic review
Transmission-dynamic modelling</gtr:partnerContribution><gtr:piContribution>Advice on transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Michigan State University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Community Health</gtr:department><gtr:description>Estimation of HIV transmission dynamics using genomic sequences-2013</gtr:description><gtr:id>36A5FE19-5AAD-42E9-8032-F22D035FF5B8</gtr:id><gtr:impact>PMID: 22761556</gtr:impact><gtr:outcomeId>s9n3MeDPevn-1</gtr:outcomeId><gtr:partnerContribution>provision of anonymised data set.</gtr:partnerContribution><gtr:piContribution>All analysis of data
first author on PMID: 22761556</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Vaccine Initiative (EVI)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>MVI - 2013</gtr:description><gtr:id>4E02A614-681C-4432-BD7E-A0C89A4AE595</gtr:id><gtr:impact>Paper in draft; Report to GAVI; Conference presentations at Multilateral Initiative on Malaria Conference 2013, Epidemics 2013 and ASTMH 2013</gtr:impact><gtr:outcomeId>ivwBjTYuX9u-1</gtr:outcomeId><gtr:partnerContribution>Provision of data, discussion meetings</gtr:partnerContribution><gtr:piContribution>Estimating the public health impact of the RTS,S vaccine and research into transmission-blocking vaccine measurement and trial design</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>What are the public health outcomes, costs and cost-effectiveness of GUM and primary care based STI services, and how should these be planned in order to maximise STI control and cost-effectiveness for a population? PW 2012</gtr:description><gtr:id>E3746F09-C8FF-488A-8E5E-E25463E3814A</gtr:id><gtr:impact>Mercer et al Sexually Transmitted Infections 2012; 88: 9-15</gtr:impact><gtr:outcomeId>dr3sUCUKB8T-2</gtr:outcomeId><gtr:partnerContribution>Study design
Survey implementation
Statistical analysis
Transmission-dynamic modelling</gtr:partnerContribution><gtr:piContribution>Advice on transmission-dynamic modelling and survey design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>PoPART Consortium</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>PopART Phylogentics Study (2014)</gtr:description><gtr:id>6A279001-F134-4818-A373-58AA7F235DFB</gtr:id><gtr:impact>Too early to report scientific impacts.</gtr:impact><gtr:outcomeId>5460c29213bb00.48707705-1</gtr:outcomeId><gtr:partnerContribution>Scientific collaboration; providing data, samples &amp;amp; laboratory analysis/work.</gtr:partnerContribution><gtr:piContribution>Leadership &amp;amp; scientific coordination</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PHE HPRU (Public Health England) - 2015</gtr:description><gtr:id>549BADD7-C60E-4E51-92E1-8629B6C82DDD</gtr:id><gtr:impact>NIHR Health Protection Research Unit in Respiratory Infections and NIHR Health Protection Research Unit in Modelling Methodology</gtr:impact><gtr:outcomeId>56d6dbcc5ada77.98454807-1</gtr:outcomeId><gtr:partnerContribution>Modelling and new testing of new samples</gtr:partnerContribution><gtr:piContribution>Modelling and new testing of new samples</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>China Centre for Disease Control</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Influenza in China</gtr:description><gtr:id>1E8BE895-A337-49A2-A0EC-D7876F9DF170</gtr:id><gtr:impact>Exchange of existing data, collection of new data on mobility in China and building modelling capacity in China</gtr:impact><gtr:outcomeId>810448BF51C-1</gtr:outcomeId><gtr:partnerContribution>Exchange of existing data and collection of new data on mobility in China</gtr:partnerContribution><gtr:piContribution>Expertise in the epidemiological/statistical analysis and modelling of influenza.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>PANGEA Consortium</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Phylogenetics and Networks for Generalised HIV Epidemics in Africa</gtr:description><gtr:id>9D62E9AC-77A7-4DF5-9F7F-BDAFF6185EBA</gtr:id><gtr:impact>HIV consensus sequences for 4000 samples and corresponding sequence alignment</gtr:impact><gtr:outcomeId>58af01472963b4.17678792-1</gtr:outcomeId><gtr:partnerContribution>Data provision</gtr:partnerContribution><gtr:piContribution>Data analysis</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>Malawi, Republic of</gtr:country><gtr:department>Malawi-Liverpool Wellcome Trust Clinical Research Programme</gtr:department><gtr:description>Treating malaria in pregnancy and drug resistance</gtr:description><gtr:id>21714CC0-0F85-46C5-9D84-4508C0671B99</gtr:id><gtr:impact>Collaborated in successful grant application. No other impacts yet.</gtr:impact><gtr:outcomeId>58aef7e8c89211.54564005-1</gtr:outcomeId><gtr:partnerContribution>data collection and post doc supervision in country</gtr:partnerContribution><gtr:piContribution>data analysis for modelling and post doc supervision time</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Initiative for Vaccine Research</gtr:department><gtr:description>WHO - malaria vaccine cost effectiveness</gtr:description><gtr:id>6AC37F46-1B70-4837-8526-BBFAC4A045C3</gtr:id><gtr:impact>Presentation to the WHO QUIVER meeting and preparation of a formal report/paper for use by the WHO Initiative for Vaccine Research unit.</gtr:impact><gtr:outcomeId>sxDvzsnoPgx-1</gtr:outcomeId><gtr:piContribution>Literature review of the cost effectiveness of delivering malaria interventions</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>WHO South East Asia (SEARO). TB Modelling and Control Priorities.</gtr:description><gtr:id>96DE3D65-AB9C-454B-B2C2-692D373A761F</gtr:id><gtr:impact>Dissemination of preliminary outputs among expert groups.</gtr:impact><gtr:outcomeId>58c812335689e0.52090612-1</gtr:outcomeId><gtr:partnerContribution>Programmatic people, crafting the message, collaborating with stakeholder</gtr:partnerContribution><gtr:piContribution>Presentation preparation to a ministerial meeting. Development of Mathematical Models, including health economics.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Biostatistics Unit</gtr:department><gtr:description>Real-time influenza modelling PW</gtr:description><gtr:id>4126EA85-47DC-4C8B-A141-E9FC0A8B0ED9</gtr:id><gtr:impact>Birrell PJ et al. Proceedings of the National Academy of Sciences of the USA 2011; 108(45): 18238-18243</gtr:impact><gtr:outcomeId>LQxVyuqqZAC-1</gtr:outcomeId><gtr:partnerContribution>Study design and analysis</gtr:partnerContribution><gtr:piContribution>Contribution to study design and analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Clinical Vaccinology and Tropical Medicine (CCVTM)</gtr:department><gtr:description>Design of clinical trials to test novel entomological approaches to dengue control. CD</gtr:description><gtr:id>D88374A1-3858-4373-8D0D-5E8FDEDBCA45</gtr:id><gtr:impact>Paper in press: Wolbers M, Kleinschmidt I, Simmons CP and Donnelly CA. Considerations in the design of clinical trials to test novel entomological approaches to dengue control. PLoS Neglected Tropical Diseases in press.</gtr:impact><gtr:outcomeId>p2bP2xWA3fR-2</gtr:outcomeId><gtr:partnerContribution>Wolbers M (statistical programming expertise), Kleinschmidt I (expertise in stepped wedge design), Simmons CP (dengue epidemiology expertise)</gtr:partnerContribution><gtr:piContribution>I have both statistical (including experimental design) and epidemiological expertise.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Florida</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Dengue Modelling Consortium UoF-2013</gtr:description><gtr:id>605CE9B3-169F-41CC-96A9-E90A27792D01</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>BCiFEmKAQT1-1</gtr:outcomeId><gtr:partnerContribution>Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate.</gtr:partnerContribution><gtr:piContribution>Founder. Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>M?decins Sans Fronti?res (MSF)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Armand Sprecher and Dirk Schumacher</gtr:description><gtr:id>1A7BE47A-E625-4D1E-917B-797470F46350</gtr:id><gtr:impact>r package Tracer has been published</gtr:impact><gtr:outcomeId>58c8184e2f25a1.43549604-1</gtr:outcomeId><gtr:partnerContribution>Formulating needs for contact tracing efforts during emergency outbreak response</gtr:partnerContribution><gtr:piContribution>Developing model and r package for optimising contact tracing efforts</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Industrial University of Santander</gtr:collaboratingOrganisation><gtr:country>Colombia, Republic of</gtr:country><gtr:description>Zika in Columbia: early characterisation of epidemiological potential</gtr:description><gtr:id>A026B802-896D-43E8-B061-95DC27B2ADFF</gtr:id><gtr:impact>DOI: 10.1126/science.aag0219</gtr:impact><gtr:outcomeId>58a5bce7671fc7.43779512-2</gtr:outcomeId><gtr:partnerContribution>Processing of samples, serosurveys and analysing data</gtr:partnerContribution><gtr:piContribution>Analyse data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Economic modelling of TB in hard to reach groups PW</gtr:description><gtr:id>DA3C5D2A-B5B2-4E1E-A366-48704FF98358</gtr:id><gtr:impact>Report for NICE

Statistics
Public health
Clinical medicine</gtr:impact><gtr:outcomeId>pXWphzUgjCc-1</gtr:outcomeId><gtr:partnerContribution>Analysis of data from TB surveillance</gtr:partnerContribution><gtr:piContribution>Health economic transmission-dynamic modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chinese Center for Disease Control and Prevention (China CDC)</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>China CDC and China WHO</gtr:description><gtr:id>3CF77F63-5B42-44A4-88BA-C531867A6A50</gtr:id><gtr:impact>In process</gtr:impact><gtr:outcomeId>58a2dba12dc6d3.08564900-1</gtr:outcomeId><gtr:partnerContribution>Provide data</gtr:partnerContribution><gtr:piContribution>Modelling expertise</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Molecular Epidemiology HIV group-2013</gtr:description><gtr:id>28242D1D-ED5A-4442-8034-A32FF4AB059C</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>ddAjvHzgpAn-1</gtr:outcomeId><gtr:partnerContribution>The group meets every three months to share research information and data.</gtr:partnerContribution><gtr:piContribution>Talk given.
Attending research meetings</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Trento</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>School Closure-2013</gtr:description><gtr:id>F351A211-77B4-4BF4-92D5-19BFD505F4FC</gtr:id><gtr:impact>not yet</gtr:impact><gtr:outcomeId>dasXKaq8XiQ-1</gtr:outcomeId><gtr:partnerContribution>analysis</gtr:partnerContribution><gtr:piContribution>analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>HIV Monitoring Foundation (SHM)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>HIV Monitoring Foundation - Prof Peter Reiss - 2015</gtr:description><gtr:id>A4415786-CDF6-41B5-86A4-55585E939AD8</gtr:id><gtr:impact>PMID: 26558543, 26529093, 26738795</gtr:impact><gtr:outcomeId>56d6d753dbeb04.18011986-1</gtr:outcomeId><gtr:partnerContribution>Clinical data and epidemiological monitoring</gtr:partnerContribution><gtr:piContribution>Modelling and phylogenetics</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of Saudi Arabia</gtr:collaboratingOrganisation><gtr:country>Saudi Arabia, Kingdom of</gtr:country><gtr:description>MERS Coronovirus- Saudi -2013</gtr:description><gtr:id>84A877D3-4553-4073-9CEF-89AE519A2A06</gtr:id><gtr:impact>Corresponding publication. PMID 23787162</gtr:impact><gtr:outcomeId>eAKL6phCwmk-1</gtr:outcomeId><gtr:partnerContribution>Assessing epidemic risk of MERS-CoV. Implications for health risk assessment and control.</gtr:partnerContribution><gtr:piContribution>Assessing epidemic risk of MERS-CoV. Implications for health risk assessment and control.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Collaborating Institute on Polio-2013</gtr:description><gtr:id>38BD1759-A87C-4123-AE6F-838D01426801</gtr:id><gtr:impact>An indirect consequence of this collaboration is that funding from the WHO has successfully been sought, after WHO based individuals at the Collaborating Institute on Polio suggested that we should apply for funding. Our subsequent application was successful (see 'Global Polio Eradication Initiative' under further funding).</gtr:impact><gtr:outcomeId>fu2rto8ys35-1</gtr:outcomeId><gtr:partnerContribution>Polio data</gtr:partnerContribution><gtr:piContribution>Data analysis and modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>University of Toronto (Dr Ophira Ginsburg) - 2015</gtr:description><gtr:id>1127D5B3-DAAE-4318-815C-DACA4C65B9C0</gtr:id><gtr:impact>Paper forthcoming</gtr:impact><gtr:outcomeId>56d6ea71e08186.77130142-1</gtr:outcomeId><gtr:partnerContribution>Co-author</gtr:partnerContribution><gtr:piContribution>Health equity and women's cancer review for Lancet series</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HIV Modelling Consortium (2014)</gtr:description><gtr:id>5C47AF8E-2683-49C8-85EA-DB729DF85709</gtr:id><gtr:impact>Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic.</gtr:impact><gtr:outcomeId>5460896aadad62.01682602-1</gtr:outcomeId><gtr:partnerContribution>Research activities in the mathematical modelling of the HIV epidemic.</gtr:partnerContribution><gtr:piContribution>The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of Oxford (Prof Charles Vincent) - 2015</gtr:description><gtr:id>E0A94808-DA12-48C8-9900-F2981A06D1AD</gtr:id><gtr:impact>Paper submitted</gtr:impact><gtr:outcomeId>56d6e9e7d10d77.02181002-1</gtr:outcomeId><gtr:partnerContribution>Sponsor of the study and co-author</gtr:partnerContribution><gtr:piContribution>Econometric anlaysis of patient safety incidents/medical errors in hospitals, in particular of the number of life years lost and the cost of increased length of stay attributable to adverse events.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>COSI</gtr:description><gtr:id>739F6B60-3D7D-4B22-8125-46C005A9B363</gtr:id><gtr:impact>project funded by the BBSRC, MRC, Wellcome Trust (who contributed equally to the costs). DEFRA have also provided support</gtr:impact><gtr:outcomeId>fSMPwGScVJv-1</gtr:outcomeId><gtr:partnerContribution>access to data on swine influenza</gtr:partnerContribution><gtr:piContribution>statistical analysis of swine influenza</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Phylogenetics and Networks for Generalised HIV Epidemics in Africa</gtr:description><gtr:id>C618F82A-1216-4E2D-8848-2F55FAB6888B</gtr:id><gtr:impact>HIV consensus sequences for 4000 samples and corresponding sequence alignment</gtr:impact><gtr:outcomeId>58af01472963b4.17678792-2</gtr:outcomeId><gtr:partnerContribution>Data provision</gtr:partnerContribution><gtr:piContribution>Data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Swansea University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medicine</gtr:department><gtr:description>Sheppard 2013 and 2014</gtr:description><gtr:id>C3BC1341-502D-4267-A63B-7FFECB3D7D6E</gtr:id><gtr:impact>PMID 23279096, 23818615, 24586045</gtr:impact><gtr:outcomeId>Xpiu1dbDKXB-1</gtr:outcomeId><gtr:partnerContribution>Sampling of isolates, whole-genome sequencing, in vitro experiments.</gtr:partnerContribution><gtr:piContribution>Statistical analysis of genomic data from Campylobacter jejuni and coli.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Medicine</gtr:department><gtr:description>Modernising Medical Microbiology 2013 and 2014</gtr:description><gtr:id>91BA21C6-0592-4E21-9460-D5F64256DD0E</gtr:id><gtr:impact>PMID 23259504, 23164609, 23204167, 23658690, 24066741, 24172133, 24853639, 24336451, 24433924, 25267672. This is a highly multi-disciplinary collaboration, connecting evolutionary biology, genomics, medical microbiology and epidemiology.</gtr:impact><gtr:outcomeId>huSB5gxUBy7-1</gtr:outcomeId><gtr:partnerContribution>Sampling of isolates and whole-genome sequencing. Expertise in clinical microbiology.</gtr:partnerContribution><gtr:piContribution>Statistical analysis of genomic data from Staphylococcus aureus and Clostridium difficile isolated from hospital settings, with the aim to improve our understanding of both evolution and epidemiology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Medicine</gtr:department><gtr:description>MMM XD</gtr:description><gtr:id>F50E59B7-0386-480B-95BD-42B75436D954</gtr:id><gtr:impact>PMID 21625511, 21829375, 22393007, 22674929, 22868263. Manuscript submitted investigating nosocomial transmission of C. difficile. Manuscript submitted investigating diversity of S. aureus within hosts. Manuscript submitted describing an outbreak of S. aureus in Brighton. This is a highly multi-disciplinary collaboration, connecting evolutionary biology, genomics, medical microbiology and epidemiology.</gtr:impact><gtr:outcomeId>KxTFKvhDVTM-1</gtr:outcomeId><gtr:partnerContribution>Sampling of isolates and whole-genome sequencing. Expertise in clinical microbiology.</gtr:partnerContribution><gtr:piContribution>Statistical analysis of genomic data from Staphylococcus aureus and Clostridium difficile isolated from hospital settings, with the aim to improve our understanding of both evolution and epidemiology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanofi Pasteur MSD</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dengue Modelling Consortium SP-2013</gtr:description><gtr:id>9DAA70C3-6025-460D-8793-F4BC9F8F91EF</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>GXvYPQAHniE-1</gtr:outcomeId><gtr:partnerContribution>Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate.</gtr:partnerContribution><gtr:piContribution>Founder. Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Measuring the impact of school closure and illness on social contact patterns PW</gtr:description><gtr:id>BBA3FF7E-DCE5-4907-B29E-0ADFB5527FE1</gtr:id><gtr:impact>Paper in Health Technology Assessment: Eames et al. 2010</gtr:impact><gtr:outcomeId>V5K4X6DQ6o9-1</gtr:outcomeId><gtr:partnerContribution>Study design: survey instrument &amp;amp; sampling strategy
Survey implementation</gtr:partnerContribution><gtr:piContribution>Study design: survey instrument &amp;amp; sampling strategy</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Targeting men for better sexual health: The BallsEye programme PW 2012</gtr:description><gtr:id>F617B023-4DC5-4737-9D15-A6CB97C818F0</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>LznBnyBFC2u-1</gtr:outcomeId><gtr:partnerContribution>Systematic review
Health economics
Public health
Statistical analysis</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Clinical and cost-effectiveness of technologies for testing and treating sexual partners of people with sexually transmitted infections: Evidence synthesis and mathematical modelling study PW 2012</gtr:description><gtr:id>4658B73A-7A2F-48FF-A0B1-CFB41F32F95E</gtr:id><gtr:impact>Report for NIHR
Paper submitted

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>ijyk8pxxz9G-6</gtr:outcomeId><gtr:partnerContribution>Systematic review
Transmission-dynamic modelling</gtr:partnerContribution><gtr:piContribution>Advice on transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>US Centers for Disease Control</gtr:description><gtr:id>9F92F146-6089-4174-8861-DE4695EB7AC3</gtr:id><gtr:impact>Publication on the H1N1 pandemic influenza outbreak in a school in Pennsylvania (paper under revision in PNAS)</gtr:impact><gtr:outcomeId>MfBT2oofGoQ-1</gtr:outcomeId><gtr:partnerContribution>In exchange for our modelling and statistical expertise we have been provided with data on H1N1 pandemic influenza, seasonal influenza and pertussis.</gtr:partnerContribution><gtr:piContribution>mathematical modelling and statistics relating to the 2009 H1N1 pandemic, seasonal influenza and the recent pertussis epidemic in the US</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Fluscape JHU (2013)</gtr:description><gtr:id>34F8FB1A-063B-471C-A97C-08DCC9162D69</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>avydHGabEmD-1</gtr:outcomeId><gtr:partnerContribution>Analysis</gtr:partnerContribution><gtr:piContribution>Analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>HIV Monitoring Foundation (SHM)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Mathematical models for the Dutch resurgent HIV epidemic</gtr:description><gtr:id>41A0D57A-C810-4834-9367-AB629D45EDB8</gtr:id><gtr:impact>19809510</gtr:impact><gtr:outcomeId>4CDF4E96A0F-1</gtr:outcomeId><gtr:partnerContribution>Provision of data and joint supervision of a PhD project</gtr:partnerContribution><gtr:piContribution>Development and fitting of models to inform policy. Joint supervision of a PhD project and assistance with statistical analysis.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Global Fund to Fight AIDS, Tuberculosis and Malaria</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>GFATM - 2015</gtr:description><gtr:id>CB871A27-E92E-42D3-84AD-B6B197D6C679</gtr:id><gtr:impact>Forthcoming</gtr:impact><gtr:outcomeId>56d6d94cac8893.80181990-1</gtr:outcomeId><gtr:partnerContribution>Provision of questions and data</gtr:partnerContribution><gtr:piContribution>Collaboration on modelling malaria to inform the investment case, 2017-2022 strategy refresh and allocation formula</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Indiana University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HIV Modelling Consortium (2014)</gtr:description><gtr:id>73179FE2-3B7B-4B18-A8B4-CDB23F5E28B6</gtr:id><gtr:impact>Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic.</gtr:impact><gtr:outcomeId>5460896aadad62.01682602-9</gtr:outcomeId><gtr:partnerContribution>Research activities in the mathematical modelling of the HIV epidemic.</gtr:partnerContribution><gtr:piContribution>The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Epidemiology and Population Health</gtr:department><gtr:description>LSHTM</gtr:description><gtr:id>8CF9DC9C-792B-40D0-A17C-7EF1B71FDB91</gtr:id><gtr:impact>The impact of illness and the impact of school closure on social contact patterns.
EAMES, K.T.; Tilston, N.L.; White, P.J.; Adams, E.; EDMUNDS, W.J.;
Health Technol Assess, 2010; 14(34):267-312

NIHR grant awarded</gtr:impact><gtr:outcomeId>VoGizQs6Qe5-1</gtr:outcomeId><gtr:piContribution>expertise in modelling the impact of school closure on influenza transmission</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of North Carolina at Chapel Hill</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HIV Modelling Consortium (2014)</gtr:description><gtr:id>9020E70D-11F6-4B7D-837C-EEE672805228</gtr:id><gtr:impact>Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic.</gtr:impact><gtr:outcomeId>5460896aadad62.01682602-10</gtr:outcomeId><gtr:partnerContribution>Research activities in the mathematical modelling of the HIV epidemic.</gtr:partnerContribution><gtr:piContribution>The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Interferon gamma tests for the rapid identification of active tuberculosis disease PW</gtr:description><gtr:id>DAF84251-B7EB-4338-AA70-AF4EA973FE45</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>Kf6WWBBmVaC-4</gtr:outcomeId><gtr:partnerContribution>Clinical research
Statistical analysis
Health economics</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK Severe Influenza Surveillance System PW</gtr:description><gtr:id>0C13D288-0CF3-4BC6-BE40-5147DA12B5B2</gtr:id><gtr:impact>Report to Department of Health
Bolotin et al PLoS ONE 2012; 7(1): e30279</gtr:impact><gtr:outcomeId>BdfwKqW79pQ-3</gtr:outcomeId><gtr:partnerContribution>Study design and analysis</gtr:partnerContribution><gtr:piContribution>Contributed to study design and analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Warwick Mathematics Institute</gtr:department><gtr:description>University of Warwick</gtr:description><gtr:id>8C7A127D-7017-48BF-86C7-443D23542E95</gtr:id><gtr:impact>Targeting vaccination against novel infections: risk, age and spatial structure for pandemic influenza in Great Britain.
Keeling MJ, White PJ.
J R Soc Interface. 2010 Oct 13.</gtr:impact><gtr:outcomeId>ciFZUpBUpgL-1</gtr:outcomeId><gtr:piContribution>Mathematical modelling to inform targeted vaccination against H1N1 pandemic influenza</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of Saudi Arabia</gtr:collaboratingOrganisation><gtr:country>Saudi Arabia, Kingdom of</gtr:country><gtr:description>MERS-CoV collaboration - 2014</gtr:description><gtr:id>F30DCBFC-CE3C-4C24-A288-E9ED6534D939</gtr:id><gtr:impact>Provided epidemiological analysis and modelling of the MERS-Coronavirus epidemic in Saudi Arabia.</gtr:impact><gtr:outcomeId>5462125d6dc6d2.33758376-1</gtr:outcomeId><gtr:partnerContribution>Access to data. Analysis and modelling.</gtr:partnerContribution><gtr:piContribution>Epidemiological analysis and modelling of the MERS-Coronavirus epidemic in Saudi Arabia.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sussex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Brighton and Sussex Medical School</gtr:department><gtr:description>Clinical and cost-effectiveness of technologies for testing and treating sexual partners of people with sexually transmitted infections: Evidence synthesis and mathematical modelling study PW 2012</gtr:description><gtr:id>8DFD5B84-28CB-44FC-B555-5F2EFE96843E</gtr:id><gtr:impact>Report for NIHR
Paper submitted

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>ijyk8pxxz9G-4</gtr:outcomeId><gtr:partnerContribution>Systematic review
Transmission-dynamic modelling</gtr:partnerContribution><gtr:piContribution>Advice on transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Trachoma Research</gtr:description><gtr:id>A24E6042-44FC-4692-9D80-61B41EDE8398</gtr:id><gtr:impact>19529762, 19333364, 17521595</gtr:impact><gtr:outcomeId>DBAE9F1CF5A-1</gtr:outcomeId><gtr:partnerContribution>provision of intervention study data</gtr:partnerContribution><gtr:piContribution>expertise in mathematical modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Oliver Morgan (WHO - Acting Director Health Information Systems)</gtr:description><gtr:id>1B15EBFF-B836-4DAA-899D-5D9227050C40</gtr:id><gtr:impact>too early</gtr:impact><gtr:outcomeId>58c817f5537756.36657432-1</gtr:outcomeId><gtr:partnerContribution>Establishment and identification of modelling needs for situational awareness during outbreak response</gtr:partnerContribution><gtr:piContribution>Establishment and identification of modelling needs for situational awareness during outbreak response</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bill and Melinda Gates Foundation</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Global Alliance for Vaccination and Immunisation (GAVI)</gtr:department><gtr:description>Yellow Fever Collaboration - 2015</gtr:description><gtr:id>FD69FE92-79D9-4E8A-8252-C44E8B096C7F</gtr:id><gtr:impact>PMID: 24800812</gtr:impact><gtr:outcomeId>56d6fa548b26a0.48867858-1</gtr:outcomeId><gtr:partnerContribution>WHO - data provision on yellow fever occurance; GAVI - data on vaccination activity</gtr:partnerContribution><gtr:piContribution>Estimating the impact of yellow fever vaccination in Africa</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Engineering Science</gtr:department><gtr:description>Malaria Atlas Project</gtr:description><gtr:id>B7DBFA01-0FD9-4BE3-801E-0F2185DEB114</gtr:id><gtr:impact>NEJM - paper. Bhatt, S 2016</gtr:impact><gtr:outcomeId>58c80e84a08f63.42425672-1</gtr:outcomeId><gtr:partnerContribution>Data</gtr:partnerContribution><gtr:piContribution>Bringing spatial expertise to outbreak mapping</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Economics and Political Science (University of London)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Social Policy</gtr:department><gtr:description>Matteo Gallizi (LSE)</gtr:description><gtr:id>DEE94A4D-AEA7-4779-8C9A-8F5F6836B341</gtr:id><gtr:impact>Data from final survey awaited. Likelihood check. Then apply for grant in the future to expand detail and scale of experiment (including lab experiments)

Day-long PPI panel in September</gtr:impact><gtr:outcomeId>58c7f5db2f5be8.66073959-1</gtr:outcomeId><gtr:partnerContribution>Expertise in behavioral econ in designing and conducting flu vaccination study (PHE Porton Down)</gtr:partnerContribution><gtr:piContribution>Managed the collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wisconsin-Milwaukee</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Zika - University of Wisconsin</gtr:description><gtr:id>4A8E324E-66A1-4042-AC5F-927001D311E7</gtr:id><gtr:impact>too early to report</gtr:impact><gtr:outcomeId>58c706de26e4a1.91818467-1</gtr:outcomeId><gtr:partnerContribution>Serological surveys, fieldwork, and testing.</gtr:partnerContribution><gtr:piContribution>Investigators from the MRC Centre for Outbreak Analysis and Modelling designed the collaboration and are now overseeing it.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hannover Medical School</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute for Medical Microbiology</gtr:department><gtr:description>Suerbaum - 2013 and 2014</gtr:description><gtr:id>B241B64D-6028-403B-A28C-3631EA10A91D</gtr:id><gtr:impact>PMID 23898187, 23836820, 25218701</gtr:impact><gtr:outcomeId>tRja7Wi4mS8-1</gtr:outcomeId><gtr:partnerContribution>Sampling of isolates, whole-genome sequencing, in vitro experiments.</gtr:partnerContribution><gtr:piContribution>Statistical analysis of genomic data from Campylobacter jejuni and Helicobacter pylori. Statistical analysis of in vitro experiments in Helicobacter pylori.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Zika - Institut Pasteur</gtr:description><gtr:id>B2C7EE13-3F78-43E1-8CC5-947183EAD81B</gtr:id><gtr:impact>Too early to report</gtr:impact><gtr:outcomeId>58c7062a749171.64542874-1</gtr:outcomeId><gtr:partnerContribution>Training of lab techniques and provision of reagents.</gtr:partnerContribution><gtr:piContribution>Investigators from the MRC Centre for Outbreak Analysis and Modelling designed the collaboration and are now overseeing it.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>FluScape Liverpool (2014)</gtr:description><gtr:id>5267B84F-BDCD-429B-9876-B8ED755FAD05</gtr:id><gtr:impact>Several papers published.</gtr:impact><gtr:outcomeId>54609ae75a4410.68594997-1</gtr:outcomeId><gtr:partnerContribution>Helped to win grants and publish papers</gtr:partnerContribution><gtr:piContribution>Helped to win grants and publish papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bern</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>HIV estimation in Europe</gtr:description><gtr:id>A23292BC-4EED-42A9-8D42-5F3640873DB2</gtr:id><gtr:impact>Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners.
Hallett TB, Smit C, Garnett GP, de Wolf F.
Sex Transm Infect. 2010 Jul 18.</gtr:impact><gtr:outcomeId>EwEjPqZbEFe-2</gtr:outcomeId><gtr:partnerContribution>access to data on HIV transmission in Europeaccess to data on HIV transmission in Europe</gtr:partnerContribution><gtr:piContribution>statistical and modelling techniques for estimating HIV transmission</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Estimating burden of influenza in USA - 2014</gtr:description><gtr:id>DD232AE9-20C7-4BB5-9075-5FB367EDD053</gtr:id><gtr:impact>Paper published, collaboraiton with public health officials at CDC</gtr:impact><gtr:outcomeId>56d6e3b734b804.41241415-1</gtr:outcomeId><gtr:partnerContribution>Providing data and expertise</gtr:partnerContribution><gtr:piContribution>Developing model to assist CDC in interpreting their surveillance systems</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Jinan University</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Larry Liao - 2016</gtr:description><gtr:id>E8C71D0A-A695-48F1-978D-6BC7B6A355C6</gtr:id><gtr:impact>no impacts yet</gtr:impact><gtr:outcomeId>58c802e108f0a9.12876881-1</gtr:outcomeId><gtr:partnerContribution>immuniological assays</gtr:partnerContribution><gtr:piContribution>provision of samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Targeting men for better sexual health: The BallsEye programme PW 2012</gtr:description><gtr:id>D2FCF9E5-CE44-4B24-82B2-4C5E8CBD90E9</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>LznBnyBFC2u-3</gtr:outcomeId><gtr:partnerContribution>Systematic review
Health economics
Public health
Statistical analysis</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Malaria Collaborative Research</gtr:description><gtr:id>0AFD0488-6094-4035-9E5F-DA66E2BDF99D</gtr:id><gtr:impact>19848588, 19198649, 18826573, 18613962, 18387180, 18166074,</gtr:impact><gtr:outcomeId>A6B817555D7-1</gtr:outcomeId><gtr:partnerContribution>on-going academic collaboration; provision of data.</gtr:partnerContribution><gtr:piContribution>On-going academic collaboration in development and application of malaria models.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Malaria in Pregnancy Consortium</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MiP - 2014</gtr:description><gtr:id>32B39964-A23B-47F3-9C3E-A2F8A46E8CE1</gtr:id><gtr:impact>PMID: 25103519; PMID: 23511473</gtr:impact><gtr:outcomeId>545764452e94a1.34729336-1</gtr:outcomeId><gtr:partnerContribution>Modelling results</gtr:partnerContribution><gtr:piContribution>Continued collaboration modelling the impact of new strategies for reducing the burden of malaria in pregnancy</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hong Kong</gtr:collaboratingOrganisation><gtr:country>Hong Kong, Special Administrative Region of China</gtr:country><gtr:department>School of Public Health and Department of Community Medicine</gtr:department><gtr:description>hong kong infectious disease serological cohort SR</gtr:description><gtr:id>2C890ACE-691E-49FB-B716-303F755A4D92</gtr:id><gtr:impact>manuscript under review at plos med on social contacts as risk factors for infectious disease</gtr:impact><gtr:outcomeId>b6KbNu76TE7-1</gtr:outcomeId><gtr:partnerContribution>as above plus implement field work and implement lab testing.</gtr:partnerContribution><gtr:piContribution>designed field work, managed field work, co ducted analyses, designed analyses. drafted manuscripts, edited ,manuscripts. interpreted results</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Real-time influenza modelling PW</gtr:description><gtr:id>002DD9B1-979C-4542-BB5B-650EA2D9A17E</gtr:id><gtr:impact>Birrell PJ et al. Proceedings of the National Academy of Sciences of the USA 2011; 108(45): 18238-18243</gtr:impact><gtr:outcomeId>LQxVyuqqZAC-2</gtr:outcomeId><gtr:partnerContribution>Study design and analysis</gtr:partnerContribution><gtr:piContribution>Contribution to study design and analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Baylor College of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Baylor College of Medicine</gtr:description><gtr:id>66D5B44B-A916-4AE5-80D0-918B98A9BBB9</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58aadea5de6f02.41092852-1</gtr:outcomeId><gtr:partnerContribution>Rotavirus virology; mass spectrometry for breast milk study</gtr:partnerContribution><gtr:piContribution>Lead coordinator on a study and design of clinical study design</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health, Pakistan</gtr:collaboratingOrganisation><gtr:country>Pakistan, Islamic Republic of</gtr:country><gtr:description>NIH Pakistan</gtr:description><gtr:id>18DAA668-EB08-485E-9212-5A9C9F48FBF2</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58aadf244c2627.80838195-1</gtr:outcomeId><gtr:partnerContribution>Provide sequencing data and surveillance data</gtr:partnerContribution><gtr:piContribution>Analyse data</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Clinical and cost-effectiveness of technologies for testing and treating sexual partners of people with sexually transmitted infections: Evidence synthesis and mathematical modelling study PW 2012</gtr:description><gtr:id>7C4A837B-0193-4163-B790-9FB88B2D53F0</gtr:id><gtr:impact>Report for NIHR
Paper submitted

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>ijyk8pxxz9G-2</gtr:outcomeId><gtr:partnerContribution>Systematic review
Transmission-dynamic modelling</gtr:partnerContribution><gtr:piContribution>Advice on transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Economics and Political Science (University of London)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Anthropology</gtr:department><gtr:description>Sara Machado</gtr:description><gtr:id>6C3E01AA-BABE-4144-B661-379348D3B031</gtr:id><gtr:impact>Data from final survey awaited. Likelihood check. Then apply for grant in the future to expand detail and scale of experiment (including lab experiments)</gtr:impact><gtr:outcomeId>58c7f871eb3e00.76932536-1</gtr:outcomeId><gtr:partnerContribution>expertise in experimental and behavioural economics</gtr:partnerContribution><gtr:piContribution>Managing the collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>Department of Pandemic and Epidemic Diseases</gtr:department><gtr:description>WHO - Margaret Lamunu</gtr:description><gtr:id>180CF548-7D9C-44B9-BC20-680839FA67E0</gtr:id><gtr:impact>7 short reports and one report on long-term vaccination strategy, these informed decisions made by SAGE</gtr:impact><gtr:outcomeId>58c12b5d6a3a91.58449329-1</gtr:outcomeId><gtr:partnerContribution>Provided primarily case data from Angola and the DRC, and some local geographic data</gtr:partnerContribution><gtr:piContribution>Support Angola yellow fever outbreak response work by informing the vaccination strategy through modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PHE through MRC grant MR/J008761/1 (2013)</gtr:description><gtr:id>4AF44EC9-8476-403E-89E8-5952C4512B4B</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>s179wfeE2YC-1</gtr:outcomeId><gtr:partnerContribution>Virology</gtr:partnerContribution><gtr:piContribution>Modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>The cost effectiveness of genetic markers for antibiotic resistance in tuberculosis PW</gtr:description><gtr:id>0504A52C-DA65-4469-AA77-2D5C89379F30</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine</gtr:impact><gtr:outcomeId>c1SyGHu4uGT-2</gtr:outcomeId><gtr:partnerContribution>Systematic review
Statistical analysis
Health economics</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Methods for using sequence data in epidemic models</gtr:description><gtr:id>B872A626-1C38-4BCC-82CC-2E60FE24E029</gtr:id><gtr:impact>linking epidemiological data with human and pathogen genetic data</gtr:impact><gtr:outcomeId>712077BC566-1</gtr:outcomeId><gtr:piContribution>mathematical modelling expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Colorado</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>rapidd influenza poultry SR</gtr:description><gtr:id>8AC6FDB8-5121-493E-AC56-5E583D3BEAFB</gtr:id><gtr:impact>pmids 22458429, 22459665</gtr:impact><gtr:outcomeId>FCM3cMv6yAv-1</gtr:outcomeId><gtr:partnerContribution>Designed, implemented, and interpreted experiments. Drafted and edited manuscripts.</gtr:partnerContribution><gtr:piContribution>Designed and interpreted experiments. Edited manuscripts.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sarah Cleveland - Glasgow</gtr:description><gtr:id>B7E04036-6BF3-41B5-B742-90EACD4E66FF</gtr:id><gtr:impact>too early to report</gtr:impact><gtr:outcomeId>58c707b75b8831.99497942-1</gtr:outcomeId><gtr:partnerContribution>Veterinary expertise, data collected, and infrastructure contributed.</gtr:partnerContribution><gtr:piContribution>Centre Investigator, Christl Donnelly directly involved in the design and (planned) analysis of epidemological and ecological data relating to rabies control in Serengeti</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Laboratory for Urgent Response to Biological Threats</gtr:department><gtr:description>Zika in Columbia: early characterisation of epidemiological potential</gtr:description><gtr:id>1D4A7110-F77E-4C9C-973F-32BA85703B13</gtr:id><gtr:impact>DOI: 10.1126/science.aag0219</gtr:impact><gtr:outcomeId>58a5bce7671fc7.43779512-1</gtr:outcomeId><gtr:partnerContribution>Processing of samples, serosurveys and analysing data</gtr:partnerContribution><gtr:piContribution>Analyse data</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Interferon gamma tests for the rapid identification of active tuberculosis disease PW</gtr:description><gtr:id>7955779B-81BA-4360-86D9-23356B5B9D73</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>Kf6WWBBmVaC-2</gtr:outcomeId><gtr:partnerContribution>Clinical research
Statistical analysis
Health economics</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Epidemiologic Databases to Evaluate AIDS (IeDEA)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>HIV Modelling Consortium (2014)</gtr:description><gtr:id>92988BF6-89C1-46ED-B405-4BB54F50D3C7</gtr:id><gtr:impact>Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic.</gtr:impact><gtr:outcomeId>5460896aadad62.01682602-6</gtr:outcomeId><gtr:partnerContribution>Research activities in the mathematical modelling of the HIV epidemic.</gtr:partnerContribution><gtr:piContribution>The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Public Health England (Dr Dale Weston and Dr Richard Amlot) - 2015</gtr:description><gtr:id>F2968BFB-7126-44F2-90E9-F3C2FACC6A7C</gtr:id><gtr:impact>Final draft of the paper under way</gtr:impact><gtr:outcomeId>56d6e9491f76b9.95297648-1</gtr:outcomeId><gtr:partnerContribution>Analysis</gtr:partnerContribution><gtr:piContribution>Literature review on how studies incorporate behavior into mathematical transmission models of infecticious disease</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sussex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Brighton and Sussex Medical School</gtr:department><gtr:description>Targeting men for better sexual health: The BallsEye programme PW 2012</gtr:description><gtr:id>78451B4B-B23E-4BA2-8565-7425F1627218</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>LznBnyBFC2u-5</gtr:outcomeId><gtr:partnerContribution>Systematic review
Health economics
Public health
Statistical analysis</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HIV Modelling Consortium (2014)</gtr:description><gtr:id>25968B3C-1E3B-48D8-90C9-AB8691EE86CA</gtr:id><gtr:impact>Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic.</gtr:impact><gtr:outcomeId>5460896aadad62.01682602-3</gtr:outcomeId><gtr:partnerContribution>Research activities in the mathematical modelling of the HIV epidemic.</gtr:partnerContribution><gtr:piContribution>The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Centre for Disease Prevention and Control (ECDC)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>Review on the impact of school closure during the 2009 influenza pandemic SC</gtr:description><gtr:id>647F6585-943E-48A5-BE11-E3A20080FE20</gtr:id><gtr:impact>1 paper in review</gtr:impact><gtr:outcomeId>JYEqpRTJxd9-1</gtr:outcomeId><gtr:partnerContribution>Contribution to the review; provide data</gtr:partnerContribution><gtr:piContribution>Review the impact of school closure during the 2009 influenza pandemic</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Christian Medical College, Vellore</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:department>Wellcome Laboratory</gtr:department><gtr:description>CMC NG 2012</gtr:description><gtr:id>E4FFD71F-47AE-4B5F-B69B-73842D37D3E6</gtr:id><gtr:impact>too early</gtr:impact><gtr:outcomeId>KEyccMvi6hr-1</gtr:outcomeId><gtr:partnerContribution>Two clinical trials begun at CMC in Vellore, India</gtr:partnerContribution><gtr:piContribution>PI on a clinical trial of oral vaccines and collaborator on another</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Worldwide Antimalarial Resistance Networkn WWARN</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Worldwide Antimalarial Resistance Network / Sanofi Limited / DNDI</gtr:description><gtr:id>EAA1A6F6-3323-479A-A568-2B0C496AB01E</gtr:id><gtr:impact>Forthcoming</gtr:impact><gtr:outcomeId>56d6fb03819661.19343631-1</gtr:outcomeId><gtr:partnerContribution>Provided data and scientific advice</gtr:partnerContribution><gtr:piContribution>Analysis of data to estimate the profilactic effect of anti-malerials</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Stellenbosch</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>Stellenbosch University (Prof Ronelle Burger) - 2015</gtr:description><gtr:id>BCA03388-C56C-42A7-BCE5-F1031A40A204</gtr:id><gtr:impact>Paper submitted</gtr:impact><gtr:outcomeId>56d6ea29b9fa50.05748754-1</gtr:outcomeId><gtr:partnerContribution>Co-author</gtr:partnerContribution><gtr:piContribution>Econometric analysis of changes in hypertensive status and awareness of status in a cohort of individuals from the National Income Dynamics Survey of South Africa.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of the UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department for International Development (DfID)</gtr:department><gtr:description>Mathematical models for Viet Nam &amp;amp; Cambodia to explore the impact of control measures to reduce the risk of H5N1 outbreaks in poultry</gtr:description><gtr:id>B8FCFD2E-A689-459B-8055-F12F5C585917</gtr:id><gtr:impact>greater understanding of the impact of control measures on the spread of avian influenza.</gtr:impact><gtr:outcomeId>D19B812C8DB-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input</gtr:partnerContribution><gtr:piContribution>Development and fitting of mathematical models to inform policy</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Interferon gamma tests for the rapid identification of active tuberculosis disease PW</gtr:description><gtr:id>3943018E-CE2A-4555-A819-525CCE76AA31</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>Kf6WWBBmVaC-3</gtr:outcomeId><gtr:partnerContribution>Clinical research
Statistical analysis
Health economics</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Medicine</gtr:department><gtr:description>UoO NG</gtr:description><gtr:id>2FE114A6-4003-44DE-8A90-14ABFDE58D17</gtr:id><gtr:impact>too early</gtr:impact><gtr:outcomeId>UZ261JHFBLh-1</gtr:outcomeId><gtr:partnerContribution>Design of immunological assays and training of staff in FACS analysis</gtr:partnerContribution><gtr:piContribution>PI on a clinical trial of oral vaccines and collaborator on another</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>BEEHIVE - Wellcome Trust -2013</gtr:description><gtr:id>B0387774-E69C-4D5C-83D0-4DEAA25A137B</gtr:id><gtr:impact>European Research Council have awarded a GBP &amp;pound;2m 'Advance Grant' to Imperial College for further research arising out of the pilot study.</gtr:impact><gtr:outcomeId>qjTAUbJocRY-1</gtr:outcomeId><gtr:partnerContribution>Sanger carried out genetic sequencing of samples and supplied the research data to Imperial and AMC.</gtr:partnerContribution><gtr:piContribution>BEEHIVE (Bridging the Evolution and Epidemiology of HIV in Europe). Pilot feasibility study</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Analysis of the 2009-10 influenza pandemic PW</gtr:description><gtr:id>1889728F-F9C9-415A-9ACC-B0D0439067C4</gtr:id><gtr:impact>Campbell et al. Epidemiology and Infection 2011;139(10):1560-1569

Clinical medicine
Epidemiology
Public health
Statistics</gtr:impact><gtr:outcomeId>heFgJmM6zCG-2</gtr:outcomeId><gtr:partnerContribution>Study design and analysis</gtr:partnerContribution><gtr:piContribution>Contribution to study design and analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pittsburgh</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration with Univ of Pittsburgh (Don Burke) via NIH MIDAS network</gtr:description><gtr:id>575A839A-B79E-49D7-A8E6-2BCEF28A63D6</gtr:id><gtr:impact>This work represented a major source of evidence to support pandemic preparedness work undertaken by the US, UK, WHO and other countries. Outputs were PubMed ID 16642006 and the following 2005 paper: Ferguson NM; Cummings DA; Cauchemez S; Fraser C; Riley S; Meeyai A; Iamsirithaworn S; Burke DS. (08 Sep 2005). Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 437:209-214. (PubMed ID 16079797)</gtr:impact><gtr:outcomeId>07E39C57296-1</gtr:outcomeId><gtr:partnerContribution>Collection of data, exchange of ideas, interaction with US policymakers</gtr:partnerContribution><gtr:piContribution>I developed pandemic influenza simulations for modelling intervention strategies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>MERS Coronovirus- Pasteur -2013</gtr:description><gtr:id>12AD8522-5540-42C1-BFF5-048F7E8870C1</gtr:id><gtr:impact>Corresponding publication. PMID 23787162</gtr:impact><gtr:outcomeId>SwehuxTBSGm-1</gtr:outcomeId><gtr:partnerContribution>Assessing epidemic risk of MERS-CoV. Implications for health risk assessment and control.</gtr:partnerContribution><gtr:piContribution>Assessing epidemic risk of MERS-CoV. Implications for health risk assessment and control.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>M?decins Sans Fronti?res (MSF)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>M?decins Sans Fronti?res Operational Centre Amsterdam (MSF OCA)</gtr:department><gtr:description>MSF - Malaria collaboration</gtr:description><gtr:id>45FB5397-78FA-4CA8-AFD8-6FF56CFA10FD</gtr:id><gtr:impact>Training provided in malaria control to MSF country managers.</gtr:impact><gtr:outcomeId>58adaa0d3c8aa2.23224620-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise</gtr:partnerContribution><gtr:piContribution>Co-supervising PhD looking into Malaria in humanitarian settings</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Centre for Disease Prevention and Control (ECDC)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>Review on school closure and flu pandemics</gtr:description><gtr:id>DBF11E04-CC18-484D-BD51-50DCDC31CAE5</gtr:id><gtr:impact>19628172</gtr:impact><gtr:outcomeId>A0A3E664DFC-1</gtr:outcomeId><gtr:partnerContribution>collaborative interaction</gtr:partnerContribution><gtr:piContribution>performed the literature review and drafted the paper</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Comparing Influenza transmission (between 1918 and 2009) - 2013</gtr:description><gtr:id>CA7ACE68-626D-41FD-AD1C-26A4C973B891</gtr:id><gtr:impact>not yet</gtr:impact><gtr:outcomeId>twjXvUZQZ3T-1</gtr:outcomeId><gtr:partnerContribution>data provision and analysis</gtr:partnerContribution><gtr:piContribution>analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>PATH</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>PATH Malaria Vaccine Initiative</gtr:department><gtr:description>Subcontract with Rathbone Medical Centre funded by MVI (2014)</gtr:description><gtr:id>1F693132-15CB-4B33-8288-76AA96C9B3C8</gtr:id><gtr:impact>nothing yet</gtr:impact><gtr:outcomeId>54534e38d2d1e2.75569573-1</gtr:outcomeId><gtr:partnerContribution>generating the data in the lab</gtr:partnerContribution><gtr:piContribution>mathematical models of data generated in the lab</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard T.H. Chan School of Public Health</gtr:department><gtr:description>Marc Lipsitch and Yonatan Grad (Harvard University) - 2015</gtr:description><gtr:id>FFECD057-2C74-4BB3-AF2F-594808E99C04</gtr:id><gtr:impact>PMID: 26518045</gtr:impact><gtr:outcomeId>56d6dc70774ab3.91387044-1</gtr:outcomeId><gtr:partnerContribution>All authors reviewed the literature, sythesised evidence, and identifed gaps in knowledge to propose a research agenda</gtr:partnerContribution><gtr:piContribution>Drug-resistance in gonorrhea: reviewing the literature, sythesising evidence, and identifying gaps in knowledge to propose a research agenda</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Johns Hopkins Bloomberg School of Public Health</gtr:department><gtr:description>Dengue Modelling Consortium JHU-2013</gtr:description><gtr:id>255D955F-CEB8-451E-A846-8245A4A05E08</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>QnSAg2Zmcir-1</gtr:outcomeId><gtr:partnerContribution>Modelling and analysis of Sanofi Pasteur's dengue vaccine candidate.</gtr:partnerContribution><gtr:piContribution>Founder. Also one of three academic groups providing modelling and analysis of Sanofi Pasteur's dengue vaccine candidate.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Epidemiology and Population Health</gtr:department><gtr:description>Design of clinical trials to test novel entomological approaches to dengue control. CD</gtr:description><gtr:id>85720386-6C9F-4391-8767-95806FCD6511</gtr:id><gtr:impact>Paper in press: Wolbers M, Kleinschmidt I, Simmons CP and Donnelly CA. Considerations in the design of clinical trials to test novel entomological approaches to dengue control. PLoS Neglected Tropical Diseases in press.</gtr:impact><gtr:outcomeId>p2bP2xWA3fR-3</gtr:outcomeId><gtr:partnerContribution>Wolbers M (statistical programming expertise), Kleinschmidt I (expertise in stepped wedge design), Simmons CP (dengue epidemiology expertise)</gtr:partnerContribution><gtr:piContribution>I have both statistical (including experimental design) and epidemiological expertise.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bern</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Clinical and cost-effectiveness of technologies for testing and treating sexual partners of people with sexually transmitted infections: Evidence synthesis and mathematical modelling study PW 2012</gtr:description><gtr:id>D5FBD7B2-3479-40AA-92B8-69AF360DB196</gtr:id><gtr:impact>Report for NIHR
Paper submitted

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>ijyk8pxxz9G-1</gtr:outcomeId><gtr:partnerContribution>Systematic review
Transmission-dynamic modelling</gtr:partnerContribution><gtr:piContribution>Advice on transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>What are the public health outcomes, costs and cost-effectiveness of GUM and primary care based STI services, and how should these be planned in order to maximise STI control and cost-effectiveness for a population? PW 2012</gtr:description><gtr:id>DF902B4B-E0D0-44F0-A93A-9E955106ECCC</gtr:id><gtr:impact>Mercer et al Sexually Transmitted Infections 2012; 88: 9-15</gtr:impact><gtr:outcomeId>dr3sUCUKB8T-4</gtr:outcomeId><gtr:partnerContribution>Study design
Survey implementation
Statistical analysis
Transmission-dynamic modelling</gtr:partnerContribution><gtr:piContribution>Advice on transmission-dynamic modelling and survey design</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Targeting men for better sexual health: The BallsEye programme PW 2012</gtr:description><gtr:id>04A20539-DD28-4FDD-985B-7732D6DEF2D1</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>LznBnyBFC2u-2</gtr:outcomeId><gtr:partnerContribution>Systematic review
Health economics
Public health
Statistical analysis</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>The cost effectiveness of genetic markers for antibiotic resistance in tuberculosis PW</gtr:description><gtr:id>F567182C-37E5-4DD6-9922-F2A3BA2DF95A</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine</gtr:impact><gtr:outcomeId>c1SyGHu4uGT-1</gtr:outcomeId><gtr:partnerContribution>Systematic review
Statistical analysis
Health economics</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Rakai Community Cohort Study (RCCS)</gtr:description><gtr:id>9F946A67-CB1C-4A6D-BC3C-BB2CA0300552</gtr:id><gtr:impact>DOI: http://dx.doi.org/10.7554/eLife.20492</gtr:impact><gtr:outcomeId>5893342af28776.32615112-2</gtr:outcomeId><gtr:partnerContribution>Provide data</gtr:partnerContribution><gtr:piContribution>Data analysis and modelling to examine the evolution of virulence in HIV</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Clinical Research</gtr:department><gtr:description>LSHTM - malaria collaboration</gtr:description><gtr:id>8627E4A6-99AA-4756-93AF-5284656E119C</gtr:id><gtr:impact>Manuscripts are in preparation</gtr:impact><gtr:outcomeId>58adb2e6658666.49707604-1</gtr:outcomeId><gtr:partnerContribution>Collected data</gtr:partnerContribution><gtr:piContribution>Advising on interpretation of transmission studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanofi</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Worldwide Antimalarial Resistance Network / Sanofi Limited / DNDI</gtr:description><gtr:id>0F8AE17D-1D1A-4ECF-993B-D3CD423E106F</gtr:id><gtr:impact>Forthcoming</gtr:impact><gtr:outcomeId>56d6fb03819661.19343631-2</gtr:outcomeId><gtr:partnerContribution>Provided data and scientific advice</gtr:partnerContribution><gtr:piContribution>Analysis of data to estimate the profilactic effect of anti-malerials</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Monash University</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Eliminate Dengue Program</gtr:department><gtr:description>EliminateDengue NF 2012</gtr:description><gtr:id>2ACCD2FA-C59A-41C2-9A60-7CA59178858E</gtr:id><gtr:impact>Pending (papers submitted)</gtr:impact><gtr:outcomeId>TMKCP4s8fHv-1</gtr:outcomeId><gtr:partnerContribution>Other aspects of the development of the Wolbachia system</gtr:partnerContribution><gtr:piContribution>Contributing modelling expertise to the development of Wolbachia as a novel vector control for dengue</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Zika in Columbia: early characterisation of epidemiological potential</gtr:description><gtr:id>8E0F2C5C-DD48-47CF-9AF6-00FADFE17839</gtr:id><gtr:impact>DOI: 10.1126/science.aag0219</gtr:impact><gtr:outcomeId>58a5bce7671fc7.43779512-4</gtr:outcomeId><gtr:partnerContribution>Processing of samples, serosurveys and analysing data</gtr:partnerContribution><gtr:piContribution>Analyse data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Modelling Influenza in the USA - 2013</gtr:description><gtr:id>076BB994-C2D2-43E5-BA8A-E39DB72467D0</gtr:id><gtr:impact>Exchange of existing data and collaborative work on modelling disease trends.</gtr:impact><gtr:outcomeId>6EFEBE89329-1</gtr:outcomeId><gtr:partnerContribution>Exchange of existing data and collaborative work on modelling disease trends. Collection of data on index patients and expertise in disease surveillance and influenza epidemiology</gtr:partnerContribution><gtr:piContribution>Expertise in the epidemiological/statistical analysis and modelling of influenza.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Industrial University of Santander</gtr:collaboratingOrganisation><gtr:country>Colombia, Republic of</gtr:country><gtr:description>Zika Collaboration - 2015</gtr:description><gtr:id>EB288F8E-8CBF-4DFA-B434-D7802827DEC8</gtr:id><gtr:impact>Forthcoming</gtr:impact><gtr:outcomeId>56d6f9f6e9aa92.08888622-1</gtr:outcomeId><gtr:partnerContribution>Epidemiological research on flaviviruses</gtr:partnerContribution><gtr:piContribution>Modelling of the Zika virus to characterise the transmission dynamics of the first wave of Zika in Colombia</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HIV Modelling Consortium (2014)</gtr:description><gtr:id>51FDFD95-67E2-4E4D-9191-4DE22406E28A</gtr:id><gtr:impact>Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic.</gtr:impact><gtr:outcomeId>5460896aadad62.01682602-4</gtr:outcomeId><gtr:partnerContribution>Research activities in the mathematical modelling of the HIV epidemic.</gtr:partnerContribution><gtr:piContribution>The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Global Fund to Fight AIDS, Tuberculosis and Malaria</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>ESP - 2015</gtr:description><gtr:id>B3F0E18E-EF0B-48F3-91BE-BC2025EF7454</gtr:id><gtr:impact>Forthcoming</gtr:impact><gtr:outcomeId>56d6da4f89fa83.91143200-1</gtr:outcomeId><gtr:partnerContribution>Support for the country process and provision of local data</gtr:partnerContribution><gtr:piContribution>Support for Elimination Scenario Planning exercises using modelling to support strategic planning in endemic countries</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>MIDAS with Pasteur (2014)</gtr:description><gtr:id>784F527A-E993-4F31-A720-E06A06B7AC43</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:outcomeId>54609a3ed69e00.40934020-1</gtr:outcomeId><gtr:partnerContribution>Co-wrote the grant application</gtr:partnerContribution><gtr:piContribution>Grant won from NIH</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>MERS-CoV collaboration - 2014</gtr:description><gtr:id>514D9E19-9EE7-42D3-ABFA-0BE4FA3E8AF1</gtr:id><gtr:impact>Provided epidemiological analysis and modelling of the MERS-Coronavirus epidemic in Saudi Arabia.</gtr:impact><gtr:outcomeId>5462125d6dc6d2.33758376-2</gtr:outcomeId><gtr:partnerContribution>Access to data. Analysis and modelling.</gtr:partnerContribution><gtr:piContribution>Epidemiological analysis and modelling of the MERS-Coronavirus epidemic in Saudi Arabia.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ministry of Defence (MOD)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HIV Modelling Consortium (2014)</gtr:description><gtr:id>66B8C81C-5CF6-460A-BA11-F71849F605F8</gtr:id><gtr:impact>Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic.</gtr:impact><gtr:outcomeId>5460896aadad62.01682602-7</gtr:outcomeId><gtr:partnerContribution>Research activities in the mathematical modelling of the HIV epidemic.</gtr:partnerContribution><gtr:piContribution>The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>HIV Monitoring Foundation (SHM)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>BEEHIVE - Academic Medical Centre -2013</gtr:description><gtr:id>4285C3A6-EFC8-4D06-84EF-1E187B4785E3</gtr:id><gtr:impact>European Research Council have awarded a GBP &amp;pound;2m 'Advance Grant' to Imperial College for further research arising out of the pilot study.</gtr:impact><gtr:outcomeId>VoW9qhtQ1wm-1</gtr:outcomeId><gtr:partnerContribution>AMC collected samples from Dutch hospitals, storing and documenting them prior to sending to Sanger</gtr:partnerContribution><gtr:piContribution>BEEHIVE (Bridging the Evolution and Epidemiology of HIV in Europe). Pilot feasibility study</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tan Tock Seng Hospital</gtr:collaboratingOrganisation><gtr:country>Singapore, Republic of</gtr:country><gtr:description>Influenza transmission in Singapore</gtr:description><gtr:id>49AF65ED-635F-48CA-A3AB-E481E4E51D09</gtr:id><gtr:impact>Increased mathematical modelling capacity at the National University of Singapore</gtr:impact><gtr:outcomeId>789D80EA801-1</gtr:outcomeId><gtr:partnerContribution>provision of influenza data from Singapore.</gtr:partnerContribution><gtr:piContribution>Support for fellowship (mentor and collaborators) to develop and apply models of influenza transmission in Singapore. Also an on-going collaboration on STD modelling</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hong Kong</gtr:collaboratingOrganisation><gtr:country>Hong Kong, Special Administrative Region of China</gtr:country><gtr:department>School of Public Health and Department of Community Medicine</gtr:department><gtr:description>University of Hong Kong - 2015</gtr:description><gtr:id>D306A05C-955D-492B-BEFC-019E6A920CDA</gtr:id><gtr:impact>Several publications and successful new awards (Any paper with Dr Kendra Wu and Dr Kin On Kwok as the co-authors)</gtr:impact><gtr:outcomeId>56d6db1ade2906.65944160-1</gtr:outcomeId><gtr:partnerContribution>Helped to win grants and publish papers</gtr:partnerContribution><gtr:piContribution>Collaboration on fieldwork and analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Makerere University</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>Rakai Community Cohort Study (RCCS)</gtr:description><gtr:id>C3435AA8-CA2B-4FAE-AD43-804068538542</gtr:id><gtr:impact>DOI: http://dx.doi.org/10.7554/eLife.20492</gtr:impact><gtr:outcomeId>5893342af28776.32615112-1</gtr:outcomeId><gtr:partnerContribution>Provide data</gtr:partnerContribution><gtr:piContribution>Data analysis and modelling to examine the evolution of virulence in HIV</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK Severe Influenza Surveillance System PW</gtr:description><gtr:id>B9763C14-3745-462A-9DB4-1ED65443A4DC</gtr:id><gtr:impact>Report to Department of Health
Bolotin et al PLoS ONE 2012; 7(1): e30279</gtr:impact><gtr:outcomeId>BdfwKqW79pQ-2</gtr:outcomeId><gtr:partnerContribution>Study design and analysis</gtr:partnerContribution><gtr:piContribution>Contributed to study design and analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bill and Melinda Gates Foundation</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>TB Modelling and Analysis Consortium TBMAC</gtr:department><gtr:description>TB-Mac Global targets exercise - 2014</gtr:description><gtr:id>3EB5B116-B52A-46A1-BE24-F6FEB6CEB2E1</gtr:id><gtr:impact>Papers in progress; multidisciplinary collaboration with health economists</gtr:impact><gtr:outcomeId>56d6e36c72ba85.76776451-1</gtr:outcomeId><gtr:partnerContribution>Coordinating the whole exercise amongst India, China and South Africa groups</gtr:partnerContribution><gtr:piContribution>Exercise involved three different countries: I led the and coordinated the effort from India</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Guangzhou No. 12 People's Hospital</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Fluscape GZ12 (2013)</gtr:description><gtr:id>93085E72-D4AC-4EA9-85F9-0E5975D5928F</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>fdnQLTPgsUL-1</gtr:outcomeId><gtr:partnerContribution>Field work</gtr:partnerContribution><gtr:piContribution>Analysis</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Health (DH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK Severe Influenza Surveillance System PW</gtr:description><gtr:id>FC8C0D05-1891-4633-98F4-36D4ACDEA431</gtr:id><gtr:impact>Report to Department of Health
Bolotin et al PLoS ONE 2012; 7(1): e30279</gtr:impact><gtr:outcomeId>BdfwKqW79pQ-1</gtr:outcomeId><gtr:partnerContribution>Study design and analysis</gtr:partnerContribution><gtr:piContribution>Contributed to study design and analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Manish Pareek PhD project PW</gtr:description><gtr:id>0C73E8BE-75DD-4887-A900-96FF497EA2C5</gtr:id><gtr:impact>Mercer et al Sexually Transmitted Infections 2012; 88: 9-15</gtr:impact><gtr:outcomeId>iV3xhMoBZv2-1</gtr:outcomeId><gtr:partnerContribution>Supervision of study design and analysis</gtr:partnerContribution><gtr:piContribution>Supervision of study design and analysis, and health economic analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>CDC - ABC (Active Bacterial Core surveillance) - Captain Matt Moore - 2015</gtr:description><gtr:id>BC37EDFC-7789-46C0-84CB-CE388A552262</gtr:id><gtr:impact>Forthcoming publication</gtr:impact><gtr:outcomeId>56d6d87ae83f33.99533344-1</gtr:outcomeId><gtr:partnerContribution>Data interpretation and epidemiological analysis</gtr:partnerContribution><gtr:piContribution>Data analysis and modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brunel University London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>The cost effectiveness of genetic markers for antibiotic resistance in tuberculosis PW</gtr:description><gtr:id>2D62F8CF-45A5-4088-89CD-2CC312B99BED</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine</gtr:impact><gtr:outcomeId>c1SyGHu4uGT-4</gtr:outcomeId><gtr:partnerContribution>Systematic review
Statistical analysis
Health economics</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kenyan Institute for Medical Research (KEMRI)</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:description>Treating malaria in pregnancy and drug resistance</gtr:description><gtr:id>F31E174D-B7DB-41E9-A69D-EFD5D83D3805</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:outcomeId>58aef8a5ef4545.20475167-1</gtr:outcomeId><gtr:partnerContribution>data collection</gtr:partnerContribution><gtr:piContribution>data analysis for modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard T.H. Chan School of Public Health</gtr:department><gtr:description>HIV treatment as prevention</gtr:description><gtr:id>FECFFA1D-9DC5-4B60-A003-A59CE11F7E4F</gtr:id><gtr:impact>increased data sharing and intellectual collaboration</gtr:impact><gtr:outcomeId>07F29B100C4-1</gtr:outcomeId><gtr:partnerContribution>Provision of data</gtr:partnerContribution><gtr:piContribution>Development and fitting of mathematical models to inform policy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HIV Modelling Consortium (2014)</gtr:description><gtr:id>494F1959-242E-40E2-9C65-98BCAEFEB4D2</gtr:id><gtr:impact>Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic.</gtr:impact><gtr:outcomeId>5460896aadad62.01682602-2</gtr:outcomeId><gtr:partnerContribution>Research activities in the mathematical modelling of the HIV epidemic.</gtr:partnerContribution><gtr:piContribution>The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Harvard Flu Surveillance Partnership</gtr:description><gtr:id>E2FCE71F-7FDE-43C3-B34A-FB479B5433C9</gtr:id><gtr:impact>creation of web based epidemic surveillance software - publication pending.</gtr:impact><gtr:outcomeId>683757AF0F4-1</gtr:outcomeId><gtr:partnerContribution>expertise in web-based disease surveillance</gtr:partnerContribution><gtr:piContribution>expertise in statistical methods</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>UCSF School of Medicine - 2015</gtr:description><gtr:id>555C6167-7084-4563-AF01-B3D955F803EA</gtr:id><gtr:impact>Project on HIV epidemiology and a publication PMID: 25542958</gtr:impact><gtr:outcomeId>56d6d816c06fd4.16098380-1</gtr:outcomeId><gtr:partnerContribution>Genetic analysis and clinical work</gtr:partnerContribution><gtr:piContribution>Modelling and data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Ex Flu-2013</gtr:description><gtr:id>291AFEF6-98D2-4005-951E-5D39757C4D39</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>XEhqM7dkH1M-1</gtr:outcomeId><gtr:partnerContribution>Alison Aiello: Principal Investigator
Amanda Simanek: Study coordination, subject interaction
Arnold Monto: Senior study coordinator</gtr:partnerContribution><gtr:piContribution>Sample design</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of York (Prof Steve Martin) - 2015</gtr:description><gtr:id>A879D3D6-C869-473E-BDF6-F2C4B95A2711</gtr:id><gtr:impact>Paper submitted</gtr:impact><gtr:outcomeId>56d6e990e978c3.40640620-1</gtr:outcomeId><gtr:partnerContribution>Contributor to the analysis</gtr:partnerContribution><gtr:piContribution>Econometric analysis of determinants of life expectancy, identifying what determinants have shown strongest association with life expectancy over the last 20 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of Oxford (Prof Pete Gething) - 2015</gtr:description><gtr:id>E3D68B71-9082-45A9-A3D7-C0F5AA305011</gtr:id><gtr:impact>Several papers in progress</gtr:impact><gtr:outcomeId>56d6de2b02ae90.62413299-1</gtr:outcomeId><gtr:partnerContribution>Working together to develop spatial estimates of AIDS statistics.</gtr:partnerContribution><gtr:piContribution>Working together to develop spatial estimates of AIDS statistics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Oxford University - Dr Robin Thompson</gtr:description><gtr:id>C99A89DF-FA1E-4A0C-8A0F-569642877D03</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58a2d71d4dcdc4.14077960-1</gtr:outcomeId><gtr:partnerContribution>Contribute to R-package EpiEstim and draft a manuscript describing possible application of the package to analyse outbreak data</gtr:partnerContribution><gtr:piContribution>Leading the analysis and package development</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Public health modelling (2014)</gtr:description><gtr:id>4FB6BFBE-646E-4839-A086-490F4DBC3A0D</gtr:id><gtr:impact>Multiple publications, reported elsewhere.</gtr:impact><gtr:outcomeId>545269707ce0a2.71067112-1</gtr:outcomeId><gtr:partnerContribution>Infectious-disease transmission-dynamic modelling</gtr:partnerContribution><gtr:piContribution>Infectious-disease transmission-dynamic modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of KwaZulu-Natal</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>Reconstructing the early spread of HIV in South Africa</gtr:description><gtr:id>B10035CB-1EED-4F0F-86BE-8D98036A2CBD</gtr:id><gtr:impact>Publication: Reconstructing the early spread of HIV in South Africa</gtr:impact><gtr:outcomeId>58af08aace3c59.85221125-1</gtr:outcomeId><gtr:partnerContribution>Data provision</gtr:partnerContribution><gtr:piContribution>Data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Methods for evaluating the severity of a new rapidly emerging pathogen CF</gtr:description><gtr:id>C1A80D29-513A-4377-AE9E-27DC534F80AF</gtr:id><gtr:impact>Paper under review in PLOS Med</gtr:impact><gtr:outcomeId>gQFS1sU11tk-1</gtr:outcomeId><gtr:partnerContribution>They provided intellectual input and helped with scenario planning</gtr:partnerContribution><gtr:piContribution>We developed new methods and CDC helped us make them relevant</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Flu Vaccination programme efficacy modelling-2013</gtr:description><gtr:id>289C6A59-B11B-470D-B058-A0E661938185</gtr:id><gtr:impact>Paper to report on this work is in publication.</gtr:impact><gtr:outcomeId>qUeDAZnVZWY-1</gtr:outcomeId><gtr:partnerContribution>Assessment of transmission model.</gtr:partnerContribution><gtr:piContribution>Assessment of transmission model.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of North Carolina at Chapel Hill</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HIV Modelling</gtr:description><gtr:id>B692938E-000D-4B80-835B-A16EB6BE4C01</gtr:id><gtr:impact>19367154</gtr:impact><gtr:outcomeId>90D21F480D5-1</gtr:outcomeId><gtr:partnerContribution>academic collaboration and provision of HIV data.</gtr:partnerContribution><gtr:piContribution>On-going collaboration to develop HIV transmission models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>WHO Collaborating Centre</gtr:description><gtr:id>D8F724C7-9C54-44EF-A8F1-B4429389C2AB</gtr:id><gtr:impact>Along with publications previously reported on e-Val in 2009, there have been numerous internal WHO reports (see example below) and contributions to data analysis made by the Outbreak Centre in the last year. 

e.g.: WHO (2010) Seroepidemiologic studies for the 2009 influenza A H1N1 pandemic. Wkly Epidemiol Rec, June, No. 24, 2010, 85, 229-236. Available at: http://www.who.int/wer/2010/wer8524.pdf

The Terms of Reference for the Collaborating Center are:
1) to provide rapid analysis of urgent infectious disease problems, notably outbreaks and events of international concern.
2) to provide technical research capability in specific disease areas.
3) to provide training/capacity building in modelling
4) coordination of expertise in infectious disease modelling
5) Contribute to WHO information products as indicated and related activities in the work plan subject to WHO approval.</gtr:impact><gtr:outcomeId>r8kxDzMuZLg-1</gtr:outcomeId><gtr:partnerContribution>We have established a formal partnership with the leading organisation for global health and gained access to invaluable data to inform our research as well as an opportunity to interact with experts, both in country and at the WHO, working on a variety of infectious diseases.</gtr:partnerContribution><gtr:piContribution>Further to our interactions with WHO during the 2009 H1N1 pandemic, we have formalised our relationship as a Collaborating Center.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Intellectual Ventures</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Institute for Disease Modelling in Seattle. Phil Ekhoff</gtr:description><gtr:id>FA56311C-73A8-481A-BF13-884FF3721292</gtr:id><gtr:impact>Various presentations IVCC invited speaker
RBM</gtr:impact><gtr:outcomeId>58c80da9ce41b1.88478671-1</gtr:outcomeId><gtr:partnerContribution>Core new method for outbreak mapping</gtr:partnerContribution><gtr:piContribution>Bringing spatial expertise to outbreak mapping</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bill and Melinda Gates Foundation</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Global Alliance for Vaccination and Immunisation (GAVI)</gtr:department><gtr:description>GAVI Alliance</gtr:description><gtr:id>53DC27DC-CD4C-41CD-AE54-CF90BB19CA2E</gtr:id><gtr:impact>Only recently established</gtr:impact><gtr:outcomeId>58c12bb29bd560.37197253-1</gtr:outcomeId><gtr:partnerContribution>Provide funding and contacts to modelling groups</gtr:partnerContribution><gtr:piContribution>Established Vaccine Impact Modelling Consortium to provide vaccine impact estimates to Gavi and improve used models</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>GSK Biologicals SA</gtr:department><gtr:description>GSK - 2013</gtr:description><gtr:id>71985A18-82CF-4A29-A218-6E30DE0BD655</gtr:id><gtr:impact>PMID 23613845; PMID 23454164, PMID 25012228; One submitted publication; Multiple conference presentations</gtr:impact><gtr:outcomeId>Xh4SyrTC1aM-1</gtr:outcomeId><gtr:partnerContribution>Provision of data from all Phase II studies</gtr:partnerContribution><gtr:piContribution>Understanding biological mechanisms in the RTS,S vaccine and implications for public health impact</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Public Health England, HIV molecular epidemiology (2014)</gtr:description><gtr:id>5878089D-B0CF-45E9-A834-1258CB0FEE8F</gtr:id><gtr:impact>No outcomes.</gtr:impact><gtr:outcomeId>545370775ad4f8.41045409-1</gtr:outcomeId><gtr:partnerContribution>Provision of data and cleaning data. Direction of policy questions.</gtr:partnerContribution><gtr:piContribution>Analysis of HIV-1 sequence data from the UK drug resistance database</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Polio Eradication</gtr:description><gtr:id>5504F9F4-CD87-47D1-AB2E-B621D3A44FFA</gtr:id><gtr:impact>19624278, 18923171, 17448821, 17110580</gtr:impact><gtr:outcomeId>F34581169C1-1</gtr:outcomeId><gtr:partnerContribution>provision of surveillance data, academic collaboration</gtr:partnerContribution><gtr:piContribution>surveillance data, scientific collaboration</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>Vietnam, Socialist Republic of</gtr:country><gtr:department>Oxford University Clinical Research Unit Vietnam (OUCRU)</gtr:department><gtr:description>Design of clinical trials to test novel entomological approaches to dengue control. CD</gtr:description><gtr:id>0D720DA2-588A-4717-BF01-F96323F002F6</gtr:id><gtr:impact>Paper in press: Wolbers M, Kleinschmidt I, Simmons CP and Donnelly CA. Considerations in the design of clinical trials to test novel entomological approaches to dengue control. PLoS Neglected Tropical Diseases in press.</gtr:impact><gtr:outcomeId>p2bP2xWA3fR-1</gtr:outcomeId><gtr:partnerContribution>Wolbers M (statistical programming expertise), Kleinschmidt I (expertise in stepped wedge design), Simmons CP (dengue epidemiology expertise)</gtr:partnerContribution><gtr:piContribution>I have both statistical (including experimental design) and epidemiological expertise.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Clinical and cost-effectiveness of technologies for testing and treating sexual partners of people with sexually transmitted infections: Evidence synthesis and mathematical modelling study PW 2012</gtr:description><gtr:id>175246FD-BBF8-437B-BF76-EB1AE6617B5C</gtr:id><gtr:impact>Report for NIHR
Paper submitted

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>ijyk8pxxz9G-3</gtr:outcomeId><gtr:partnerContribution>Systematic review
Transmission-dynamic modelling</gtr:partnerContribution><gtr:piContribution>Advice on transmission-dynamic modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>PANGEA Consortium</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>The Gates Foundation PANGEA HIV Consortium - 2015</gtr:description><gtr:id>D680744F-EC26-4091-8180-2685AD39D2B7</gtr:id><gtr:impact>Publications summarising the findings of the exercise.</gtr:impact><gtr:outcomeId>56d6e69e759ed2.19844270-1</gtr:outcomeId><gtr:partnerContribution>Organization of the simulation exercise</gtr:partnerContribution><gtr:piContribution>Participated in a large simulation exercise to evaluate epidemiological inference methods</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Maryland</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Institute of human virology - similar to global fund</gtr:description><gtr:id>EDF945A7-2740-4127-924E-84D1A6407EC5</gtr:id><gtr:impact>Paper and a policy brief which are currently in review.</gtr:impact><gtr:outcomeId>58c7ef87776b55.57768983-1</gtr:outcomeId><gtr:partnerContribution>Modelling the impact of treatment-as-prevention on HIV in Nigeria and the role of concentrated transmission in high risk groups.</gtr:partnerContribution><gtr:piContribution>Modelling the impact of treatment-as-prevention on HIV in Nigeria and the role of concentrated transmission in high risk groups.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wisconsin-Madison</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pathobiological Sciences</gtr:department><gtr:description>Zika in Columbia: early characterisation of epidemiological potential</gtr:description><gtr:id>BC1B363C-2541-4F95-8465-9207D3CB6D2B</gtr:id><gtr:impact>DOI: 10.1126/science.aag0219</gtr:impact><gtr:outcomeId>58a5bce7671fc7.43779512-3</gtr:outcomeId><gtr:partnerContribution>Processing of samples, serosurveys and analysing data</gtr:partnerContribution><gtr:piContribution>Analyse data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>The WHO Rapid Pandemic Assessment Collaboration</gtr:description><gtr:id>8C4E42A5-D2EF-4CA7-A47D-5148621D2AD2</gtr:id><gtr:impact>19433588</gtr:impact><gtr:outcomeId>BFBE2BA544E-1</gtr:outcomeId><gtr:partnerContribution>Local expertise on Mexican flu outbreaks, international expertise on policy needs</gtr:partnerContribution><gtr:piContribution>expertise in statistics, genetics, bioinformatics and mathematical modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>BEEHIVE: Bridging the Evolution and Epidemiology of HIV in Europe (2014)</gtr:description><gtr:id>412AC0A6-FA25-4414-B7EB-EE4577FC9D2C</gtr:id><gtr:impact>More cohorts involved than anticipated, but too early to report scientific impacts.</gtr:impact><gtr:outcomeId>5460c1ce61c0d7.92999745-2</gtr:outcomeId><gtr:partnerContribution>Scientific collaboration; providing data, samples &amp;amp; laboratory analysis/work.</gtr:partnerContribution><gtr:piContribution>Leadership &amp;amp; scientific coordination</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Global Fund to Fight AIDS, Tuberculosis and Malaria</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>GFATM (Erik Volz consultancy) - 2015</gtr:description><gtr:id>A9EF11BC-6BF9-42C6-A175-17655EB77E2F</gtr:id><gtr:impact>Paper and a policy brief which are currently in review.</gtr:impact><gtr:outcomeId>56d6e5ff71b378.04958317-1</gtr:outcomeId><gtr:partnerContribution>Provision of questions and data</gtr:partnerContribution><gtr:piContribution>Modelling the impact of treatment-as-prevention on HIV in Nigeria and the role of concentrated transmission in high risk groups.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Estimating burden of influenza in USA - 2014</gtr:description><gtr:id>507C336F-7AD3-43EC-9296-E39A78AB16AE</gtr:id><gtr:impact>Papers in progress: collaboration with public health officials at CDC</gtr:impact><gtr:outcomeId>545369d2c67b43.40263447-1</gtr:outcomeId><gtr:partnerContribution>Providing data and expertise</gtr:partnerContribution><gtr:piContribution>Developing model to assist CDC in interpreting their surveillance systems</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Centre for Disease Prevention and Control (ECDC)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>ECDC</gtr:description><gtr:id>5BDE316E-2BAF-467F-AB84-8294D72AD4D9</gtr:id><gtr:impact>a manuscript is in preparation, presentation to ECDC</gtr:impact><gtr:outcomeId>Y1dBJuBkvQk-1</gtr:outcomeId><gtr:partnerContribution>Access to data on school closures during the 2009 H1N1 pandemic for use in the development of new analysis tools and methods.</gtr:partnerContribution><gtr:piContribution>Review of the national and local experiences on school closures during the 2009 H1N1 pandemic</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department For Environment, Food And Rural Affairs (DEFRA)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Blue-Tongue Virus Modelling for UK</gtr:description><gtr:id>8CC0A2E3-DA71-4B41-AF65-E26D60AD26AE</gtr:id><gtr:impact>Increased understanding of the dynamics and spread of Blue-Tongue virus in the UK.</gtr:impact><gtr:outcomeId>B1683AA3FB9-1</gtr:outcomeId><gtr:piContribution>Provided support in model coding and development</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Global lineages</gtr:description><gtr:id>C128086C-295E-4499-8D25-6DDDB2E360E9</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>58af0ffb46c5f4.69480723-1</gtr:outcomeId><gtr:partnerContribution>Data provision</gtr:partnerContribution><gtr:piContribution>Data analysis and laboratory work</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Colombian Institute of Family Welfare</gtr:collaboratingOrganisation><gtr:country>Colombia, Republic of</gtr:country><gtr:description>Memorandum of Understanding with National Institute of Health - Colombia</gtr:description><gtr:id>AF544B27-2EA8-4D90-8ABE-76F8B012B819</gtr:id><gtr:impact>Too early to report</gtr:impact><gtr:outcomeId>58c708ad4990a0.95545379-1</gtr:outcomeId><gtr:partnerContribution>Commitment to cooperative working and exchange of research in public health and education activities in science and technology.</gtr:partnerContribution><gtr:piContribution>Commitment to cooperative working and exchange of research in public health and education activities in science and technology.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Manish Pareek PhD project PW</gtr:description><gtr:id>F9AA980B-D104-4DCF-8DF5-8A3CA50E24CA</gtr:id><gtr:impact>Mercer et al Sexually Transmitted Infections 2012; 88: 9-15</gtr:impact><gtr:outcomeId>iV3xhMoBZv2-2</gtr:outcomeId><gtr:partnerContribution>Supervision of study design and analysis</gtr:partnerContribution><gtr:piContribution>Supervision of study design and analysis, and health economic analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of York (Prof Karl Claxton) - 2015</gtr:description><gtr:id>20552D7B-7CC4-4A22-931D-A2A3B7265D61</gtr:id><gtr:impact>Several papers in progress</gtr:impact><gtr:outcomeId>56d6de71059cd1.08763525-1</gtr:outcomeId><gtr:partnerContribution>Working together to understand optimal decision making in resource allocation in the face of uncertainty</gtr:partnerContribution><gtr:piContribution>Working together to understand optimal decision making in resource allocation in the face of uncertainty</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>i-sense</gtr:description><gtr:id>D291F8BB-7D28-408F-8388-E5346045E07A</gtr:id><gtr:impact>presentation at isense consortium meetings</gtr:impact><gtr:outcomeId>58c7fb01e197a8.74442968-1</gtr:outcomeId><gtr:partnerContribution>statisical analysis</gtr:partnerContribution><gtr:piContribution>Infectious disease modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of Liverpool - 2015</gtr:description><gtr:id>B904C303-B8E5-4ABB-A3CA-261AE6DAE51F</gtr:id><gtr:impact>Applied for a new award from the Wellcome Trust via University of Liverpool, which was successful.</gtr:impact><gtr:outcomeId>56d6e7c954a550.78054267-1</gtr:outcomeId><gtr:partnerContribution>Fit a transmission dynamics mathematical to a meta-analysis of published entomological studies to predict the added public health benefit of switching from standard to PBO bednets for mosquito control.</gtr:partnerContribution><gtr:piContribution>Consultancy work for Global Fund project</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Istituto Zooprofilattico Sperimentale Delle Venezie (IZSVe)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Research and Development (IZSVe)</gtr:department><gtr:description>Rabies and Canine Distemper</gtr:description><gtr:id>CB3A5465-5D59-409B-946E-57C44D17086E</gtr:id><gtr:impact>Rhodes, C. J., Donnelly, C. A., De Nardi, M. and Cattoli, G. Epidemiology of rabies and distemper infection in the fox population of north-eastern Italy. 2010c (in revision)</gtr:impact><gtr:outcomeId>arJUnDo9dJh-1</gtr:outcomeId><gtr:partnerContribution>access to data on rabies and canine distemper virus in Italian foxes.</gtr:partnerContribution><gtr:piContribution>statistical analysis and modelling of canine distemper and rabies in Italian foxes</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Phylodynamics of Streptococcus pneumoniae CF</gtr:description><gtr:id>0E2741D8-4EB0-49CE-995C-CBF721527C0C</gtr:id><gtr:impact>Paper to be submitted to PLOS Genetics, preparing a grant strategy</gtr:impact><gtr:outcomeId>Mx5ALQjnQ6P-1</gtr:outcomeId><gtr:partnerContribution>They sequence, and share intellectual leadership</gtr:partnerContribution><gtr:piContribution>We provide analytical support and share intellectual leadership on study of Streptococcus pneumoniae</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Combined Phylogenetic and Epidemiological Analysis in Seattle</gtr:description><gtr:id>C8B937F0-4943-4DBD-863E-E3E930AC0B5D</gtr:id><gtr:impact>Nothing yet.</gtr:impact><gtr:outcomeId>58af046036ccf9.23280786-1</gtr:outcomeId><gtr:partnerContribution>Data collection in future</gtr:partnerContribution><gtr:piContribution>Nothing yet</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Laboratory Lysavirus Dynamics and Host Adaptation</gtr:department><gtr:description>Institut Pasteur - Herve Bourhy</gtr:description><gtr:id>3613809D-E2BA-49C3-A393-81658DFA8402</gtr:id><gtr:impact>Supervise an MSc student, workshop on rabies in Cameroon (Dec 2016)</gtr:impact><gtr:outcomeId>58a5bbec7d68a0.67255901-1</gtr:outcomeId><gtr:partnerContribution>Provide data</gtr:partnerContribution><gtr:piContribution>Analyse data</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Christian Medical College, Vellore</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>Polio vaccine clinical trials (2014)</gtr:description><gtr:id>EB47ADC7-E99F-4CDF-9C72-0E068D9C433E</gtr:id><gtr:impact>John, J., et al. (2014). &amp;quot;Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial.&amp;quot; The Lancet.</gtr:impact><gtr:outcomeId>54526094404d24.37680505-1</gtr:outcomeId><gtr:partnerContribution>grant writing, scientific analysis</gtr:partnerContribution><gtr:piContribution>grant writing, scientific analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Evaluation of the London TB Find and Treat Project PW</gtr:description><gtr:id>30D35AE3-1D49-4D0E-9C59-12173527E688</gtr:id><gtr:impact>Jit et al. British Medical Journal 2011; 343: d5376.
Reports for Department of Health</gtr:impact><gtr:outcomeId>tEhkni3Br3d-1</gtr:outcomeId><gtr:partnerContribution>Analysis of data from TB surveillance and the Find &amp;amp; Treat service</gtr:partnerContribution><gtr:piContribution>Health economic transmission-dynamic modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>WHO Ebola Response Group - 2014</gtr:description><gtr:id>4563E7AA-EB4A-436D-9257-36F4F5130DC4</gtr:id><gtr:impact>Pubmed ID 25244186</gtr:impact><gtr:outcomeId>545cd6db0819d8.90912398-1</gtr:outcomeId><gtr:partnerContribution>Access to data; Collaboration on pubmed ID 25244186</gtr:partnerContribution><gtr:piContribution>Data cleaning and analysis; Pubmed ID 25244186</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Global Malaria Programme</gtr:department><gtr:description>WHO GMP -2013</gtr:description><gtr:id>E5E88FDC-767B-47F0-9D25-10CC1BF53C26</gtr:id><gtr:impact>PMID: 22673908; PMID: 22050911; PMID 23550770</gtr:impact><gtr:outcomeId>hxt88mc9wsp-1</gtr:outcomeId><gtr:partnerContribution>Intellectual partnership, relevant questions to support public health policy</gtr:partnerContribution><gtr:piContribution>Collaboration on various topics - input into burden estimation, cost-effectiveness of malaria interventions, drug resistance, insecticide resistance, elimination strategies. Collaboration on scenario analysis and cost-efefctiveness for the Global Technical Strategy.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>PATH</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>PATH Malaria Vaccine Initiative</gtr:department><gtr:description>Subcontract with Rathbone Medical Centre funded by MVI - 2015</gtr:description><gtr:id>7CFE6DDA-564A-4BA1-A2E8-3730B86EC492</gtr:id><gtr:impact>PMID: 26063320, 25541384, 25597498 and other forthcoming papers</gtr:impact><gtr:outcomeId>56d6e735d89317.68843134-1</gtr:outcomeId><gtr:partnerContribution>Generating the data in the lab</gtr:partnerContribution><gtr:piContribution>Mathematical models of data generated in the lab</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Health (DH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Analysis of the 2009-10 influenza pandemic PW</gtr:description><gtr:id>779473FC-5A6D-482E-BB24-F9140D9AA93B</gtr:id><gtr:impact>Campbell et al. Epidemiology and Infection 2011;139(10):1560-1569

Clinical medicine
Epidemiology
Public health
Statistics</gtr:impact><gtr:outcomeId>heFgJmM6zCG-1</gtr:outcomeId><gtr:partnerContribution>Study design and analysis</gtr:partnerContribution><gtr:piContribution>Contribution to study design and analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>Vietnam, Socialist Republic of</gtr:country><gtr:department>Oxford University Clinical Research Unit Vietnam (OUCRU)</gtr:department><gtr:description>Dengue in Vietnam - 2012</gtr:description><gtr:id>2CF68016-AD1D-4178-A0B6-FA70D944F630</gtr:id><gtr:impact>Exchange and collection of data on dengue pathogenesis, impact of control measures and associated modelling.</gtr:impact><gtr:outcomeId>DFFACC55135-1</gtr:outcomeId><gtr:partnerContribution>Access to data on dengue infection in Vietnam</gtr:partnerContribution><gtr:piContribution>Expertise in mathematical modelling and statistical analysis of infectious disease data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Drugs for Neglected Diseases initiative (DNDi)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Worldwide Antimalarial Resistance Network / Sanofi Limited / DNDI</gtr:description><gtr:id>2501ADC9-F19A-42F6-9214-936B788AF8C9</gtr:id><gtr:impact>Forthcoming</gtr:impact><gtr:outcomeId>56d6fb03819661.19343631-3</gtr:outcomeId><gtr:partnerContribution>Provided data and scientific advice</gtr:partnerContribution><gtr:piContribution>Analysis of data to estimate the profilactic effect of anti-malerials</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Analysis of early H1N1 outbreak in UK</gtr:description><gtr:id>492AC1B6-509A-4FA0-ACE6-4E1C366CAAEE</gtr:id><gtr:impact>The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom Azra C Ghani1*, Marc Baguelin2*, Jamie T Griffin1*, Stefan Flasche2,6*, Richard Pebody2*, Albert Jan Van Hoek2*, Simon Cauchemez1, Ian M Hall 3, Christl A Donnelly1, Chris Robertson4,6, Michael T White1, Iain Barrass3, Christophe Fraser1, Alison Bermingham2, James Truscott1, Joanna Ellis2, Helen E Jenkins1, George Kafatos2, Tini Garske1, Ross Harris2, Jim McMenamin4, Colin Hawkins2, Nick Phin2, Andr&amp;eacute; Charlett2, Maria Zambon2, W. John Edmunds2,5, Mike Catchpole2, Steve Leach3, Peter J White1,2, Neil M Ferguson1+, Ben S. Cooper2+. In Review and also available on PLoS Currents - Influenza</gtr:impact><gtr:outcomeId>D39DBBCD390-1</gtr:outcomeId><gtr:partnerContribution>Provision of early data on H1N1 pandemic in the UK</gtr:partnerContribution><gtr:piContribution>Collaborative analysis of early H1N1 case data from the UK</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medicines for Malaria Venture (MMV)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>MMV -2013</gtr:description><gtr:id>5C4629E7-CF21-4D29-95E8-5CC8A50BD82A</gtr:id><gtr:impact>Paper in draft; Conference presentations at ASTMH 2012, Multilateral Initiative on Malaria Conference 2013</gtr:impact><gtr:outcomeId>WzAMGwZ9TQ4-1</gtr:outcomeId><gtr:partnerContribution>Provision of data, insight into appropriate questions</gtr:partnerContribution><gtr:piContribution>Development and application of models to consider the impact of and cost-effectiveness of switching to a new drug for first-line therapy in African countries (the impact of different anti-malarials as first-line therapy)</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>FIND Diagnostics (India)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>FIND Diagnostics India - 2015</gtr:description><gtr:id>32E43311-DA1E-4C67-8214-5B1B257BA50B</gtr:id><gtr:impact>One paper published, one in review, and one in preparation stage.</gtr:impact><gtr:outcomeId>56d6e287295609.54571464-1</gtr:outcomeId><gtr:partnerContribution>Co-authored several papers</gtr:partnerContribution><gtr:piContribution>Contributed statistical analysis to &amp;quot;Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India&amp;quot; and led the modelling efforts for the publication &amp;quot;The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis&amp;quot;</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Past and current plague epidemics</gtr:description><gtr:id>7908752D-51F9-4B52-89C4-4945BA19EA5F</gtr:id><gtr:impact>increased understanding of Plague</gtr:impact><gtr:outcomeId>DF0741BC3A8-1</gtr:outcomeId><gtr:partnerContribution>Exchange of existing data, collaborative work on epidemiological genetics modelling</gtr:partnerContribution><gtr:piContribution>mathematical modelling and epidemiological genetics</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>International Clinical Research Centre (ICRC)</gtr:department><gtr:description>Collaboration re HIV and Hormonal Contraception TH</gtr:description><gtr:id>D9458FD4-F6EE-490A-A470-C856EACAF91B</gtr:id><gtr:impact>Paper: Butler et al</gtr:impact><gtr:outcomeId>gGk7rfxAv2V-1</gtr:outcomeId><gtr:partnerContribution>They write the proposed trial protocol and contribute clinical evidence.</gtr:partnerContribution><gtr:piContribution>We analysed the data that this group has collected in new ways that have informed decision-making on several issues in relation to family planning needs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HIV Modelling Consortium (2014)</gtr:description><gtr:id>8C152D86-FA06-4EEE-907D-E9A9EA234A87</gtr:id><gtr:impact>Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic.</gtr:impact><gtr:outcomeId>5460896aadad62.01682602-5</gtr:outcomeId><gtr:partnerContribution>Research activities in the mathematical modelling of the HIV epidemic.</gtr:partnerContribution><gtr:piContribution>The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Within host diversity</gtr:description><gtr:id>62E69082-8CF3-4B0D-94F1-3C4A96B4836A</gtr:id><gtr:impact>Sequenced data has emerged. Work ongoing on publication.</gtr:impact><gtr:outcomeId>58af0f971f5933.46177583-1</gtr:outcomeId><gtr:partnerContribution>Data provision</gtr:partnerContribution><gtr:piContribution>Data analysis and laboratory work</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Modelling HIV evolution</gtr:description><gtr:id>D87C84F3-49CC-4F02-98A0-8744C013C71B</gtr:id><gtr:impact>17954909</gtr:impact><gtr:outcomeId>B905CA5D4BE-1</gtr:outcomeId><gtr:partnerContribution>Provision of data</gtr:partnerContribution><gtr:piContribution>Development and fitting of mathematical models to better understand HIV evolution</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Interferon gamma tests for the rapid identification of active tuberculosis disease PW</gtr:description><gtr:id>9614FF07-CD07-4712-8BF1-9B82B6C2D2A7</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>Kf6WWBBmVaC-1</gtr:outcomeId><gtr:partnerContribution>Clinical research
Statistical analysis
Health economics</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of Oxford (Prof Holm Uhlig) - 2015</gtr:description><gtr:id>316A0E5F-9BAC-4AD4-8343-4E5F52A5FAEC</gtr:id><gtr:impact>Forthcoming</gtr:impact><gtr:outcomeId>56d6e0306180a3.73605232-1</gtr:outcomeId><gtr:partnerContribution>Training in flow cytometry</gtr:partnerContribution><gtr:piContribution>Collaboration on Gates study</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>CDC NG 2012</gtr:description><gtr:id>A4EA32D4-4406-4704-AD67-A71AFB090C66</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>X5WsLkt7ZmG-1</gtr:outcomeId><gtr:partnerContribution>Provision of sequence data and joint analysis</gtr:partnerContribution><gtr:piContribution>Analysis of genetic sequence data for poliovirus</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>PANGEA Consortium</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>PANGEA (2014)</gtr:description><gtr:id>3450D50E-BD58-4E31-BD91-61B27A4784E7</gtr:id><gtr:impact>Too early to report scientific impacts.</gtr:impact><gtr:outcomeId>5460c35caf0d90.39696395-1</gtr:outcomeId><gtr:partnerContribution>Scientific collaboration; providing data, samples &amp;amp; laboratory analysis/work.</gtr:partnerContribution><gtr:piContribution>Coordination of scientific analysis</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cape Town</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>Review of HIV modelling PW</gtr:description><gtr:id>9222FCEA-47A6-49B1-9903-1766911EA245</gtr:id><gtr:impact>Johnson &amp;amp; White. Sexually Transmitted Infections 2011; 87(7): 629-634</gtr:impact><gtr:outcomeId>tQp49a6tEuG-1</gtr:outcomeId><gtr:partnerContribution>Study design and analysis</gtr:partnerContribution><gtr:piContribution>Contribution to study design and analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of New South Wales</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>School of Public Health and Community Medicine NSW</gtr:department><gtr:description>N95 respirators and Flu Transmission</gtr:description><gtr:id>40D163D8-60D4-45ED-B4E6-3194FB7BB9C4</gtr:id><gtr:impact>MacIntyre CR; Wang Q; Cauchemez S; Seale H; Dwyer DE; Yang P; Shi W; Gao Z; et a; lPang X; Zhang Y; Wang X; Duan W; Rahman B; Ferguson N. (May 2011). A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Respi Viruses. 5:170-179</gtr:impact><gtr:outcomeId>TMdTQnF8smc-1</gtr:outcomeId><gtr:partnerContribution>Our interaction with Prof MacIntyre has facilitated our research on the role of face masks and respirators in the prevention of influenza transmission.</gtr:partnerContribution><gtr:piContribution>Mathematical analysis of a randomized clinical trial</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Institut Pasteur - Simon Cauchemez</gtr:description><gtr:id>8B98792D-C1BA-4D9A-A38A-BF8A72B22CC3</gtr:id><gtr:impact>doi: 10.1073/pnas.1519235113</gtr:impact><gtr:outcomeId>58a5bba69f1ce7.12058815-1</gtr:outcomeId><gtr:partnerContribution>Analyse data on MERS-CoV virus</gtr:partnerContribution><gtr:piContribution>Analyse data on MERS-CoV virus</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>United States Agency for International Development</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>PEPFAR</gtr:description><gtr:id>2771775B-750C-4050-8DA4-6ED77C9D8EDF</gtr:id><gtr:impact>Publications
Imperial producing estimates
High profile</gtr:impact><gtr:outcomeId>58c80ee4dca600.04093300-1</gtr:outcomeId><gtr:partnerContribution>Data</gtr:partnerContribution><gtr:piContribution>Generating estimates</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Antigen Discovery Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Vaccine immune responses</gtr:description><gtr:id>23D16857-D3E8-47A7-9BE6-C3B80342B9CC</gtr:id><gtr:impact>Publication. Information on vaccine responses in a clinical trial will be available in the future.</gtr:impact><gtr:outcomeId>58af106c8c09a1.34040060-1</gtr:outcomeId><gtr:partnerContribution>Data provision</gtr:partnerContribution><gtr:piContribution>Data analysis</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Emory University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Infectious Diseases</gtr:department><gtr:description>Read - 2013 and 2014</gtr:description><gtr:id>5B0CE2BD-1098-4E7D-8DD4-E1EC3C8411E9</gtr:id><gtr:impact>PMID 22891032, 23532978</gtr:impact><gtr:outcomeId>J2ZvQwBjoX6-1</gtr:outcomeId><gtr:partnerContribution>Whole-genome sequencing of bacterial isolates.</gtr:partnerContribution><gtr:piContribution>Statistical analysis of genomic data from Chlamydia trachomatis and psittaci.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>HIV estimation in Europe</gtr:description><gtr:id>D56B6F7D-2111-4F61-B490-9CEFEF92542A</gtr:id><gtr:impact>Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners.
Hallett TB, Smit C, Garnett GP, de Wolf F.
Sex Transm Infect. 2010 Jul 18.</gtr:impact><gtr:outcomeId>EwEjPqZbEFe-1</gtr:outcomeId><gtr:partnerContribution>access to data on HIV transmission in Europeaccess to data on HIV transmission in Europe</gtr:partnerContribution><gtr:piContribution>statistical and modelling techniques for estimating HIV transmission</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brunel University London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Targeting men for better sexual health: The BallsEye programme PW 2012</gtr:description><gtr:id>29461E44-6368-4E4A-A0A8-147D287A832B</gtr:id><gtr:impact>No outputs yet

Statistics
Public health
Clinical medicine
Health economics</gtr:impact><gtr:outcomeId>LznBnyBFC2u-4</gtr:outcomeId><gtr:partnerContribution>Systematic review
Health economics
Public health
Statistical analysis</gtr:partnerContribution><gtr:piContribution>Transmission-dynamic modelling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bill and Melinda Gates Foundation</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>TB Modelling and Analysis Consortium TBMAC</gtr:department><gtr:description>TB-Mac Global targets exercise (2014)</gtr:description><gtr:id>10753212-CC14-41E5-9336-552FA94886A0</gtr:id><gtr:impact>Papers in progress; multidisciplinary collaboration with health economists</gtr:impact><gtr:outcomeId>545368daa172f6.67260074-1</gtr:outcomeId><gtr:partnerContribution>Coordinating the whole exercise amongst India, China and South Africa groups</gtr:partnerContribution><gtr:piContribution>Exercise involved three different countries: Dr Nimalan Arinaminpathy led the and coordinated the effort from India</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sanger Institute and Wellcome Trust - 2015</gtr:description><gtr:id>99F47783-957C-4A0E-90C2-3B1962E2209D</gtr:id><gtr:impact>Forthcoming</gtr:impact><gtr:outcomeId>56d6e57f89dd41.08478574-1</gtr:outcomeId><gtr:partnerContribution>N/A</gtr:partnerContribution><gtr:piContribution>N/A</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Murdoch University</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Murdoch University, Perth, Australia (Dr Xiaohui Zhang) - 2015</gtr:description><gtr:id>1AA99C68-FAFF-438E-B043-9BF4EDC8A776</gtr:id><gtr:impact>Paper forthcoming in the journal Health Economics.</gtr:impact><gtr:outcomeId>56d6e8ee9fb069.49382499-1</gtr:outcomeId><gtr:partnerContribution>Analysis</gtr:partnerContribution><gtr:piContribution>Econometric analysis to determine the most important drivers of healthcare expenditure growth in OECD countries using a common factor model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brown University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HIV Modelling Consortium (2014)</gtr:description><gtr:id>8BED5434-75AA-46F0-83E7-4BA15E86E982</gtr:id><gtr:impact>Coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Improved scientific support for decision-making with regard to the HIV epidemic.</gtr:impact><gtr:outcomeId>5460896aadad62.01682602-8</gtr:outcomeId><gtr:partnerContribution>Research activities in the mathematical modelling of the HIV epidemic.</gtr:partnerContribution><gtr:piContribution>The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy makers, in conjunction with the targeted and responsive commissioning of new work. Its central objective is to help improve scientific support for decision-making by coordinating a wide range of research activities in the mathematical modelling of the HIV epidemic.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of Liverpool (Prof Miren Iturriza-Gomara ) - 2015</gtr:description><gtr:id>5F131344-6735-46AE-87AD-7101C5F40E1D</gtr:id><gtr:impact>Forthcoming</gtr:impact><gtr:outcomeId>56d6dfe920aa48.01330270-1</gtr:outcomeId><gtr:partnerContribution>Running of a clinical trial site</gtr:partnerContribution><gtr:piContribution>Analysis and sequencing of the microbiota for multi-site clinical trial</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Illinois at Urbana-Champaign</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Microbiology</gtr:department><gtr:description>Whitaker XD</gtr:description><gtr:id>C820591B-3C73-43A6-8307-A7BF56F8EA37</gtr:id><gtr:impact>PMID 22363207. Manuscript submitted describing genomic distribution of recombination in Sulfolobus islandicus.</gtr:impact><gtr:outcomeId>nnocFprLfYz-1</gtr:outcomeId><gtr:partnerContribution>Sampling of bacterial isolates, whole-genome sequencing.</gtr:partnerContribution><gtr:piContribution>Statistical analysis of genomic data from Sulfolobus islandicus.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Isaac Newton Institute lecture - 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8C4D1FE3-7E97-4080-BEC5-ED75752CCD32</gtr:id><gtr:impact>Attended by about 50 researchers and invited guests - but the talk was widely advertised and tweeted. The talk was live streamed and available online afterwards so was available to the wider public.

The talk was reported in an article in the Sunday Times newspaper. http://www.thesundaytimes.co.uk/sto/news/uk_news/Environment/article1310810.ece</gtr:impact><gtr:outcomeId>W3fwffUT8UA</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.newton.ac.uk/programmes/IDD/special_lecture</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Cherwell talk - 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0DCCD754-181C-4DE2-B7E2-5B56BAFAD69B</gtr:id><gtr:impact>100 students in attendance.

Too soon to say</gtr:impact><gtr:outcomeId>P8Lq8cyxTY7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Life Festival - WH - 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F92D96C6-B07C-4EED-8A26-4934B15FA41B</gtr:id><gtr:impact>Over 1200 visitors attended the MRC centenary 'Life Festival' at the Science Museum. Through participation in our games and activities visitors learned about the concepts of infection, vaccination, and herd immunity.

97% of event visitors rated their experience as 'positive', with many visitors leaving specific positive feedback about our activities.</gtr:impact><gtr:outcomeId>YUk2jS6hUoK</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/medicine/publichealth/mrscentreforoutbreakanalysisandmodelling/newssummary/news_19-6-2013-17-29-45#fni-4</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at St Ebbe's Primary School, Oxford, Year 1.  Mrs Godby teacher CD</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>AE092B34-AB79-494C-8FEC-7D01CB8E05F8</gtr:id><gtr:impact>30 children heard about 'germs', transmission and the importance of handwashing.

_</gtr:impact><gtr:outcomeId>kQE3Qfys9zA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Estimating Yellow Fever Disease Burden in Africa - WHO Engagement MVK</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B5F65FB8-E951-4D00-A6C3-72211FF8DD64</gtr:id><gtr:impact>Coordination of expert panel, presentations and peer-revewed publication (in preparation)

Results add to evidence base to make policy decisions</gtr:impact><gtr:outcomeId>Z7Us4NxT8cP</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Collaboration with Oxford Clinical Micriobiology (2014)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F4CA869C-176C-4B59-BBCE-744A3FF4EFD8</gtr:id><gtr:impact>Seminar and day of meetings. Sponsored postdoctoral fellowship application. Made plans for future meetings.

Sponsored postdoctoral fellowship application</gtr:impact><gtr:outcomeId>54537559587c27.11256429</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>workshop facilitator</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Meeting in collaboration with Christian Medical College (CMC) - 2015</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>101CA797-9E46-4768-A34F-A587249845E6</gtr:id><gtr:impact>Discussions around biological challenges to effective vaccines in the developing world. Sharing latest research, new collaborations and disseminating research outcomes.</gtr:impact><gtr:outcomeId>56d7051a526ff6.84656392</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Imperial Festival - James Hay</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A1C7667F-8E27-4038-8283-F3F67A7F1FF2</gtr:id><gtr:impact>Imperial Festival event development (with Harriet Mills - now at Bristol having left in 2016)</gtr:impact><gtr:outcomeId>58c805f38cf202.71890639</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mobile pathogens in a changing world: impacts on ecosystem, human and wildlife health - Grantham Institute (June 2015)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6327F6D1-48C9-482A-8E71-95AC17513056</gtr:id><gtr:impact>This public lecture was recorded and made accessible online. Broaden professional network.</gtr:impact><gtr:outcomeId>56d7071d4f81e3.84586846</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/naturalsciences/climatechange/eventssummary/event_5-5-2015-11-17-13</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>13E4B48E-1146-440E-9EEC-CD0F8842AD3A</gtr:id><gtr:impact>Festival talk followed by lively discussion with the audience. http://www.cam.ac.uk/sciencefestival/files/2012/02/Cambridge-Science-Festival-2012-Programme.pdf 6pm - 7pm, 15 March 2012, University of Cambridge
&amp;quot;Outbreak: how epidemiologists work to protect you&amp;quot;

_</gtr:impact><gtr:outcomeId>DEKQD5ceDf4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cam.ac.uk/sciencefestival/files/2012/02/Cambridge-Science-Festival-2012-Programme.pdf</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MALEra Modelling Group</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3E5DA346-636F-43B8-99E7-C753148F2F10</gtr:id><gtr:impact>Development of research agenda for modelling for malaria eradication

White Report Due 2010</gtr:impact><gtr:outcomeId>D0C829C754B</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk at Society for Molecular Biology and Evolution Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E3025D67-0EBC-4467-A22F-20032FD55F8F</gtr:id><gtr:impact>Invited talk at Society for Molecular Biology and Evolution Meeting</gtr:impact><gtr:outcomeId>58c00b5193afa3.25336772</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.pneuomogen.net/smbe</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Plenary talk at the International Symposium on Pneumococcai and Pneumococcal Diseases</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>27C2BE87-2548-418C-B84A-5DAF49993726</gtr:id><gtr:impact>Invited to give a plenary talk at the International Symposium on Pneumococcai and Pneumococcal Diseases</gtr:impact><gtr:outcomeId>58c00a7bd9c882.62223758</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.isppd2016.kenes.com</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Malaria No More Events in Parliament - 2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>77AFC4CA-CFC7-444B-BB47-891AA7852D4F</gtr:id><gtr:impact>Stall as part of an event organised by Malaria No More to engage politicians with the need for the UK to continue to support global malaria programs. We ran a computer game in which the MPs were asked to allocate the UK malaria budget to different interventions and see how many lives they saved.

Engaged with politicians</gtr:impact><gtr:outcomeId>5457676925d715.25596920</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Crest Awards: Surpervising sixth former science project</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>91369828-CF4D-4132-9A45-611AF052D54C</gtr:id><gtr:impact>Visit school monthly and supervise sixth former to develop and carry out her own research project</gtr:impact><gtr:outcomeId>58aefa94c9ee98.55637528</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.crestawards.org/</gtr:url><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presenting current understanding of the problems of insecticide resistance for malaria control to funding bodies (Gates Foundation)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1770B0D5-6368-44CA-892A-4B37136FB186</gtr:id><gtr:impact>Presenting current understanding of the problems of insecticide resistance for malaria control to funding bodies (Gates Foundation).</gtr:impact><gtr:outcomeId>58adb51cf37234.76768073</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HPA2012 XD</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>320503F2-70B4-4653-AEE9-161DA4A550B9</gtr:id><gtr:impact>HPA conference &amp;quot;Health Protection 2012&amp;quot; in the University of Warwick on 12th September 2012. Website URL: https://www.hpa-events.org.uk/hpa/frontend/reg/thome.csp?pageID=64783&amp;amp;eventID=144&amp;amp;eventID=144 . Title of presentation: &amp;quot;Whole-genome sequencing reveals limited hospital transmission of Clostridium difficile&amp;quot;

Interest of audience shown by many questions and positive feedback at the end of the presentation. Slides of talk are available on the conference website.</gtr:impact><gtr:outcomeId>CnMPUvjze7H</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Models for malaria control and elimination</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D81F1C78-0831-407E-B7CF-E271D67CAC9D</gtr:id><gtr:impact>Presentation to Global Malaria Program staff, ~15 participants

none</gtr:impact><gtr:outcomeId>FCeAhz3RbFK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford talk - 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C02F5B51-7DA4-40B7-B4C7-E55509E7C32B</gtr:id><gtr:impact>Gave presentation.

Interest of audience shown by many questions and positive feedback at the end of the presentation.</gtr:impact><gtr:outcomeId>BdBSpQPSsqN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WHO Global Technical Strategy Steering Committee, Regional Workshops and international advisory committee presentations - 2014</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0DA8F82E-A40E-4583-9B17-02C6C453AB22</gtr:id><gtr:impact>Member of the steering committee and participant in regional workshop engaging country programmes, WHO country and regional officers and other stakeholders. The presentations made as part of the committee were used to gather feedback for the development of the strategy for malaria for 2016-2030.

Development of Global Technical Strategy document</gtr:impact><gtr:outcomeId>54577fe18a7fd0.00572732</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:url>http://www.who.int/malaria/areas/global_technical_strategy/en/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CDC Plenary Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5DE85FBB-E8E0-4B85-B148-41823A3D75E5</gtr:id><gtr:impact>Plenary lecture at the International Conference for Emerging Infectious Diseases (Centers for Disease Control and Prevention, Atlanta, USA)

none</gtr:impact><gtr:outcomeId>ksKYrK2C5PQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Warwick - Bovine TB</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>20D36BC7-F367-465E-AD03-BE913D6337F7</gtr:id><gtr:impact>Participant/Instructor on a workshop on Bovine TB attended by both academics and farmers.

none</gtr:impact><gtr:outcomeId>RyQhEnvih4H</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Warwick talk - 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>126D6CBD-C0E4-427B-A0AE-E15B71EE0C87</gtr:id><gtr:impact>Gave presentation.

Interest of audience shown by many questions and positive feedback at the end of the presentation.</gtr:impact><gtr:outcomeId>BoGGnpbnjp2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ITM Colloquium 2014 - The Human Factor: Social Science in Global Health (24-27 November, 2014)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>09BFF593-1011-4532-887D-497E9FB91817</gtr:id><gtr:impact>Beyond the Clinical Trial: A Health Economics Perspective presentation as part of panel on 'Global health and clinical research: empowerment, exploitation or partnership?' Disseminate research, provoke questions and expand professional network</gtr:impact><gtr:outcomeId>56d707f64dd264.34218558</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.itg.be/internet/colloq2014/index</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Technology Strategy Board Oxford - 2013</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1571F2DC-C7E0-4B31-9199-079B45F6754A</gtr:id><gtr:impact>Health economic assessment of diagnostics. The public health angle. The UK diagnostics forum is a government funded iniative to support private sector innovations

none yet</gtr:impact><gtr:outcomeId>rKeNRhfKbcq</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>mathematical modeling of malaria at RBM/WHO Monitoring and Evaluation Research Group meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>901CCA49-2D48-4AF1-A4D9-501DF1519914</gtr:id><gtr:impact>Presentation to research group members (composed of WHO, RBM and Global Fund staff, local staff involved in the resistance containment project and academic advisors/invitees followed by questions and discussion. ~ 30 participants

none</gtr:impact><gtr:outcomeId>qpneWAWCThX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Institution Masterclasses for Year 9s</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>77FA3DEF-676F-4034-8555-DF2A71874E33</gtr:id><gtr:impact>Organized a special class/experience for students on the theme of epidemics and networks. To engage students with mathematics and its application.</gtr:impact><gtr:outcomeId>56d701611a4c67.33715502</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.rigb.org/education/masterclasses</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>KoR Primary School visits NG</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D66A2FCD-04EE-45B9-8ADA-512D3A2A88FD</gtr:id><gtr:impact>This in collaboration with the illustration company &amp;quot;House of illustration&amp;quot;, where we taught children about micro-organisms, through art and scientific facts about each example. I helped develop the ideas with the illustrator, who visited the school ~6 times. I ensured that the micro-organisms chosen were relevant and there would be learning outcomes for the children. I also visited the school twice, gave a short lesson and practical and helped with the children's activities

Presentation was made to 2 classes of school children (KS2, age ~8). Hands on demonstration of the use of microscopes, which involved looking at swimming Artemia, and fungi. Children were very excited about seeing live animals and fungi under the microscope and on the projector. One child commented with certainty that she was going to be a parasitologist when she was older, once I told her what the name was of someone that looked at worms!</gtr:impact><gtr:outcomeId>GV6EoUaWjtc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Swansea talk - 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EC11E3B2-4EFB-4A55-9328-880D89BDA3CF</gtr:id><gtr:impact>Gave presentation.

Interest of audience shown by many questions and positive feedback at the end of the presentation.</gtr:impact><gtr:outcomeId>JhDqbHiyzpx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Health Foundation of India (PHFI) - 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F22B1567-448E-47B8-BAFA-6AF8C2934298</gtr:id><gtr:impact>Delivering a mathematics course workshop at PHFI

too soon to say</gtr:impact><gtr:outcomeId>NLDf77kKGsk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DIDE Short Course: Introduction to Mathematical Models of the Epidemiology and Control of Infectious Diseases (2015)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B9F3869A-503E-4E77-9CF9-87245408721E</gtr:id><gtr:impact>Outreach and networking with health professionals from all over the world, leading to new collaborations and the implementation of MRC Centre-developed models, techniques, and tools in health institutions across the globe.</gtr:impact><gtr:outcomeId>56d70117a8c374.07482508</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.infectiousdiseasemodels.org</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HIV transmission elimination initiative, Amsterdam</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D531B462-672E-4633-988F-4F57E5024151</gtr:id><gtr:impact>Coordination of current research in HIV epidemiology in Amsterdam, and advice on methodology</gtr:impact><gtr:outcomeId>58af0a20bb9d29.28677359</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://hteam.nl</gtr:url><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WHO HIV Guidelines Committees (2014)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BCC2B0D4-2940-4AEE-8450-07401D7C48AD</gtr:id><gtr:impact>Updated WHO guidelines on HIV treatment &amp;amp; circumcision.</gtr:impact><gtr:outcomeId>54608b2c61d0d1.79277298</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Code Club - 2015</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7D6F8E95-606E-444D-A092-76CF6B8AA49E</gtr:id><gtr:impact>Ran an afterschool club for primary level pupils.</gtr:impact><gtr:outcomeId>56d701935c0300.65602429</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>https://www.codeclub.org.uk/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>House of Lords Science Select Committee</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BD7FB906-F606-457F-AF91-0E8252415E0A</gtr:id><gtr:impact>Presentation to select committee on pandemic flu

Better understanding of potential threat and impact of responses</gtr:impact><gtr:outcomeId>ED4D32894DC</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EFSA - Blue Tongue Virus</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>84D3F8EE-203B-427E-B129-609349C2A4B8</gtr:id><gtr:impact>Modelling work undertaken to assess risks of movement of BTV-affected animals

EFSA report &amp;amp; recommendations</gtr:impact><gtr:outcomeId>29E9D16E4AE</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Global TB burden was revised in relation to 2016 paper. High degree of coverage (Daily Mail, New York Times).</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C75DB4A4-2063-4926-AEA6-95EC9A5CCF20</gtr:id><gtr:impact>Press and media engagement following publication of TB burden paper.</gtr:impact><gtr:outcomeId>58c813d4678085.52691876</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://timesofindia.indiatimes.com/india/No-of-Indias-TB-patients-may-be-double-the-estimate-Lancet/articleshow/53852055.cms</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cosy Science - Caf? Scientifque - Zika virus (Pierre)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>20F78498-3C62-4531-B048-BF0F4A56ACF8</gtr:id><gtr:impact>A public talk/caf&amp;eacute; scientifique on the zika virus transmission and epidemiology</gtr:impact><gtr:outcomeId>58a5c07c3dbc75.77087259</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Discussion Meeting CF</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9331EC31-D93F-48D0-9E8B-324D49316C82</gtr:id><gtr:impact>Royal Society Discussion Meeting and Kavli Symposium Meeting, &amp;quot;Next-generation molecular and evolutionary epidemiology of infectious diseases' 14-17 May, London and Kavli.

Led to editing a special issue of Philosophical Transactions of the Royal Society Series B, in production.</gtr:impact><gtr:outcomeId>SWmVTeLuarL</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media Interviews</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>70B8F18E-9532-4E0D-A099-6B1BCBD8BD0D</gtr:id><gtr:impact>Numerous interviews by all MRC Outbreak Centre staff to the media (e.g. Times, Guardian, Telegraph, Radio 4, BBC News, Sky, ITN)

increased public understanding of infectious disease modelling and epidemics/pandemics</gtr:impact><gtr:outcomeId>F7EEAC68AD5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Big Push - 2013</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>56C73E1A-0D1B-4C4F-A08B-F307D4FB31E8</gtr:id><gtr:impact>Centre Investigator, Professor Tim Hallett, wrote a feature analysis for the Huffington Post as a part of their 'Big Push' campaign in partnership with The Global Fund.

too early to say</gtr:impact><gtr:outcomeId>VrRxLqqhQAx</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/medicine/publichealth/mrscentreforoutbreakanalysisandmodelling/newssummary/news_30-5-2013-14-14-14</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CDC Summit on HIV Prevention</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C0190D7E-4B1B-40C6-BCAE-69A1C84BA219</gtr:id><gtr:impact>Two day workshop of key academics

CDC policy document on ART as prevention</gtr:impact><gtr:outcomeId>C0630A83CA3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Big Bang - PW - 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>65462B8F-49E4-42DA-BC8C-29165DEEAF7D</gtr:id><gtr:impact>Over 1000 school children visited the MRC Centre for Outbreak Analysis and Modelling's stand, where children were 'infected' and 'vaccinated' to teach the basics of infectious disease epidemiology.

unknown</gtr:impact><gtr:outcomeId>a7T3pV6PEo3</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Statistical Society</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>64D75848-0F5F-4134-A557-AA76CDE8AAB5</gtr:id><gtr:impact>One day workshops on statistics for journalists

none</gtr:impact><gtr:outcomeId>F1A35B8DA6C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Infectious Disease Modelling Short Courses - WHO Engagement MVK</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>04E26CF5-0FFE-4CD8-A58E-5CFDBFB27381</gtr:id><gtr:impact>Meeting held with WHO staff

Raising awareness/education of use of mathematical modelling for decision making</gtr:impact><gtr:outcomeId>MDQkemQ6ibe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Data and modelling working group. Gates Foundation, India (2014)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>61E34A28-3889-46D7-A5F0-62FD7BC9779A</gtr:id><gtr:impact>Decisions were reached that were important for several Gates-funded studies in India.

Criteria decided upon in the meeting became part of organisational practice</gtr:impact><gtr:outcomeId>54536bd98adc78.12209005</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Summer Science NP - 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EE443709-A781-4198-977F-7A9116462582</gtr:id><gtr:impact>Caf&amp;eacute; Scientifique (Royal Society Summer Science Exhibition). Dr Nim Pathy gave a talk on the impact of increasing globalisation upon infectious disease risk. Around 75-100 people attended the event and took active part in discussions, raising several questions about pandemics and diseases.

Not known yet.</gtr:impact><gtr:outcomeId>PSH77CGcK7s</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/medicine/publichealth/mrscentreforoutbreakanalysisandmodelling/newssummary/news_21-6-2013-10-37-26</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wilton Park Talk</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>83DA61BB-DBB1-468A-BAEE-A41FB739AB63</gtr:id><gtr:impact>Talk to 2 day Foreign-Office organised meeting with policy makers from multiple countries discussing pandemic response and preparedness

Better understanding of potential/actual threat of flu pandemic and impact of responses</gtr:impact><gtr:outcomeId>CBE53D5A2A3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chair of UNAIDS HIV Reference Group (2014)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>045AC306-790D-4557-9F94-F3820D8C79B3</gtr:id><gtr:impact>Developed methods for generating AIDS statistics.</gtr:impact><gtr:outcomeId>54608c17d2b757.87404397</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.epidem.org</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SAGE Working Group on Polio vaccines</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9D4AE6A1-9BE2-499D-815D-CAB1B1F7A174</gtr:id><gtr:impact>member of committee

Will produce WHO position paper on polio vaccines</gtr:impact><gtr:outcomeId>F5024BD0826</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UNICEF, Cambodia Office</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F8F7B59C-D64B-4535-AEA8-1DFADF22528D</gtr:id><gtr:impact>Presentation of research findings

none</gtr:impact><gtr:outcomeId>4F77D0AC25B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RSS Journalists Day, December 2010.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0C2E4941-D343-466E-BFAD-6FF2E62CA084</gtr:id><gtr:impact>Audience - ~50 journalists with Q&amp;amp;A

follow-up contact from 2 journalists</gtr:impact><gtr:outcomeId>D9b4HKchUzW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Caf? Scientifique AG</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E193EF72-D56E-4D04-883D-C1C7760EDA16</gtr:id><gtr:impact>An informal discussion on a set topic. I gave a 10 minute introduction and then there was a 1 hour discussion involving around 25 members of the general public.

_</gtr:impact><gtr:outcomeId>kCCgf3LVaTL</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar series at University of Pavia, Italy &quot;Epidemiology of the 2014 Ebola outbreak in West Africa&quot; (May 2015)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>111B430A-DE31-4449-96BB-EAA050172324</gtr:id><gtr:impact>Seminar in the series on Modern and Ancient Plagues (malaria, tuberculosis, HIV and Ebola). Disseminating research outcomes and influencing younger researchers.</gtr:impact><gtr:outcomeId>56d6ff5a6d2998.55525284</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://www.collegiovolta.org/articles/ebola-seminar</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Introduction to Infectious Disease Modelling Course for 6th form pupils (April 2015)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>345A9951-057B-4DB5-BA27-1CEAF13AC4BE</gtr:id><gtr:impact>Raising awareness on the practical use of mathematics; Influencing young students and sharing scientific information</gtr:impact><gtr:outcomeId>56d703cabe1053.39067670</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RAPIDD workshop - 2013</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4A35D99E-B132-46EA-BEA1-7841A75A7ED0</gtr:id><gtr:impact>Member of organising committee, helped select participants and organise the workshop. Gave a 30 minutes presentation on &amp;quot;Recombination and association mapping in bacteria&amp;quot;, University of Glasgow, 4th September 2013

Very successful workshop as evidenced by good attendence and discussions.</gtr:impact><gtr:outcomeId>f6FwwWKQiY1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>workshop facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Uncovered TH</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0BE9B9C8-6629-4AA8-8EE4-21FF834FB95D</gtr:id><gtr:impact>_</gtr:impact><gtr:outcomeId>XkbAEcHSsxn</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Department of Health Scientific Pandemic Influenza advisory committee modeling sub-group (SPI-M) PW</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>09D73754-6901-4E29-A968-71B120947BF0</gtr:id><gtr:impact>2009 - date 

Influence on policy

Revisions to pandemic planning</gtr:impact><gtr:outcomeId>VA9HFRXERB4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Harriet Code Club (2014)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D65AF2C0-A88E-44EA-9802-3369EBEF48ED</gtr:id><gtr:impact>~30 pupils each week attended a code club at a local school

Positive feedback from school and good attendence</gtr:impact><gtr:outcomeId>54609bc5e3a9c7.05476988</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>https://www.codeclub.org.uk/</gtr:url><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Tackling Public Health Priorities Through the Social Determinants of Health, University of Newcastle, May 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>870ABE4F-B960-4BAE-AC64-E7E8BD7D1724</gtr:id><gtr:impact>Exchange of scientific ideas. Broader network of collaborators</gtr:impact><gtr:outcomeId>56d707b6d9e138.02257508</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stakeholder conferences for HIV - 2015</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>61E85004-5166-41A0-A2FA-887C0153C3E2</gtr:id><gtr:impact>Meet and present to borad cross-sectional stakeholders from programme managers to policy leaders in Kenya, the DR, Botswana, Malawi, China and Brazil. Sharing actionable information, influence on country-level policy making.</gtr:impact><gtr:outcomeId>56d704bd015ac6.78143698</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Intl Union Against TB &amp; Lung Dis conference PW</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>326CCF0A-2398-4069-9FF2-D857135AD8E0</gtr:id><gtr:impact>International Union Against TB &amp;amp; Lung Disease conference, London, 4-6 July 2012. https://www.hpa-events.org.uk/hpa/frontend/reg/thome.csp?pageID=56137&amp;amp;eventID=125&amp;amp;eventID=125 (1) Tackling TB in the Age of Austerity: is the London TB Find &amp;amp; Treat service cost-effective? Peter J White, Mark Jit, Helen R Stagg, Robert W Aldridge, Ibrahim Abubakar; (2) Tailoring tuberculosis interventions in different hard-to-reach population settings to ensure valuable resources are used cost-effectively. T Mugwagwa, M Jit, H Stagg, L Pimpin, Y Choi, A Hayward, A Story, R Aldridge, J Lord, I Abubakar, P White

Too soon to say</gtr:impact><gtr:outcomeId>i2B1ixWfqFB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School presentation CF</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FB7A08A2-5A9A-48D3-8582-90DB99840BFD</gtr:id><gtr:impact>60 final year primary school pupils attended a workshop I organised centred around understanding the wonderful and sometimes dangerous world of bacteria.

Generated enthusiasm, and managed to avoid embarassing my son too much.</gtr:impact><gtr:outcomeId>UhbbbsMDhAt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to parliament: pandemic flu</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1A6E6402-700A-4DB9-BCAF-9FD9A64D9631</gtr:id><gtr:impact>Presentation to cross-party group on pandemic flu (incl SofS DH and shadow)

Better understanding of potential threat and impact of responses</gtr:impact><gtr:outcomeId>A4313A7160C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Microbial source attribution using genetic data workshop</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C5897015-12A0-4682-BF23-C6B1D5E93BBD</gtr:id><gtr:impact>Source attribution workshop at Imperial. People from around the world came to discuss and present upon the subject.</gtr:impact><gtr:outcomeId>58c7f230dd0751.74736435</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://whoinfectedwhom.org/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pandemic Influenza workshop at the Science Museum (31 July 2015) - INfluENCE Project  (Department of Health)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>51266CA6-B74F-4006-9E85-121E2FD6EBD1</gtr:id><gtr:impact>Discuss and disseminate research outcomes of the project with stakeholders from across the government and commercial organizations, but also with members of public. Discussion of effective messaging, behaviour change and communication and the research on the National Pandemic flu service.</gtr:impact><gtr:outcomeId>56d7047172a780.00195971</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society - Computational Frontiers</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D9FBD4B8-81A5-4D06-8229-F0FB646B61E2</gtr:id><gtr:impact>Plenary lecture at Royal Society meeting on Computational Frontiers in Science

none</gtr:impact><gtr:outcomeId>guiHjQmH59o</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIH Workshop (November 2015)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>43EB88EA-42C5-4DF4-A3FD-5CB68A7AFE1F</gtr:id><gtr:impact>National Institute of Allergy and Indecticious Disease (USA) workshop: Infectious Disease Research: Quantitative Methods and Models in the era of Big Data; Presentation title: Scalable Phylogenetic and Phylodynamic Inference in the Era of Big Data; November 9-10, 2015. The NIH meeting generated a publicly available presentation describing our recent work on statistical methods for analysing pathogen genetic data. This meeting also fostered collaborations between contributors to the workshop. Volz initiated a new collaboration with Marc Suchard (Professor of Statistics, University of California Los Angeles) to improve on the methods presented at the meeting.</gtr:impact><gtr:outcomeId>56d706d3c2b356.06539333</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://respond.niaid.nih.gov/conferences/infectiousdiseaseresearch/pages/agenda.aspx</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Life Fesitival (2013)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BD432A57-0A52-40A6-AD3A-7825CB4E389B</gtr:id><gtr:impact>The MRC Centre for Outbreak Analysis and Modelling joined several London-based MRC Centres to collaborate with theatre company Non Zero One and the Science Museum to deliver &amp;quot;LIFE: a healthy game of chance and choice&amp;quot; to launch the MRC Centenary Open Week in June 2013. Members of the public attended the event to learn about infectious disease outbreaks through intercative activities.

Not known</gtr:impact><gtr:outcomeId>54620ecdca2101.21140255</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/medicine/publichealth/mrscentreforoutbreakanalysisandmodelling/newssummary/news_19-5-2014-16-16-5</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edinburgh Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2BC185F3-63E4-466C-99EF-804626ED7AD5</gtr:id><gtr:impact>Presented a public lecture on Tracking Infection in the 21st Century to ~100 people at the Edinburgh Science Festival.

none</gtr:impact><gtr:outcomeId>f5qDsFcU7tu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Royal Society, London - Ebola: Inside an Epidemic (9 March, 2015)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E19CBD6B-9089-41A3-B2A6-47F21E8F8153</gtr:id><gtr:impact>Share information about epidemiology of Ebola and research outcomes of recent work on the outbreak in West Africa. Audience received comprehensive information on the Ebola epidemic.</gtr:impact><gtr:outcomeId>56d6fd3c1ab077.32338992</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://royalsociety.org/events/2015/03/ebola-panel/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to All-Party Parliamentary Group on AIDS, TB and Malaria - 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>36EAACE6-3A0B-429C-AD6A-A75F628A12A1</gtr:id><gtr:impact>Presentation to parliamentarians and other interested groups on the progress towards malaria elimination

Informed parliamentarians and other interested groups</gtr:impact><gtr:outcomeId>54576d48e29397.09021585</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Workshop XD</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C78250B5-0706-4820-A838-638C33B3377B</gtr:id><gtr:impact>Royal Society Workshop on &amp;quot;Next-generation epidemiology of infectious disease&amp;quot;, taking place in Chicheley Hall, Buckinghamshire on 15-17th May 2012. Website URL: http://royalsociety.org/events/2012/epidemiology-infectious-disease/ . Title of presentation: &amp;quot;Microevolution in Clostridium difficile genomes reveals limited hospital transmission&amp;quot;

Interest of audience shown by many questions and positive feedback at the end of the presentation. Audio recording of talk available on the conference website.</gtr:impact><gtr:outcomeId>WGUJtyuTCJh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society of Tropical Medicine and Hygiene - debate on the non-specific effects of vaccines (Sept 2016)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C0C4B44D-8628-4369-B1E6-D76C9C63DC02</gtr:id><gtr:impact>Had to take the opposing side on the issue of vaccines having strong non-specific effects</gtr:impact><gtr:outcomeId>58aadfcf620576.26523673</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A short scientific meeting to celebrate the opening of the MRC CLIMB Centre in Swansea, UK (22-23-Oct-2015)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EC5CAC3B-7C9B-480E-A6C9-CF50B0C867BF</gtr:id><gtr:impact>Expanding professional network and stimulating questions</gtr:impact><gtr:outcomeId>56d705c3b89845.72306787</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.sheppardlab.com/notmolepi2015</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blood Safety Meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ED5F7AD3-1110-44E1-B6CB-CDBFA2F2A10A</gtr:id><gtr:impact>Talk at an evening event

increased understanding of spongiform encephalopathies to inform policy</gtr:impact><gtr:outcomeId>F07A603C1B3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at UNION Conference at end of 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>67CA0190-529E-4083-9E2A-21779CF2C043</gtr:id><gtr:impact>presentation</gtr:impact><gtr:outcomeId>58c813450f3610.55103249</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MIDAS Dynamics of Preparedness conference PW</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>591381E7-8377-4507-BD37-6710E587407D</gtr:id><gtr:impact>MIDAS Dynamics of Preparedness conference, Pittsburgh, 22-24 October 2012. https://midas.pitt.edu/index.php?option=com_fabrik&amp;amp;view=form&amp;amp;formid=20&amp;amp;Itemid=473 Performance of England's National Pandemic Flu Service in mass treatment and rapid surveillance. Peter White, Tom Nichols, Barry Evans, Richard Pebody, Andr&amp;eacute; Charlett, Gillian Smith, Xu-Sheng Zhang, Neil Ferguson

Too soon to say</gtr:impact><gtr:outcomeId>dQ9k3igBWKh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Designing Phase III Trials for potential transmission blocking vaccines in malaria (2014)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9B9E63D6-7A22-40E8-8B70-3D5747F64011</gtr:id><gtr:impact>Report submitted to Federal Drugs Administration (USA) based on the groups recommendations

Pending FDA decision</gtr:impact><gtr:outcomeId>54534f59c6e357.74215134</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sources of HIV transmission in the Netherlands</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9B526E08-7761-497E-A0C4-4B2FBDD68C78</gtr:id><gtr:impact>Guiding future provision strategies in HIV amongst MSN</gtr:impact><gtr:outcomeId>58af093279a090.44748853</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The UNION Conference on Lung Health (Cape Town, RSA) December 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>947A2AB4-09D7-4E3C-BDFB-B60405130256</gtr:id><gtr:impact>Presenation on 'Pricing and market impact of new TB medicines and regimens' as part of the 'Access to TB medicines beyond 2015: the dynamics of demand and supply' panel</gtr:impact><gtr:outcomeId>56d7060d272461.95190116</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://capetown.worldlunghealth.org/body/Programme-2015-web.pdf</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Northampton High School - Global health and career opportunities in the field</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7DC84D87-8708-4EB8-BA6D-478CDBC3C99D</gtr:id><gtr:impact>Talk about various career opportunities in the field of global health to school pupils</gtr:impact><gtr:outcomeId>58a2dd0a9da7f8.07361160</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Training provided in malaria control to MSF country managers</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B6F22C29-9219-4DA7-B5E5-EEE6723A49C3</gtr:id><gtr:impact>Gave lecture, workshop and ran discussion on the best way to control malaria using vector control in humanitarian settings. This will enable the audience to implement best pratice in their local settings.</gtr:impact><gtr:outcomeId>58adb4c3f2e7b2.74610717</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Country-specific technical advisory groups on polio eradication</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FE3E1B81-31E8-487B-A28A-2150B3413082</gtr:id><gtr:impact>Technical advisor

Provided evidence to support decision making on vaccine use</gtr:impact><gtr:outcomeId>1420F505772</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Guardian Q and A - 2013</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9B7D4313-4E30-4E58-963A-3C83A72D57E0</gtr:id><gtr:impact>I wrote a non-technical Q&amp;amp;A article to inform the public about the scientific evidence on badger culling and bovine TB. 



Article appeared online and remains there as a resource. It has been tweeted among those interested in bovine TB.</gtr:impact><gtr:outcomeId>H8fiHsfHGXV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.theguardian.com/environment/2013/oct/11/badger-cull-key-science-questions-answered</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Coordination of the H1N1 informal mathematical modelling network - WHO Engagement MVK</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E043C5E2-C318-44DA-86C6-EA2E06425030</gtr:id><gtr:impact>Meetings, teleconferences, peer-revoewed publications

Real-rime results for decision making; Results add to evidence base to make policy decisions and for future pandemic planning</gtr:impact><gtr:outcomeId>Fptdva9N1ap</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to the Gates Foundation leadership</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F69D24BA-09AC-4FAE-9B9A-E90ADEF32CD1</gtr:id><gtr:impact>Advising the Gates Foundation leadership on the Foundation research priorities for the next 5 years</gtr:impact><gtr:outcomeId>58a2de89e967e4.36521869</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Modelling options for enhanced malaria control and elimination in Bioko Island</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ECA30623-D265-4860-B8D0-3EAD061AD16F</gtr:id><gtr:impact>Talk to program managers, companies and the program funder Marathon Oil followed by questions and discussion. ~ 30 participants

none</gtr:impact><gtr:outcomeId>bH167rhBwtT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advisory Committee on Polio Eradication</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>650D04B5-28A2-4456-AB6F-D5F66360D650</gtr:id><gtr:impact>Technical advisor

Research has led to explicit immunity targets for programmes and supported use of new vaccines.</gtr:impact><gtr:outcomeId>BC5A530A97F</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Modelling Course, Delhi (2014)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6659D362-7D3C-4201-ACFB-A3CBD5FCCF07</gtr:id><gtr:impact>Centre members ran a modelling course in Delhi in collaboration with the Public Health Foundation India.</gtr:impact><gtr:outcomeId>545261da8d2163.52223150</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIHR HPRU Open Day (5 March, 2015)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>111997C3-19FD-4AB5-B20A-9EDB03102567</gtr:id><gtr:impact>Three National Institute for Health Research Health Protection Research Units (NIHR HPRUs) based at Imperial College London organzied their first joint open day. Following the talks, guests were invited to speak to researchers about their work and take part in interactive displays, including a game showing how infection can spread and growing bacteria from fingertip swabs.</gtr:impact><gtr:outcomeId>56d6fdf7109e91.78964134</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/medicine/departmentofmedicine/healthprotectionresearchunit/newssummary/news_1-4-2015-10-58-58</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Talk NG - 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A18D13D9-B40A-4AC9-8661-0AE68280FB0E</gtr:id><gtr:impact>Fitzjohn's Primary School talk on Infectious Diseases, with microscopes practical session. 40 pupils (8-9 yrs old).

none yet</gtr:impact><gtr:outcomeId>isMFR3fWF1N</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DIDE Short Course: Introduction to Mathematical Models of the Epidemiology and Control of Infectious Diseases - 2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B7712038-519D-4A6E-937E-AA4F78B0A84D</gtr:id><gtr:impact>40 attendees.

Outreach and networking with health professionals from all over the world, leading to new collaborations and the implementation of MRC Centre-developed models, techniques, and tools in health institutions across the globe.</gtr:impact><gtr:outcomeId>54620b65aca809.81978251</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.infectiousdiseasemodels.org/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK HIV Molecular Epidemiology Group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B9F9BF58-1491-4C70-B61B-B2381D52F23E</gtr:id><gtr:impact>Coordination of current research in HIV epidemiology in the UK</gtr:impact><gtr:outcomeId>58af09a9a06096.63866299</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013,2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Times profile piece on Neil Ferguson</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>11D36314-39DA-49BC-9ACE-546AB8618DB1</gtr:id><gtr:impact>Times piece on prominent young(ish) scientists

increased public understanding of science and scientists</gtr:impact><gtr:outcomeId>312DC3CD736</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>College de France talk - 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>199D825C-BA2B-4612-A739-DECECF9D2656</gtr:id><gtr:impact>Gave presentation.

Interest of audience shown by many questions and positive feedback at the end of the presentation.</gtr:impact><gtr:outcomeId>jyv5NJyMeu2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Estimating mortality of the influenza A H1N1 pandemic - WHO Engagement MVK</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1DCF82C1-E96D-4C83-B7B9-23B62817CE24</gtr:id><gtr:impact>Coordination of 30+ expert panel, face-to-face meeting in London, numerous presentations at scientific conferences and to WHO audiances, peer-reviewed publication(s)

Results add to evidence base to make policy decisions and for future pandemic planning</gtr:impact><gtr:outcomeId>R3enJYVRT4w</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture in Cardiff</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F62A815F-B4AB-4743-B1DD-3377B1EF5521</gtr:id><gtr:impact>Neil Ferguson public lecture at Cardiff University

increased public understanding of science</gtr:impact><gtr:outcomeId>7174BACFFE3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust Conference talk -  2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>60DD717A-4FA0-414D-BBCE-B4BF923D2580</gtr:id><gtr:impact>Infectious Disease Genomics &amp;amp; Global Health. 16-18 Oct 2013. Cambrige. Enhancing epidemiological surveillance of HIV with molecular data.

none yet</gtr:impact><gtr:outcomeId>EptXx47E6gk</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.hinxton.wellcome.ac.uk/advancedcourses/IDG&amp;GHprogramme.pdf</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at New Hinksey Primary School, Oxford, Years 5 and 6.  Rachael Tucker teacher CD</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>36D92B9F-B261-4AB4-B743-8285996733F6</gtr:id><gtr:impact>30 children heard about disease transmission, how outbreaks are studied and the importance of handwashing.

_</gtr:impact><gtr:outcomeId>M2zLwbBKnMs</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science media centre briefing SR</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6F4E2B3D-BF3A-49D4-BEAD-EEB8FF69B613</gtr:id><gtr:impact>_</gtr:impact><gtr:outcomeId>dMBLUoPwoVC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Imperial Fringe - 2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9DE3AD9A-D519-4C36-BE4B-E0282C5ECE8B</gtr:id><gtr:impact>Members of the public attended the event to learn about infectious disease outbreaks through intercative activities.

Not known</gtr:impact><gtr:outcomeId>rqBdghKuW66</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/newssummary/news_1-11-2012-13-44-43</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A practical short course on influenza and other infectious disease modelling (for WHO, Dubai) (2014)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>14054614-4F14-4427-8B8A-6322571E9CA5</gtr:id><gtr:impact>Public health practitioners were informed and enthused

Stimulated discussions on future collaborations with WHO and wider use of modelling techniques</gtr:impact><gtr:outcomeId>54526cce81b608.51887101</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Imperial Festival (May 2015)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7F9DAB72-BCE4-4973-B94A-E504673EAD5C</gtr:id><gtr:impact>Over 400 researchers and exhibitors Imperial College and partner institutes across the local area and the wider academic community demonstrated the livelier side of science to thousands of people throughout the weekend, following&amp;nbsp;events for school children&amp;nbsp;and&amp;nbsp;youngsters at Imperial's Early Years Education Centre&amp;nbsp;earlier in the week. The main outcome was the dissemination of research outcomes to wider public and spreading the word about the work of the Centre.</gtr:impact><gtr:outcomeId>56d6ff1395c363.15019743</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>https://www.imperial.ac.uk/be-inspired/festival/about/festival-2015</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Heron-Allen Lecture at Lady Margaret Hall Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>82EB8C35-890B-4100-80CE-4746685B8924</gtr:id><gtr:impact>Public lecture

Increased awareness</gtr:impact><gtr:outcomeId>D158E4AD231</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Aix-en-Provence talk to students from primary school to A-levels (Anne Cori)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EDBF6129-8B7A-4E29-AED8-C853BFB97E4B</gtr:id><gtr:impact>A stall at a science fair on the topic: &amp;quot;How can maths help understand epidemic dynamics?&amp;quot;</gtr:impact><gtr:outcomeId>58a2d7bc806d40.04515694</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.matheopolis.fr/MPT/crbst_28.html</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Attendance at World Economic Forum, Davos</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>84C42B00-E879-44FB-85E0-937AA96D9F13</gtr:id><gtr:impact>Attended WEF meeting to talk about pandemics, emergin infections, modelling

Increased awareness</gtr:impact><gtr:outcomeId>B7D9F9DECD9</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to WHO China</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8077E6A1-04F8-4050-A908-D5BD9E1A2EA7</gtr:id><gtr:impact>Talk on the use of modelling for determining vaccination strategy</gtr:impact><gtr:outcomeId>58a2de168f1f82.53575596</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FAO Workshops on H5N1 in South East Asia</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>981498EE-4620-464D-965A-E7274AE2B70E</gtr:id><gtr:impact>Workshops in Cambodia and Thailand

increased understanding of the epidemiology of H5N1 in South East Asia</gtr:impact><gtr:outcomeId>BCC717AD1F1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article written for Significance: Heroic Sacrifice or tragic mistake? Revisiting the Eyam Plague 30 years on</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2ECDCFD7-AAAC-43A4-B52E-9D0FB47AFF72</gtr:id><gtr:impact>Article written for Significance magazine. Readership of 28,000 in bi-monthly magazine.</gtr:impact><gtr:outcomeId>58c021ef516562.93911271</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.significancemagazine.com</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sense About Science</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ED739084-A66D-441A-AF6F-0BAAFC9B48AC</gtr:id><gtr:impact>Introduction to interacting with the media

none</gtr:impact><gtr:outcomeId>F7AFE6308B1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Life Festival - SR - 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>85F519D0-1EB6-4271-880C-36FE79501886</gtr:id><gtr:impact>Over 1200 visitors attended the MRC centenary 'Life Festival' at the Science Museum. Through participation in our games and activities visitors learned about the concepts of infection, vaccination, and herd immunity.

97% of event visitors rated their experience as 'positive', with many visitors leaving specific positive feedback about our activities.</gtr:impact><gtr:outcomeId>WYwLN59G2KV</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/medicine/publichealth/mrscentreforoutbreakanalysisandmodelling/newssummary/news_19-6-2013-17-29-45#fni-4</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>William Guy Lecturer - Royal Statistical Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D710E505-7947-435F-83B6-2ACE886B9A0E</gtr:id><gtr:impact>statistics
&amp;quot;using numbers to control diseases&amp;quot; 
trained as a STEM ambassador</gtr:impact><gtr:outcomeId>58c709fcafac43.46642374</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>https://www.statslife.org.uk/news/2957-christl-donnelly-announced-as-new-rss-william-guy-lecturer</gtr:url><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rapid Response to events of international concern - WHO Engagement MVK</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8C3DCBA9-E45E-4B1A-A052-BCE87A6D5CC8</gtr:id><gtr:impact>We provided summary results for internal WHO use; peer-reviewed publications; technical expertise in teleconferences with other experts, etc.

Real-rime results for decision making; Results add to evidence base to make policy decisions and for future pandemic planning</gtr:impact><gtr:outcomeId>ti6eYHjNYpx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SMBE2012 XD</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3B26B1DF-076B-44B4-942B-AACB7F0FE632</gtr:id><gtr:impact>Conference of the Society of Molecular Biology and Evolution taking place from 23rd to 27th June 2012 in Dublin, Ireland. I was organising a symposium on Microbial Genome Evolution, which involved inviting keynote speakers, selecting contributed presentations, chairing the symposium, selecting poster contributions, etc.

This symposium was very successful as shown by high levels of attendence (in spite of other symposia running in parallel) and fruitful discussions that followed.</gtr:impact><gtr:outcomeId>YXd8YSjPNyK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WHO Patient Safety Program</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>95416A2D-5B43-474E-8B97-E3AF0545B5DE</gtr:id><gtr:impact>multiple meetings, presentations and reports

Leading to a global patient safety challenge on antimicrobial resistance</gtr:impact><gtr:outcomeId>0A96E53CC4F</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Govt. Scientific Advisory Group for Emergencies - 2014</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>135A58A4-4CB9-4A08-8686-0647E8C41045</gtr:id><gtr:impact>Informed UK and international decision-making on responding to the West African Ebola epidemic.

Improved efficiency &amp;amp; effectiveness of UK response in West Africa.</gtr:impact><gtr:outcomeId>54621d4c118753.31439225</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Big Bang - CD - 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1AD5A9B4-2EAA-403D-9FC7-6356B64C071C</gtr:id><gtr:impact>Over 1000 school children visited the MRC Centre for Outbreak Analysis and Modelling's stand, where children were 'infected' and 'vaccinated' to teach the basics of infectious disease epidemiology.

none recorded</gtr:impact><gtr:outcomeId>jgTEaN2ZGwB</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/medicine/newssummary/news_19-3-2013-13-28-18</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Highdown School - 2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5AF5136A-9BEC-4897-9669-EEE21458F4BB</gtr:id><gtr:impact>200 Year 8 pupils attended a science fair. We ran an interactive stall including background poster, a demonstration game and computer-based models of influenza transmission.

Informed students about malaria. The school is interested in continuing this for future years.</gtr:impact><gtr:outcomeId>E8c8DmfhcyN</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UNAIDS/WHO/SACEMA Male Circumcision</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5750C408-C6A3-43A3-9CAB-4BD7ACD02836</gtr:id><gtr:impact>Two day workshop of key academics

19901974 / UNAIDS report</gtr:impact><gtr:outcomeId>7F40E01EE89</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RAPIDD (Research and Policy for Infectious Disease Dynamics) Evoluiton Meeting (Cambridge) - 2015</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>736D2CC5-B304-480F-B1A6-55E26D84B2EA</gtr:id><gtr:impact>Marc Lipsitch, Colin Russell and Steven Riley as key organizers. Exchange of scientific ideas, and draft paper to describe the potential and predict evolution.</gtr:impact><gtr:outcomeId>56d702d991f3a4.53535256</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>An introduction to infectious-disease modelling: Infectious Disease Research Network (supported by MRC Centre for Outbreak Analysis and Modelling) - 2014</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A3DA001B-8593-4EAC-8497-2FA4BA19DD88</gtr:id><gtr:impact>Scientists were informed and enthused.

Informed public health professionals: what infectious diseases modelling can and can not do; what its data requirements are; how to critically appraise models.</gtr:impact><gtr:outcomeId>54526c1097dc43.42996738</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>workshop facilitator</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/medicine/publichealth/mrscentreforoutbreakanalysisandmodelling/newssummary/news_13-1-2014-12-14-26</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SEAC</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>44E9F306-8333-4748-A16C-012DA22C2998</gtr:id><gtr:impact>Provide scientific advice on Spongiform Encephalopathy epidemiology

government reports and policy recommendations</gtr:impact><gtr:outcomeId>2B430E457CB</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society - Pandemic Flu</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7C6FF16B-6E8E-470F-8216-D02730BAC840</gtr:id><gtr:impact>Plenary lecture at a Royal Society Conference on Pandemic Influenza

none</gtr:impact><gtr:outcomeId>BcsgpMTyRak</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview on Radio 4 programme Material World - Badger Culling</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9122E1A9-1E0A-4A60-BB17-6BBF76D0E41B</gtr:id><gtr:impact>http://www.bbc.co.uk/programmes/b012r7tk

none</gtr:impact><gtr:outcomeId>L8jTwoGS9T5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Science Festival talks</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C877AC9E-DD4C-45A0-B315-0A78CB422AEB</gtr:id><gtr:impact>Presentation of Modelling Epidemics at Science Festival in Liverpool, Sept 08

increased public understanding of science</gtr:impact><gtr:outcomeId>617104A330A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>&quot;Mathematical modelling of interventions against tuberculosis&quot; presentation at Fogarty TB scientific workshop organized by the National Institute of Research in Tuberculosis (NIRT) (Pune, India)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0B5D1175-FFBD-439F-A337-90D8D9FA38FE</gtr:id><gtr:impact>New ongoing collaboration with the Institute and broader network of colleagues.</gtr:impact><gtr:outcomeId>56d7065354a3b8.74169282</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Media Centre - Seasonal Flu Briefing</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A72A86AA-2F0F-492A-BD59-3DA2AB471207</gtr:id><gtr:impact>Brief presentation followed by a question and answer session. Audience: ~20 journalists.

several follow-up interviews with Centre staff</gtr:impact><gtr:outcomeId>YQvZygsttSe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Annual Conference of the Society of General Microbiology (2014)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>353B0277-BD9A-4843-B22B-BDECBF49D74C</gtr:id><gtr:impact>Gave presentation.

Interest of audience shown by many questions and positive feedback at the end of the presentation.</gtr:impact><gtr:outcomeId>54525b2ca0c517.28322592</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Introduction to Infectious Disease Modelling to inform policy making (Mar 2016)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>361445A7-8EA9-4DD3-892B-C30BBBB6B60E</gtr:id><gtr:impact>Day-long workshop on infectious disease epidemiology hosted by MRC Centre Investigators and with a focus on influencing policy making. Attended by ~100 public health practitioners, students, and researchers.</gtr:impact><gtr:outcomeId>58c7fec869bac7.76942223</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public choice analysis of priority setting in health, presentation at the roundtable meeting 'Political Economy of Priority Setting in Health', Center for Global Development, Washington, D.C., February 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0F2BC222-612A-41B7-9DE3-964044443DA0</gtr:id><gtr:impact>Expanding the network of collaborators. A working paper published based on the presentation in partnership with someone present at the event.</gtr:impact><gtr:outcomeId>56d70767a3ebf8.95835883</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Department of Health Scientific Influenza Surveillance Steering Group (ISSG) PW</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1648707F-F154-45F0-B87D-887D150C4538</gtr:id><gtr:impact>2010-date

Improvements in surveillance systems. Funding of studies to develop new surveillance systems.

Revisions to pandemic planning.

Bolotin et al. PLoS ONE paper. Other papers being written.</gtr:impact><gtr:outcomeId>Pyoyxfh9V39</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interbiew on BBC 4 - Inside Science with Adam Rutherford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7A04586D-FE44-4F32-BD9A-3120B6A01574</gtr:id><gtr:impact>Weekly scientific magazine programme: marking major developments and major scientific breakthroughs to help the audience better understand the scientific process and scientific disciplines.</gtr:impact><gtr:outcomeId>58c022b4b4a365.63036600</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/programmes/b036f7w2</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2020 Vision lecture to school children</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>50531B0D-449F-4535-977A-38D15B053096</gtr:id><gtr:impact>Lecture to 500 school children at a 1 day '2020 vision' science meeting for children in London

Awareness of science behind pandemic planning</gtr:impact><gtr:outcomeId>383490BC17D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1AA885E3-7EC5-41FF-8EEC-54F1EF583DD9</gtr:id><gtr:impact>Talk on pandemic modelling and the H1N1 pandemic

increased public understanding of the H1N1 pandemic and the role of mathematical modelling</gtr:impact><gtr:outcomeId>F1255C0D3A4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Badger Culling Debate - London Zoo</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>919A9CAD-A36D-41B4-9AC9-8ABE1EF225B6</gtr:id><gtr:impact>public debate on the impact of badger culling on the transmission of bovine tuberculosis

http://www.zsl.org/zsl-london-zoo/whats-on/communicating-science-debate-badgers-bovine-tb,451,EV.html</gtr:impact><gtr:outcomeId>evdLw79KL3s</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.zsl.org/zsl-london-zoo/whats-on/communicating-science-debate-badgers-bovine-tb,451,EV.html</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Masterclass in Mathematics - 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5EBDD0A7-D0E4-440F-9578-680A9692F96C</gtr:id><gtr:impact>The Royal Instititution organises Saturday morning maths Masterclasses for 50-60 year 9's from schools in London. The Masterclass Harriet teaches on is called &amp;quot;Networks Rule the World&amp;quot; and covers epidemic spread on networks. The children learn how the structure of contact networks can influence disease spread, how vaccination works and how travel and transport networks can influence disease spread. http://www.rigb.org/education/masterclasses

Each session has received positive feedback from the children and helpers involved. The children have been very engaged with the session, with many being inspired by the use of mathematics on a &amp;quot;real world&amp;quot; and easily relatable problem.</gtr:impact><gtr:outcomeId>RKaYuvMCZRT</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Bath University</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>48E48520-43C4-4818-AE90-230D457574AF</gtr:id><gtr:impact>Public lecture entitled, 'Epidemics - How to Control the Risks to Public Health

none</gtr:impact><gtr:outcomeId>Zf2qFwUhTpa</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>U of Reading talk - 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3A1F5272-61A1-46B9-97E4-83374B641898</gtr:id><gtr:impact>Talk to Department of Mathematics and Statistics, University of Reading, 7th June 2013.

Interest of audience shown by many questions and positive feedback at the end of the presentation.</gtr:impact><gtr:outcomeId>C3oiuCqDPHk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>Pre-2006,2006,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Media Centre</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7BB3353C-86AC-4559-9BF3-5F3338CC49F0</gtr:id><gtr:impact>Press briefing on H1N1

Increased public understanding of the H1N1 pandemic</gtr:impact><gtr:outcomeId>7AABEA58DD4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DIDE Short Course: Introduction to Mathematical Models of the Epidemiology &amp; Control of Infectious Diseases; An interactive short course for professionals - 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F3DA40E2-542D-46CF-A2DC-0EED9D263357</gtr:id><gtr:impact>The course was organised and co-hosted by Dr Anne Cori; a core member of Centre PI Professor Christophe Fraser's HIV research group. There were approximately 40 attendees.

40 attendees. Outreach and networking with health professionals from all over the world, leading to new collaborations and the implementation of MRC Centre-developed models, techniques, and tools in health institutions across the globe.</gtr:impact><gtr:outcomeId>d1nkshZHqTF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.infectiousdiseasemodels.org/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Short Course in Infectious Disease Epidemiology CF</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3A0300B2-1548-4579-AE25-3630C89743E7</gtr:id><gtr:impact>&amp;gt;40 Public Health Professionals (and some Academics) attended our Annual 2 week short course in infectious disease modelling.

This course continues to be highly succesful, and over the years has proven to be influential due to the large number of influential 'graduates' of the course.</gtr:impact><gtr:outcomeId>Dq6Xso33cZc</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture Biosys, Copenhagen</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A823FB59-32B5-4160-98B6-BE15A20F32CC</gtr:id><gtr:impact>public lecture

none</gtr:impact><gtr:outcomeId>D8F060439F5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Participation in WHO Initiative for Vaccine Research</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BA4F9697-BAC5-4DE6-A42F-5FB72AF6E877</gtr:id><gtr:impact>~30 attendees, questions, discussion

White MT, Conteh L, Cibulskis R, Ghani AC (2011). Cost and cost-effectiveness of malaria control interventions - a systematic review. Malaria Journal, 10:337</gtr:impact><gtr:outcomeId>iqcdE841A11</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Consise meetings - 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5E8D1ED6-4DAD-4DB9-81C6-5102DF8D5446</gtr:id><gtr:impact>Attending two Concise workshops (Hong Kong and Cape Town)

Infuenza seroepidemiology meetings to develop protocol for investigation of closed settings.</gtr:impact><gtr:outcomeId>oRj6perzca7</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>https://consise.tghn.org/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Infectious Disease Genomics Symposium Beer &amp; Pizza Science Evening (20-Oct-2015) at University College London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>52009511-E363-4471-9237-1D076491E630</gtr:id><gtr:impact>Expanding professional network, influencing younger researchers and stimulating questions</gtr:impact><gtr:outcomeId>56d7056261b3b0.48705767</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>https://www.ucl.ac.uk/ugi/ugi-seminar-events-publication/beerpizzaOct1015</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RAPIDD (Research and Policy for Infectious Disease Dynamics) workshop on Gravity Models, Disease Spread, and Spatial Scales (Cambridge University) (Sept 7-9, 2015)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BDAC5C0B-7CBB-4E80-8F2E-96830294F782</gtr:id><gtr:impact>Main goal was exchange of scientific ideas; outcome new collaborations with participants</gtr:impact><gtr:outcomeId>56d70282d8bc25.79654289</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>7004</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Maternal Flu Immunisation CRA</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:fundingRef>EPIDZC14</gtr:fundingRef><gtr:id>B19D2AF2-80D1-4B35-9AD8-0F5947A9EEF6</gtr:id><gtr:outcomeId>58c926fbab5143.30225859</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99210</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>H99: IHI iSense internal funding. Digital Disease Detection.</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>35983F5D-038D-4E1E-A955-C7DDE602D95B</gtr:id><gtr:outcomeId>58c6d81b475814.87005037</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150510</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Junior Research Fellowship - Ilaria Dorigatti (Within-host dynamics of dengue virus pathogenesis and the human antibody response)</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Imperial College London</gtr:fundingOrg><gtr:id>94CE5BF7-51DC-4456-BBD3-770103C8A3A1</gtr:id><gtr:outcomeId>58c970e77acb55.81931389</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>444000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Rush Foundation: Understanding Health Externalities in HIV Intervention To Inform Budget Allocation in Africa</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Rush Foundation</gtr:fundingOrg><gtr:id>949CEF48-B2B4-4E17-BE9E-F283EB0019CA</gtr:id><gtr:outcomeId>J6vcpJ2XwPo</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>145130</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust: Studentship for Marcus Shepheard</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>083705/Z/07/Z</gtr:fundingRef><gtr:id>424D6E58-A51F-4988-958F-BF8E4CFFBE54</gtr:id><gtr:outcomeId>j8pdXn2ixT7</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>590469</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Fellowship: Merging theory and field studies for infectious disease dynamics</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>093488/Z/10/Z</gtr:fundingRef><gtr:id>4FAE814D-AD35-49FA-BCE1-ABFDF14616DE</gtr:id><gtr:outcomeId>a2sfdY5zXBf</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>62836</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WHO: HIV Modelling Consortium WHO Guidelines - 2013</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:fundingRef>HIV/SIP</gtr:fundingRef><gtr:id>17E3CBD7-D86C-4D0E-B6C4-D56AA7ED9395</gtr:id><gtr:outcomeId>oSQurrdkzN4</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>378084</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Phase variable epigenetic regulation in Firmicutes</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>RM33G0360</gtr:fundingRef><gtr:id>0C4A70CB-8EB6-4FEC-9E8B-5CD96B1CB4F5</gtr:id><gtr:outcomeId>58c821fccc63b2.51992891</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>316782</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MMV: Modeling of different potential implementations of existing ACTs and other anti-malarial products in development.&amp;quot;</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medicines for Malaria Venture (MMV)</gtr:fundingOrg><gtr:fundingRef>MMV AD-12-1400-03</gtr:fundingRef><gtr:id>D1C0A9E2-1649-4448-87C9-05DAD1CB4EFD</gtr:id><gtr:outcomeId>54105d7836b7f2.88666122</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>111089</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Mapping the risk of international infectious disease spread</gtr:description><gtr:end>2018-06-02</gtr:end><gtr:fundingOrg>United States Agency for International Development</gtr:fundingOrg><gtr:fundingRef>AID-OAA-F-16-00115</gtr:fundingRef><gtr:id>5D5DA867-2A19-45DD-8254-A425CF1003BD</gtr:id><gtr:outcomeId>58c92305a34071.11365755</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14021</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR: HPRU in Respiratory Infections at Imperial College London</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>WHRR_P47123</gtr:fundingRef><gtr:id>037210C4-0E28-4E8B-9F78-35C53BA3364F</gtr:id><gtr:outcomeId>53f20b2d9800e3.65549025</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>164152</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Fellowship - Rafal Mostowy (The role of recombination in the evolution and epidemiology of the bacterial pathogen streptoccus pneumoniae)</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>329515</gtr:fundingRef><gtr:id>9B2652A7-4AC2-4114-89BC-277EA0222508</gtr:id><gtr:outcomeId>ep14sz131E9</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>141000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre Grant: Centre for Outbreak Analysis and Modelling - equipment supplement</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K010174/1</gtr:fundingRef><gtr:id>0155C844-359C-4A89-82A8-B1C9A636E67C</gtr:id><gtr:outcomeId>53e23c2b45a3a9.96830882</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Senior Investigator Award</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>P/O 427921</gtr:fundingRef><gtr:id>ED7AEAD8-FE7C-43A5-AAA2-B04D0CC6B3B6</gtr:id><gtr:outcomeId>19671238AFF0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WHO: Economic appraisals of seasonal influenza vaccine in low &amp;amp; middle income countries (LMIC) - Work Package 3</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:fundingRef>EPIDZC14</gtr:fundingRef><gtr:id>8FABFC0B-F5C9-44AF-92EE-E3142F08E484</gtr:id><gtr:outcomeId>53f21acfb07026.78261169</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>117089</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Yellow Fever - Impact of immunisation in Africa</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1117543</gtr:fundingRef><gtr:id>37FEAD5F-F8EB-402A-9768-88CE73D80B7E</gtr:id><gtr:outcomeId>58c6ebedd62357.11271160</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>38527</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Modelling the incremental value of alternative strategies to IPT for malaria in pregnancy</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Jhpiego</gtr:fundingOrg><gtr:id>9E993251-F0C3-4E71-89DF-BB3AC9CC9350</gtr:id><gtr:outcomeId>58c92754cb6188.88248664</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR: TB Reach: Improving the management and control of tuberculosis among hard to reach groups</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>RP-PG-0407-10340</gtr:fundingRef><gtr:id>03FF7923-0753-438C-B5A1-FC18C5251660</gtr:id><gtr:outcomeId>H7pAsEN7RDy</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2261061</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ERC: BEEHIVE (Bridging the Evolution and Epidemiology of HIV in Europe)</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>339251</gtr:fundingRef><gtr:id>A0C2B558-2AB6-4B13-B7F5-11F72EA33511</gtr:id><gtr:outcomeId>53e391931f2a25.41701218</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>385936</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMGF: Control of TB in India: developing analytical tools</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1095710</gtr:fundingRef><gtr:id>022C92D7-49B8-401B-AEC1-A9497330C46B</gtr:id><gtr:outcomeId>53f206c3a74fb7.30673560</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>165459</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The evolution of influenza virus; Studies of within host and between host evolution to improve pandemic risk assessment and vaccine updates</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>200187/Z/15/Z</gtr:fundingRef><gtr:id>BB74F87B-188F-462C-A7E6-634D85152B38</gtr:id><gtr:outcomeId>58c6df1552f9d9.83578785</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>222968</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UNAIDS: Providing academic leadership through a Secretariat for the UNAIDS reference group on estimates modelling &amp;amp; projections (extension)</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Joint United Nations Programme on HIV/AIDS (UNAIDS)</gtr:fundingOrg><gtr:fundingRef>EIP/DFA/PG/ca12/18</gtr:fundingRef><gtr:id>4DA02DCA-91FC-4553-8321-B8D891763E20</gtr:id><gtr:outcomeId>Yh4Sbya2EWS</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>24526</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CAPS (Cooking and Pneumonia Study)</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K006533/1</gtr:fundingRef><gtr:id>EE9DE675-2864-49B9-B9C7-3539A5E36AF5</gtr:id><gtr:outcomeId>58c81f66dfed75.05899849</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1010322</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PATH/MVI: Measuring the population efficacy of TBIs - the Transmission Population Assay</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Program for Appropriate Technology in Health (PATH)</gtr:fundingOrg><gtr:fundingRef>GAT.0888-11-06546-COL</gtr:fundingRef><gtr:id>31315D7F-C063-4E2F-8900-28265718A6FB</gtr:id><gtr:outcomeId>541025e33ac2d7.57885607</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>481855</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Defra: Transmission modeling and cost-effectiveness analysis of cattle vaccination at a herd level</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Department For Environment, Food And Rural Affairs (DEFRA)</gtr:fundingOrg><gtr:fundingRef>SE3130</gtr:fundingRef><gtr:id>F1DE531C-8EB7-4EC6-9EA9-325692F4E758</gtr:id><gtr:outcomeId>kcvzUdbU3Zw</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>149824</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Zika in Columbia: early characterisation of epidemiological potential</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MC_PC_15091</gtr:fundingRef><gtr:id>E500E497-FF4E-4248-93EA-8DF82B80A998</gtr:id><gtr:outcomeId>58c917719dfc26.92741903</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>264829</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Fellowship: The effect of population structure on the evolution and progression of infectious disease</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>091737/Z/10/Z</gtr:fundingRef><gtr:id>E9DED5BF-6204-4D6D-8F16-FC8BBDC4467E</gtr:id><gtr:outcomeId>skLJvZKAwU8</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>179101</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DFID/MRC/Wellcome Trust Joint Global Health Trials Scheme</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>RF020305</gtr:fundingRef><gtr:id>041010CF-1471-4768-9E6D-AA28C1408A65</gtr:id><gtr:outcomeId>56d431b1edb9d1.83632732</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>111000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH NIAD: New methods for the design and evaluation of large HIV prevention interventions</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>1R01AI112339-01</gtr:fundingRef><gtr:id>7D6B9E97-1B90-40C7-B3F5-6196DC387658</gtr:id><gtr:outcomeId>53e3948f980207.61769474</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300098</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Fellowship - Michael White (Modelling the contribution of relapse infections to the epidemiology and control of Plasmodium vivax malaria)</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L012170/1</gtr:fundingRef><gtr:id>497D1637-8576-49E5-BE98-0DF6B977E2A2</gtr:id><gtr:outcomeId>54105b4b702913.56802827</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3528583</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR: NIHR HPRU in Modelling Methodology</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>HPRU-2012-10080</gtr:fundingRef><gtr:id>1BFC1EE1-F6EC-4113-9EFA-CDEFCF264469</gtr:id><gtr:outcomeId>53e3665a29fa45.48742747</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>165459</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Collaborative Award</gtr:description><gtr:end>2020-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>200187/Z/15/Z</gtr:fundingRef><gtr:id>41EB22AB-CBD2-4FA5-9DDC-3BE925B03A90</gtr:id><gtr:outcomeId>56d43e087330c9.88814987</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48496</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Health economics of MDR TB testing in the UK - 2013</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>5E5C47FC-89F3-455C-A811-699C578C875F</gtr:id><gtr:outcomeId>tsCw6MTnKnt</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>204213</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Impact of maternally derived antibodies and microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>JXR11990</gtr:fundingRef><gtr:id>09692952-D3D0-4B41-9AEA-03B0912F8AE4</gtr:id><gtr:outcomeId>58c6d33ca84974.75335178</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>104352</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Multidisciplinary Studies of HIV/AIDS and Aging (R21)</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>1R21AG053093 - 01</gtr:fundingRef><gtr:id>684A5742-3BD1-452D-B91C-DBFD0088C926</gtr:id><gtr:outcomeId>58c935f5dd0350.96345540</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>245728</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust PhD Programme for Clinicians Fellowship for Bhargavi Rao: Artemisinin combination therapy and the health system</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>090791/Z/09/Z</gtr:fundingRef><gtr:id>38854E01-1077-4A82-9462-44D9F2B190F1</gtr:id><gtr:outcomeId>p8c5qqv1mxk</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>326242</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Population Health Science Fellowship: Evaluation of Interventions and Diagnostics of Neglected tropical Diseases in sub-Saharan Africa</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0902130</gtr:fundingRef><gtr:id>EC6CA754-B23E-48B1-A2FA-9B0DCA03C95C</gtr:id><gtr:outcomeId>X25Zkhk7nVp0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>780182</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU FP7:PREDEMICS</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>278433</gtr:fundingRef><gtr:id>E5D48DE5-2E81-4C6B-B989-E2C3CD742CFF</gtr:id><gtr:outcomeId>L87NSQq3Dja</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75881</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Understanding Assays Used to Measure Malaria Transmission-Blocking Activity: Bridging Data Between the Laboratory and the Field</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>IRD 304549/00</gtr:fundingRef><gtr:id>0ECF36A6-C367-405B-92FE-0912732D8AD6</gtr:id><gtr:outcomeId>58c6ed885efe31.09929757</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>462124</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>World Bank: Investigating reasons for epidemiological changes in HIV in African countries</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>World Bank Group</gtr:fundingOrg><gtr:fundingRef>7164102</gtr:fundingRef><gtr:id>C33308E3-CD88-4982-8A4C-DA71120E27E5</gtr:id><gtr:outcomeId>Yh8yVYynHow</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>499180</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Providing academic leadership through a Secretariat for the UNAIDS reference group on estimates modelling &amp;amp; projections</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Joint United Nations Programme on HIV/AIDS (UNAIDS)</gtr:fundingOrg><gtr:fundingRef>PO201153562</gtr:fundingRef><gtr:id>9D4C192F-4787-44A3-9ACB-8599FC3F1CC2</gtr:id><gtr:outcomeId>58c92fddde0174.35251581</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>165784</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Four-Year PhD Studentship - Mr Oliver J Watson</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>C357C0BA-3314-4137-A1C5-19584E505BAB</gtr:id><gtr:outcomeId>56d42f8c685a94.42138946</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1882747</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The life course of human immune responses to influenza infection and vaccination</gtr:description><gtr:end>2021-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>200861/Z/16/Z</gtr:fundingRef><gtr:id>BC876E7B-5352-44BE-90A8-4F2EBBCE93AD</gtr:id><gtr:outcomeId>58c6dff96a6dd2.39252281</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>188510</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PATH/MVI/Gates: Modelling the public health impact and cost-effectiveness of the RTS,S malaria vaccine in malaria endemic countries</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Program for Appropriate Technology in Health (PATH)</gtr:fundingOrg><gtr:fundingRef>06258</gtr:fundingRef><gtr:id>FBF25C7B-69B1-43BD-A0D5-44221A651942</gtr:id><gtr:outcomeId>54102af6bf4e16.45376546</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>360512</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC: Centre for Outbreak Analysis and Modelling - studentships</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>1U54GM088491-01</gtr:fundingRef><gtr:id>6D2E23B3-3E19-442F-9DD9-35A1D2E15A48</gtr:id><gtr:outcomeId>53e395e1ac7e64.07358832</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>249139</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Laboratory Refurbishment Award</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>35E14AB6-05ED-4C1F-B656-986A45EE99F8</gtr:id><gtr:outcomeId>58c6d48494f029.72066732</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>213109</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DH: Effectiveness for Testing for and Treatment for Latent TB (HALT Study)</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Department of Health (DH)</gtr:fundingOrg><gtr:fundingRef>015/0306</gtr:fundingRef><gtr:id>47600D24-3C26-4CF2-AA5C-5BAB6E8B7EAB</gtr:id><gtr:outcomeId>MiG654kLGaL</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90666</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Modelling malaria transmission and control in the Democratic Republic of Congo (NIH-UNC)</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>5101262</gtr:fundingRef><gtr:id>F42A04C8-A372-43AC-96B2-BF44E4B3BC8E</gtr:id><gtr:outcomeId>56d42ed852d3a6.29263229</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>165784</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Four-Year PhD Studentship - Mr Robin Maximillian Schaefer</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>109313/Z/15/Z</gtr:fundingRef><gtr:id>F2085101-EE12-4B48-A67C-1B16F8E35E0B</gtr:id><gtr:outcomeId>56d42fd346a155.84249657</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>245383</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sir Henry Wellcome Fellowship. Modelling the impact of HSV-2 interventions on HIV transmission in sub-Saharan Africa.</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>WT082623</gtr:fundingRef><gtr:id>8BD2CB9B-3985-4BB8-AD50-25A7EEEC86A8</gtr:id><gtr:outcomeId>n8GMUyTqBZb</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>39537</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Spatial Uncertainty: Data, Modeling, and Communication (R03)</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>1R03AI125001-01A1</gtr:fundingRef><gtr:id>57D53B9F-D50D-428C-A33E-94205A525A69</gtr:id><gtr:outcomeId>58c9373882b3f7.11166306</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>94640</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DH: EMIT</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Department of Health (DH)</gtr:fundingOrg><gtr:fundingRef>RGS:103272</gtr:fundingRef><gtr:id>A38FADE1-6258-4F45-85A2-5BB6101B1D8B</gtr:id><gtr:outcomeId>TXqDxSsgjJ7</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>142150</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Juior Research Fellowship - Hannah Slater (Modelling the spatial heterogeneity of malaria transmission and the impact of spatially targetted interventions to eliminate malaria)</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Imperial College London</gtr:fundingOrg><gtr:id>1593D843-AE7F-45CF-BA67-2A77EA93CF64</gtr:id><gtr:outcomeId>58c9712ee030a3.72917059</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>73171</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR: Targeting men for better sexual health: The Ballseye Programme</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>RP-PG-0707-10208</gtr:fundingRef><gtr:id>3AC667F8-9E71-4742-8B23-17598A1ED36E</gtr:id><gtr:outcomeId>qS7ApGwpo96</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>961146</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC: Understanding herd immunity and incidence variation for rapidly evolving pathogens: influenza in England and Wales, 1986 to 2009</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J008761/1</gtr:fundingRef><gtr:id>DA37A853-936F-4C8C-A318-D247C823D942</gtr:id><gtr:outcomeId>JuzkzaqYkXf</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>487817</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BGMF: Mathematical modelling of poliovirus transmission to support the endgame</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1099374</gtr:fundingRef><gtr:id>ABC694BC-73EF-47DE-AA33-36B74F887DBF</gtr:id><gtr:outcomeId>CdQD8zUSRaU</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>403170</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A genealogical approach to tracking bacterial transmission</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4F47BFD6-2563-4CE9-9805-A05183AFD744</gtr:id><gtr:outcomeId>58c6e0f29e0028.69350261</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99091</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WHO: Gut mucosal immunity induced by vaccine and wild-type poliovirus in India</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:fundingRef>PO 200245063</gtr:fundingRef><gtr:id>5C9FE341-9516-4CDB-9A92-CEBDA9836C6B</gtr:id><gtr:outcomeId>aMg4TFTZqZf</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>316782</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Modelling antimalarial target product profiles for reducing P. falciparum malaria transmission</gtr:description><gtr:end>2019-02-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>PO14/00561</gtr:fundingRef><gtr:id>6F84B93B-33EB-41CA-BE3B-C83B85B5288B</gtr:id><gtr:outcomeId>58c924e766bac2.31469105</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>226449</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMGF: Phylogenetics Networks to Address Transmission of HIV (PANGEA_HIV)</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1084352</gtr:fundingRef><gtr:id>146735B1-2915-4313-AAD9-FA6A1892F179</gtr:id><gtr:outcomeId>53e24cb60f14a3.24047768</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>704320</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Interaction Between Hormonal Contraceptives and HIV Risk</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1067133</gtr:fundingRef><gtr:id>E9535E99-311E-4A68-97C3-F7CE7D156C8B</gtr:id><gtr:outcomeId>58c92cb88c2d18.80967205</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>122980</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Research Project Grant (R01) PA-07-070</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:fundingOrg><gtr:id>847EFE26-BBC1-435D-BCEF-48F616A40BBF</gtr:id><gtr:outcomeId>56d4317538b829.18938647</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>754023</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Improving Delivery of HIV Prevention and Treatment through Implementation Science and Translational Research (R01)</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>1R01AI120913-01</gtr:fundingRef><gtr:id>18BB53F5-D594-41F8-9A73-47BFBF0D281A</gtr:id><gtr:outcomeId>56d430b730f7b1.96475035</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>559766</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Secretariat of the UNAIDS Reference Group on Estimates, Modelling, and Projections</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Joint United Nations Programme on HIV/AIDS (UNAIDS)</gtr:fundingOrg><gtr:fundingRef>SIE/SIM/PG/MM/ca/14/20</gtr:fundingRef><gtr:id>5672B2EF-DB0E-489B-8C4E-F1580B916749</gtr:id><gtr:outcomeId>56d43d0b5140a4.90312617</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>37139</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research and Development of Reconstructing HIV Epidemics from HIV Phylogenetics</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>340798</gtr:fundingRef><gtr:id>FB72F07F-5B0D-4BE6-85C1-2FD54B9D30F8</gtr:id><gtr:outcomeId>58c6eb6ce569e8.80432199</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>144781</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Marie Curie Research Institute</gtr:department><gtr:description>Marie Curie Fellowship - Francois Blanquart (Predicting the evolution of resistance in streptococcus pneumoniae - H2020)</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>Marie Curie</gtr:fundingOrg><gtr:fundingRef>657768</gtr:fundingRef><gtr:id>2F2804C1-D658-49C2-85A0-E534D839E1DE</gtr:id><gtr:outcomeId>58c96fd5c13ba2.53528985</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>161331</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Predicting the impact of insecticide resistance and new paradigms of vector control</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>IVCC</gtr:fundingOrg><gtr:id>8222DF61-F545-40F3-AD1C-8FA8F88CB7C5</gtr:id><gtr:outcomeId>58c6ee37b7e8e5.95092376</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>355171</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dorothy Hodgkin Fellowship - Lucy Okell (Modelling the control of artemisinin-based antimalarial drug resistance)</gtr:description><gtr:end>2020-12-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:fundingRef>N/A</gtr:fundingRef><gtr:id>0D87040D-6C65-4623-9296-70E3BFD1009D</gtr:id><gtr:outcomeId>56d71dbf15a6f6.40726059</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>112723</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH: Methodologies and Formative Work for Combination HIV Prevention Approaches</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>3C0DB296-1DC7-46E6-BFD6-36639D564F9D</gtr:id><gtr:outcomeId>53f327baab0a55.13985483</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1531054</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH: PopART: Cluster randomized trial of the impact of a combination HIV prevention</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>HPTN 071</gtr:fundingRef><gtr:id>CFA1E54D-0442-4B1A-BC5D-C922D6125A96</gtr:id><gtr:outcomeId>qNorgfzkqeh</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>125923</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HMJF: Influenza severity in the US military/CONSISE</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF)</gtr:fundingOrg><gtr:fundingRef>Contract No. 775696</gtr:fundingRef><gtr:id>49EDF8BF-2A9B-4051-9885-A5EB61F3C45B</gtr:id><gtr:outcomeId>53f216c640f312.60205943</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1933493</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre Grant: Centre for Outbreak Analysis and Modelling</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0600719/1</gtr:fundingRef><gtr:id>3A9EB03F-CF69-4EA5-AB43-AA1AD594AC6E</gtr:id><gtr:outcomeId>B79DB3B85710</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>958185</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMGF Project Grant: Vaccine Modelling Initiative (VMI) 2</gtr:description><gtr:end>2019-06-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1092240</gtr:fundingRef><gtr:id>92F78ACB-27A2-45B8-8F03-1F07C6B8EDAF</gtr:id><gtr:outcomeId>kSeHuscsUEn</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1908442</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BGMF: Treat children in India for enteric infections to improve their response to oral poliovirus vaccine (expanded grant)</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1039135</gtr:fundingRef><gtr:id>9287B9D7-499E-49EC-B82F-EB325CEB5113</gtr:id><gtr:outcomeId>DBtvCDbbHNr</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>26958</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>An integrated approach to understand the emergence and spread of extensively resistant Gram-negative bacteria in China</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/P007597/1</gtr:fundingRef><gtr:id>324A6B4E-FB7C-4D72-9CB3-9461F4ABE6AF</gtr:id><gtr:outcomeId>58c6e1fce26fc7.42436832</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>76406</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Statistical model for SMFA precision</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>R0002102 MVI-SMFA</gtr:fundingRef><gtr:id>A55744A8-0661-44FA-BE73-1BA84CFCE3D8</gtr:id><gtr:outcomeId>58c6edf75255c0.09674045</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>146860</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AMZAC (Azithromycin for Seasonal Malaria Chemoprevention)</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>ITDCZA2510</gtr:fundingRef><gtr:id>AE103189-13AA-4E2F-8A23-2A303B88845D</gtr:id><gtr:outcomeId>58c82042ac7ba2.33612176</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30828</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Modeling to Understand the Epidemiological Impact and Market Impact of Harmonized Regimens for MDR-TB</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>578A5D67-8E15-4C10-89F0-F66601869E82</gtr:id><gtr:outcomeId>58c6e3936e7660.30520824</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>166330</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IVCC (Liverpool School of Tropical Medicine and Hygiene)</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Liverpool School of Tropical Medicine</gtr:fundingOrg><gtr:id>4BA475B2-6670-480F-AC67-812BDBD0C3DE</gtr:id><gtr:outcomeId>56d43db4aafa08.65125776</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>222968</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Providing academic leadership through a Secretariat for the UNAIDS reference group on estimates modelling &amp;amp; projections</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Joint United Nations Programme on HIV/AIDS (UNAIDS)</gtr:fundingOrg><gtr:fundingRef>EIP/DFA/PG/ca12/18</gtr:fundingRef><gtr:id>6014A6B4-CE90-46D4-A993-DCA986A7DC17</gtr:id><gtr:outcomeId>58c9335270bd32.63310015</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>139790</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Imperial College Trust</gtr:department><gtr:description>Junior Research Fellowship - Rafal Mostowy (Understanding the contribution of horizontal exchange of genes to the evolution of antigenic diverity in bacteria)</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Imperial College London</gtr:fundingOrg><gtr:id>EE8F41DF-C85A-47DF-8805-1F92582640EF</gtr:id><gtr:outcomeId>58c97577425502.62452159</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>301527</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU FP7: PREHDICT: Health Economic Modelling of PREvention Strategies for HPV-related diseases in European Countries</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>242061</gtr:fundingRef><gtr:id>4B7E28BE-DD44-42A4-81C7-1976EB81E71B</gtr:id><gtr:outcomeId>HCh97ZpUPHB</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>254463</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH: The immune landscape of human influenza in households, towns and cities in southern China</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>5R01TW008246-04</gtr:fundingRef><gtr:id>D3E746E3-FF2C-493C-AB90-497B61F506E2</gtr:id><gtr:outcomeId>D5Myqhmzw5m</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>759182</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Identification of factors promoting the emergence of pathogens with human pandemic potential with zoonotic backgrounfd and related prevention strategies</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>F50AC995-D430-4338-8580-DFB8A1073328</gtr:id><gtr:outcomeId>58c6cdac53e0b2.94533581</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>643883</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Near-Infrared Spectroscopy: A One-Stop-Shop for Mosquito Epidemiological Monitoring</gtr:description><gtr:end>2020-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/P01111X/1</gtr:fundingRef><gtr:id>4A7B8CE3-D71A-4420-8E83-5EC176201059</gtr:id><gtr:outcomeId>58c8175f967c22.59377466</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>42075</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>Maximising the public health impact of new approaches to control malaria in pregnancy through the translation of evidence-based global policies to country level policies and plans.</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:fundingRef>CSA-2014-276</gtr:fundingRef><gtr:id>F9039485-9169-4992-8D09-52279A50F81C</gtr:id><gtr:outcomeId>58c928a8f0e400.24090040</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>768126</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH MIDAS Initiative: Mathematical Models in the study of Infectious Disease spread and control (2009-14)</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>1U54GM088491-01</gtr:fundingRef><gtr:id>8D82A935-1199-494E-ACD8-66BB95E4EB2E</gtr:id><gtr:outcomeId>BkxTiTJ6rXA</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>407785</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology Fellowship K O'Reilly - 2013 (Development of statistical modelling framework to inform real-time immunization strategies for elimination of poliomyelitis and other diseases)</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J14362/1</gtr:fundingRef><gtr:id>807081A6-EFFC-4B0A-837B-BEBC9D43A820</gtr:id><gtr:outcomeId>M2co6PG5Bi1</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>24636</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Defra: A study to examine the interactions between cattle and badgers.</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Department For Environment, Food And Rural Affairs (DEFRA)</gtr:fundingOrg><gtr:fundingRef>ZSL ref: N587</gtr:fundingRef><gtr:id>D0D8592D-CB88-434F-A2F8-E4D89C609F23</gtr:id><gtr:outcomeId>ptdFkGvCK1D</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>231402</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Target Malaria - Controlling the mosquito vectors of malaria with engineered endonucleases</gtr:description><gtr:end>2020-01-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1141988</gtr:fundingRef><gtr:id>E7EF52CF-E47F-422E-A9E0-4357188B67CE</gtr:id><gtr:outcomeId>58c921b7965670.61015485</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>786465</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMGF: PreP - ARV-based HIV Prevention Technologies</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1032254</gtr:fundingRef><gtr:id>9CFA6CF4-0DA0-4083-81CA-B0079A60075E</gtr:id><gtr:outcomeId>Tf2mYw4ix2G</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>890687</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMPIRIE: European managment platform for emerging and re-emerging infectious diseases entities.</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>223498</gtr:fundingRef><gtr:id>D79D9A3D-560B-4146-962D-66124455BB38</gtr:id><gtr:outcomeId>8C85A5343EC0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH: Genetic epidemiology of malaria in the Democratic Republic of Congo</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>1R01AI107949-01A1</gtr:fundingRef><gtr:id>DA852826-0778-471C-A4DB-2DEB252E55C2</gtr:id><gtr:outcomeId>54105941eef2a6.81237425</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>218091</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WHO: Statistical and mathematical analysis of polio surveillance data to support the endgame</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:fundingRef>200953530</gtr:fundingRef><gtr:id>B7D3BE1B-262C-416A-98D8-CC54D0D0A3C7</gtr:id><gtr:outcomeId>53f21163646ba7.00475334</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15587</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WHO Guidelines ARV Revision 2015</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:fundingRef>2015/523611-0</gtr:fundingRef><gtr:id>4AD514BB-E4F0-4ABF-A49E-48DB4DEBD6A2</gtr:id><gtr:outcomeId>58c9308429e5e2.94541673</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>670090</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society University Research Fellowship: Mathematical Modelling of Human Contact Networks and Implications for Infectious Disease</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Royal Society of Medicine</gtr:fundingOrg><gtr:fundingRef>516002.K5789/KK UF041279</gtr:fundingRef><gtr:id>79E5499D-CC72-4329-B979-59B302278A7C</gtr:id><gtr:outcomeId>MgARWdY4pwv</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2004-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40810</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Building TRUST</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>Sub Award No. 1800014</gtr:fundingRef><gtr:id>4DF5EE30-0159-4A4C-8329-1E67B7FC7A84</gtr:id><gtr:outcomeId>58c6e5aecae164.03580728</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>368031</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Fellowship: Assessing the impact of HIV-1 in the black Caribbean community in south London</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0802431/1</gtr:fundingRef><gtr:id>95ECE092-D36F-4577-B88C-E235E54A70AC</gtr:id><gtr:outcomeId>Hcy4vzKTCNo</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR: Validation of new technologies for diagnosis and treatment evaluation of tuberculosis</gtr:description><gtr:end>2018-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>12/65/27</gtr:fundingRef><gtr:id>1921EDA5-DE29-4B34-93BE-BB0B2EF26BE6</gtr:id><gtr:outcomeId>53f222597b6de4.19212134</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>219507</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Geospatial modelling for malaria risk stratification and intervention targeting</gtr:description><gtr:end>2020-11-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>2E9E0607-9662-4162-B3C2-7653AA61EFF3</gtr:id><gtr:outcomeId>58c6ecd38949b3.35188080</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>281370</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Fellowship - Bob Verity (Genetic data as a signal of changing malaria transmission)</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/N01507X/1</gtr:fundingRef><gtr:id>A65BD675-9F47-4FD2-A4D0-65363DC08ACF</gtr:id><gtr:outcomeId>58c970868bb130.42678775</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Fellowship - Epidemiology and evolution of pathogenic human enteroviruses - Margarita Pons Salort</gtr:description><gtr:end>2019-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>106073/Z/14/Z</gtr:fundingRef><gtr:id>233DC0AA-1925-4CF0-A8B4-6080293356F7</gtr:id><gtr:outcomeId>56d431f11ad936.69929010</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Fellowship: Uncovering Determinants of eco-evo Pathogen Dynamics with ABC&amp;igrave;.</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>092311/Z/10/Z</gtr:fundingRef><gtr:id>B470FE79-E468-43DE-B398-DA37C97DA749</gtr:id><gtr:outcomeId>gJpEtyMR63T</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>280558</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Supplement to MRC Centre Award: A continental-scale simulator for modelling malaria eradication strategies</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0600719</gtr:fundingRef><gtr:id>919CA426-344B-4BC0-86FF-B6A4D56C8F6D</gtr:id><gtr:outcomeId>anJXh9DtNWL</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>187871</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC: Analytical methodology to perform genome-wide association studies in bacteria</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/L023458/1</gtr:fundingRef><gtr:id>51018C9E-0B58-4F08-97BF-DA3D44423201</gtr:id><gtr:outcomeId>53f20630be2f05.55270694</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>83044</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH: PopART-Phylogenetics</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>6EB2CAA9-DB74-4F36-99A6-91C3B9876EB0</gtr:id><gtr:outcomeId>k3DURN95tE9</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1466564</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MIDAS 2: Models for synthesising molecular, clinical and epidemiological data, and translation to public health response (NIH)</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>1U01GM110721-01</gtr:fundingRef><gtr:id>38693A1C-A100-475D-87CF-B01F3118047C</gtr:id><gtr:outcomeId>545a40fda28e63.29043097</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>61482</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMGF: Treat children in India for enteric infections to improve their response to oral poliovirus vaccine</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1036117</gtr:fundingRef><gtr:id>147C6D9A-BDB5-49EF-A779-D1B62D3735A3</gtr:id><gtr:outcomeId>Gmg5UEbsnUw</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>407784</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology Fellowship: Understanding the spatial dynamics of poliomyelitis and improved planning and mass vaccination campaigns.</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J14362/1</gtr:fundingRef><gtr:id>8C81370E-4E3E-4308-90DE-E211BE04F3C8</gtr:id><gtr:outcomeId>T8QWveRXWEr</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Quantifying future clinical burden of an ageing HIV-positive patient population: a modelling analysis for the USA and Italy</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Gilead Sciences, Inc.</gtr:fundingOrg><gtr:fundingRef>212011616</gtr:fundingRef><gtr:id>043F387C-3CEB-4C60-AA38-152A96E5E011</gtr:id><gtr:outcomeId>58c9312b6a7513.16764045</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>418907</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Fellowship: Synthesising data from multiple spatial scales and levels of detail to improve malaria transmission model predictions</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1002284</gtr:fundingRef><gtr:id>5800813C-67B1-4C61-9E62-FA35CC0DB519</gtr:id><gtr:outcomeId>XJasGGTcFU70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>81332</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMGF Malaria in Pregnancy (MiP) Consortium: Mathematical models to guide treatment and prevention strategies for P.falciparum malaria in pregnancy</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>GATES FDN CONSORTIUM</gtr:fundingRef><gtr:id>278CAE5B-D70B-44DA-88C5-926EF573C7B9</gtr:id><gtr:outcomeId>oENAmeAjN5v0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>89147</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DH: Improving communication with the public about antivirals and vaccination during the next pandemic</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Government of the UK</gtr:fundingOrg><gtr:fundingRef>N/A</gtr:fundingRef><gtr:id>D3B6FCAB-6B52-4C47-A30C-A78B2422018E</gtr:id><gtr:outcomeId>54059215e82bd5.53685182</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>784089</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>HIV Prevention Trials Network (HPTN)</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>FHI 360</gtr:fundingOrg><gtr:fundingRef>UM1 AI068619</gtr:fundingRef><gtr:id>13DDE45D-AA0E-40C6-AFE6-9500D264725D</gtr:id><gtr:outcomeId>56d4305cd798e0.91772079</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>264579</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MIDAS Project with UC San Diego AntiViral Research Center (AVRC)</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>58214101</gtr:fundingRef><gtr:id>D5213C8A-1A84-4366-9618-29EA31AA2508</gtr:id><gtr:outcomeId>58c6e4b93aaa31.49597232</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>177479</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) Treatment for HIV</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Viiv Healthcare</gtr:fundingOrg><gtr:id>94F47575-8FC6-4E9E-97B3-9DC9A2083992</gtr:id><gtr:outcomeId>56d43bb5245a21.49131973</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48496</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>NIHR HTA: The cost effectiveness of genetic markers for antibiotic resistance in tuberculosis.</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>10/96/01</gtr:fundingRef><gtr:id>727A9A6D-A539-48F3-B30C-1F2FE796D180</gtr:id><gtr:outcomeId>MH5vcAAeETJ0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>165784</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Four-Year PhD Studentship - Mr Finlay Campbell</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>919E69EE-FE0C-4B00-A9B1-6F4A088D0E4C</gtr:id><gtr:outcomeId>56d42f320c6509.50403435</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>403372</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Gates: Modelling the impact of diagnostics in global health: The BMGF Diagnostics Consortium</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1095124</gtr:fundingRef><gtr:id>15ABF87D-2531-40C5-8DA7-60428D76DD18</gtr:id><gtr:outcomeId>541055ec1a6347.14225298</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2080207</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMGF HIV Modelling Consortium</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1022972</gtr:fundingRef><gtr:id>0F90B185-F2B8-4CA0-8563-7B2003347123</gtr:id><gtr:outcomeId>qd5VF5ijuMA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>129932</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HPA: Evaluation of the TB Find and Treat Project</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Department of Health (DH)</gtr:fundingOrg><gtr:fundingRef>DoH via HPA</gtr:fundingRef><gtr:id>C252EC82-54AE-4BA2-9262-7C40A88474BC</gtr:id><gtr:outcomeId>W61JXr6r2iS0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15733</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Defra: Ecological and epidemiological effects of small-scale badger culling.</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Department For Environment, Food And Rural Affairs (DEFRA)</gtr:fundingOrg><gtr:fundingRef>SE3272</gtr:fundingRef><gtr:id>14126F33-DECE-4620-AE08-D408C993A709</gtr:id><gtr:outcomeId>YXXxWhL1TRT</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>79228</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR: Interferon gamma tests for the rapid identification of active tuberculosis disease</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>08/106/02</gtr:fundingRef><gtr:id>48D35B62-85C6-4512-8CDF-C5F5B6E80CEE</gtr:id><gtr:outcomeId>oyYNRPx9mtg0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>708513</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sir Henry Dale Fellowship - Nick Croucher (Evolutionary dynamics underlying pneumococcal genomic diversity)</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>104169/Z/14/Z</gtr:fundingRef><gtr:id>E2889945-8BC7-43D3-AE22-CBF98D2AC8E3</gtr:id><gtr:outcomeId>58c97027a2d706.01638018</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80930</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU: Building an Integrated Genetic infectious disease epidemilogy approach (transferred to UCL)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>260801-BIG_IDEA</gtr:fundingRef><gtr:id>CCA7917C-5C2F-446C-81D5-8EE9EDF53923</gtr:id><gtr:outcomeId>n5RTNakQ3gm</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2092163</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre Grant: Centre for Outbreak Analysis and Modelling (Renewal)</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K010174/1</gtr:fundingRef><gtr:id>1DBC5A01-34C9-489E-8D63-5D1EF4FB5921</gtr:id><gtr:outcomeId>53f36396e4c8a7.34579826</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3225806</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Global Alliance for Vaccination and Immunisation (GAVI)</gtr:department><gtr:description>Vaccine Impact Modelling Consortium (VIMC) - Sub-contracts</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>00A70132-EEA1-44E5-8FD0-7F1BB5AC82C3</gtr:id><gtr:outcomeId>58c91dde355d46.39927327</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>18059</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pathfinder: Experimental Human Challenge with Genetically Modified Commensals to Investigate Respiratory Tract Mucosal Immunity and Colonisation</gtr:description><gtr:end>2020-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/N026993/1</gtr:fundingRef><gtr:id>AD96CD2B-D79E-4BCB-AFC8-7DACEDB61522</gtr:id><gtr:outcomeId>58c6e1a650b260.10614300</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>285102</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC fellowship JM - 2013</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J012254/1</gtr:fundingRef><gtr:id>AC900CBC-34CC-4264-B7A3-2FFB13B50756</gtr:id><gtr:outcomeId>eXbPQPdNZ4p</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>165096</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH: Targeting Primary Infection with Antiretrovirals to Prevent Transmission</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>1R01 AI083059-01</gtr:fundingRef><gtr:id>DF60FA59-0197-4A0B-8764-0C448387446A</gtr:id><gtr:outcomeId>QmRbX5LDUzm</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre Renewal - Equipment Sub # 2</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K010174/1B</gtr:fundingRef><gtr:id>A0176695-BB57-4087-B1F3-28C57F62A239</gtr:id><gtr:outcomeId>58c90ad3e073c5.67797367</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3360479</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMGF: HIV Modelling Consortium (renewal 2013)</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1084364</gtr:fundingRef><gtr:id>0251037B-D5EE-4594-B77C-71E8B9A6C9C2</gtr:id><gtr:outcomeId>TKaPFpNn7TS</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1755066</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMGF Project Grant: Vaccine Modelling Initiative (VMI)</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>705580-1</gtr:fundingRef><gtr:id>EAF12712-CB60-4C23-AD4B-83B2C99E0818</gtr:id><gtr:outcomeId>8D121EBA9A60</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>167022</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cost-effectiveness systematic screening and treatment of pregnant women by CHW</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>305662</gtr:fundingRef><gtr:id>6FC4280A-1C69-44FA-ABF2-A9AC6D2D43C7</gtr:id><gtr:outcomeId>58c81eb643a8a2.95828897</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>285102</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Fellowship: Optimal trial design for a release of malaria-refractory transgenic mosquitoes</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J012254/1</gtr:fundingRef><gtr:id>8DB4651E-116F-439B-ADFB-9C08B20D9FBF</gtr:id><gtr:outcomeId>iCeaj3t5o7D</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>331798</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMGF: The interaction between hormonal contraceptives and HIV risk</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1067133</gtr:fundingRef><gtr:id>C8AC2470-9706-43DF-8578-2433043E9EC0</gtr:id><gtr:outcomeId>oW399Xyg6qn</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>167527</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Population Effects of Antretroviral Therapy to Reduce HIV Transmission (PopART) - Health Economics</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>PO15001410</gtr:fundingRef><gtr:id>29BC763D-0411-4DB6-8155-9D612DFD0D0F</gtr:id><gtr:outcomeId>58c92232408cc3.90337798</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2147546</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMGF: Application of mathematical models to guide and evaluate malaria control and elimination programs</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1068440</gtr:fundingRef><gtr:id>00A9CB88-D028-468C-91F1-D7BE3F0656FC</gtr:id><gtr:outcomeId>R7yaMFhW99k</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>165784</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Four-Year PhD Studentship - Miss Isobel Routledge</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>109310/Z/15/Z</gtr:fundingRef><gtr:id>057B9A35-4D54-4246-BDDC-50DC3F7DEAC1</gtr:id><gtr:outcomeId>56d43010c97288.98848009</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>179101</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>RooPfs (Can improved housing provide additional protection against clinical malaria over current practice? A household-randomised controlled trial)</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>RF020305</gtr:fundingRef><gtr:id>8CC2166F-25D6-46AF-AE14-C46C17A216B1</gtr:id><gtr:outcomeId>58c820f3019279.47575640</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>27990</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WHO: Developing a model of the impact of artemisinin resistance</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:fundingRef>PO 200833521</gtr:fundingRef><gtr:id>D1DD6D02-F96C-428D-ADB2-2E99BA5DE4ED</gtr:id><gtr:outcomeId>rSGWdZFe3rP</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>299834</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Fellowship - Patrick Walker (Understanding trends towards malaria elimination in Western Kenya)</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L012189/1</gtr:fundingRef><gtr:id>038F6B5F-0578-413C-B63E-F74F4F3960DF</gtr:id><gtr:outcomeId>54105bfd6e0793.40769582</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>13115</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Department for International Development (DfID)</gtr:department><gtr:description>Population Effects of Antretroviral Therapy to Reduce HIV Transmission (PopART) - Health Economics</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>Government of the UK</gtr:fundingOrg><gtr:id>FA40340A-5E9E-4CD3-BE2B-7561433FBF27</gtr:id><gtr:outcomeId>58c9228bdbfa27.01680241</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>162798</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Improving the efficacy of malaria prevention in an insecticide resistant Africa</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>200222/B/15/Z</gtr:fundingRef><gtr:id>2F53360E-0C0D-453E-9D44-7E84F0BB8D81</gtr:id><gtr:outcomeId>58c6ee8a1d92e9.01134435</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3757557</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Vaccine Impact Modelling Consortium (VIMC) - Secretariat</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1157270</gtr:fundingRef><gtr:id>22D17739-D6A9-4CAC-AA61-D46E4A84805F</gtr:id><gtr:outcomeId>58c6ec64b85637.93706245</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR - Senior Investigators Award (budget uplift)</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>P/O 427921</gtr:fundingRef><gtr:id>1D21969F-24AD-49DC-9D10-A38AC848AAFA</gtr:id><gtr:outcomeId>58c916cb1f4d71.18627383</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>305791</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Fellowship: Spatio-temporal dynamics of drug-resistant Plasmodium falciparum malaria in Africa: implications for public health</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1002387</gtr:fundingRef><gtr:id>E9FFF1DB-0C6E-4A58-9D4D-F8A8CC709071</gtr:id><gtr:outcomeId>UTmRTxCR9EJ</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Sitting on the advisory committee of GORN. To inform and guide development of new tools for outbreak response</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>98FA1BD0-4FCC-4CFB-8CE4-50087332C119</gtr:id><gtr:impact>collaboration on tool development</gtr:impact><gtr:outcomeId>58c8192425ea24.42704383</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Economic modelling of TB in hard to reach groups</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FE4AE71B-466F-49CA-9721-830A958ED4B3</gtr:id><gtr:impact>_</gtr:impact><gtr:outcomeId>GjxGqvJy3b7</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contribution to WHO Report on the use of mass drug administration for malaria - 2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B81A0EE8-1961-421E-8333-781C20DD3A73</gtr:id><gtr:outcomeId>56d7090030b920.83755398</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NERVTAG (New and Emerging Respiratory Virus Threats Advisory Group) - 2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D8570D6E-A67F-42FA-A8E3-7CCBD62206DD</gtr:id><gtr:outcomeId>56d708d381fe59.37564474</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Epi Et - and Field Epi Training Program (PHE/CDC courses).</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>CC39EB32-D26C-4192-858C-615DE5A8F268</gtr:id><gtr:impact>Helping to redesign teaching modules for these courses</gtr:impact><gtr:outcomeId>58c8196365a062.40962464</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Recommendation for the long-term vaccination strategy for YF informing SAGE decisions</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E90C6863-5980-4E6D-B880-72E5101210C9</gtr:id><gtr:outcomeId>58c12e9a946984.85460674</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation to the JMM (Joint Monitoring Mission) for the National Tuberculosis Programme assessment in India. Report availbale here: http://www.tbonline.info/media/uploads/documents/jmmdraft2015.pdf</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>59D7F914-F4D5-4FD8-9CE1-9178F53F155D</gtr:id><gtr:outcomeId>56d70d46d87777.73201734</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type><gtr:url>http://www.tbonline.info/media/uploads/documents/jmmdraft2015.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chair of UNAIDS HIV Reference Group (2014)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B547683D-A01F-42B7-A2CA-B17E65206B4A</gtr:id><gtr:impact>The methods were updated to improve the precision &amp;amp; accuracy of countries view on the epidemics to inform local deceison making.</gtr:impact><gtr:outcomeId>54608da9339bd0.08662073</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://www.epidem.org</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Global Fund - secure agreement on GF investment case</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C7EC9831-022E-4455-87B5-222646540E83</gtr:id><gtr:impact>Support for the Global Fund on their investment decisions</gtr:impact><gtr:outcomeId>58a2deef8f8684.80145052</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SPI (Scientific Pandemic Influenza advisory committee) - 2013</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E6614485-B102-4B0F-AB70-CD5DE1F91E5D</gtr:id><gtr:impact>Provided expert advice on influenza pandemic planning and response, to ensure that the UK Government is provided with a high standard of scientific advice to support planning and response to a pandemic in the UK, which is identified in the National Risk Register of Civil Emergencies as one of the 4 highest priority risks.</gtr:impact><gtr:outcomeId>hFJ7JCcdmcG</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advice to UK DH on responding to the UK H1N1 pandemic</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>A95D86C6-61EF-4D20-ADE3-424582E7CCC2</gtr:id><gtr:outcomeId>046A6C2B964</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Sources of HIV transmission in The Netherlands</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>573A9EDF-3751-4645-9442-95138C92022A</gtr:id><gtr:impact>Improved knowledge amongst professional practitioners about the sources of HIV transmission in The Netherlands, which subsequently led to improvements in treatment, access to care, survival, morbidity and quality of life for people living with HIV in The Netherlands</gtr:impact><gtr:outcomeId>58af0aef304ed9.20613564</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MESA malERA Refresh Panel: Health Systems and Policy Research</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F17EA36F-160E-47B3-A56A-964EFD5DD659</gtr:id><gtr:outcomeId>56d710b020a659.04258587</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.malariaeradication.org/malera-refresh/health-systems-and-policy-research</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Consultation on data sharing during public health emergencies; later included in WHO Guidelines on data sharing -2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F535D7F1-D536-43C9-80BB-19163ECF7DD1</gtr:id><gtr:outcomeId>56d7095ae51fa4.25240061</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>London TB Find and Treat service (Parliamentary Hearings)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B705DE66-4157-48BE-8716-AD4B21321986</gtr:id><gtr:outcomeId>ASP5WdUMTch</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type><gtr:url>http://www.publications.parliament.uk/pa/ld200809/ldhansrd/text/90630-0001.htm</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Work Informing a government-planned field trial of BCG cattle vaccine. 2013</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BCA0C48A-AD8F-4C19-952B-620F6C990BC6</gtr:id><gtr:outcomeId>i6bjY5nhgao</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Commissioner on Lancet Commission for Global Surgery - 2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3C712D01-2D5B-4A21-91DC-DC2A1F8C7AD6</gtr:id><gtr:outcomeId>56d71212074438.77003455</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Polio immunisation plans</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6717CD82-9F98-47B6-AD9E-1664209D6271</gtr:id><gtr:outcomeId>4BAA75B287A</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type><gtr:url>http://www.polioeradication.org</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Providing direct technical support to Pakistan Ministry of Health and WHO</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>D21CE2D4-4EAB-4DCA-AC0C-D40440F12937</gtr:id><gtr:impact>Working with WHO and government offices to offer risk assessment and campaign planning for polio eradication</gtr:impact><gtr:outcomeId>58aae11c3e53e9.88618439</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contributor to WHO research roadmap on Zika</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>EC16AF87-2ED5-4D48-B7F8-F79C2C2CE253</gtr:id><gtr:impact>Informed short term public health research priorities for responding to the Latin American Zika epidemic</gtr:impact><gtr:outcomeId>58c037b486cff4.83671005</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://www.who.int/csr/research-and-development/r_d_zika_involvement/en/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NIH (Expert consultation on finding 'unknowing' HIV) - 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>4BAAC73B-0444-4D53-B3AA-7D930D04F23F</gtr:id><gtr:impact>Improved regulatory environment in HIV.</gtr:impact><gtr:outcomeId>ofQQYbUKPBP</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SPI-M (Scientific Pandemic Influenza advisory committee: Modelling subcommittee) - 2013</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B99EAFAA-F0C0-42CC-A2B7-E0F859AD94C6</gtr:id><gtr:impact>Provided expert advice on influenza pandemic planning and response, to ensure that the UK Government is provided with a high standard of scientific advice to support planning and response to a pandemic in the UK, which is identified in the National Risk Register of Civil Emergencies as one of the 4 highest priority risks.</gtr:impact><gtr:outcomeId>KY1WD4tB8Q4</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Global Fund - develop KPIs for GF</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>8FC23C6C-0AF6-4B86-9B63-0D3EA6F6527D</gtr:id><gtr:impact>Supported the Global Fund with the development of their Key Performance Indicators (KPIs)</gtr:impact><gtr:outcomeId>58a2df2d021ae3.86288985</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advice to the World Health Organisation on the H1N1 pandemic</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>EF6C8171-8EA3-40C7-BC23-D521831E7404</gtr:id><gtr:outcomeId>95EB9302C91</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Publication of journal article on increase to TB burden. Influencing global numbers and strategy</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>41A281F2-1CC4-4A6B-9DAC-00EB0931D233</gtr:id><gtr:impact>Significant influence on global understanding of TB burden</gtr:impact><gtr:outcomeId>58c81494ab2c75.46568629</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type><gtr:url>http://timesofindia.indiatimes.com/india/No-of-Indias-TB-patients-may-be-double-the-estimate-Lancet/articleshow/53852055.cms</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO - Malaria Interventions</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6F98F7B9-52D8-4E25-89C4-739189C942B2</gtr:id><gtr:outcomeId>WuUvyyUhLzr</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Attended Davos as one of three Imperial representatives (including Alice Ghast and Kieth Nions). Advice to policy makers</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2E63E6D2-5B7A-4705-BC60-376D60C8DC62</gtr:id><gtr:impact>reputation (representing Imperial at global forum)</gtr:impact><gtr:outcomeId>58c7f9d1728ef1.68762222</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type><gtr:url>https://youtu.be/Ws2VcwRFEIE</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Coordination of multi-country research on specific topics of interest to WHO (e.g. H1N1pdm infection) resulting in peer-reviewed publications MVK</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>FF7FE85E-1D78-40A1-86AF-56FDC4FB1BB0</gtr:id><gtr:outcomeId>WqYfHq1tNws</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Malaria Policy Advisory Committee</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3003D85A-EB91-4B25-A2A1-A9E5D6DEB76A</gtr:id><gtr:outcomeId>58c66e1cecbba8.46294060</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Home Office - Security and Identity</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9193C71F-2BFA-40B3-B300-459DFAEBB8B6</gtr:id><gtr:outcomeId>TLgPB8xiU5Y</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>IVCC talk - Bhatt - (relating to decisions) - budgeting vector control . Effect of interventions</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6CDBC166-BFCA-4DAB-9628-C8A3F96EA542</gtr:id><gtr:outcomeId>58c81073ac3b76.13181509</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Infectious disease modelling short course - 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C0EF64B6-0A81-45BC-87E7-465E9D083EE0</gtr:id><gtr:impact>Informed public health professionals: what infectious diseases modelling can and can not do; what its data requirements are; how to critically appraise models.</gtr:impact><gtr:outcomeId>k7GfoQzhDdj</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.infectiousdiseasemodels.org/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Technical expertise on WHO led teleconferences for influenza, yellow fever, meningitis, and other pathogens</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E4A1454E-E32E-4770-B31B-7DEB1F06817F</gtr:id><gtr:impact>information not provided</gtr:impact><gtr:outcomeId>HCQZPAj47Gq</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>DEFRA - modelling</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3E366FE9-F6C7-41AF-8549-EA27476631E9</gtr:id><gtr:outcomeId>By3x8T8bfdP</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>CHPR Serology Surveillance Flu Steering Group - 2013</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1AAA6CE1-BDFE-4630-B5A3-5E2FD1F08CA4</gtr:id><gtr:impact>Improved information with which to choose influenza vaccine strategies</gtr:impact><gtr:outcomeId>KXg8KZZQdZV</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Numerous citations in UK DH, US DHHS and WHO planning documents</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>ECA07B04-3C07-45B4-A1E0-044152776F66</gtr:id><gtr:outcomeId>F09C17F1942</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://europepmc.org/abstract/MED/16642006</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Measures of efficacy of anti-malaria interventions against malaria transmission</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AA619717-C95D-4D33-8033-FA26C5603FBC</gtr:id><gtr:outcomeId>TtAdrPL7frb</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type><gtr:url>http://www.who.int/vaccine_research/malaria_malvac2010/en/index.html</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Zoonoses Workshop - Tanzania - Feb 2016 - 25 attendees including policy makers</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>06B93749-6EAA-429E-9F34-61CA0C26C010</gtr:id><gtr:outcomeId>56d70a3c0b4454.01455586</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advice to EU on H1N1 pandemic (ECDC, DG-SANCO)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>F539329D-B82D-43BC-9955-3E1B33E330D3</gtr:id><gtr:outcomeId>86441E01DF4</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Global Technical Strategy for Malaria, 2016-2030 (2015)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>142BA154-5B10-472A-9E97-CD72965AB71F</gtr:id><gtr:impact>http://www.who.int/malaria/areas/global_technical_strategy/en/; http://www.who.int/malaria/areas/global_technical_strategy/WHO_HTM_GMP_2014.11_eng.pdf?ua=1;</gtr:impact><gtr:outcomeId>56d70aa8625a20.60976536</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.who.int/malaria/areas/global_technical_strategy/en</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>polio2 NG</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3DAE9EE7-A2B3-49E7-9E58-16DCE6107049</gtr:id><gtr:outcomeId>Gj84aftHjVs</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contribution to NICE (The National Institute for Health and Care Excellence) Guidance on TB - 2015</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>National Guideline on Treatment of Latent Tuberculosis Infection</gtr:guidelineTitle><gtr:id>0471AA61-59B9-4533-82EA-C2C145D8F972</gtr:id><gtr:outcomeId>56d70bbf0a3d86.65462793</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.nice.org.uk/guidance/ng33/evidence/appendix-i-imperial-college-ltbi-treatment-report-30-april-2015-80851860834</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Preparatory Meeting of the Global Fund Fifth Replenishment (2017-2019), 16-17 December 2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>7BB927F6-2953-494A-AD55-D15348FA7CAA</gtr:id><gtr:outcomeId>56d70c3514f961.33086927</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>World Health Organisation Steering Committee for Global Malaria Technical Strategy - 2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>47464616-C7F1-4D73-BDCB-416AAC106E46</gtr:id><gtr:outcomeId>56d712344c4bf3.29391353</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://www.who.int/malaria/areas/global_technical_strategy/steering_committee/en</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Outbreak response for yellow feevr in Angola</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6960FE81-9494-4C19-A601-E7963484BDB3</gtr:id><gtr:outcomeId>58c12e3b295cc7.02688101</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://apps.who.int/iris/bitstream/10665/246103/1/WHO-YF-ENB-16.2-eng.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Elimination Scenario Planning (WHO policy document) AG</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>B5C58400-CF9C-44BB-A1D8-00E660C27971</gtr:id><gtr:outcomeId>URf74y9v6ur</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Department of Health - SPI</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7228D641-2841-4589-BDEE-C3BA1DDB7C68</gtr:id><gtr:outcomeId>Nyq5UFZBzS7</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Evidence Review Group on Malaria Burden Estimation (WHO committee) AG</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>8CBAACC6-A9C8-454A-AEFA-FD953C40C4D0</gtr:id><gtr:outcomeId>tfUHkXx5TCV</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Provision of malaria vaccine public health impact scenarios to WHO and GAVI - 2013</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>11E37092-5D8A-4E9B-A63A-5CDC43E74FC8</gtr:id><gtr:outcomeId>VqxyzQEtW1Y</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO CONSULTATION ON INFLUENZA DISEASE BURDEN (External Expert) (December 2014)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>BABBE7AF-189A-4A03-9FA8-23F396FAED89</gtr:id><gtr:outcomeId>56d70b29c5fa30.21185383</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Global Technical Strategy Steering Committee - 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>78E45650-9440-4574-9716-32CDD856958E</gtr:id><gtr:outcomeId>GF5tNwBf4JZ</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type><gtr:url>http://www.who.int/malaria/areas/global_technical_strategy/en/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Flu Burden (2014)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B7C1772C-639B-484A-AEBE-E5D2394142B3</gtr:id><gtr:impact>Improved methodology for measuring the burden of influence and hence maker better policy decisions.</gtr:impact><gtr:outcomeId>54609cd83c33c2.38603311</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://www.who.int/immunization/topics/influenza/en/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Estimating the epidemic potential of swine-origin H3N2v influenza virus - results presented during a briefing to the director of US CDC SC</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>4283B3EC-8D46-45CB-BA98-748D1B2BB0C3</gtr:id><gtr:outcomeId>tnoAqpjiykM</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Designing Phase III Trials for potential transmission blocking vaccines in malaria (2014)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>84151719-1EE6-4D14-AE50-018D26E55760</gtr:id><gtr:outcomeId>5453500a9323b8.97155570</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>The International Decision Support Initiative (iDSI)&amp;nbsp;supprted by Bill &amp;amp; Melinda Gates Foundation</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>977208C1-8646-4E7C-88FB-20A5839001C6</gtr:id><gtr:outcomeId>56d710639de380.53035379</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Economic evaluation of London TB Find &amp;amp; Treat service (DH)</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>26D70965-8EF8-4AE5-856B-217CFDE83A2B</gtr:id><gtr:outcomeId>BYSWkSgQdRq</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://www.bmj.com/site/video/findandtreat.xhtml</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Source of scientific data on the impacts of badger culling CD</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>445E746B-9D43-449F-B46E-F76E244AF14C</gtr:id><gtr:outcomeId>mn1dAcgPpkC</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO public health research agenda for Influenza. Speaker for the modelling stream of these guidelines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AE908875-97A4-4EF0-B65B-9D6F68D1B7C5</gtr:id><gtr:outcomeId>58c808b6a6ffe1.48628903</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cabinet Office Advisory Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BF59CE4E-613E-4C7C-BC7F-64CA75A913C2</gtr:id><gtr:outcomeId>Ygqi79mPLFa</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Older adult Polio vaccination &amp;amp; infection - 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>BCFFF778-4E5E-4AE2-88AB-E7FDA2F43BA1</gtr:id><gtr:impact>no information</gtr:impact><gtr:outcomeId>EyztauqPEY8</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Presented evidence for US National Academy of Science on the risks and benefits of gain-of-function experiments - 2015</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>4B728A5A-8F3E-410C-B250-E131DEE1CE36</gtr:id><gtr:outcomeId>56d7093d6f5a37.65520538</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Eliminating Yellow fever Epidemics (EYE) WHO meeting</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E17A4F7C-D186-4DD7-BCF0-E9735F660A3A</gtr:id><gtr:outcomeId>58c12ebd9961e5.88024723</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/csr/disease/yellowfev/eye-strategy/en/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Towards the Elimination of Hepatitis B and C by 2030. The draft WHO Global Hepatitis Strategy, 2016-2021 and global elimination targets.</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5B27D70B-2AD7-43ED-A216-D04922116D39</gtr:id><gtr:outcomeId>56d70c6071c179.78154052</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>H5N1 Surveillance &amp;amp; Monitoring in Poultry</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9E502779-6875-4039-AB03-E2986BEFA534</gtr:id><gtr:outcomeId>3C746214DC8</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Methodology and Research Panel Membership - 2015</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>9C6D5DBF-B164-42E8-8B06-6B899A97C065</gtr:id><gtr:outcomeId>56d70cf8a75dc8.86874590</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Seasonal Malaria Chemoprophylaxis (WHO policy document) AG</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>07A022B9-1721-448D-958A-D4337C1B79EC</gtr:id><gtr:outcomeId>iZq69dSx5a8</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Continued engagement with leadership at Bill &amp;amp; Melinda Gates Foundation TH</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AE2EB6F2-0441-4371-97C8-138482C923D9</gtr:id><gtr:impact>not known</gtr:impact><gtr:outcomeId>HMSXRPwCKoX</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Technical assistance to WHO for WHO documentation (e.g., Weekly Epidemiologic Record publications) MVK</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>4B029507-45DF-4741-B16F-3953D5F417B8</gtr:id><gtr:outcomeId>QT69xzhQozL</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Paper (PMID: 26093978) on new vaccine strategies to finish polio eradication led to introduction of vaccine campaigns by Global Polio Eradication Programme in Nigeria, Pakistan and Afghanistan</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>72F60970-676D-40CE-87BF-638F84B7AF6A</gtr:id><gtr:outcomeId>56d70cda188944.13619995</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Stop TB Partnership (provision of advice for Global Drug Facility Committee) - 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>777D016E-2E0A-4589-ACF2-ED1D7ABA9BA0</gtr:id><gtr:impact>no information</gtr:impact><gtr:outcomeId>NZbc7QpHQmz</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>PopART (citation in new WHO consolidated treatment and testing guidelines) - 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>A29A7CBA-515A-4E8D-AE49-7C61B03E19EE</gtr:id><gtr:outcomeId>q66tSM9rJCc</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www1.imperial.ac.uk/departmentofmedicine/divisions/infectiousdiseases/infectious_diseases/hiv_trials/hiv_prevention_technologies/popart/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advised WHO HIV Guidelines Committees (2014)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>085C090B-83CD-437C-AFDE-8351D9B41E27</gtr:id><gtr:impact>The WHO HIV treatment guidelines changed.</gtr:impact><gtr:outcomeId>54608ce6236062.41242502</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Work Foundation panel discussion on assessing work productivity of people working with HIV/AIDS.</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>9226C7A1-4A74-4557-A56A-3FE12FCF0DC6</gtr:id><gtr:impact>Economic</gtr:impact><gtr:outcomeId>58c7fa3cd88014.30462921</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://theworkfoundation.com</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Department of Health Ebola modelling group (2014)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>EC9D133F-2D76-4320-A5B5-FBF0CA62DEA8</gtr:id><gtr:impact>Provided expert advice on Ebola epidemic response in West Afica, and preparedness for the UK, to ensure that the UK Government is provided with a high standard of scientific advice to support the response in West Africa and preparedness for the UK.</gtr:impact><gtr:outcomeId>54526d83ad21c1.10226188</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the Scientific Programme Committee (CROI 'Conference on Retroviruses and Opportunistic Infections' 2016 Boston) - 2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2EC4AD27-77EF-4038-BABC-C22EB837020C</gtr:id><gtr:outcomeId>56d70ca0d60d34.66245584</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Continued engagment with the PEPFAR leadership TH</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>74BD7E57-7987-41EF-AF89-7ABABE6C7757</gtr:id><gtr:impact>re-orientation of budgeting priorities -- but this is confidential stuff currently</gtr:impact><gtr:outcomeId>WLwmYcUxTuz</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Ebola Response Group - 2014</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>B4F04D8B-FF8E-46DE-A9F6-95CD69F2D238</gtr:id><gtr:impact>Improvements in survival, morbidity or quality of life re Ebola.</gtr:impact><gtr:outcomeId>545cdab05f03c6.60861592</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type><gtr:url>http://www.nejm.org/doi/full/10.1056/NEJMoa1411100?query=featured_home</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Collaboration on Modelling Dengue Vaccines - Strategic Advisory Group of Experts (SAGE) - 2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F0D9AF2B-8B9F-4055-9A24-18BE268044A2</gtr:id><gtr:outcomeId>56d708ae866f43.64507126</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Consultations on 2013 HIV testing and treatment guidelines CF</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>56DF922A-1DF4-4353-98A6-9D055975BE2A</gtr:id><gtr:outcomeId>mNgR2VpvJZz</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advice to US govt (White House, HHS, CDC) on responding to the H1N1 pandemic</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>7E6349BE-E460-4488-864C-895245F5E7FD</gtr:id><gtr:outcomeId>BB1BAB96D5A</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advice to US govt (White House, HHS, CDC) on pandemic planning</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>7DA653A7-3404-4772-9644-F29F72367C3D</gtr:id><gtr:outcomeId>8B3F530C8AA</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Attendance at WHO policy meetings on anitmicrobial resistance and HIV prevention</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F9973B53-23B2-472A-8FB0-C3144C79F557</gtr:id><gtr:outcomeId>3E0D57D48AD</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>&amp;quot;Estimating direct and indirect protection from influenza vaccination in the USA&amp;quot; (forthcoming) for CDC (USA) containing information to be included in national messaging on vaccination</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>&amp;quot;Estimating direct and indirect protection from influenza vaccination in the USA&amp;quot; (forthcoming)</gtr:guidelineTitle><gtr:id>CCBE95A7-7DA5-473C-B7AD-587239135F7E</gtr:id><gtr:outcomeId>56d70dab013077.01812664</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Elimination Scenario Planning (WHO Country Guidance Document) - 2013</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>1A8CD7EA-A6CD-4438-89CD-3B3ADFCC3FA3</gtr:id><gtr:outcomeId>JBKVqgF8xAA</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.who.int/malaria/publications/atoz/9789241507028/en/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Consise Steering Committee - 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3C1E2E28-B70A-41BA-A06B-8B0412A722B6</gtr:id><gtr:impact>More accurate assesment of influenza burden.</gtr:impact><gtr:outcomeId>PiiTbwfaCMV</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Pandemic Flu Service (report) - 2015</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>76593F00-C4D3-43E2-932C-C1DA9EB3CA8F</gtr:id><gtr:outcomeId>56d70be3d68940.86127865</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>CDC - Disease Severity</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6DFFB86B-F4EB-454D-98B0-7772111A4B8F</gtr:id><gtr:outcomeId>MmiXihNbZZQ</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>PHE influenza partnership: The impact of mathematical modelling of influenza: better decisions for Public Health (2015)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>B33F48F5-592D-4CDD-ACA9-03C1AA39F0FD</gtr:id><gtr:outcomeId>56d70f04aab215.60618183</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Monitoring disappearence of polio type 2 globally, providing weekly analysis of data to &amp;quot;polio partners&amp;quot;: Gates, WHO, CDC (April 2016)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5188C517-4C22-4266-91D6-CE6F82C38005</gtr:id><gtr:outcomeId>58aae03a4ea590.32776712</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Norwegian National Institute of Public Health consultation on learning the lessons on Ebola -2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D8A39D92-C024-4F17-AAEA-4DABF031A106</gtr:id><gtr:outcomeId>56d709ab6c4263.99622895</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Investment Case for Global Fund 2017</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E1ACCA92-A1A7-4C4D-BDF9-8A0896A18118</gtr:id><gtr:impact>TBC</gtr:impact><gtr:outcomeId>58c66ce79a2179.62664602</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.theglobalfund.org/documents/publications/other/Publication_InvestmentCase_Summary_en/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO recommnedations on 'Conditions for use of long-lasting insecticidal nets treated with a pyrethroid and piperonyl butoxide' (December 2015)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2B5BAB80-2D78-4FFA-A13C-CE6E795E55D1</gtr:id><gtr:outcomeId>56d70fca486fd3.13713262</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.who.int/malaria/publications/atoz/use-of-pbo-treated-llins-report-nov2015.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Global Plan for Insecticide Resistance Management (GPIRM) - WHO AG</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>E9C556AF-CA88-4108-9AE1-D209B0178BEF</gtr:id><gtr:outcomeId>MtPBAiFb48F</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>&amp;quot;The Costs to Patients and Health Services of six Patient Safety Incidents: Evidence from English Hospitals&amp;quot; (forthcoming paper) presented to the Department of Health (NHS England)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>82EC3B94-08C2-4FF2-AD1F-B6415A8A0126</gtr:id><gtr:outcomeId>56d710839f9123.03723735</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advice to UK DH on pandemic planning via 'SPI' advisory committee</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C6AB2A9B-BF8C-4F62-B0FA-110F748BA529</gtr:id><gtr:outcomeId>A7995A4E092</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership in Core WHO Committee on the use of ART (2015)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>0ADEA3E2-2320-4B14-99A1-EE04C54A6784</gtr:id><gtr:outcomeId>56d70c12c1efc4.00261467</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Global polio immunisation</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D37013E0-EC09-447F-A597-4E67B42AA8FF</gtr:id><gtr:outcomeId>6118908CD54</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Policy Recommendation for the RTS,S malaria vaccine (2015)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C79D8ECD-582F-46CB-B228-0E57740BD28E</gtr:id><gtr:outcomeId>56d70af3affe71.54171211</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.who.int/immunization/policy/position_papers/malaria/en</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NICE revision of guidelines for TB control</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9FDC0D09-EE46-41E5-B662-0E012353F898</gtr:id><gtr:outcomeId>goF7MLmvUrv</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://www.nice.org.uk/nicemedia/live/11978/56320/56320.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Uptake of new molecular diagnostic tools for TB in India (2014)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>37AAD755-E882-4DF7-8912-E5795B71A073</gtr:id><gtr:outcomeId>54536d9b7860a4.43161630</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>DH Flu colloquium led by SofS DH</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C576CCF4-1EB5-49CB-ADA2-C5857D4F627D</gtr:id><gtr:outcomeId>1312F4ACA05</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Scientific Committee for Advanced Data and Modelling - 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>0BE6149F-48D0-4855-8C60-B2A69340F047</gtr:id><gtr:impact>Improved outbreak response policies for pandemic influenza.</gtr:impact><gtr:outcomeId>W3S5WbTaDw1</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://www.chp.gov.hk/en/sas2/101/110/108.html</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Bovine TB Advice to DEFRA</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3A9998BA-2E50-4398-AA61-33B40149DC61</gtr:id><gtr:outcomeId>5460f1eccb4885.09963668</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>vCJD projections and modelling</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C9B29179-3C1E-4A00-8F68-8AD7444A4B12</gtr:id><gtr:outcomeId>46A92AC471B</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Serological Epidemiology of Influenza Steering Group - Health protection Agency</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>32EA903F-9E1B-49BF-BE91-18CB7CEAF39F</gtr:id><gtr:outcomeId>iRrhsjm2dxb</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO SAGE Polio - 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>1771C33B-FACB-4112-9834-E5F8E0844389</gtr:id><gtr:outcomeId>Fhvz5e57U6k</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Spi-M committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>45C2DC6E-6D79-4F17-A485-D133CC0583C7</gtr:id><gtr:impact>contribution to government Spi-M panel</gtr:impact><gtr:outcomeId>58c7ff5fac8b74.87416578</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>https://www.gov.uk/government/groups/scientific-pandemic-influenza-subgroup-on-modelling</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Continued engagement with UNAIDS leaderships TH</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C71AFECF-8FE3-4116-ADED-2EFFEC414B99</gtr:id><gtr:impact>_</gtr:impact><gtr:outcomeId>PCTqEJFhC4e</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Evidence Review Group on Malaria Burden Estimation (WHO Committee) - 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>FF39FB5C-189B-4CBA-BA82-D7C17EF896D9</gtr:id><gtr:outcomeId>R3PruYaSa7r</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type><gtr:url>http://www.who.int/malaria/mpac/evidencereviewgroups/en/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Measles and Polio Committee UK - 2013</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F05889DB-7304-45F0-93F9-597C2B280BB4</gtr:id><gtr:outcomeId>dbe2gvyH3pp</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Continued engagement with WHO leadership TH</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>4CF18CDD-ECEE-4DF0-82EB-441710A2ACDF</gtr:id><gtr:impact>_</gtr:impact><gtr:outcomeId>X7AbBFXino7</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Evaluation of the London TB Find and Treat Project</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>4CAE6CA8-C08C-40B4-8F3B-DA97FA7FAE60</gtr:id><gtr:impact>not known</gtr:impact><gtr:outcomeId>Ew2VHaiPkrS</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>DH Pandemic Influenza Scientific Advisory Group</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3BB20648-D97E-420D-B18F-FDACF0CE4A4C</gtr:id><gtr:outcomeId>CF225C8D928</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>polio1 NG</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>59EE6B48-4877-40A2-951F-DCE0217B1B4D</gtr:id><gtr:outcomeId>kRK3kNViP2T</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Continuation from 2015 reporting on CRO work. Modelling being used to advocate for major policy shifts for TB control in the region, as used by WHO.</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>32270CBF-5881-43CB-99EE-42C486490823</gtr:id><gtr:outcomeId>58c8142ebf7ed1.64277993</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Severity of influenza pandemics. To feed into WHO guidelines on influenza severity.</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>887C87BB-A6D2-471C-8B3A-B4050AA46A1B</gtr:id><gtr:outcomeId>58c809dd318738.42046907</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/influenza/en/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Malaria Elimination Guidelines - 2014</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>7B89A801-FBB6-41DD-9862-BC7E8ADD78F2</gtr:id><gtr:outcomeId>5463411175c907.69674825</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/newssummary/news_12-6-2014-18-17-49</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Transmission Study Working Group for DEFRA on efficacy of BCG vaccination for cattle - 2015</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2642D78F-498B-4555-A7FF-082A5505C3CA</gtr:id><gtr:outcomeId>56d70a5ecdeb33.18480116</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO and Wellcome Trust Joint Consultation on preparing for the next epidemic -2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>30C0B866-11F1-46B0-BEEE-B97743821581</gtr:id><gtr:outcomeId>56d709845aa7f0.86393456</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Presentation to WHO Expert Review Group on Bednets - 2016</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:guidelineTitle>Conditions for use of long-lasting insecticidal nets treated with a pyrethroid and piperonyl butoxide</gtr:guidelineTitle><gtr:id>8BC4E108-8326-4342-A5C8-9C2E1D553C94</gtr:id><gtr:impact>It is estimated that 68% of malaria deaths have been averted through use of bednets though there is increasing fear that the effectiveness of these nets is being reduced by the presence of mosquitoes resistant to insecticide. A new type of net is available that claims to overcome the problems of pyrethroid resistance but it much more expensive so it is unclear where and when control programmes should invest in this type of net. Our work was used to justify the current WHO policy for the use of these nets.</gtr:impact><gtr:outcomeId>58adb6fec6f336.87743468</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.who.int/malaria/publications/atoz/use-of-pbo-treated-llins-report-nov2015.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>RCUK - Global Uncertainties</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D2BE9C18-021F-4E49-B95E-FDE693D2B00D</gtr:id><gtr:outcomeId>Gkr5poARUcb</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO HIV treatment committee - 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>EE27F66F-E47E-44A5-8985-326F579399F0</gtr:id><gtr:impact>WHO HIV treatment guidelines changed.</gtr:impact><gtr:outcomeId>aHXgnebZZpv</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MERS-CoV collaboration</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C412AA4A-9CFA-4DB3-B478-A7837A30B4E4</gtr:id><gtr:impact>Improvements in survival, morbidity or quality of life re MERS Co-V.</gtr:impact><gtr:outcomeId>54621deedbf959.43567091</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Market and transmission dynamics for efficient procurement of second-line TB drugs (2014)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A3ECBEAF-22E8-4C02-9A30-E6E4A1E23F6E</gtr:id><gtr:outcomeId>546328b2d5d0b2.54070895</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>the Bovine TB Science Review Group, Wales</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>A56021EB-FF69-4B0D-B076-42324A4EEEEA</gtr:id><gtr:outcomeId>axoC5fxmz1J</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contributor to WHO research roadmap on Influenza</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>738842E2-E14F-48F5-9616-75257A86C580</gtr:id><gtr:impact>Co-chaired one stream of WHO's periodic review of global influenza research priorities</gtr:impact><gtr:outcomeId>58c0385bdc0420.35227157</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://www.who.int/csr/research-and-development/r_d_blueprint_plan_of_action.pdf?ua+1</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies.</gtr:description><gtr:id>CB6AD160-7583-4F06-80A3-6D5E17D703FF</gtr:id><gtr:impact>PMID: 26633770</gtr:impact><gtr:outcomeId>56d96817a0fc82.65412398</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Database from a systematic review on different diagnostics on malaria - 2015</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Wide range of statistical and modelling methods for the analysis of Ebola and other infectious disease outbreaks</gtr:description><gtr:id>BD2ADCED-00F1-47AB-8D63-BCE9D3DD5438</gtr:id><gtr:impact>PMID: 25539446, 26029377</gtr:impact><gtr:outcomeId>56d7168b15c9c5.40645318</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Ebola data analysis tools -2015</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>SeqTrack is an algorithm for reconstructing genealogies implemented in the adegenet package in the R environment</gtr:description><gtr:id>A13D22AA-0A38-4102-AA98-CDCC17822420</gtr:id><gtr:impact>none as yet</gtr:impact><gtr:outcomeId>546391de8c0202.89322100</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>SeqTrack</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>general method for fitting spatial processes with complete flexibility</gtr:description><gtr:id>B59D65AA-8F3B-4D2B-B1A3-45C5602248DA</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>58c810e1302a70.91435498</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Large scale kernels</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Estimating the reproduction number in real time. Excel package and R package. Computer packages that will allow non-specialist to better analyse outbreaks</gtr:description><gtr:id>B8B77638-9928-40B9-9B88-6297F775804E</gtr:id><gtr:impact>Ready to be released, will be released with paper which is under review. Has been piloted during our 2 week short course, was very enthusiastically received</gtr:impact><gtr:outcomeId>54639311904c63.36354001</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Estimating the reproduction number in real time CF</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Global climate data , different geographic resolutions to be used to inform models of dengue and other vector-borne diseases</gtr:description><gtr:id>8A53C30B-95DB-4033-96C2-2100886EA92B</gtr:id><gtr:impact>Feeding into the dengue model, used to produce global risk maps of dengue infection</gtr:impact><gtr:outcomeId>58c12fa68d70f4.67624759</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Climate data dataset</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Xls / Stata, preferences of n=400 households who are recipients of the Roopfs housing intervention. Data base was generated through a cross-section survey among households receiving house improvements as part of a Randomized-controlled trial in The Gambia. They were asked about money spent on housing, about their satisfaction with the house (and its components) and about malaria perception, in addition to personal/socio-economic characteristics.</gtr:description><gtr:id>BB988DAF-D101-404A-B73C-B53B5DC02794</gtr:id><gtr:impact>Analysis and publications in progress</gtr:impact><gtr:outcomeId>58c7cd8a8aeab8.61607833</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Malaria - Housing Preference Dataset</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Dataset with epidemiological information on HIV incident cases and HIV serodiscordent couples in the Rakai communities in Uganda</gtr:description><gtr:id>640E0BFF-9E1E-468B-B45F-DF1A79D0D165</gtr:id><gtr:impact>Publically available</gtr:impact><gtr:outcomeId>589335dd3d0818.19058171</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Rakai dataset - 2016</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://datadryad.org/resource/doi:10.5061/dryad.7kr85</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Xls / Stata, preferences of n=2000 respondents who are recipients of the Roopfs housing intervention. Data base was generated through a cross-section survey among households receiving SMC Randomized-controlled trial in Burkina Faso.</gtr:description><gtr:id>967273D7-7ED2-478E-A1BB-3EBA8046E4DB</gtr:id><gtr:impact>Analysis and publications in progress.</gtr:impact><gtr:outcomeId>58c7cdba9c5a83.88224389</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Malaria - SMC risk perception</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Systematic review of sulphadoxine-pyrimethamine resistance in plasmodium falciparum</gtr:description><gtr:id>2CAEE148-FD26-44E8-890D-5947E536624F</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:outcomeId>58aefe22657973.72363495</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Malaria drug resistance mutations database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>The Fluscape cohort is a longitudinal cohort that looks at influenza infection in a detailed manner and pairs this with information on social contacts. By working on a fine geographical scale in a randomly selected communities with characterized contact patterns and immune profile, the Fluscape cohort attempts to relate the infection risk of individuals to their social contact patterns and to the connectivity of the community in which they live.&amp;nbsp;</gtr:description><gtr:id>375F1E90-E513-4ECB-A604-ADFE2B9A3265</gtr:id><gtr:impact>Several publications and ongoing work</gtr:impact><gtr:outcomeId>56d716f8135035.28282575</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>FluScape Project data set - 2015</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Dataset on the correlates of immunogenicity for oral poliovaccines</gtr:description><gtr:id>825B60E9-494F-42D5-B49B-8EF71D256F73</gtr:id><gtr:impact>Ability to predict vaccine response and effectiveness</gtr:impact><gtr:outcomeId>58aae1b0b19309.09760893</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Dataset from the EVI study</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Generated and analysed a database and provided raw data and analysis online</gtr:description><gtr:id>2C3AD72A-F21C-4AC3-922E-A46D236B489C</gtr:id><gtr:impact>Provided online meta analysis of the impact of pyrethoid resistance on mosquito control</gtr:impact><gtr:outcomeId>58adc70c2e4d21.29505148</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Meta analysis of impact of pyrethoid resistance on mosquito control</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>https://elifesciences.org/content/5/e16090</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Contact and serological data form Hong Kong</gtr:description><gtr:id>B08BD9C5-6534-4F06-8FEA-608B09060B98</gtr:id><gtr:impact>Too early to determine.</gtr:impact><gtr:outcomeId>54609d43d03d44.42080862</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Hong Kong Flu Contacts - 2014</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://rspb.royalsocietypublishing.org/content/281/1789/20140709/suppl/DC1</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>How to assess the statistical power of testing for effects of badger culling</gtr:description><gtr:id>2E0B3814-2F27-4325-AF52-D5555E2FFECC</gtr:id><gtr:impact>PMID: 26374782</gtr:impact><gtr:outcomeId>56d716549017c4.61465916</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Exploration of the power of routine surveillance data to assess the impacts of industry-led badger culling on bovine tuberculosis incidence in cattle herds - 2015</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Software tool. This tool fits infectious disease models to pathogen genetic sequence data</gtr:description><gtr:id>5D1CCD54-4F90-4FDA-BBBF-9DAD3F17EF59</gtr:id><gtr:impact>currently being used by a researcher at Cambridge (vet. med) and Los Alamos Natl Laboratories.</gtr:impact><gtr:outcomeId>546081daf15a94.65467102</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>rcolgem - 2013</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>http://colgem.r-forge.r-project.org/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Null model to predict future incidence</gtr:description><gtr:id>50BF1E21-FAB7-4365-8AEF-D6DE91E3ABA2</gtr:id><gtr:impact>Ability to produce better forecast data</gtr:impact><gtr:outcomeId>58a5c0bb987e18.19731181</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Forecasting incidence</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>PCR (polymerase chain reaction) data analysis technique normally does not have uncertainty around it, the new analysis technique generates 95% confidence intervals for quantitative PCR derived data.</gtr:description><gtr:id>17C62393-E8AE-4B23-AF58-AD5D84BFF6AE</gtr:id><gtr:impact>Paper published: &amp;quot;Improving statistical inference on pathogen densities estimated by quantitative molecular methods: malaria gametocytaemia as a case study&amp;quot;</gtr:impact><gtr:outcomeId>56d7189a7ab143.70133889</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PCR data sets analysis improvement - 2015</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Software tool. 'Coalescent Liklihood for Generalized Epidemic Models'. This tool fits infectious disease models to pathogen genetic sequence data</gtr:description><gtr:id>BA759547-83CF-4133-BA13-3D4CB8B76977</gtr:id><gtr:impact>too early to know about this yet.</gtr:impact><gtr:outcomeId>5460818732cdb3.85182666</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>colgem - 2013</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>https://code.google.com/p/colgem/</gtr:url></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>rcolgem statistical inference and modeling of genealogies generated by epidemic and ecological processes. It is a package for phylodynamic inference using population genetic models. rcolgem implements coalescent models for populations with nonlinear dynamics and potentially many demes.</gtr:description><gtr:id>6EBFCC2F-EAFF-43A2-9E1D-F0B9D9FD4F07</gtr:id><gtr:impact>Used in various publications. For ex. http://www.ncbi.nlm.nih.gov/pubmed/26006189</gtr:impact><gtr:outcomeId>56d9b1b19cbf92.03798974</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>rcolgem - 2015</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>http://colgem.r-forge.r-project.org</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>a multivariate method designed to identify and describe clusters of genetically related individuals. When group priors are lacking, DAPC uses sequential K-means and model selection to infer genetic clusters. Our approach allows extracting rich information from genetic data, providing assignment of individuals to groups, a visual assessment of between-population differentiation, and contribution of individual alleles to population structuring.</gtr:description><gtr:id>4E1D8B0B-58DB-4986-B840-981E5B5BFD4A</gtr:id><gtr:impact>most highly accessed paper in BMC Genetics since its publication 6 weeks ago</gtr:impact><gtr:outcomeId>5463918b1a6497.58511808</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Discriminant Analysis of Principal Components (DAPC)</gtr:title><gtr:type>Data handling &amp; control</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Synthesizes local surveillance data on rates of chlamydia testing and diagnosis with information on natural history</gtr:description><gtr:id>06151371-0AC1-4989-B272-442088E7E83C</gtr:id><gtr:impact>Corresponding publication in press</gtr:impact><gtr:outcomeId>58c7ffca27c5b7.93394466</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Estimating local chlamydia incidence and prevalence using surveillance data</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Analysis of clinical and demographic patient data through 2012</gtr:description><gtr:id>579DB503-D81A-413A-86D4-D5F558817FB2</gtr:id><gtr:impact>The HIV Drug Resistance Database provides a unique resource for molecular epidemiological studies of HIV transmission among more than 60 thousand patients diagnosed with HIV in the UK. The database contains unique information about risk factors for HIV transmission, and our group is developing and applying novel statistical approaches to mining this information with the ultimate goal of tailoring public health interventions to reduce transmission risk.</gtr:impact><gtr:outcomeId>56d71866c47214.16075210</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>UK HIV Drug Resistance Sequences Database - 2015</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.hivrdb.org.uk/</gtr:url></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Evaluating for optimal strategy in use of different forms of diagbostic tools</gtr:description><gtr:id>27523A3B-0171-4D93-AB04-9F7C31725382</gtr:id><gtr:impact>Publically available analysis tools for download in Excel - PMID: 26633764</gtr:impact><gtr:outcomeId>56d713aa4263d9.38799825</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>The role of rapid diagnostics in managing Ebola epidemics - 2015</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Arising from surveys in urban slums in India (in Patna and Mumbai), the database casts fresh light on the care seeking amongst TB patients in these areas. The surveys were conducted by the Foundation for Medical Research, and Dr. Pathy's involvement is to help them in its statistical analysis.</gtr:description><gtr:id>5DA69F0C-9515-4B0D-B04B-1BAE700D1DE4</gtr:id><gtr:impact>Performing statistical analysis for a paper to be published</gtr:impact><gtr:outcomeId>56d71837af1e09.12754062</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Patterns of TB care seeking in urban slums in India (The Foundation for Medical Research, India) - 2015</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>ensemble method to combine metamodels</gtr:description><gtr:id>DE214A78-F6F8-48EC-B68F-EC5E936040AA</gtr:id><gtr:impact>paper in review</gtr:impact><gtr:outcomeId>58c810b1067354.18121463</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Stacking</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>It is a database of anitbody titres for different influenza strains for anonymized samples collected in england and wales between 1999 and 2004</gtr:description><gtr:id>EB62C8D5-B5F9-44BE-A991-72A24CA6B9FA</gtr:id><gtr:impact>Not published yet.</gtr:impact><gtr:outcomeId>56d716c6eafec9.37699196</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Public Health England Serum Archive data - 2015</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Model developed to capture the healthcare system in India, and TB transmission</gtr:description><gtr:id>88273462-3AFF-4F61-89DE-7EF747C505AC</gtr:id><gtr:impact>Model is being applied to address different questions of TB strategy, by PHFI colleagues</gtr:impact><gtr:outcomeId>54536e05c8e317.92355426</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Imperial College/Public Health Foundation of India (ICPHFI) model for the TB epidemic in India - 2014</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Geograph is a framework for GIS analyses in R. A typical application would be computing friction routes. It is more flexible than any currently available GIS freeware and has some unique features, such as the ability to work on a spherical referential rather than 2D maps; this is important when working at large geographic scales as any 2D projection of the world (or large regions thereof) will lead to considerable deformation.</gtr:description><gtr:id>CCF49989-A365-4D0C-81C3-BC79DAF3806C</gtr:id><gtr:impact>used for analysis of geographical data in 19586946</gtr:impact><gtr:outcomeId>5463911ec3a4a6.77201002</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Geograph R package</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>TB Burden inference through drug sales method</gtr:description><gtr:id>855D65E8-AB83-4650-8491-5C88F10E5439</gtr:id><gtr:impact>IMS health using in collab with Gates foundation</gtr:impact><gtr:outcomeId>58c814f97e1df8.01360712</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>TB Burden inference through drug sales method</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>http://www.sciencedirect.com/science/article/pii/S1473309916302596</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>open data on outbreaks</gtr:description><gtr:id>2D8FE611-04AA-4CA6-8BB4-D9C08067A11E</gtr:id><gtr:impact>over 500 downloads per month from predominantly external users</gtr:impact><gtr:outcomeId>58c819a0cfc507.32229376</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Outbreaks</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.repidemicsconsortium.org/outbreaks</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>In order to identify which determinants are most strongly associated with life expectancy, using extreme bound analysis technique applied to this publically available data set.</gtr:description><gtr:id>522D8F5B-9777-4723-90F5-A6CFA98CC227</gtr:id><gtr:impact>Used for a forthcoming paper</gtr:impact><gtr:outcomeId>56d718bff15902.06874198</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>World Development Indicators - 2015</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>http://data.worldbank.org/data-catalog/world-development-indicators</gtr:url></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>The dataset comprises information of medical visits and costs of 7164 individuals with diagnosis of Chagas disease in Colombia between 2010-2014. The data was obtained from the Individual Registers for Health Services in Colombia at the Ministry of Health and integrated with four different dictionaries and algorithms to classify the stages of the disease and trajectories of care for this population.</gtr:description><gtr:id>20401D1A-F372-414F-A51F-9F48CA247412</gtr:id><gtr:impact>No impact yet. Will be part of a publication and costs &amp;amp; CE eventually reported back to Colombian MoH.</gtr:impact><gtr:outcomeId>58c7ce026f30b3.36517014</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Colombia - Chagas Costs (Colombia Chagas individual level provider treatment costs)</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>method to determine whether malaria will be eliminated from a country if disease importation ceased</gtr:description><gtr:id>E49EF04F-3549-4C1D-A127-9D5FF260B888</gtr:id><gtr:impact>method is being discussed by WHO</gtr:impact><gtr:outcomeId>54535126cf8696.88325725</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Methods of determining Malaria elimination - 2014</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/newssummary/news_12-6-2014-18-17-49</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>R-code for estimating mutation frequencies from data on the prevalence of drug resistance in infected humans</gtr:description><gtr:id>D2998C02-597C-4446-A57E-BF01D7631229</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58aefe7b5f9b76.77054811</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Model for estimating mutation frequencies in parasites</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Software package for the Bayesian inference of infectious disease transmission from a phylogeny. The input is a dated phylogeny, where leaves correspond to pathogens isolated from the infected hosts. The main output is a transmission tree which indicates who infected whom. Such reconstruction can be achieved by colouring the branches of the phylogeny using a separate colour for each host, and such that the subtree coloured in a given colour represents the evolution happening within the corresponding host. Changes of colours on branches therefore correspond to transmission events from one host to another.</gtr:description><gtr:id>FBB7A7C9-9E12-46C4-88AC-DEC1F02D6F61</gtr:id><gtr:impact>PMID 24714079</gtr:impact><gtr:outcomeId>545796c1113c66.48408246</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>TransPhylo (2014)</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>https://code.google.com/p/transphylo/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Computer software to evaluate the potential impact of malaria interventions in African countries</gtr:description><gtr:id>B30CB6A7-1833-4434-92A9-B8CA281A39CD</gtr:id><gtr:impact>The tool has been formally released as part of a WHO guidance document. It was applied in Rwanda in September 2014 as part of their assessment of the feasibility of malaria elimination</gtr:impact><gtr:outcomeId>5457833c66b626.97620585</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>From malaria control to malaria elimination: a manual for elimination scenario planning - 2014</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>http://www.who.int/malaria/publications/atoz/9789241507028/en/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>A model that helps to evaluate HBV vaccination policy</gtr:description><gtr:id>92CBF04A-0625-402B-96B2-E40E16B0BB5A</gtr:id><gtr:impact>A model that helps to evaluate impact of the current vaccination policy and to evaluate policy choices going forward for China CDC</gtr:impact><gtr:outcomeId>58a2e9c5b86273.16081308</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HBV model - 2016</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>computation and visualisation of incidence</gtr:description><gtr:id>BB634BA5-C2DC-475C-925A-C815B298A680</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>58c81a25449770.01994972</gtr:outcomeId><gtr:title>Incidence</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.repidemicsconsortium.org/</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>App to be potentially used by WHO and other stakeholders involved</gtr:description><gtr:id>614E9651-5E81-46B3-B2AE-FF9740372651</gtr:id><gtr:impact>Used by decision makers</gtr:impact><gtr:outcomeId>58c12f44078692.97140454</gtr:outcomeId><gtr:title>RShiny app for yellow fever vaccination coverage in Africa</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:url>https://polici.shinyapps.io/yellow_fever_africa/</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>SimBAc is whole-genome bacterial evolution simulator that is roughly two orders of magnitude faster than previous software and includes a more general model of bacterial evolution, allowing both within- and between-species homologous recombination.</gtr:description><gtr:id>3B3D9DCC-FBE6-4EA8-9801-13683ABD8AF6</gtr:id><gtr:impact>Since methods modelling bacterial recombination generally focus on only one of these two modes of recombination, the possibility to simulate both allows for a general and fair benchmarking.</gtr:impact><gtr:outcomeId>56d7178de7faa0.13039472</gtr:outcomeId><gtr:title>SimBac -2015</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/tbrown91/SimBac</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>R package and web interface for exploring phylogenetic tree landscapes and detecting phylogenetic incongruence</gtr:description><gtr:id>89ACA3B8-E03A-40E9-AF3E-F0908E7E71E6</gtr:id><gtr:impact>This package is currently the object of publication to be submitted in 2016.</gtr:impact><gtr:outcomeId>56d6d1a8251841.91283435</gtr:outcomeId><gtr:title>Exploration of phylogenetic tree landscapes - 2015</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/thibautjombart/treescape</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Suite of statistical software to analyse the effect of homologous and non-homologous recombination events on bacterial genome sequences</gtr:description><gtr:id>EDF55FEA-1CA4-41E0-B7D7-553FC02E6282</gtr:id><gtr:impact>This suite of methods includes ClonalFrame, ClonalOrigin, GenoPlast and SimMLST. All methods are distributed freely through an internet website: http://tinyurl.com/9dhhgqj and code is open source and free under the terms of the GNU Public Licence (GPL). These tools have been used and cited in over 200 publications.</gtr:impact><gtr:outcomeId>546392a6554322.60782855</gtr:outcomeId><gtr:title>ClonalFrame XD</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://tinyurl.com/9dhhgqj</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>ClonalFrameML can analyse hundreds of genomes in a matter of hours. It uses maximum likelihood inference to simultaneously detect recombination in bacterial genomes and account for it in phylogenetic reconstruction.</gtr:description><gtr:id>66A90A77-1BC4-465C-909A-53F301035227</gtr:id><gtr:impact>The software received 9 citations within the first few weeks of publication and its predecessor software package received over 500 citations.</gtr:impact><gtr:outcomeId>56d717c9c24b49.65007009</gtr:outcomeId><gtr:title>ClonalFrameML (Updated ClonalFrame) - 2015</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://clonalframeml.googlecode.com/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Simulation code - publicly available and in use (GPL 3 License)</gtr:description><gtr:id>6A946606-B62B-4C4E-B418-4A4DC8637253</gtr:id><gtr:impact>facilitates ongoing research</gtr:impact><gtr:outcomeId>58af0bc64be588.40712216</gtr:outcomeId><gtr:title>PANGEA HIV Simulator</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://github.com/olli0601/PANGEA.HIV.sim</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>outbreaker is a new approach for reconstructing densely sampled epidemics and inferring transmission trees ('who infected whom') from pathogen genomic sequences. It is also the first approach of this kind of be widely available as a free and open-source software.</gtr:description><gtr:id>61C43A29-23EC-49C0-8E7D-FE348D9D814A</gtr:id><gtr:impact>While the method is still under evaluation, it has already received noticeable interest from the community, with two workshops having been dedicated to its presentation the &amp;quot;Genepi workshop&amp;quot;, London, UK 2013 and the &amp;quot;pre-ESCAIDES workshop on molecular outbreak epidemiology&amp;quot;, Stockholm, Sweden, 2013.</gtr:impact><gtr:outcomeId>5461fc39ef8769.89303652</gtr:outcomeId><gtr:title>Outbreaker - 2013</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://sites.google.com/site/therepiproject/r-pac/outbreaker</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Software to analyse pathogen genetics</gtr:description><gtr:id>C9AB1194-24B5-4715-89F5-7233D704D5AE</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58aae1e3392ae5.75632649</gtr:outcomeId><gtr:title>EpiGen</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/lucymli/EpiGenR</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Computer software to evaluate the potential impact of malaria interventions in African countries</gtr:description><gtr:id>3CF981D6-B036-44B9-BC5C-D3F7804B8D74</gtr:id><gtr:impact>The tool has been formally released as part of a WHO guidance document. It was applied in Rwanda in September 2014 as part of their assessment of the feasibility of malaria elimination</gtr:impact><gtr:outcomeId>5457842e198f61.09922513</gtr:outcomeId><gtr:title>Elimination Scenario Planning and Malaria Tools Software - 2014</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.who.int/malaria/publications/atoz/9789241507028/en/</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>R package interfacing GIS and graph algorithms to model dispersal/diffusion processes on the geographic space</gtr:description><gtr:id>DFF15C2E-29C8-4712-A8BA-5B20CC29EF16</gtr:id><gtr:impact>This package has been used in a previous form for several publications aiming to infer the historical origin of anatomically modern Humans as well as infectious diseases including plague (Y. pestis) and malaria (P. falciparum). It is also used and presented in a study of T. gondii to be submitted in 2016.</gtr:impact><gtr:outcomeId>56d6d0dd71e345.12742523</gtr:outcomeId><gtr:title>Interfacing GIS layers and spatial graphs - 2015</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/thibautjombart/geograph</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>A tool to quantify the transmissibility of a pathogen over time; the next version will allow to cope with epidemics where some cases are improted from animal reservoir or a different location, and allow using contact tracing data for intrinsict estimation of parameters</gtr:description><gtr:id>ADCDE34D-758F-47CA-94B7-9E8FC47F0621</gtr:id><gtr:impact>Will be publically available for download</gtr:impact><gtr:outcomeId>58a2d83007d893.21260650</gtr:outcomeId><gtr:title>EpiEstim (upgrade to the next version)</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/annecori/EpiEstim</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Fast molecular clock dating of phylogenetic trees with rate variation</gtr:description><gtr:id>5136A731-6B39-43D0-B100-B121F59A51A4</gtr:id><gtr:impact>Fast molecular clock dating of phylogenetic trees with rate variation</gtr:impact><gtr:outcomeId>58c7f3cc32e5d1.40203191</gtr:outcomeId><gtr:title>Treedater</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/emvolz/treedater</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>A phylogenetic tree-based approach to genome-wide association studies in microbes</gtr:description><gtr:id>BF31A254-B2F2-4725-A27F-82D8AA3A4F57</gtr:id><gtr:impact>Available to the public. Expected use in future publications.</gtr:impact><gtr:outcomeId>58c029e313e0b4.01631026</gtr:outcomeId><gtr:title>Treewas</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/caitiecollins/treeWAS</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>initiated new collaborations</gtr:description><gtr:id>FA597548-3CB7-443B-90FF-4789CF0FBFD8</gtr:id><gtr:impact>Development of Outbreaker2</gtr:impact><gtr:outcomeId>58c819ef561579.46829334</gtr:outcomeId><gtr:title>Outbreaker 2</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.repidemicsconsortium.org/outbreaker2</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Model of mechanisms or symptoms - human</gtr:description><gtr:id>5B9A1F1A-BC1D-48E0-AC6A-9C89FCFAB182</gtr:id><gtr:impact>Used for HIV &amp;amp; Ebola modelling</gtr:impact><gtr:outcomeId>54622f068556b9.00301479</gtr:outcomeId><gtr:title>EPI ESTIM - 2013</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>SNCdater is a method for dating a common ancestor of genetic sequences while simultaneously fitting a population shape model (ex. estimating transmission rates based on a random sample of pathogen genetic sequences)</gtr:description><gtr:id>DD98BD52-0ADB-4B30-BF6C-169730AB31B4</gtr:id><gtr:impact>No impact yet.</gtr:impact><gtr:outcomeId>56d71a602ad028.02240003</gtr:outcomeId><gtr:title>SNCdater - 2015</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Phylodynamic inference of epidemic population size and reproduction numbers given time scaled pathogen phylogenies. This package supports standard coalescent models and multi-scale coalescent models that account for within-host evolution. Methods are provided for simulating trees. Estimation of standard errors can be accomplished by likelihood profiling or parametric bootstrap.</gtr:description><gtr:id>595AE212-C1C3-4D63-A51D-D1664441E265</gtr:id><gtr:impact>increased kudos</gtr:impact><gtr:outcomeId>58c7f44d81c986.27934134</gtr:outcomeId><gtr:title>Skyspline</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/emvolz-phylodynamics/skyspline</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>epibase is the R package created during &amp;quot;Hackout&amp;quot;, a hackathon for the analysis of disease outbreaks using R, which took place at the MRC Centre for Outbreak Analysis and Modeling at Imperial College, London, in January 2013. It implements essential tools for handling, visualizing, and analyzing disease outbreak data.</gtr:description><gtr:id>9D154440-544F-4E32-A029-5233BD8E67D7</gtr:id><gtr:impact>The creation of epibase set up the basis of a new framework for disease outbreak analysis using free, open-source software. It gathered a community of worldwide experts in infectious disease modelling, statistics and bioinformatics working collectively on its development. It is also an essential piece of episerve, a new web-based platform for the collection and analysis of disease outbreaks, developed by Thibaut Jombart and David Aanensen, in collaboration with the Alert &amp;amp; Response Team at WHO.</gtr:impact><gtr:outcomeId>5461fc09bc8322.69193758</gtr:outcomeId><gtr:title>OutbreakTools (Epibase) - 2013</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://sites.google.com/site/therepiproject/r-pac/about</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>R package for handling and converting files with the EpiJSON format</gtr:description><gtr:id>2997ABA4-B0FD-4C4D-9E87-BB1AFD476B06</gtr:id><gtr:impact>Publication in the journal &amp;quot;Epidemics&amp;quot;; used internally by staff at PHE</gtr:impact><gtr:outcomeId>56d6ca32f16298.40492041</gtr:outcomeId><gtr:title>rEpiJson: tools for handling EpiJSON (epidemiological data) files - 2015</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/Hackout2/repijson</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>R package for phylogenetic reconstruction using multiple genes</gtr:description><gtr:id>BBC77031-E2BA-4D3B-BD3C-70C0087CBEA2</gtr:id><gtr:impact>This package is currently the object of an invited publication in Molecular Ecology Resource, to be submitted in 2016</gtr:impact><gtr:outcomeId>56d6d174ca8014.61601937</gtr:outcomeId><gtr:title>Phylogenetics with multiple genes - 2015</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/thibautjombart/geograph</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Method for reconstructing bacterial evolution</gtr:description><gtr:id>7581D03B-B807-4987-B3AB-0412F6015D2B</gtr:id><gtr:impact>Available to the public and frequently cited in publications</gtr:impact><gtr:outcomeId>58c00be87b4768.94519980</gtr:outcomeId><gtr:title>Gubbins</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://sanger-pathogens.github.io/gubbins</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Helps country program teams to understand the strengths and weaknesses of the programs that they offer for the care of people living with HIV</gtr:description><gtr:id>D1624BE8-EA12-4C01-B61F-E1B8AB3BC426</gtr:id><gtr:impact>Has been used in various WHO workshops, in 23 countries</gtr:impact><gtr:outcomeId>58a2e937bbf996.85923413</gtr:outcomeId><gtr:title>HIV care cascade modelling tool</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://jackolney.shinyapps.io/ShinyCascade/</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Software interface provided to run our published transmission model</gtr:description><gtr:id>B39F00A5-6E8E-4A60-947B-159E1F7AB387</gtr:id><gtr:impact>- Malaria Tools is a user-interface to our combined intervention model for P.falciparum malaria. The model can be used to explore the impact of bednets, indoor residual spraying, mass treatment, IPTi and a pre-erythrocytic vaccine on transmision. Various options are available to define the coverage, start-time and properties of each of these interventions. 
 - The tool was used as part of a WHO workshop for elimination scenario planning held with the Gambia &amp;amp; Senegal national malaria control programmes. 
 - The tool will be released as part of the Elimination Scenario Planning Country Guidance document. The tool was reviewed by the WHO Malaria Policy Advisory Committee in 2013. It was also used by CHAI as part of an elimination planning document provided to the Haitian government in September 2013. 
Collaboration with WHO .
www.imperial.ac.uk/malariamodelling/toolsdata</gtr:impact><gtr:outcomeId>54623a490f24a6.48457701</gtr:outcomeId><gtr:title>Malaria Tools - 2013 and 2014</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.who.int/malaria/publications/atoz/9789241507028/en/</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>The software allows researchers, policy makers and public health practitioners to assess the impact of various testing strategy in the context of an Ebola outbreak. The users can explore the implication of the strategies in term of patient or transmission perceptive with the former focusing on Case Fatality Ratio and the latter focussing on the Reproduction number.</gtr:description><gtr:id>4107FC97-469E-4B6E-8781-21E640613FBC</gtr:id><gtr:impact>N/A - Published in Nature publication - http://www.nature.com/nature/journal/v528/n7580_supp_custom/full/nature16041.html</gtr:impact><gtr:outcomeId>56d71be71238d7.52745597</gtr:outcomeId><gtr:title>EbolaDiagnostics - 2015</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://tools.epidemiology.net/EbolaRDTs.jar</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Reconstructs transmission networks using genomic data</gtr:description><gtr:id>85885E78-3656-4E3E-9CF5-B74838A89EFA</gtr:id><gtr:impact>Available to the public. Expected future use in publications.</gtr:impact><gtr:outcomeId>58c0296adc1749.27667421</gtr:outcomeId><gtr:title>Transphylo</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/xavierdidelot/Transphylo</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Visualisation and analysis of epidemiological contact networks</gtr:description><gtr:id>3D1FB1D5-A355-494C-95FC-444739C49125</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>58c81a57e71767.52770901</gtr:outcomeId><gtr:title>Epicontacts</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.repidemicsconsortium.org/</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>815CA38B-8BD5-499D-9189-A56A45FE8677</gtr:id><gtr:title>Improving Control of Antibiotic-Resistant Gonorrhea by Integrating Research Agendas Across Disciplines: Key Questions Arising From Mathematical Modeling.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a876bb97d62383481a937f8ad991d9e0"><gtr:id>a876bb97d62383481a937f8ad991d9e0</gtr:id><gtr:otherNames>Grad YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>56d41e868e7184.78798511</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6A9F049-7B41-4AE4-8662-38348A2C199E</gtr:id><gtr:title>Reducing uncertainty about flavivirus infections</gtr:title><gtr:parentPublicationTitle>The Lancet Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d089aeea375cacb98e3c9cb5a31eac6b"><gtr:id>d089aeea375cacb98e3c9cb5a31eac6b</gtr:id><gtr:otherNames>Kucharski A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>588b590c5b5983.19664622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5B55DD3-8578-4492-8783-214E2B500359</gtr:id><gtr:title>Estimating the transmissibility of H5N1 and the effect of vaccination in Indonesia.</gtr:title><gtr:parentPublicationTitle>Transboundary and emerging diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/256159da0b605caed5f2456efb37ed15"><gtr:id>256159da0b605caed5f2456efb37ed15</gtr:id><gtr:otherNames>Walker PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1865-1674</gtr:issn><gtr:outcomeId>pm_13908_28_23731554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE397014-A3DF-4010-A5D2-1F8FE45ED632</gtr:id><gtr:title>Viral evolution from one generation of human influenza infection to the next.</gtr:title><gtr:parentPublicationTitle>Hong Kong medical journal = Xianggang yi xue za zhi</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfb5062b3b74deb6e922dc6a4250846e"><gtr:id>bfb5062b3b74deb6e922dc6a4250846e</gtr:id><gtr:otherNames>Riley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1024-2708</gtr:issn><gtr:outcomeId>pm_13908_28_23775179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27BEA1C4-E365-4FAF-80E5-41D5202E3AC0</gtr:id><gtr:title>Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/464a69d208034edf889526a6f84cdb83"><gtr:id>464a69d208034edf889526a6f84cdb83</gtr:id><gtr:otherNames>Weinert LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d5b6b295164.50639725</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A5C0D07-0F37-4B52-9927-39095CC4904D</gtr:id><gtr:title>Model-Based Comprehensive Analysis of School Closure Policies for Mitigating Influenza Epidemics and Pandemics.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/961a04f1172f263d778d75330bb81455"><gtr:id>961a04f1172f263d778d75330bb81455</gtr:id><gtr:otherNames>Fumanelli L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>585d626d4da413.94975373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F2FE6F5-CB97-4EA5-9EE5-AE6ECFFAAC33</gtr:id><gtr:title>The effect of protected areas on pathogen exposure in endangered African wild dog (Lycaon pictus) populations</gtr:title><gtr:parentPublicationTitle>Biological Conservation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/869952871690113ef7f3d6036613f4de"><gtr:id>869952871690113ef7f3d6036613f4de</gtr:id><gtr:otherNames>Prager K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>JwmqcXegKfM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B6F22D6-FC4B-4E8B-BA16-6DB4CA0CCC26</gtr:id><gtr:title>Epidemiological analysis of the Eyam plague outbreak of 1665-1666.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c4aa2aec517e6bc829e37e77ca0f66e"><gtr:id>2c4aa2aec517e6bc829e37e77ca0f66e</gtr:id><gtr:otherNames>Whittles LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn><gtr:outcomeId>585d6ff9b3b509.75834506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3702927-EB3F-4317-8BE8-D77DE69E184E</gtr:id><gtr:title>Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d582accefa04f804d6bab230d9dd36e"><gtr:id>5d582accefa04f804d6bab230d9dd36e</gtr:id><gtr:otherNames>Martin NK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>5462239dbab6b8.16743376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3787B029-E3D0-4AD0-BE72-097B28D3DBBF</gtr:id><gtr:title>Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b989275d9cde99e5fc1608935ac6ad38"><gtr:id>b989275d9cde99e5fc1608935ac6ad38</gtr:id><gtr:otherNames>Simonsen L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>585d62797c9880.08786753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EF905D3-94E9-4741-BD53-EA7DFC3F1545</gtr:id><gtr:title>Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f9116e1c85e2e30752be8b026cb75b5"><gtr:id>4f9116e1c85e2e30752be8b026cb75b5</gtr:id><gtr:otherNames>Laurie KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn><gtr:outcomeId>pm_13908_28_22548725</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCA111C4-5716-4877-86BA-FC02C2DAFE1F</gtr:id><gtr:title>Close encounters of the infectious kind: methods to measure social mixing behaviour.</gtr:title><gtr:parentPublicationTitle>Epidemiology and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84337833d8b63ad1be8a59ca8f98e55c"><gtr:id>84337833d8b63ad1be8a59ca8f98e55c</gtr:id><gtr:otherNames>Read JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-2688</gtr:issn><gtr:outcomeId>pm_13908_28_22687447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B7704A5-913E-423D-A6FD-EBBC3784CBC2</gtr:id><gtr:title>Worldwide Population Structure, Long-Term Demography, and Local Adaptation of Helicobacter pylori.</gtr:title><gtr:parentPublicationTitle>Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6c3e7137dd69ce98a3e88cb2457e511"><gtr:id>f6c3e7137dd69ce98a3e88cb2457e511</gtr:id><gtr:otherNames>Montano V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0016-6731</gtr:issn><gtr:outcomeId>56d41e9136abb7.40089528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F632E3A-0374-4EFD-BE20-174B2FC04672</gtr:id><gtr:title>Estimating dengue transmission intensity from sero-prevalence surveys in multiple countries.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e52f7e4d1b169efc084463f3d538f083"><gtr:id>e52f7e4d1b169efc084463f3d538f083</gtr:id><gtr:otherNames>Imai N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>56d41e82b1c796.16876648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A96B03E-04B5-4DAC-B1C4-01FFAD96370D</gtr:id><gtr:title>SimBac: simulation of whole bacterial genomes with homologous recombination.</gtr:title><gtr:parentPublicationTitle>Microbial genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b4c2de3224e05e33b35f73a70bbd952"><gtr:id>9b4c2de3224e05e33b35f73a70bbd952</gtr:id><gtr:otherNames>Brown T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2057-5858</gtr:issn><gtr:outcomeId>585d5dfb046c70.64962983</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8479CA9D-9761-47E8-ADFF-304A6692730A</gtr:id><gtr:title>CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd4b424460e03e5dc9b6ba07e301546f"><gtr:id>cd4b424460e03e5dc9b6ba07e301546f</gtr:id><gtr:otherNames>Cori A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>56d41e80dc3831.63501879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C25B9C90-33F3-4392-9D0A-69D512891D44</gtr:id><gtr:title>The complexity and diversity of the Pathogenicity Locus in Clostridium difficile clade 5.</gtr:title><gtr:parentPublicationTitle>Genome biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d338b343841e9319714389d8b64dc3c0"><gtr:id>d338b343841e9319714389d8b64dc3c0</gtr:id><gtr:otherNames>Elliott B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-6653</gtr:issn><gtr:outcomeId>56d41e8f70f328.57250841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>006E6C20-A069-43DD-87DE-712020B8037F</gtr:id><gtr:title>EPIDEMIOLOGY. Countering the Zika epidemic in Latin America.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a89abe3bbb378fda0bae27997ab36b2"><gtr:id>1a89abe3bbb378fda0bae27997ab36b2</gtr:id><gtr:otherNames>Ferguson NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>585d60b2bd30b9.10047547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C64A1BC3-3F4E-4B1F-B02C-C2917E80950D</gtr:id><gtr:title>The effect of badger culling on breakdown prolongation and recurrence of bovine tuberculosis in cattle herds in Great Britain.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd9c4adcc86a0db358de948c149ccab1"><gtr:id>dd9c4adcc86a0db358de948c149ccab1</gtr:id><gtr:otherNames>Karolemeas K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23236478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C62833E-ED2C-45B7-A2E3-3690F353A2D2</gtr:id><gtr:title>Influenza Surveillance</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fabf95c590c01d1ba72eae698e9758d6"><gtr:id>fabf95c590c01d1ba72eae698e9758d6</gtr:id><gtr:otherNames>Laurie K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>585d6c88e74ea3.66227846</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45E73563-9020-446C-A085-52534A7D05EE</gtr:id><gtr:title>Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/080d9c77d9089737ba36e6a808316bf7"><gtr:id>080d9c77d9089737ba36e6a808316bf7</gtr:id><gtr:otherNames>Bejon P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>pm_13908_28_23454164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91FF12AD-6609-4796-BC7D-DBA3D15AAB5A</gtr:id><gtr:title>Global circulation patterns of seasonal influenza viruses vary with antigenic drift.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71fafd4a0e8082523ed381695139b36e"><gtr:id>71fafd4a0e8082523ed381695139b36e</gtr:id><gtr:otherNames>Bedford T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d41e88a21327.61964366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81916AB4-3A20-420E-8176-FE8BEB81D1B9</gtr:id><gtr:title>Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d5ce2fbec39f3d595f2b70754740f8a"><gtr:id>5d5ce2fbec39f3d595f2b70754740f8a</gtr:id><gtr:otherNames>Drobniewski F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>56d41e85ccba75.43548249</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75AB20BB-F263-4989-B617-7D664DB46BFC</gtr:id><gtr:title>Using routine surveillance data to estimate the epidemic potential of emerging zoonoses: application to the emergence of US swine origin influenza A H3N2v virus.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13378166d22af7a7ca5b1f192611863"><gtr:id>b13378166d22af7a7ca5b1f192611863</gtr:id><gtr:otherNames>Cauchemez S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>pm_13908_28_23472057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10A71183-4B50-48AF-851C-373EFC64C992</gtr:id><gtr:title>Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart.</gtr:title><gtr:parentPublicationTitle>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13378166d22af7a7ca5b1f192611863"><gtr:id>b13378166d22af7a7ca5b1f192611863</gtr:id><gtr:otherNames>Cauchemez S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1025-496X</gtr:issn><gtr:outcomeId>pm_13908_28_23787162</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>116DE6D9-0415-47E3-ADEE-37BFEF86713A</gtr:id><gtr:title>Epidemiology: Making high-res Zika maps.</gtr:title><gtr:parentPublicationTitle>Nature microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfb5062b3b74deb6e922dc6a4250846e"><gtr:id>bfb5062b3b74deb6e922dc6a4250846e</gtr:id><gtr:otherNames>Riley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2058-5276</gtr:issn><gtr:outcomeId>588b59bec9c168.66274698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FF2464F-E4F0-4B66-B354-9AEE6F4A9DCE</gtr:id><gtr:title>Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/759ea59350160bfe2f4ff46945690745"><gtr:id>759ea59350160bfe2f4ff46945690745</gtr:id><gtr:otherNames>Griffin JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5462239e887524.26164927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DAC85CF-645D-41AD-A58E-6EA59FFC5AB4</gtr:id><gtr:title>Efficient inference of recombination hot regions in bacterial genomes.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c76ac3809caae85c8a46d64cb3e4ff5"><gtr:id>4c76ac3809caae85c8a46d64cb3e4ff5</gtr:id><gtr:otherNames>Yahara K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>5462239ed96b96.03847610</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A42426D-E1C5-4D5E-B5EF-E0D86AE2163C</gtr:id><gtr:title>Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d6e8ce16ad2fecd2f2f0b681fb82e91"><gtr:id>0d6e8ce16ad2fecd2f2f0b681fb82e91</gtr:id><gtr:otherNames>Garske T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>56d5b54963d8e9.12130633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA15BCF3-CAAC-41EF-BA78-495E4F59F027</gtr:id><gtr:title>Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df45bbde2fa354f91b34a4853de41aac"><gtr:id>df45bbde2fa354f91b34a4853de41aac</gtr:id><gtr:otherNames>Eaton JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>546223a3726900.58832817</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCD8296D-2232-406F-A4F8-514900791E44</gtr:id><gtr:title>Selective and genetic constraints on pneumococcal serotype switching.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e8ad1fc53d4c06210e00afb647eb318"><gtr:id>6e8ad1fc53d4c06210e00afb647eb318</gtr:id><gtr:otherNames>Croucher NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>56d5aa5dc523e6.31493122</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E936AF8-D1F6-495E-8E9E-94796964AA23</gtr:id><gtr:title>Gradual acquisition of immunity to severe malaria with increasing exposure.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/759ea59350160bfe2f4ff46945690745"><gtr:id>759ea59350160bfe2f4ff46945690745</gtr:id><gtr:otherNames>Griffin JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn><gtr:outcomeId>56d41e7c260ba6.51992729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BDDED57-428C-45A4-ADE6-0FAD6509AEDF</gtr:id><gtr:title>Nine challenges in modelling the emergence of novel pathogens.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd02f721f095349879a24459d0bf5746"><gtr:id>fd02f721f095349879a24459d0bf5746</gtr:id><gtr:otherNames>Lloyd-Smith JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>56d41e89c98a52.24750882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A48AE3E-C28E-482C-ABE7-4C32C870E40B</gtr:id><gtr:title>Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10ef8bad911c7306deddd60d7ec0d2ca"><gtr:id>10ef8bad911c7306deddd60d7ec0d2ca</gtr:id><gtr:otherNames>Meara JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>585d5a60a34fd1.61370398</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>909D4D94-B75C-4F00-8F0F-4DEF9ADCE7CE</gtr:id><gtr:title>Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac60da263bd6d4c8e27ced58924b8d43"><gtr:id>ac60da263bd6d4c8e27ced58924b8d43</gtr:id><gtr:otherNames>GBD 2015 Disease and Injury Incidence and Prevalence Collaborators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>588b58ef9880f8.78119539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05E49BF1-A658-48BB-84D5-1C0976493AE5</gtr:id><gtr:title>Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/711bbd6fe66bcd28317e546ece5fb8b7"><gtr:id>711bbd6fe66bcd28317e546ece5fb8b7</gtr:id><gtr:otherNames>Alsallaq RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23372738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3436FC61-5FAF-40A6-9F40-C2EF1A66E21A</gtr:id><gtr:title>The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f919f6ab9ec769ab2d5c25bd7250cf7c"><gtr:id>f919f6ab9ec769ab2d5c25bd7250cf7c</gtr:id><gtr:otherNames>Van Kerkhove MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn><gtr:outcomeId>pm_13908_28_23280042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34BE6CD6-9450-497D-9159-B09892EBC38E</gtr:id><gtr:title>HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c148e9ffd758a895718cfd9de060388a"><gtr:id>c148e9ffd758a895718cfd9de060388a</gtr:id><gtr:otherNames>Hayes R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>585d61a70cafc6.55041648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>957EE2D7-4D13-4CD2-B873-4ED86FB864BF</gtr:id><gtr:title>Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07eefe038ecfe88e29511c4d747f13cc"><gtr:id>07eefe038ecfe88e29511c4d747f13cc</gtr:id><gtr:otherNames>Turner HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>546223a1c8fa75.77286413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBA51DF1-7BE8-4E1C-A553-59909D2470A2</gtr:id><gtr:title>Rabies and canine distemper virus epidemics in the red fox population of northern Italy (2006-2010).</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdf299f55c5901d10bccacda54118ce6"><gtr:id>cdf299f55c5901d10bccacda54118ce6</gtr:id><gtr:otherNames>Nouvellet P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23630599</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E843B4B-F510-4899-BC0D-6330DA9F2AD2</gtr:id><gtr:title>Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3028c3c895d8c1c989ada41a623a5519"><gtr:id>3028c3c895d8c1c989ada41a623a5519</gtr:id><gtr:otherNames>Forouzanfar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>588b58f671f9a3.67007077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B96E072-0DB4-4BB6-99D5-510B61F1C84C</gtr:id><gtr:title>Multiple contributory factors to the age distribution of disease cases: a modeling study in the context of influenza A(H3N2v).</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2be76609c50fe26b2f0751299f933ef4"><gtr:id>2be76609c50fe26b2f0751299f933ef4</gtr:id><gtr:otherNames>Gambhir M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>pm_13908_28_23794728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCF3F192-133A-45EA-B9C9-1A46BE9844AA</gtr:id><gtr:title>Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd41c47ef0bc9fb86f02bf108d0615a1"><gtr:id>dd41c47ef0bc9fb86f02bf108d0615a1</gtr:id><gtr:otherNames>Estill J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_13908_28_23462219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F8841EA-B673-4930-811E-85E5CE6CF28B</gtr:id><gtr:title>Identification of pneumococcal colonization determinants in the stringent response pathway facilitated by genomic diversity.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd75dbe105014309cbdded985198a393"><gtr:id>bd75dbe105014309cbdded985198a393</gtr:id><gtr:otherNames>Li Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>56d5aa5d75d709.79359504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F186DF9-233D-452E-993F-1793050C7809</gtr:id><gtr:title>Comparative analysis of Chlamydia psittaci genomes reveals the recent emergence of a pathogenic lineage with a broad host range.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6c4d875d6c39abb500cc4793a986948"><gtr:id>a6c4d875d6c39abb500cc4793a986948</gtr:id><gtr:otherNames>Read TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_13908_28_23532978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD3BCFF0-437D-4700-951B-AD7F2C619A80</gtr:id><gtr:title>Healthy Life-Years Lost and Excess Bed-Days Due to 6 Patient Safety Incidents: Empirical Evidence From English Hospitals.</gtr:title><gtr:parentPublicationTitle>Medical care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eba3301a2c79f18af3fe9c2ff64a5961"><gtr:id>eba3301a2c79f18af3fe9c2ff64a5961</gtr:id><gtr:otherNames>Hauck KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0025-7079</gtr:issn><gtr:outcomeId>585d5db1d96571.88509079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D80EF653-C1BE-4628-81E6-85C8FAB66C3C</gtr:id><gtr:title>Healthcare-associated outbreak of meticillin-resistant Staphylococcus aureus bacteraemia: role of a cryptic variant of an epidemic clone.</gtr:title><gtr:parentPublicationTitle>The Journal of hospital infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/330a23d3a323cc30bbcedd3851e07800"><gtr:id>330a23d3a323cc30bbcedd3851e07800</gtr:id><gtr:otherNames>Miller RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0195-6701</gtr:issn><gtr:outcomeId>5462239d6c8d52.53755703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBE7B96C-3BDF-475E-9A06-362B311537F3</gtr:id><gtr:title>Differential efficacy of dengue vaccine by immune status.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c11a7d496361e106b86337130b0812dd"><gtr:id>c11a7d496361e106b86337130b0812dd</gtr:id><gtr:otherNames>Rodriguez-Barraquer I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56d41e8285aa99.65405359</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7F2B40B-3BA2-452E-8675-BC9F66EA661A</gtr:id><gtr:title>HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3836941586349b96d92e748acb29da1"><gtr:id>a3836941586349b96d92e748acb29da1</gtr:id><gtr:otherNames>Faria NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>546223a652fb99.16840873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>591DE480-F62D-4BA5-BC3C-3F1F73A900AE</gtr:id><gtr:title>The importance of mosquito behavioural adaptations to malaria control in Africa.</gtr:title><gtr:parentPublicationTitle>Evolution; international journal of organic evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30c316e87c13c59ab6957837870c0878"><gtr:id>30c316e87c13c59ab6957837870c0878</gtr:id><gtr:otherNames>Gatton ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-3820</gtr:issn><gtr:outcomeId>pm_13908_28_23550770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF5801A3-0691-491F-AE5E-62855F9DC5E5</gtr:id><gtr:title>Biological challenges to effective vaccines in the developing world.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad477705d4c8966434296d200f476ba2"><gtr:id>ad477705d4c8966434296d200f476ba2</gtr:id><gtr:otherNames>Grassly NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>56d41e843c7b62.87357019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42C737B4-43D7-44C4-8404-B98445C2A383</gtr:id><gtr:title>Biased sex-ratio and sex-biased heterozygote disadvantage affect the maintenance of a genetic polymorphism and the properties of hybrid zones.</gtr:title><gtr:parentPublicationTitle>Journal of evolutionary biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdf299f55c5901d10bccacda54118ce6"><gtr:id>cdf299f55c5901d10bccacda54118ce6</gtr:id><gtr:otherNames>Nouvellet P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1010-061X</gtr:issn><gtr:outcomeId>585d606dbf3161.42533995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>613FCF53-4A30-4E83-9736-27EAC76F9FED</gtr:id><gtr:title>A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2be76609c50fe26b2f0751299f933ef4"><gtr:id>2be76609c50fe26b2f0751299f933ef4</gtr:id><gtr:otherNames>Gambhir M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>5675e31246be6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F70BFAA3-4362-4B21-95DF-10A3F9D37756</gtr:id><gtr:title>The contribution of badgers to confirmed tuberculosis in cattle in high-incidence areas in England.</gtr:title><gtr:parentPublicationTitle>PLoS currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79868534e48f6997fa2239eae60f7e26"><gtr:id>79868534e48f6997fa2239eae60f7e26</gtr:id><gtr:otherNames>Donnelly CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2157-3999</gtr:issn><gtr:outcomeId>54622396420900.60228691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D42496F-E248-4160-A6E5-B9507B1B38C3</gtr:id><gtr:title>A simple incidence-based method to avoid misinterpretation of bovine tuberculosis incidence trends in great britain.</gtr:title><gtr:parentPublicationTitle>PLoS currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2952317a2b16c178bf973bc023b4a739"><gtr:id>2952317a2b16c178bf973bc023b4a739</gtr:id><gtr:otherNames>Blake IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-3999</gtr:issn><gtr:outcomeId>5462239e636977.09601505</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7AEA48A-D7D6-452A-BF38-CD3F46D39770</gtr:id><gtr:title>Acute-stage transmission of HIV: effect of volatile contact rates.</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf520788473038730237541d2398b3b5"><gtr:id>bf520788473038730237541d2398b3b5</gtr:id><gtr:otherNames>Romero-Severson EO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn><gtr:outcomeId>546223a72ad771.92606044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC6668F0-4ACF-469D-B73B-A6518609F39B</gtr:id><gtr:title>Modulation of malaria infection in Anopheles gambiae mosquitoes exposed to natural midgut bacteria.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c48935add6bac714336207eb92541cbc"><gtr:id>c48935add6bac714336207eb92541cbc</gtr:id><gtr:otherNames>Tchioffo MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5462239bec2492.10957168</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AC82767-6C10-4396-9ACB-35D1A6553D0A</gtr:id><gtr:title>The role of China in the global spread of the current cholera pandemic.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4561cf01b513731abf1179209f974d"><gtr:id>3b4561cf01b513731abf1179209f974d</gtr:id><gtr:otherNames>Didelot X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>56d41e902a86e3.48162625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97AA30B5-2AC4-45AB-9EB8-767593AE26AD</gtr:id><gtr:title>The epidemiology of non-polio enteroviruses: recent advances and outstanding questions.</gtr:title><gtr:parentPublicationTitle>Current opinion in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3de28e6626628d1ba178bed34daf818"><gtr:id>a3de28e6626628d1ba178bed34daf818</gtr:id><gtr:otherNames>Pons-Salort M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0951-7375</gtr:issn><gtr:outcomeId>56d41e834d3c68.72957311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E12505FC-BA71-4194-AC3A-9E75383AD9F3</gtr:id><gtr:title>Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c7f58166c346880df2e21561edd0911"><gtr:id>6c7f58166c346880df2e21561edd0911</gtr:id><gtr:otherNames>Magiorkinis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>pm_13908_28_23382662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA6CABC2-B3CF-43E1-9302-7A956247755F</gtr:id><gtr:title>Asymptomatic malaria infections: detectability, transmissibility and public health relevance.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/257135c67b585b044c8c4d0cf4577d5b"><gtr:id>257135c67b585b044c8c4d0cf4577d5b</gtr:id><gtr:otherNames>Bousema T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>585d5bc49c84f3.37658960</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1C0BCAB-3963-49FF-BA16-EA2DC08532D0</gtr:id><gtr:title>Early HIV infection in the United States: a virus's eye view.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47920c0acbc786b9526f10999fa6b48c"><gtr:id>47920c0acbc786b9526f10999fa6b48c</gtr:id><gtr:otherNames>Hallett TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5462239c217649.71076427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD9AE6EE-2FDA-4D1C-88E3-6299E2A14DAA</gtr:id><gtr:title>Burkholderia pseudomallei sequencing identifies genomic clades with distinct recombination, accessory, and epigenetic profiles.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a76dc46428caf782cf4e26428ccc8f4"><gtr:id>7a76dc46428caf782cf4e26428ccc8f4</gtr:id><gtr:otherNames>Nandi T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>546223a575c3e8.79908997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9139D9F2-F091-4DCB-9F59-2580FBDCC8E6</gtr:id><gtr:title>The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/730ae9ad8c71b39ddf56c92de27a5308"><gtr:id>730ae9ad8c71b39ddf56c92de27a5308</gtr:id><gtr:otherNames>Slater HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>546223a2000c29.10728743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59E3F1BE-AB1A-4854-AA34-981FA511D9B5</gtr:id><gtr:title>Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a767365930b6b2dd0dc6fbe61fd53c9"><gtr:id>5a767365930b6b2dd0dc6fbe61fd53c9</gtr:id><gtr:otherNames>Anderson SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>546223a320bb70.94568833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6592E42C-539E-45C4-AAD7-6F7B33D0B954</gtr:id><gtr:title>Mathematical Modelling to Guide Drug Development for Malaria Elimination.</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/730ae9ad8c71b39ddf56c92de27a5308"><gtr:id>730ae9ad8c71b39ddf56c92de27a5308</gtr:id><gtr:otherNames>Slater HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn><gtr:outcomeId>585d5a1c4aa369.89709585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA0AA1A6-2D95-4954-B6FD-CFFC179111B3</gtr:id><gtr:title>Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65cbd9d842ba99e94f69ec7e2078218c"><gtr:id>65cbd9d842ba99e94f69ec7e2078218c</gtr:id><gtr:otherNames>Stagg HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>588b5e418856f8.74588317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B64AC93-2ED3-4A9E-84EA-0A931D54B861</gtr:id><gtr:title>Development of malaria transmission-blocking vaccines: from concept to product.</gtr:title><gtr:parentPublicationTitle>Advances in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1ae91a136cc1808e002adb45e242f69"><gtr:id>e1ae91a136cc1808e002adb45e242f69</gtr:id><gtr:otherNames>Wu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0065-308X</gtr:issn><gtr:outcomeId>56d41e8a4a45c0.15740454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA86627A-447D-4E4D-A1D6-1C499EE0AA4F</gtr:id><gtr:title>EpiJSON: A unified data-format for epidemiology.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/079aa6fe1af959b9c6a034a2441b76d5"><gtr:id>079aa6fe1af959b9c6a034a2441b76d5</gtr:id><gtr:otherNames>Finnie TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>585d5972037196.39324932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95BD8F6B-3CF1-430A-971E-908AA10DC454</gtr:id><gtr:title>Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/688c724f0634d353269671f0a3751196"><gtr:id>688c724f0634d353269671f0a3751196</gtr:id><gtr:otherNames>Wu L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d41e7a2f45e9.17783354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E62D5F04-2A70-446F-A4F2-3D03CC5AE206</gtr:id><gtr:title>Population genomic datasets describing the post-vaccine evolutionary epidemiology of Streptococcus pneumoniae.</gtr:title><gtr:parentPublicationTitle>Scientific data</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e8ad1fc53d4c06210e00afb647eb318"><gtr:id>6e8ad1fc53d4c06210e00afb647eb318</gtr:id><gtr:otherNames>Croucher NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2052-4463</gtr:issn><gtr:outcomeId>56d5aa5d13f0a1.10557872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C07B9D9-6A50-4E45-90E9-994D6C5760E5</gtr:id><gtr:title>Estimating HIV incidence from case-report data: method and an application in Colombia.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f3f681ea56f6b0d406703ce4fd841e"><gtr:id>d4f3f681ea56f6b0d406703ce4fd841e</gtr:id><gtr:otherNames>Vesga JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>56d41e8d10f613.32542665</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A56D79D1-3B43-4575-8735-700F1536EC00</gtr:id><gtr:title>Transmission-blocking interventions eliminate malaria from laboratory populations.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52bf13b5cdd139c825dbf1ce53b3ee3a"><gtr:id>52bf13b5cdd139c825dbf1ce53b3ee3a</gtr:id><gtr:otherNames>Blagborough AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_13908_28_23652000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C31F53C-10AC-4A7B-84EE-F34DD90DC6BC</gtr:id><gtr:title>Polio eradication. Efficacy of inactivated poliovirus vaccine in India.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9c35ed80ae5a50060eed0c566c50d77"><gtr:id>c9c35ed80ae5a50060eed0c566c50d77</gtr:id><gtr:otherNames>Jafari H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>546223a4baa464.51098964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A49021F-23B8-4328-BDC4-3B0F18467CF2</gtr:id><gtr:title>Inferring the source of transmission with phylogenetic data.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a65aa60d956f1da3c46cfe9f95a31f"><gtr:id>29a65aa60d956f1da3c46cfe9f95a31f</gtr:id><gtr:otherNames>Volz EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>5462239ced0532.14002438</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F103D572-9C44-4F87-BC35-E51423ADBA97</gtr:id><gtr:title>PANGEA-HIV: phylogenetics for generalised epidemics in Africa.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5802b8e89cc50816134996d592422a4"><gtr:id>e5802b8e89cc50816134996d592422a4</gtr:id><gtr:otherNames>Pillay D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>56d41e7f837d53.07835935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFBC557A-F332-4DAD-8EAE-29878DD7512D</gtr:id><gtr:title>Six challenges in measuring contact networks for use in modelling.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d5a6dd9d53a7c1b95463407fb940380"><gtr:id>7d5a6dd9d53a7c1b95463407fb940380</gtr:id><gtr:otherNames>Eames K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>56d41e89188aa6.45012400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45492789-031A-4B9C-BC85-289101A568FB</gtr:id><gtr:title>Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d7c09246b97cf11b635811454bc6d05"><gtr:id>8d7c09246b97cf11b635811454bc6d05</gtr:id><gtr:otherNames>Armistead JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>5462239e3efc50.28091175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52244E74-4BC7-43AB-990D-B642BD889D10</gtr:id><gtr:title>Context-dependent amphibian host population response to an invading pathogen.</gtr:title><gtr:parentPublicationTitle>Ecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc289eb44f653487c3f45e847ebeb54"><gtr:id>0dc289eb44f653487c3f45e847ebeb54</gtr:id><gtr:otherNames>Doddington BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-9658</gtr:issn><gtr:outcomeId>pm_13908_28_24015523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8754E453-B9A7-4138-BF04-A0059EE7AD0A</gtr:id><gtr:title>Dynamic Variation in Sexual Contact Rates in a Cohort of HIV-Negative Gay Men.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf520788473038730237541d2398b3b5"><gtr:id>bf520788473038730237541d2398b3b5</gtr:id><gtr:otherNames>Romero-Severson EO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>56d41e81188073.78428244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC7EEA83-EFED-4AD9-B9EA-12A109CF74C6</gtr:id><gtr:title>Within-host and between-host evolutionary rates across the HIV-1 genome.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4414ac3db7b9c7b9f7b7ce26ce25461b"><gtr:id>4414ac3db7b9c7b9f7b7ce26ce25461b</gtr:id><gtr:otherNames>Alizon S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>pm_13908_28_23639104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C2E313B-FA3C-4C36-ADEA-94E8158E2BD9</gtr:id><gtr:title>Post-migration follow-up of migrants at risk of tuberculosis</gtr:title><gtr:parentPublicationTitle>LANCET INFECTIOUS DISEASES</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e16bccffeff5c712220e79048bb5656c"><gtr:id>e16bccffeff5c712220e79048bb5656c</gtr:id><gtr:otherNames>White Peter J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>5a35e37cb252a3.62505822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A59B2FF-ABED-40E0-A04B-59FA8A5FDCEB</gtr:id><gtr:title>Viral phylodynamics.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a65aa60d956f1da3c46cfe9f95a31f"><gtr:id>29a65aa60d956f1da3c46cfe9f95a31f</gtr:id><gtr:otherNames>Volz EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>546223981e7b49.86324122</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5A3503D-7CCA-482C-85AE-45CCEB33A539</gtr:id><gtr:title>Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The Netherlands.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/869b1b9088a192a10571e20539225f70"><gtr:id>869b1b9088a192a10571e20539225f70</gtr:id><gtr:otherNames>Smit M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5462239a3a0c17.78659556</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCCF90A6-6525-4F6B-A3BB-0072479E18ED</gtr:id><gtr:title>OutbreakTools: a new platform for disease outbreak analysis using the R software.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/564b3b1fb34e1a022612ae9017c16220"><gtr:id>564b3b1fb34e1a022612ae9017c16220</gtr:id><gtr:otherNames>Jombart T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>546223a19f6ed0.38131250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD0DE177-FFE8-4C42-B14F-823E8A050F24</gtr:id><gtr:title>Evaluation of geospatial methods to generate subnational HIV prevalence estimates for local level planning.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79565c49856ed96564685a76962c8c8c"><gtr:id>79565c49856ed96564685a76962c8c8c</gtr:id><gtr:otherNames>Subnational Estimates Working Group of the HIV Modelling Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>585d6a563ae6a9.67652523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88BBD5A3-297E-416E-83D2-0647D5284F3A</gtr:id><gtr:title>Tetracycline Selective Pressure and Homologous Recombination Shape the Evolution of Chlamydia suis: A Recently Identified Zoonotic Pathogen.</gtr:title><gtr:parentPublicationTitle>Genome biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/769fe65e18f6a869f1a9f4f947b903b8"><gtr:id>769fe65e18f6a869f1a9f4f947b903b8</gtr:id><gtr:otherNames>Joseph SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1759-6653</gtr:issn><gtr:outcomeId>585d5d6a2a9e27.20420088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B77D371-04AD-47B0-ABBF-39C924CB5BB3</gtr:id><gtr:title>Increased transmissibility explains the third wave of infection by the 2009 H1N1 pandemic virus in England.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c09949b52b81a62d75b0ca5b0178b50"><gtr:id>6c09949b52b81a62d75b0ca5b0178b50</gtr:id><gtr:otherNames>Dorigatti I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13908_28_23882078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94AA74BA-E3FD-4830-922A-6ED47BAAFD3C</gtr:id><gtr:title>The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcf87374f92387f9506905446404477a"><gtr:id>fcf87374f92387f9506905446404477a</gtr:id><gtr:otherNames>Sachdeva KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d41e84c5d563.20107081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>272F4460-E34F-4450-9ED0-FEEC94DF407F</gtr:id><gtr:title>Design and methods of a social network isolation study for reducing respiratory infection transmission: The eX-FLU cluster randomized trial.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4c6a0ad40d17ae3d28fe0082d9e0b2e"><gtr:id>b4c6a0ad40d17ae3d28fe0082d9e0b2e</gtr:id><gtr:otherNames>Aiello AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>585d59749c6366.13422866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08169EAF-D59E-45F9-AC67-90E56D30E337</gtr:id><gtr:title>Contact transmission of influenza virus between ferrets imposes a looser bottleneck than respiratory droplet transmission allowing propagation of antiviral resistance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5caf874bd586c4c3603017fcd830d59"><gtr:id>f5caf874bd586c4c3603017fcd830d59</gtr:id><gtr:otherNames>Frise R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d5c19ea80d8.65447549</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59D9FF24-7071-4724-A57C-076820E3CD89</gtr:id><gtr:title>Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5658030333b8bb972d6197230bfc9aa"><gtr:id>b5658030333b8bb972d6197230bfc9aa</gtr:id><gtr:otherNames>Penny MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56d41e79995a95.45278382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE55AD18-B6F8-4EE7-9665-484616112016</gtr:id><gtr:title>Quantifying the mosquito's sweet tooth: modelling the effectiveness of attractive toxic sugar baits (ATSB) for malaria vector control.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f768e77bdb0f6ed61e52b8b25a383b"><gtr:id>c4f768e77bdb0f6ed61e52b8b25a383b</gtr:id><gtr:otherNames>Marshall JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_13908_28_23968494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F763D8E3-A6B7-4737-92F8-209B37B1B2FC</gtr:id><gtr:title>Sources of HIV infection among men having sex with men and implications for prevention.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cd76249779913dfda6133932a845c6d"><gtr:id>6cd76249779913dfda6133932a845c6d</gtr:id><gtr:otherNames>Ratmann O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>56d4672500a851.01803320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2E8E904-C061-4CC8-9719-86D62F063B12</gtr:id><gtr:title>The contribution of social behaviour to the transmission of influenza A in a human population.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f741f76c2b1d78183e956abc23d9da33"><gtr:id>f741f76c2b1d78183e956abc23d9da33</gtr:id><gtr:otherNames>Kucharski AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>546223a2253773.24582966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7E6713A-B1F9-4884-AB33-3FB84B7A7017</gtr:id><gtr:title>A synthetic gene drive system for local, reversible modification and suppression of insect populations.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/818fc2e20a7e375ad376e97231a8f9cc"><gtr:id>818fc2e20a7e375ad376e97231a8f9cc</gtr:id><gtr:otherNames>Akbari OS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>pm_13908_28_23541732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F65B84CE-C675-4E9A-81B4-2E421A335A93</gtr:id><gtr:title>Five challenges for spatial epidemic models.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfb5062b3b74deb6e922dc6a4250846e"><gtr:id>bfb5062b3b74deb6e922dc6a4250846e</gtr:id><gtr:otherNames>Riley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>56d41e8957c6d0.28305163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F03F599B-61FD-47A6-BAF0-05F46978CD4B</gtr:id><gtr:title>A restatement of the natural science evidence base relevant to the control of bovine tuberculosis in Great Britain.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a722c8f786c344519dd6d97338e084e7"><gtr:id>a722c8f786c344519dd6d97338e084e7</gtr:id><gtr:otherNames>Godfray HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn><gtr:outcomeId>pm_13908_28_23926157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51467F6B-8655-4FE2-89FC-E2A53DC0C67B</gtr:id><gtr:title>Dispersion of the HIV-1 Epidemic in Men Who Have Sex with Men in the Netherlands: A Combined Mathematical Model and Phylogenetic Analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c64cabb2f672b4d549d1ca9b6d5848d0"><gtr:id>c64cabb2f672b4d549d1ca9b6d5848d0</gtr:id><gtr:otherNames>Bezemer D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>56d41e809b1099.26965403</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61D63775-B911-4A84-ABF0-8F09E698FF8F</gtr:id><gtr:title>Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f741f76c2b1d78183e956abc23d9da33"><gtr:id>f741f76c2b1d78183e956abc23d9da33</gtr:id><gtr:otherNames>Kucharski AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>56d41e88d467e8.90199613</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>547DA07C-AEB2-4255-A627-E0416A9935D1</gtr:id><gtr:title>Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07dfabc74b6b6824d6b3ac8d5c7a6063"><gtr:id>07dfabc74b6b6824d6b3ac8d5c7a6063</gtr:id><gtr:otherNames>Sawa P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_13908_28_23468056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1536B953-ED25-4321-9AD1-1FC75288A1D2</gtr:id><gtr:title>Why the proportion of transmission during early-stage HIV infection does not predict the long-term impact of treatment on HIV incidence.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df45bbde2fa354f91b34a4853de41aac"><gtr:id>df45bbde2fa354f91b34a4853de41aac</gtr:id><gtr:otherNames>Eaton JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>546223a67893c6.62566690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05CD8929-8C08-493C-9F6C-35292B721428</gtr:id><gtr:title>Cohort Profile: A study of influenza immunity in the urban and rural Guangzhou region of China: the Fluscape Study.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc30a99b64fb741aa217c51f3a645f0e"><gtr:id>cc30a99b64fb741aa217c51f3a645f0e</gtr:id><gtr:otherNames>Jiang CQ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>56d41e86b47621.09223442</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9C17C86-BBCE-461E-B5AE-28978885666A</gtr:id><gtr:title>HCV and HIV: shared challenges, shared solutions.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8771de02624d7e2124c5b84e936f501"><gtr:id>c8771de02624d7e2124c5b84e936f501</gtr:id><gtr:otherNames>Cooke GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>585d5a86a02813.19356972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC183977-2164-4D0B-A923-6ADA03B2FD2C</gtr:id><gtr:title>A New Method for Estimating the Coverage of Mass Vaccination Campaigns Against Poliomyelitis From Surveillance Data.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/655c39e8716399568ab2af00be3a22b9"><gtr:id>655c39e8716399568ab2af00be3a22b9</gtr:id><gtr:otherNames>O'Reilly KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>56d41e83802087.94736641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>945CE33C-5DCA-45D0-8DFA-41A113BE93C1</gtr:id><gtr:title>Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/384f794748bc85c2fc08a066092b27a1"><gtr:id>384f794748bc85c2fc08a066092b27a1</gtr:id><gtr:otherNames>Dingle KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_13908_28_23204167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10DF1EFD-2061-4C93-841F-5B494F66CA4F</gtr:id><gtr:title>Faster Detection of Poliomyelitis Outbreaks to Support Polio Eradication.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2952317a2b16c178bf973bc023b4a739"><gtr:id>2952317a2b16c178bf973bc023b4a739</gtr:id><gtr:otherNames>Blake IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>56d41e7d46c146.39254452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22389155-3EA9-4B7B-BD43-6C5024BD55B7</gtr:id><gtr:title>The effects of taxing sugar-sweetened beverages across different income groups.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/051dea896965c11682564b739821a77d"><gtr:id>051dea896965c11682564b739821a77d</gtr:id><gtr:otherNames>Sharma A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>585d5873d27b02.13708469</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02BF3B8C-DAD9-4A60-BA29-CCB014744C83</gtr:id><gtr:title>Heterogeneity in the frequency and characteristics of homologous recombination in pneumococcal evolution.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6a548075cca0184f8ccb7c9d984281"><gtr:id>ad6a548075cca0184f8ccb7c9d984281</gtr:id><gtr:otherNames>Mostowy R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>585d62736c8338.01353940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB60A64A-B179-4E59-BA44-0A0D8F06F092</gtr:id><gtr:title>A systematic review of reported reassortant viral lineages of influenza A.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/027454f475c9478478c151d850908532"><gtr:id>027454f475c9478478c151d850908532</gtr:id><gtr:otherNames>Pinsent A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>56d41e8752c737.71221384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>536F34DB-AA70-47F9-9DAB-89739AF454C4</gtr:id><gtr:title>The role of older children and adults in wild poliovirus transmission.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2952317a2b16c178bf973bc023b4a739"><gtr:id>2952317a2b16c178bf973bc023b4a739</gtr:id><gtr:otherNames>Blake IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>546223a24b05a1.86088438</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5B58B44-3C63-4EA3-9644-5BAC689401DF</gtr:id><gtr:title>Prevalence of and risk factors for active tuberculosis in migrants screened before entry to the UK: a population-based cross-sectional study</gtr:title><gtr:parentPublicationTitle>The Lancet Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b27407ced5a03816ce8e1a4867c7d8ad"><gtr:id>b27407ced5a03816ce8e1a4867c7d8ad</gtr:id><gtr:otherNames>Aldridge R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d6ff37d4d49.65455130</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF4FD626-C942-4D88-A3BA-827B48D8A97F</gtr:id><gtr:title>Phylogeography of Toxoplasma gondii points to a South American origin.</gtr:title><gtr:parentPublicationTitle>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80e3ed6a7a5e839a2d21772dad5ff1fd"><gtr:id>80e3ed6a7a5e839a2d21772dad5ff1fd</gtr:id><gtr:otherNames>Bertranpetit E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1567-1348</gtr:issn><gtr:outcomeId>588b58bade0587.22497447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CC13EB0-C548-42E3-AD39-02D771CFDFE5</gtr:id><gtr:title>How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c711c2ba2acd5d717b141c1f5237f36"><gtr:id>7c711c2ba2acd5d717b141c1f5237f36</gtr:id><gtr:otherNames>Dimitrov DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d62f274cd50.17371080</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0733847-C7AB-4D31-90CC-8122817E5F72</gtr:id><gtr:title>Putting the burden of HIV in context.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c25fb1b9671ec61a32d2c1a5b1b78964"><gtr:id>c25fb1b9671ec61a32d2c1a5b1b78964</gtr:id><gtr:otherNames>Gregson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>5462239d220967.37866033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B915E2B-29AB-487D-8F73-04AFD91338F5</gtr:id><gtr:title>Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b9188f8c2ce7c075ae424652b80941e"><gtr:id>3b9188f8c2ce7c075ae424652b80941e</gtr:id><gtr:otherNames>Houben RMGJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>585d5a9f49ea32.25825571</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CF1AF0D-4E32-4BC7-99CE-3370E77B7BA8</gtr:id><gtr:title>Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1764b1c3a83f9a06960d7a3cc7dba18"><gtr:id>f1764b1c3a83f9a06960d7a3cc7dba18</gtr:id><gtr:otherNames>Cohen MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5462239ac58f32.28196353</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>475BCDAA-AE85-46B5-A8AF-ED9B1892C85D</gtr:id><gtr:title>Provision of malaria treatment for Ebola case contacts.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc18eece58bea84cbf83a459378d6998"><gtr:id>bc18eece58bea84cbf83a459378d6998</gtr:id><gtr:otherNames>Ghani AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>56d41e79f3d767.58016929</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD2772F1-7166-4A50-92D6-9C7DF70BF93D</gtr:id><gtr:title>Has the rate of CD4 cell count decline before initiation of antiretroviral therapy changed over the course of the Dutch HIV epidemic among MSM?</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a74578c716f92513c67acc25acc29a4"><gtr:id>3a74578c716f92513c67acc25acc29a4</gtr:id><gtr:otherNames>Gras L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23724048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7BFD0B9-F808-417D-BB66-F30415A05DB1</gtr:id><gtr:title>Suppression of a Field Population of Aedes aegypti in Brazil by Sustained Release of Transgenic Male Mosquitoes.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bd85649671259bad5bd322109984f59"><gtr:id>7bd85649671259bad5bd322109984f59</gtr:id><gtr:otherNames>Carvalho DO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>56d41e7d9fb431.32968044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9143F5B2-219F-4B12-88CE-F76C8B40AC07</gtr:id><gtr:title>Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be8295a96f0af241759ae121493ca15e"><gtr:id>be8295a96f0af241759ae121493ca15e</gtr:id><gtr:otherNames>Jewell BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d41e8de797b7.36634029</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>011098ED-347B-44CE-9B9F-4409AE9FE6EF</gtr:id><gtr:title>A Bayesian approach to inferring the phylogenetic structure of communities from metagenomic data.</gtr:title><gtr:parentPublicationTitle>Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf51097c9577e63f13fcf03fc795365f"><gtr:id>bf51097c9577e63f13fcf03fc795365f</gtr:id><gtr:otherNames>O'Brien JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0016-6731</gtr:issn><gtr:outcomeId>546223a07e7ae7.10172762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF88E5EF-F932-42EA-97CE-364A96251A76</gtr:id><gtr:title>The relationship between RTS,S vaccine-induced antibodies, CD4? T cell responses and protection against Plasmodium falciparum infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f56584c638d4ce39ec15347d619b6f1"><gtr:id>8f56584c638d4ce39ec15347d619b6f1</gtr:id><gtr:otherNames>White MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23613845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AA6B2A5-2BE1-4CE3-A690-2B7886C247DA</gtr:id><gtr:title>Increased mortality attributed to Chagas disease: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Parasites &amp; vectors</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ad1ff1a84d678c56e7af7a51014f022"><gtr:id>1ad1ff1a84d678c56e7af7a51014f022</gtr:id><gtr:otherNames>Cucunub? ZM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1756-3305</gtr:issn><gtr:outcomeId>56d5aa5e2b5767.62612789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B90CF28-E053-4B7F-A3F9-E38B8266BCA7</gtr:id><gtr:title>Faster Adaptation in Smaller Populations: Counterintuitive Evolution of HIV during Childhood Infection.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa5180596dc9af9bf8fdcbdbfa6395bb"><gtr:id>aa5180596dc9af9bf8fdcbdbfa6395bb</gtr:id><gtr:otherNames>Raghwani J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>588b5da36b0063.46769241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDAB66F7-C946-4FE7-9C27-5926E170BA3D</gtr:id><gtr:title>PLOS Currents: Outbreaks --- For findings that the world just can't wait to see.</gtr:title><gtr:parentPublicationTitle>PLoS currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9a19e0e5c7baad51cfbe6f289eef2cb"><gtr:id>b9a19e0e5c7baad51cfbe6f289eef2cb</gtr:id><gtr:otherNames>Cowling B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2157-3999</gtr:issn><gtr:outcomeId>54622399662377.84387253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3CC7EDE-7B0E-4CFB-8827-BFE81A78FB3A</gtr:id><gtr:title>A new framework and software to estimate time-varying reproduction numbers during epidemics.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd4b424460e03e5dc9b6ba07e301546f"><gtr:id>cd4b424460e03e5dc9b6ba07e301546f</gtr:id><gtr:otherNames>Cori A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>pm_13908_28_24043437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E5DB4BF-315B-4ECD-B913-B1DE1623C1B2</gtr:id><gtr:title>Tuberculosis burden in India's private sector - Authors' reply</gtr:title><gtr:parentPublicationTitle>The Lancet Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27982b3efb61f19f3555dc13dc24d6b9"><gtr:id>27982b3efb61f19f3555dc13dc24d6b9</gtr:id><gtr:otherNames>Arinaminpathy N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>588b5909c54e36.59714796</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4CE3F0D-9D3C-4B96-8F53-40C41A58734C</gtr:id><gtr:title>Genome sequencing defines phylogeny and spread of methicillin-resistant Staphylococcus aureus in a high transmission setting.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61795fdb017937d3b5fd98eb0e455021"><gtr:id>61795fdb017937d3b5fd98eb0e455021</gtr:id><gtr:otherNames>Tong SY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>56d41e7ee3bdc5.91732701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B403037A-FA53-4D52-9270-0DB025095ABD</gtr:id><gtr:title>Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.</gtr:title><gtr:parentPublicationTitle>Parasites &amp; vectors</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07eefe038ecfe88e29511c4d747f13cc"><gtr:id>07eefe038ecfe88e29511c4d747f13cc</gtr:id><gtr:otherNames>Turner HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1756-3305</gtr:issn><gtr:outcomeId>546223a109d208.78066299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73D058AC-627E-437D-84E5-129E7E20E9CF</gtr:id><gtr:title>Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d73baf845cafdc73ad61e92bec2ca251"><gtr:id>d73baf845cafdc73ad61e92bec2ca251</gtr:id><gtr:otherNames>Stoesser N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d60e3312991.35376667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2AC9C9B-A34E-42BF-82F9-43D77A9D0B1A</gtr:id><gtr:title>Surveillance of low pathogenic novel H7N9 avian influenza in commercial poultry barns: detection of outbreaks and estimation of virus introduction time.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/027454f475c9478478c151d850908532"><gtr:id>027454f475c9478478c151d850908532</gtr:id><gtr:otherNames>Pinsent A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>546223a3971049.35203188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91DF1435-9151-405C-B139-68A30C58D5A3</gtr:id><gtr:title>Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1481951921c8df5f8f0ab0e8e5d84458"><gtr:id>1481951921c8df5f8f0ab0e8e5d84458</gtr:id><gtr:otherNames>Koukounari A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>pm_13908_28_23548755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96706576-86AF-46D8-AF1C-A683E65E28BE</gtr:id><gtr:title>Global priorities for research and the relative importance of different research outcomes: an international Delphi survey of malaria research experts.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73fa9d2fecd4b65ac2d7d2116b28c79a"><gtr:id>73fa9d2fecd4b65ac2d7d2116b28c79a</gtr:id><gtr:otherNames>Mulligan JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>588b5d12dab7a6.41100935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C67AAB5E-5370-4F14-BB80-868BC14D3103</gtr:id><gtr:title>Dispersal of Engineered Male Aedes aegypti Mosquitoes.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/345af6961b3dbf1d96b57a132e3e61f3"><gtr:id>345af6961b3dbf1d96b57a132e3e61f3</gtr:id><gtr:otherNames>Winskill P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>56d41e7e9f6ab4.41730407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48B4EE1C-6D50-495C-B3A7-43D841F03BA6</gtr:id><gtr:title>Formal Comment to Pettengill: The Time to Most Recent Common Ancestor Does Not (Usually) Approximate the Date of Divergence.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09de9ad4a9999955a68404bf881ee5e3"><gtr:id>09de9ad4a9999955a68404bf881ee5e3</gtr:id><gtr:otherNames>Achtman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d41e916b7793.23732923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB39041D-F717-4231-B345-66AC3FBFC697</gtr:id><gtr:title>Comparisons of infant Escherichia coli isolates link genomic profiles with adaptation to the ecological niche.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b991510395df95724069ca1ba54f8a5"><gtr:id>5b991510395df95724069ca1ba54f8a5</gtr:id><gtr:otherNames>de Muinck EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>pm_13908_28_23384204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>347DED65-9C6A-4AD3-8692-3C33AC43FB0B</gtr:id><gtr:title>Improving statistical inference on pathogen densities estimated by quantitative molecular methods: malaria gametocytaemia as a case study.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/387c0c1157f05fb17c3c673ecd50d8fa"><gtr:id>387c0c1157f05fb17c3c673ecd50d8fa</gtr:id><gtr:otherNames>Walker M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>56d41e8c12e746.33039430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC0188EF-7ABA-462B-AD0A-882C54FAF25F</gtr:id><gtr:title>Genomic analysis to improve the management of outbreaks of bacterial infection.</gtr:title><gtr:parentPublicationTitle>Expert review of anti-infective therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4561cf01b513731abf1179209f974d"><gtr:id>3b4561cf01b513731abf1179209f974d</gtr:id><gtr:otherNames>Didelot X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1478-7210</gtr:issn><gtr:outcomeId>pm_13908_28_23566141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDDAC227-5AFC-4CD7-A0D3-D45450F87294</gtr:id><gtr:title>Linking genomics and population genetics with R.</gtr:title><gtr:parentPublicationTitle>Molecular ecology resources</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/907d0e7e2bfd661244e841aa595ce644"><gtr:id>907d0e7e2bfd661244e841aa595ce644</gtr:id><gtr:otherNames>Paradis E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1755-098X</gtr:issn><gtr:outcomeId>585d653f507fc3.82497653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1558BF19-DDBB-40D8-90D8-052EDD03EE54</gtr:id><gtr:title>Bayesian Inference of the Evolution of a Phenotype Distribution on a Phylogenetic Tree.</gtr:title><gtr:parentPublicationTitle>Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f910cfd938f25e6e6e45c466f2c7dc1"><gtr:id>1f910cfd938f25e6e6e45c466f2c7dc1</gtr:id><gtr:otherNames>Ansari MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0016-6731</gtr:issn><gtr:outcomeId>585d633dc7d510.12391815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC551062-7486-4FE3-93CC-435896DE48CD</gtr:id><gtr:title>Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma.</gtr:title><gtr:parentPublicationTitle>Journal of tropical medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6ec37a7dcfbc757aaa172ed0fdc45b1"><gtr:id>b6ec37a7dcfbc757aaa172ed0fdc45b1</gtr:id><gtr:otherNames>Ho DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1687-9686</gtr:issn><gtr:outcomeId>56d41e846d9242.05801090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35100092-8832-4183-ACE4-11CD04B36333</gtr:id><gtr:title>After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9080986dd2c4c98653e05a77311da9"><gtr:id>cf9080986dd2c4c98653e05a77311da9</gtr:id><gtr:otherNames>WHO Ebola Response Team</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>585d5cc14a4425.91257924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB1BE41A-FEE8-4C5B-9595-C74BAB715C3F</gtr:id><gtr:title>Distinguishing Between Reservoir Exposure and Human-to-Human Transmission for Emerging Pathogens Using Case Onset Data.</gtr:title><gtr:parentPublicationTitle>PLoS currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d089aeea375cacb98e3c9cb5a31eac6b"><gtr:id>d089aeea375cacb98e3c9cb5a31eac6b</gtr:id><gtr:otherNames>Kucharski A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-3999</gtr:issn><gtr:outcomeId>5462239f08f9e3.39978359</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA77CD07-D107-4B46-96E3-7C3F3C0412AC</gtr:id><gtr:title>Measurably evolving pathogens in the genomic era.</gtr:title><gtr:parentPublicationTitle>Trends in ecology &amp; evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac24e13ae82d1759571a03353a7955c7"><gtr:id>ac24e13ae82d1759571a03353a7955c7</gtr:id><gtr:otherNames>Biek R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0169-5347</gtr:issn><gtr:outcomeId>56d41e90eda518.08324184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>487CA3CC-E7E9-4C19-95E4-2F91A4B61BEF</gtr:id><gtr:title>Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc51a3c09ef13191fe709f2d522129fc"><gtr:id>fc51a3c09ef13191fe709f2d522129fc</gtr:id><gtr:otherNames>Lipsitch M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>5675e8a3aa88b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30404EFB-9C2B-4C04-9B3B-4BB987B7DCD2</gtr:id><gtr:title>Understanding the incremental value of novel diagnostic tests for tuberculosis.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27982b3efb61f19f3555dc13dc24d6b9"><gtr:id>27982b3efb61f19f3555dc13dc24d6b9</gtr:id><gtr:otherNames>Arinaminpathy N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d41e8498a8b0.19473922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CAEFF3F-7812-4588-8574-D8907F9BDE45</gtr:id><gtr:title>Modelling tree shape and structure in viral phylodynamics.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b89f82cb009e3c56beba42628f9c5455"><gtr:id>b89f82cb009e3c56beba42628f9c5455</gtr:id><gtr:otherNames>Frost SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>54622397b561b1.46735078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E01C91E9-7A78-46E5-B7F8-C94FA12CE97D</gtr:id><gtr:title>Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b91a3362856b2fcd403cabb32bde9b77"><gtr:id>b91a3362856b2fcd403cabb32bde9b77</gtr:id><gtr:otherNames>Upton LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>56d41e7c6b38f4.62763129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D04E548E-3565-48F4-B195-E3CF84F92945</gtr:id><gtr:title>Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20d4a86d76f007bbfd13b5b023bc488f"><gtr:id>20d4a86d76f007bbfd13b5b023bc488f</gtr:id><gtr:otherNames>Nair SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d62e6148f41.57820998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDA695B5-4ADC-42C0-B549-43205FF94BFB</gtr:id><gtr:title>Incidence of influenza A(H1N1)pdm09 infection, United Kingdom, 2009-2011.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a36a27fdba02f67bc73d13ae40289f36"><gtr:id>a36a27fdba02f67bc73d13ae40289f36</gtr:id><gtr:otherNames>Sridhar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>585d63b0af02b5.62567718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F66D4EE3-A418-4C47-A4B9-52BCE660E427</gtr:id><gtr:title>Transmission and control of Plasmodium knowlesi: a mathematical modelling study.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e52f7e4d1b169efc084463f3d538f083"><gtr:id>e52f7e4d1b169efc084463f3d538f083</gtr:id><gtr:otherNames>Imai N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>546223a34c7e33.83928704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E2D492E-A56A-483E-BB2C-BA4974FCF106</gtr:id><gtr:title>Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis.</gtr:title><gtr:parentPublicationTitle>The lancet. HIV</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740b47608c2a17faae775070e5702f3"><gtr:id>5740b47608c2a17faae775070e5702f3</gtr:id><gtr:otherNames>Smith JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2352-3018</gtr:issn><gtr:outcomeId>56d41e8e50ca68.01942022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00DB162E-B912-4FE0-9509-46118AFFFCC5</gtr:id><gtr:title>Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8250c8021b845b0a46cd7eb10dabcb30"><gtr:id>8250c8021b845b0a46cd7eb10dabcb30</gtr:id><gtr:otherNames>Dimitrov D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5462239ba0a876.43794793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBF4EE4A-599F-435E-B14B-0EF5C9DDA40F</gtr:id><gtr:title>Estimating Local Chlamydia Incidence and Prevalence Using Surveillance Data.</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36bf6d0791aab24f9ae44c8acd439a0b"><gtr:id>36bf6d0791aab24f9ae44c8acd439a0b</gtr:id><gtr:otherNames>Lewis J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn><gtr:outcomeId>5a31d761f1d400.63460569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD6F1FFB-CCDB-4E72-BF20-820333B0EC13</gtr:id><gtr:title>Model hierarchies in edge-based compartmental modeling for infectious disease spread.</gtr:title><gtr:parentPublicationTitle>Journal of mathematical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86318df6cb4a0bac5c20c4ed3e64f84c"><gtr:id>86318df6cb4a0bac5c20c4ed3e64f84c</gtr:id><gtr:otherNames>Miller JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0303-6812</gtr:issn><gtr:outcomeId>pm_13908_28_22911242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC7056F2-6BA8-4223-9884-E1FA28F215A8</gtr:id><gtr:title>Genome-wide association of functional traits linked with Campylobacter jejuni survival from farm to fork.</gtr:title><gtr:parentPublicationTitle>Environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c76ac3809caae85c8a46d64cb3e4ff5"><gtr:id>4c76ac3809caae85c8a46d64cb3e4ff5</gtr:id><gtr:otherNames>Yahara K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1462-2912</gtr:issn><gtr:outcomeId>588b5bed830b86.51538448</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73B78F42-253D-4636-A1C1-A058F745A381</gtr:id><gtr:title>Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bc88b7f5a276d70becb7168d1123232"><gtr:id>4bc88b7f5a276d70becb7168d1123232</gtr:id><gtr:otherNames>Ou?draogo AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56d41e8bb853e9.23935407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>624A651F-AE13-48DD-9FF9-C24CEE76E7E3</gtr:id><gtr:title>Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5112a8faee07aef7c864e22475b35b24"><gtr:id>5112a8faee07aef7c864e22475b35b24</gtr:id><gtr:otherNames>Hayward AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>585d5a919c4054.70087648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A190C1C6-3D55-41A7-AA8F-BE63FC3F6199</gtr:id><gtr:title>Inference of the properties of the recombination process from whole bacterial genomes.</gtr:title><gtr:parentPublicationTitle>Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f910cfd938f25e6e6e45c466f2c7dc1"><gtr:id>1f910cfd938f25e6e6e45c466f2c7dc1</gtr:id><gtr:otherNames>Ansari MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0016-6731</gtr:issn><gtr:outcomeId>5462239b216065.53316300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>403A2592-A2B9-4AED-BC9C-6F7D39504C34</gtr:id><gtr:title>Early real-time estimation of the basic reproduction number of emerging or reemerging infectious diseases in a community with heterogeneous contact pattern: Using data from Hong Kong 2009 H1N1 Pandemic Influenza as an illustrative example.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8175113ca74119a646bc92f844a3c697"><gtr:id>8175113ca74119a646bc92f844a3c697</gtr:id><gtr:otherNames>Kwok KO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d41e8803b851.34725240</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AA14A22-4A73-4256-B12E-769B85DF1612</gtr:id><gtr:title>A scalable assessment of Plasmodium falciparum transmission in the standard membrane-feeding assay, using transgenic parasites expressing green fluorescent protein-luciferase.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2cce341bcd61dd47e5d2a5f3b442dbd"><gtr:id>f2cce341bcd61dd47e5d2a5f3b442dbd</gtr:id><gtr:otherNames>Stone WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>546223a0a43322.36200772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E62AA81D-58DB-42FB-8B6A-6E52C0106079</gtr:id><gtr:title>HIV treatment-as-prevention research: taking the right road at the crossroads.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c148e9ffd758a895718cfd9de060388a"><gtr:id>c148e9ffd758a895718cfd9de060388a</gtr:id><gtr:otherNames>Hayes R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>56d41e7f51d616.02498847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D81702B6-FB6A-4A33-871C-F1CDFFF148C3</gtr:id><gtr:title>Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f24279cb762cddc202acc37d8f569f7"><gtr:id>4f24279cb762cddc202acc37d8f569f7</gtr:id><gtr:otherNames>Okell LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d5b66e63e78.15608367</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92466386-5AEC-4F19-A1EA-219550018560</gtr:id><gtr:title>Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f919f6ab9ec769ab2d5c25bd7250cf7c"><gtr:id>f919f6ab9ec769ab2d5c25bd7250cf7c</gtr:id><gtr:otherNames>Van Kerkhove MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn><gtr:outcomeId>pm_13908_28_23331969</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBB29EB5-FE75-4737-859F-BA63E1075428</gtr:id><gtr:title>Association between response to albendazole treatment and ?-tubulin genotype frequencies in soil-transmitted helminths.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e44cbf31205287e0617b00ac4b72a93"><gtr:id>9e44cbf31205287e0617b00ac4b72a93</gtr:id><gtr:otherNames>Diawara A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>54622398bc4241.33561522</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93569C44-70A5-414E-8CCF-5BCF5212A585</gtr:id><gtr:title>West African Ebola epidemic after one year--slowing but not yet under control.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9080986dd2c4c98653e05a77311da9"><gtr:id>cf9080986dd2c4c98653e05a77311da9</gtr:id><gtr:otherNames>WHO Ebola Response Team</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5675de201dab5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C8A909B-633A-4A37-B541-1AAD075673B2</gtr:id><gtr:title>Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5b83975ee1b92118944038d86de6e28"><gtr:id>d5b83975ee1b92118944038d86de6e28</gtr:id><gtr:otherNames>Chang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>56d5aa5cd93661.95220637</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EE9F2EE-7400-4F86-8FEF-3BE7FEFBD9B2</gtr:id><gtr:title>Diverse sources of C. difficile infection identified on whole-genome sequencing.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0a8aea65a2ad062c34fe13f676541cc"><gtr:id>c0a8aea65a2ad062c34fe13f676541cc</gtr:id><gtr:otherNames>Eyre DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_13908_28_24066741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA51E2DF-B8F8-46FF-8018-2EE301579547</gtr:id><gtr:title>Estimating Dengue Transmission Intensity from Case-Notification Data from Multiple Countries.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e52f7e4d1b169efc084463f3d538f083"><gtr:id>e52f7e4d1b169efc084463f3d538f083</gtr:id><gtr:otherNames>Imai N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>585d6296c1c011.62009008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75F03D47-19AB-4938-8DEC-3760322863A9</gtr:id><gtr:title>Share2Quit: Web-Based Peer-Driven Referrals for Smoking Cessation.</gtr:title><gtr:parentPublicationTitle>JMIR research protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/226f13d6ff3fd47eb1a099ddce057fd1"><gtr:id>226f13d6ff3fd47eb1a099ddce057fd1</gtr:id><gtr:otherNames>Sadasivam RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1929-0748</gtr:issn><gtr:outcomeId>54622399df1547.07283001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D047545A-6DFF-46F0-A6BC-820AC07233FB</gtr:id><gtr:title>Estimating the Severity and Subclinical Burden of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fd203c4935e89040e4c79986f1bdbcd"><gtr:id>1fd203c4935e89040e4c79986f1bdbcd</gtr:id><gtr:otherNames>Lessler J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>56d5aa5c7da790.34979702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D890E8C-A752-41BE-B26D-BF1BE324F97B</gtr:id><gtr:title>Phylogenetic evidence for a mild H1 pandemic in the early 1900s.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfb5062b3b74deb6e922dc6a4250846e"><gtr:id>bfb5062b3b74deb6e922dc6a4250846e</gtr:id><gtr:otherNames>Riley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>546223a12f3838.08036751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E677080-5558-4410-B8F5-67F08058D67E</gtr:id><gtr:title>Key issues in the persistence of poliomyelitis in Nigeria: a case-control study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdaf6f773b6a94d33c43e43a06821d61"><gtr:id>cdaf6f773b6a94d33c43e43a06821d61</gtr:id><gtr:otherNames>Mangal TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>546223a493c2f0.57218375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42DEC892-77C0-4AA9-87E2-2CA161CF9D2C</gtr:id><gtr:title>Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fcbd32de9119cc0a6082e9bf29ca541"><gtr:id>3fcbd32de9119cc0a6082e9bf29ca541</gtr:id><gtr:otherNames>Fraser C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>585d609e2f5d28.68353963</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF5DDF4C-5245-44A0-83E5-46CDA941BDE1</gtr:id><gtr:title>Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12d9c8174126a7d51905d8b071c61ba6"><gtr:id>12d9c8174126a7d51905d8b071c61ba6</gtr:id><gtr:otherNames>Keebler D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>546223a422b7b3.50445024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6123FCC-F55B-4FCE-B2DC-6E70CF7CEB26</gtr:id><gtr:title>Brief literature review for the WHO global influenza research agenda--highly pathogenic avian influenza H5N1 risk in humans.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f919f6ab9ec769ab2d5c25bd7250cf7c"><gtr:id>f919f6ab9ec769ab2d5c25bd7250cf7c</gtr:id><gtr:otherNames>Van Kerkhove MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn><gtr:outcomeId>pm_13908_28_24034480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>098CC525-FDB1-41B7-B173-88FA40565F45</gtr:id><gtr:title>How can we get close to zero? The potential contribution of biomedical prevention and the investment framework towards an effective response to HIV.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60b098bdeaa414a427b6827edf647f7a"><gtr:id>60b098bdeaa414a427b6827edf647f7a</gtr:id><gtr:otherNames>Stover J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d41e8db097d4.69988966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD24C6A6-2028-486C-80B1-894690E815D3</gtr:id><gtr:title>Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological Frameworks.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76f3dc26699f80a6e4d904c6887434cf"><gtr:id>76f3dc26699f80a6e4d904c6887434cf</gtr:id><gtr:otherNames>Wiseman V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>56d44b746375b9.49118530</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF6F6591-E363-41E1-9731-F967E0F4646C</gtr:id><gtr:title>Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational Study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63906b01248a2d2c2c6b91dad43ada70"><gtr:id>63906b01248a2d2c2c6b91dad43ada70</gtr:id><gtr:otherNames>International Ebola Response Team</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>585d3e1ac5f822.10896991</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1099631-47AE-42F8-B11B-6894394DEE09</gtr:id><gtr:title>Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/165c65436f9c7d1b1b589425be85822a"><gtr:id>165c65436f9c7d1b1b589425be85822a</gtr:id><gtr:otherNames>Hastings DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>585d63b4093300.52120924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB720CA1-FFA1-44FD-A863-6E340171E7C0</gtr:id><gtr:title>Bovine Tuberculosis Risk Factors for British Herds Before and After the 2001 Foot-and-Mouth Epidemic: What have we Learned from the TB99 and CCS2005 Studies?</gtr:title><gtr:parentPublicationTitle>Transboundary and emerging diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546c56752ed4a0defad02dc1e949b957"><gtr:id>546c56752ed4a0defad02dc1e949b957</gtr:id><gtr:otherNames>Vial F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1865-1674</gtr:issn><gtr:outcomeId>546223a74ee889.48460153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B06F116-8B2E-4E56-A46F-299B998B7469</gtr:id><gtr:title>Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4f8fba304c35dd62dbda644b9b48af2"><gtr:id>b4f8fba304c35dd62dbda644b9b48af2</gtr:id><gtr:otherNames>Kapulu MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56d41e8ae351a2.60697538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A680FC7-2897-47D7-9CA4-CE0923F5DD70</gtr:id><gtr:title>High levels of antimicrobial resistance among escherichia coli isolates from livestock farms and synanthropic rats and shrews in the Mekong Delta of Vietnam.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dff7dc5675a5ba804b07eb749677430"><gtr:id>6dff7dc5675a5ba804b07eb749677430</gtr:id><gtr:otherNames>Nhung NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn><gtr:outcomeId>585d60bd384fe5.57717345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0ED1EE92-9F21-4BB7-9D83-68E7B6A90DA4</gtr:id><gtr:title>Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development.</gtr:title><gtr:parentPublicationTitle>International journal of obstetric anesthesia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10ef8bad911c7306deddd60d7ec0d2ca"><gtr:id>10ef8bad911c7306deddd60d7ec0d2ca</gtr:id><gtr:otherNames>Meara JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-289X</gtr:issn><gtr:outcomeId>56d41e8223ff63.75689573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63FBDFEC-3023-4010-A035-82F686D95114</gtr:id><gtr:title>Detectable signals of episodic risk effects on acute HIV transmission: strategies for analyzing transmission systems using genetic data.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeee68738320383a2640ad36e778d7b3"><gtr:id>aeee68738320383a2640ad36e778d7b3</gtr:id><gtr:otherNames>Alam SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>54622397ebb785.33300954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2680CCE0-BF62-40B9-96B5-B808C93DB1C8</gtr:id><gtr:title>Badgers prefer cattle pasture but avoid cattle: implications for bovine tuberculosis control.</gtr:title><gtr:parentPublicationTitle>Ecology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f1d8b8b66b771183e09eafe739eea39"><gtr:id>5f1d8b8b66b771183e09eafe739eea39</gtr:id><gtr:otherNames>Woodroffe R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1461-023X</gtr:issn><gtr:outcomeId>585d6043a17b50.85656554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BCD3D0A-2F3D-4076-A61D-06CEF9941BDE</gtr:id><gtr:title>Associations between Season and Gametocyte Dynamics in Chronic Plasmodium falciparum Infections.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7e694f1d5049130e0f3ae0a95f9050"><gtr:id>bb7e694f1d5049130e0f3ae0a95f9050</gtr:id><gtr:otherNames>Gadalla AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>588b5ddc8f09c1.94578045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>996ACD67-0AB7-476F-B30E-AFFCE8AB882D</gtr:id><gtr:title>Ebola Virus Disease among Male and Female Persons in West Africa.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9080986dd2c4c98653e05a77311da9"><gtr:id>cf9080986dd2c4c98653e05a77311da9</gtr:id><gtr:otherNames>WHO Ebola Response Team</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>56d446493f8b30.64194768</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42DD6CD6-9461-4F3D-BA4C-91A355ACD1F4</gtr:id><gtr:title>Badger responses to small-scale culling may compromise targeted control of bovine tuberculosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18506ab07d82c9ee62584cc125c82bbc"><gtr:id>18506ab07d82c9ee62584cc125c82bbc</gtr:id><gtr:otherNames>Bielby J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>546223a15298f3.75320544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4740C70A-A2B0-47E9-B0C5-6EFABE038028</gtr:id><gtr:title>The Global Drug Facility and its role in the market for tuberculosis drugs.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27982b3efb61f19f3555dc13dc24d6b9"><gtr:id>27982b3efb61f19f3555dc13dc24d6b9</gtr:id><gtr:otherNames>Arinaminpathy N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54622398942649.84201469</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BAFA5A5-0A5F-4B39-91E2-DE02E6815447</gtr:id><gtr:title>Vaccine approaches to malaria control and elimination: Insights from mathematical models.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f56584c638d4ce39ec15347d619b6f1"><gtr:id>8f56584c638d4ce39ec15347d619b6f1</gtr:id><gtr:otherNames>White MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56d41e79cd3bb8.80556274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29572627-102E-4A9B-ADD3-B2197C48AD07</gtr:id><gtr:title>Plasmodium falciparum mitochondrial genetic diversity exhibits isolation-by-distance patterns supporting a sub-Saharan African origin.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c0629febd948c0bea15ec131d237b2f"><gtr:id>3c0629febd948c0bea15ec131d237b2f</gtr:id><gtr:otherNames>Tanabe K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>585d59e943a2d7.60097651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2583979D-75F3-4E53-9C46-11033C8D0322</gtr:id><gtr:title>HIV-1 transmission during early infection in men who have sex with men: a phylodynamic analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a65aa60d956f1da3c46cfe9f95a31f"><gtr:id>29a65aa60d956f1da3c46cfe9f95a31f</gtr:id><gtr:otherNames>Volz EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5462239c6f3091.12860956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CA288FA-7A74-4513-AF7B-036CBC35DFA1</gtr:id><gtr:title>Seasonal PrEP for partners of migrant miners in southern Mozambique: a highly focused PrEP intervention.</gtr:title><gtr:parentPublicationTitle>Journal of the International AIDS Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c139da6e5680a1450192925d0a9e9142"><gtr:id>c139da6e5680a1450192925d0a9e9142</gtr:id><gtr:otherNames>Cremin I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1758-2652</gtr:issn><gtr:outcomeId>56d41e8ebf45a5.91803311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B036F08E-C29C-45C5-8FEC-4E86ADB5B259</gtr:id><gtr:title>Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df45bbde2fa354f91b34a4853de41aac"><gtr:id>df45bbde2fa354f91b34a4853de41aac</gtr:id><gtr:otherNames>Eaton JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>56d41e8cd4d9d2.90744907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D1E8296-88A4-4458-8092-7381960C09DA</gtr:id><gtr:title>Using modeling to inform international guidelines for antiretroviral treatment.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47920c0acbc786b9526f10999fa6b48c"><gtr:id>47920c0acbc786b9526f10999fa6b48c</gtr:id><gtr:otherNames>Hallett TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>5462239e164592.40471878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C1385F3-6D96-47DC-9971-7B53EC9C3885</gtr:id><gtr:title>Evaluating the impact of pulse oximetry on childhood pneumonia mortality in resource-poor settings.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56c6f545f995909f32ad89fd5e9d6726"><gtr:id>56c6f545f995909f32ad89fd5e9d6726</gtr:id><gtr:otherNames>Floyd J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d41e7ac67322.10464608</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5AE5DEB-3AD5-4A09-B0C3-26CC5D398F8F</gtr:id><gtr:title>'Pre-entry screening for tuberculosis' commentary: authors' response.</gtr:title><gtr:parentPublicationTitle>Pathogens and global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bb6149dd56f801d75cf1d49c110c647"><gtr:id>1bb6149dd56f801d75cf1d49c110c647</gtr:id><gtr:otherNames>Aldridge RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2047-7724</gtr:issn><gtr:outcomeId>5675e8efad688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4919403-0953-4DDB-8B83-7FE0958E0AD2</gtr:id><gtr:title>The Ballseye programme: a mixed-methods programme of research in traditional sexual health and alternative community settings to improve the sexual health of men in the UK</gtr:title><gtr:parentPublicationTitle>Programme Grants for Applied Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77fd56d4e7327863ca5edf7da7ef39b8"><gtr:id>77fd56d4e7327863ca5edf7da7ef39b8</gtr:id><gtr:otherNames>Estcourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>588b5e4e9aa8d8.84576968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F23AAABF-C11E-4138-815D-469D89DF5FD4</gtr:id><gtr:title>Risk factors for UK Plasmodium falciparum cases.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/027454f475c9478478c151d850908532"><gtr:id>027454f475c9478478c151d850908532</gtr:id><gtr:otherNames>Pinsent A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>546223a3bb06a5.51419018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C08B9D7-75C2-4132-9513-118266A95A2A</gtr:id><gtr:title>Transmission Potential of Influenza A(H7N9) Virus, China, 2013-2014.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f741f76c2b1d78183e956abc23d9da33"><gtr:id>f741f76c2b1d78183e956abc23d9da33</gtr:id><gtr:otherNames>Kucharski AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>56d41e7d738cf9.03774813</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6E9721D-B4D5-4D0E-9DA3-0160708C096A</gtr:id><gtr:title>Public health. Measuring the path toward malaria elimination.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38bdeaa71df425665fb03a0331c8d987"><gtr:id>38bdeaa71df425665fb03a0331c8d987</gtr:id><gtr:otherNames>Churcher TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>546223a178d836.65158650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6D617E7-829A-43E9-9BC2-D73E1A8D30D2</gtr:id><gtr:title>The potential impact of improving appropriate treatment for fever on malaria and non-malarial febrile illness management in under-5s: a decision-tree modelling approach.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b08b4eee2ddf705ac85a1e9c3666af9f"><gtr:id>b08b4eee2ddf705ac85a1e9c3666af9f</gtr:id><gtr:otherNames>Rao VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23922770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15657D16-8C2C-473C-B839-A350F8CAC24E</gtr:id><gtr:title>HIV-1 Sequence Data Coverage in Central East Africa from 1959 to 2013.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3a46d7d5e0e19d078669eb91c52bbec"><gtr:id>a3a46d7d5e0e19d078669eb91c52bbec</gtr:id><gtr:otherNames>Lamers SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn><gtr:outcomeId>585d5d21736117.04044744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1900AAA3-8B2C-449C-BEC4-3DBFE6E505B4</gtr:id><gtr:title>Intra-Weekly Variations of Influenza-Like Illness in Military Populations.</gtr:title><gtr:parentPublicationTitle>Military medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08eaa1b927bdf88d6c82651d9afc97a1"><gtr:id>08eaa1b927bdf88d6c82651d9afc97a1</gtr:id><gtr:otherNames>Riley P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0026-4075</gtr:issn><gtr:outcomeId>585d644cd05fe6.59256907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>076C695F-F728-4553-86A1-8126D9B04FBC</gtr:id><gtr:title>Prospective use of whole genome sequencing (WGS) detected a multi-country outbreak of Salmonella Enteritidis.</gtr:title><gtr:parentPublicationTitle>Epidemiology and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93367b2ac1a92c79612614ed269ba568"><gtr:id>93367b2ac1a92c79612614ed269ba568</gtr:id><gtr:otherNames>Inns T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-2688</gtr:issn><gtr:outcomeId>588b593e4172f3.98075828</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D506B229-C3BC-4690-A76C-C065030BCEBB</gtr:id><gtr:title>Impact and Cost-Effectiveness of Point-Of-Care CD4 Testing on the HIV Epidemic in South Africa.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0e826191eae3c163aed55713a024123"><gtr:id>d0e826191eae3c163aed55713a024123</gtr:id><gtr:otherNames>Heffernan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d62ef46a635.97519083</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09D6E96B-96F1-4E5D-ADA2-C0B6F829C7B4</gtr:id><gtr:title>Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study.</gtr:title><gtr:parentPublicationTitle>Journal of the International AIDS Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/985d46bf527299dc8a21e90d4d50d52d"><gtr:id>985d46bf527299dc8a21e90d4d50d52d</gtr:id><gtr:otherNames>Nichols BE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1758-2652</gtr:issn><gtr:outcomeId>585d645171d541.24253165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F364EF2-3962-4E73-93E6-E9BB00DFCB37</gtr:id><gtr:title>Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e0285b810ae1bc2fb86c0fdd6a8e077"><gtr:id>9e0285b810ae1bc2fb86c0fdd6a8e077</gtr:id><gtr:otherNames>Chemaitelly H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_13908_28_23079805</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC22FD89-15C2-4876-AE58-FAFDB90E7413</gtr:id><gtr:title>Unraveling the drivers of MERS-CoV transmission.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13378166d22af7a7ca5b1f192611863"><gtr:id>b13378166d22af7a7ca5b1f192611863</gtr:id><gtr:otherNames>Cauchemez S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>585d57b862a194.65963605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6588C39B-7FB2-4C01-89EB-E02B6EEA6F73</gtr:id><gtr:title>Reductions in genetic diversity of Schistosoma mansoni populations under chemotherapeutic pressure: the effect of sampling approach and parasite population definition.</gtr:title><gtr:parentPublicationTitle>Acta tropica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe9b3847b46b91cd77a0db2e20b27cb0"><gtr:id>fe9b3847b46b91cd77a0db2e20b27cb0</gtr:id><gtr:otherNames>French MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-706X</gtr:issn><gtr:outcomeId>54622396dd57e6.81772352</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD5BD5FC-C7D8-47F4-B7AC-3E8571778CF0</gtr:id><gtr:title>Design of a Phase III cluster randomized trial to assess the efficacy and safety of a malaria transmission blocking vaccine.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4792ff1aa13d3632efdf277c03e88a00"><gtr:id>4792ff1aa13d3632efdf277c03e88a00</gtr:id><gtr:otherNames>Delrieu I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56d41e8b548fe4.11088570</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4906E7CE-1413-4FB2-B88B-FFF69835A039</gtr:id><gtr:title>The impact of pyrethroid resistance on the efficacy and effectiveness of bednets for malaria control in Africa.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38bdeaa71df425665fb03a0331c8d987"><gtr:id>38bdeaa71df425665fb03a0331c8d987</gtr:id><gtr:otherNames>Churcher TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>585d645ce3ed39.07989665</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F274CCC-3C3B-44E8-B6F7-828DF9F9A2B6</gtr:id><gtr:title>Bayesian reconstruction of disease outbreaks by combining epidemiologic and genomic data.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/564b3b1fb34e1a022612ae9017c16220"><gtr:id>564b3b1fb34e1a022612ae9017c16220</gtr:id><gtr:otherNames>Jombart T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>5462239d962f48.48826256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DAF92D0-31DD-4CD6-9946-450BCED309AA</gtr:id><gtr:title>Treatment-seeking rates in malaria endemic countries.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fa8fa69456ff93f8064916155707c41"><gtr:id>0fa8fa69456ff93f8064916155707c41</gtr:id><gtr:otherNames>Battle KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>588b5cf1c2f987.05036229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C44AEF2-6929-47D1-A104-450E1E725753</gtr:id><gtr:title>Patterns and dynamics of genetic diversity in Plasmodium falciparum: what past human migrations tell us about malaria.</gtr:title><gtr:parentPublicationTitle>Parasitology international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93899a2adbb8b788bb571180c7174d1e"><gtr:id>93899a2adbb8b788bb571180c7174d1e</gtr:id><gtr:otherNames>Mita T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1383-5769</gtr:issn><gtr:outcomeId>585d59fe3abb19.62296884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C494A4C-ADC2-4957-88A0-970697A6C897</gtr:id><gtr:title>Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d8bf33edf1e0a1f782a51976c3c6ed7"><gtr:id>2d8bf33edf1e0a1f782a51976c3c6ed7</gtr:id><gtr:otherNames>Lapidus N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23613718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15C11F31-1D37-496A-B626-F7C5D7605B7B</gtr:id><gtr:title>The potential impact of routine immunization with inactivated poliovirus vaccine on wild-type or vaccine-derived poliovirus outbreaks in a posteradication setting.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdaf6f773b6a94d33c43e43a06821d61"><gtr:id>cdaf6f773b6a94d33c43e43a06821d61</gtr:id><gtr:otherNames>Mangal TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>pm_13908_28_24100955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>402ACA9C-C988-4892-9777-27216DCB7DF4</gtr:id><gtr:title>Community-based evaluation of immigrant tuberculosis screening using interferon ? release assays and tuberculin skin testing: observational study and economic analysis.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bec628b81c50d32f8d46e0bab6dcc65f"><gtr:id>bec628b81c50d32f8d46e0bab6dcc65f</gtr:id><gtr:otherNames>Pareek M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_13908_28_22693179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D922D1CD-5DBF-4FBE-B95A-9F0B14C558C8</gtr:id><gtr:title>Can field-based mosquito feeding assays be used for evaluating transmission-blocking interventions?</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/257135c67b585b044c8c4d0cf4577d5b"><gtr:id>257135c67b585b044c8c4d0cf4577d5b</gtr:id><gtr:otherNames>Bousema T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn><gtr:outcomeId>546223978a5cf8.66469497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE7AF0A9-0E11-4CDA-A007-F4CD04132C8F</gtr:id><gtr:title>Evolutionary epidemiology: preparing for an age of genomic plenty.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/481c6c5b334649dd75673417a87f825b"><gtr:id>481c6c5b334649dd75673417a87f825b</gtr:id><gtr:otherNames>Pybus OG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>pm_13908_28_23382418</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>983104BD-D1BF-4F33-BFF9-F2EEA87B533D</gtr:id><gtr:title>Progressive genomic convergence of two Helicobacter pylori strains during mixed infection of a patient with chronic gastritis.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c5a0dcfb9248ab3b428acba57b7bfec"><gtr:id>5c5a0dcfb9248ab3b428acba57b7bfec</gtr:id><gtr:otherNames>Cao Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>546223a2731f86.59028982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6F0682E-5A1E-4ED5-A2C4-5A6235D3EFF7</gtr:id><gtr:title>Incorporating incidence information within the UNAIDS Estimation and Projection Package framework: a study based on simulated incidence assay data.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9743f1764abb97efe4123ec52059a045"><gtr:id>9743f1764abb97efe4123ec52059a045</gtr:id><gtr:otherNames>Bao L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>56d41e8ca59c31.35606165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D049BBFE-DC9C-4D95-A391-CC10036B1BF7</gtr:id><gtr:title>Population structure of Neisseria gonorrhoeae based on whole genome data and its relationship with antibiotic resistance.</gtr:title><gtr:parentPublicationTitle>PeerJ</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8893c6b163ead245e56da623288a56d6"><gtr:id>8893c6b163ead245e56da623288a56d6</gtr:id><gtr:otherNames>Ezewudo MN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d41e90961c59.88758569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B26CBFD-4922-43B4-9C4C-9A37A5FDA786</gtr:id><gtr:title>Sustainable HIV treatment in Africa through viral-load-informed differentiated care.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0347029edd25544ce2768050ff9b3d5c"><gtr:id>0347029edd25544ce2768050ff9b3d5c</gtr:id><gtr:otherNames>Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d41e8f2c25d4.83144374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B338CFAF-257E-48AC-B424-CD72265FD4C6</gtr:id><gtr:title>The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infants.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad477705d4c8966434296d200f476ba2"><gtr:id>ad477705d4c8966434296d200f476ba2</gtr:id><gtr:otherNames>Grassly NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>585d5a8c088494.61350487</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F65A6AF-302E-411D-B987-A486708021B5</gtr:id><gtr:title>Modeling the impact of interventions along the HIV continuum of care in Newark, New Jersey.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19b4d0ec83979c16ac082361a17c4cff"><gtr:id>19b4d0ec83979c16ac082361a17c4cff</gtr:id><gtr:otherNames>Birger RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5462239a9a4b86.59859888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>116F8F38-2084-4DB4-88C1-F95B073B54BF</gtr:id><gtr:title>The essential role of infection-detection technologies for malaria elimination and eradication.</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c8558ce1888b1dd78e9c0a60f3f02ea"><gtr:id>7c8558ce1888b1dd78e9c0a60f3f02ea</gtr:id><gtr:otherNames>Tietje K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn><gtr:outcomeId>585d5a170324e3.57747492</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E607202-14C8-4E04-B8C3-ED5ADF52F921</gtr:id><gtr:title>Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfd5dc2f22e7902f8275914f53086c75"><gtr:id>bfd5dc2f22e7902f8275914f53086c75</gtr:id><gtr:otherNames>John J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>546223a2eb6a80.85384018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>199C5C45-B30D-41D4-8425-FCB0EABAB24F</gtr:id><gtr:title>Recombination produces coherent bacterial species clusters in both core and accessory genomes.</gtr:title><gtr:parentPublicationTitle>Microbial genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8880ba3f89728781d9bdff5a8fca204"><gtr:id>c8880ba3f89728781d9bdff5a8fca204</gtr:id><gtr:otherNames>Marttinen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2057-5858</gtr:issn><gtr:outcomeId>56d5aa7010b253.89439443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39F98838-E7BB-4768-A231-0D00DE648ACD</gtr:id><gtr:title>Feature selection methods for identifying genetic determinants of host species in RNA viruses.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f47063ad237be224a24b1c05df0d1e5"><gtr:id>5f47063ad237be224a24b1c05df0d1e5</gtr:id><gtr:otherNames>Aguas R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>pm_13908_28_24130470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6681AB2-69FB-454B-9D6B-D7290B25C892</gtr:id><gtr:title>Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f56584c638d4ce39ec15347d619b6f1"><gtr:id>8f56584c638d4ce39ec15347d619b6f1</gtr:id><gtr:otherNames>White MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>56d41e7b323b32.44432621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>463810E2-FAB8-49BA-8760-98E37ECEFEE3</gtr:id><gtr:title>Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame.</gtr:title><gtr:parentPublicationTitle>Expert review of vaccines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7533d199dc05be90709dffd1cf0467"><gtr:id>6d7533d199dc05be90709dffd1cf0467</gtr:id><gtr:otherNames>Parker EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1476-0584</gtr:issn><gtr:outcomeId>56d41e83d1f661.08839630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E798B6F-61CE-49D2-8F89-DD58185E0956</gtr:id><gtr:title>Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a89abe3bbb378fda0bae27997ab36b2"><gtr:id>1a89abe3bbb378fda0bae27997ab36b2</gtr:id><gtr:otherNames>Ferguson NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>56d41e82e945f6.40731717</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89448DEF-28E3-4A32-A32A-8B685A77BF6C</gtr:id><gtr:title>International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE.</gtr:title><gtr:parentPublicationTitle>Clinical and vaccine immunology : CVI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f9116e1c85e2e30752be8b026cb75b5"><gtr:id>4f9116e1c85e2e30752be8b026cb75b5</gtr:id><gtr:otherNames>Laurie KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1556-679X</gtr:issn><gtr:outcomeId>585d60c22c52e5.87253720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5B08948-C788-4792-9DA5-084B6B6C167C</gtr:id><gtr:title>Role of energy sensor TlpD of Helicobacter pylori in gerbil colonization and genome analyses after adaptation in the gerbil.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79327142ced517240e08f81be09f48ea"><gtr:id>79327142ced517240e08f81be09f48ea</gtr:id><gtr:otherNames>Behrens W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>pm_13908_28_23836820</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27B694E5-6B62-4042-BFE4-0035657D7430</gtr:id><gtr:title>Chlamydiaceae Genomics Reveals Interspecies Admixture and the Recent Evolution of Chlamydia abortus Infecting Lower Mammalian Species and Humans.</gtr:title><gtr:parentPublicationTitle>Genome biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/769fe65e18f6a869f1a9f4f947b903b8"><gtr:id>769fe65e18f6a869f1a9f4f947b903b8</gtr:id><gtr:otherNames>Joseph SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-6653</gtr:issn><gtr:outcomeId>56d41e919e8d56.51395707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4213075B-25FF-416C-8DA4-5B08AE21E26F</gtr:id><gtr:title>Antiviral stockpiles for influenza pandemics from the household perspective: treatment alone versus treatment with prophylaxis.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8175113ca74119a646bc92f844a3c697"><gtr:id>8175113ca74119a646bc92f844a3c697</gtr:id><gtr:otherNames>Kwok KO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>pm_13908_28_23746802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EBAB8A9-F6C7-4692-8DFE-B6167EA78558</gtr:id><gtr:title>Longevity and determinants of protective humoral immunity after pandemic influenza infection.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a36a27fdba02f67bc73d13ae40289f36"><gtr:id>a36a27fdba02f67bc73d13ae40289f36</gtr:id><gtr:otherNames>Sridhar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>56d41e8a1a8532.65668531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD2E1841-2F79-4AFA-A2AF-0FC18EB8DB4A</gtr:id><gtr:title>The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a1ffb256ea1f8a75f52592d7011a432"><gtr:id>2a1ffb256ea1f8a75f52592d7011a432</gtr:id><gtr:otherNames>Zhang XS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f98698676c5a98</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>510F9EAC-407D-4413-9ECB-E726DAA05080</gtr:id><gtr:title>A generating function approach to HIV transmission with dynamic contact rates.</gtr:title><gtr:parentPublicationTitle>Mathematical modelling of natural phenomena</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf520788473038730237541d2398b3b5"><gtr:id>bf520788473038730237541d2398b3b5</gtr:id><gtr:otherNames>Romero-Severson EO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0973-5348</gtr:issn><gtr:outcomeId>585d5cbb6ea573.16261503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BA0F9D3-D478-4229-B79A-9E623E896EF5</gtr:id><gtr:title>Ecology, evolution and control of Chagas disease: a century of neglected modelling and a promising future.</gtr:title><gtr:parentPublicationTitle>Advances in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdf299f55c5901d10bccacda54118ce6"><gtr:id>cdf299f55c5901d10bccacda54118ce6</gtr:id><gtr:otherNames>Nouvellet P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0065-308X</gtr:issn><gtr:outcomeId>56d5aa5e6ce193.66446573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22837CF1-8C2D-4CFF-BAC4-3C8EFEE86E93</gtr:id><gtr:title>Mobile health (mHealth) approaches and lessons for increased performance and retention of community health workers in low- and middle-income countries: a review.</gtr:title><gtr:parentPublicationTitle>Journal of medical Internet research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14cae25a805b171c41b7fa79da33778a"><gtr:id>14cae25a805b171c41b7fa79da33778a</gtr:id><gtr:otherNames>K?llander K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1438-8871</gtr:issn><gtr:outcomeId>585d6c87d98a91.95603810</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BF72DBA-D485-4346-9516-79E22EFE68A1</gtr:id><gtr:title>Optimizing the precision of case fatality ratio estimates under the surveillance pyramid approach.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54df54fa1c48ae73d727d7d3624a2c58"><gtr:id>54df54fa1c48ae73d727d7d3624a2c58</gtr:id><gtr:otherNames>Pelat C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>585d5d42ae6965.30995448</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F73905DA-31F8-45E2-8A6F-B84003B81100</gtr:id><gtr:title>Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f56584c638d4ce39ec15347d619b6f1"><gtr:id>8f56584c638d4ce39ec15347d619b6f1</gtr:id><gtr:otherNames>White MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn><gtr:outcomeId>585d57ee898f99.51107571</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15B8954E-297E-4AEF-B4DC-DCDB39794AD6</gtr:id><gtr:title>Estimation of the Basic Reproductive Number and Mean Serial Interval of a Novel Pathogen in a Small, Well-Observed Discrete Population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fd3052f675ab3b1cce65819ff641463"><gtr:id>0fd3052f675ab3b1cce65819ff641463</gtr:id><gtr:otherNames>Wu KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d41e86ef8c81.81207585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48C77693-2FC3-4B55-9958-A8B74C177B74</gtr:id><gtr:title>Impact of Hepatitis C Treatment as Prevention for People Who Inject Drugs is sensitive to contact network structure.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1322e016fa9c313f9f2485c6118e351"><gtr:id>d1322e016fa9c313f9f2485c6118e351</gtr:id><gtr:otherNames>Metzig C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a361bd5c3fc43.96887028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37893C51-8526-41A0-9B1A-1F4A1D17A003</gtr:id><gtr:title>Challenges Presented by Re-Emerging Sexually Transmitted Infections in HIV Positive Men who have Sex with Men: An Observational Study of Lymphogranuloma Venereum in the UK.</gtr:title><gtr:parentPublicationTitle>Journal of AIDS &amp; clinical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adbe3ffb2cbf3812dbc1bbe1e09b62f0"><gtr:id>adbe3ffb2cbf3812dbc1bbe1e09b62f0</gtr:id><gtr:otherNames>R?nn M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>585d643ecf0530.83901240</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE993A96-1078-4689-B6A2-F83D84ABE1FC</gtr:id><gtr:title>Mobile elements drive recombination hotspots in the core genome of Staphylococcus aureus.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6711d112e031d4ba468eec992e8f0601"><gtr:id>6711d112e031d4ba468eec992e8f0601</gtr:id><gtr:otherNames>Everitt RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>546223a0d5e8d8.68679054</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C7AC9AB-E332-40F9-82B7-9EF32EFFCF14</gtr:id><gtr:title>Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc2870d741f94349c95a49719abb6d39"><gtr:id>bc2870d741f94349c95a49719abb6d39</gtr:id><gtr:otherNames>Wheelock A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23342121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>826E384D-17F4-4E6F-B359-71F2F6F3813B</gtr:id><gtr:title>Social contacts and the locations in which they occur as risk factors for influenza infection.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8175113ca74119a646bc92f844a3c697"><gtr:id>8175113ca74119a646bc92f844a3c697</gtr:id><gtr:otherNames>Kwok KO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn><gtr:outcomeId>546223a29ce9a2.97004078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F68B33CA-EDD7-492C-8512-0D9FCD4C8B34</gtr:id><gtr:title>Assessing the epidemiological effect of wolbachia for dengue control.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e60c0cab7666ed755fdcea39feae432"><gtr:id>8e60c0cab7666ed755fdcea39feae432</gtr:id><gtr:otherNames>Lambrechts L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>56d41e82506803.90221313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3EA03D4-66D6-4347-A1E2-AD8C8FCA56E1</gtr:id><gtr:title>A side door into care cascade for HIV-infected patients?</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47920c0acbc786b9526f10999fa6b48c"><gtr:id>47920c0acbc786b9526f10999fa6b48c</gtr:id><gtr:otherNames>Hallett TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>pm_13908_28_23764640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4061287-41C4-4D27-A8D1-C5219584574A</gtr:id><gtr:title>Assessing uncertainty in the burden of Hepatitis C Virus: comparison of estimated disease burden and treatment costs in the UK.</gtr:title><gtr:parentPublicationTitle>Journal of viral hepatitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db50163e9d6faf246c6431952dd5d26c"><gtr:id>db50163e9d6faf246c6431952dd5d26c</gtr:id><gtr:otherNames>Gubay F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1352-0504</gtr:issn><gtr:outcomeId>5a6f0647c77be6.41646804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA87876D-86FB-4FF2-BD1D-3613649134A4</gtr:id><gtr:title>Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad477705d4c8966434296d200f476ba2"><gtr:id>ad477705d4c8966434296d200f476ba2</gtr:id><gtr:otherNames>Grassly NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5462239f31e160.67550410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC440978-6768-44EE-9223-D2A8A03528B6</gtr:id><gtr:title>Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6f21bb337efdcec10855d91efd41df8"><gtr:id>a6f21bb337efdcec10855d91efd41df8</gtr:id><gtr:otherNames>Hontelez JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5462239aec83f9.99929844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>652F51BC-BFB5-4695-94A7-071B6090B1E2</gtr:id><gtr:title>Dynamics of genome change among Legionella species.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/769fe65e18f6a869f1a9f4f947b903b8"><gtr:id>769fe65e18f6a869f1a9f4f947b903b8</gtr:id><gtr:otherNames>Joseph SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d5c2b9610c1.35694905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>251BB422-0D04-4101-AB60-546B9FD85EB8</gtr:id><gtr:title>Multiple estimates of transmissibility for the 2009 influenza pandemic based on influenza-like-illness data from small US military populations.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08eaa1b927bdf88d6c82651d9afc97a1"><gtr:id>08eaa1b927bdf88d6c82651d9afc97a1</gtr:id><gtr:otherNames>Riley P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>pm_13908_28_23696723</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51FD1635-AF8D-48FA-972D-5051C323358B</gtr:id><gtr:title>Evolutionary history of the Clostridium difficile pathogenicity locus.</gtr:title><gtr:parentPublicationTitle>Genome biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/384f794748bc85c2fc08a066092b27a1"><gtr:id>384f794748bc85c2fc08a066092b27a1</gtr:id><gtr:otherNames>Dingle KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-6653</gtr:issn><gtr:outcomeId>5462239c466886.30225306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D21413D-D2E4-4E55-8C83-FDD04C49834A</gtr:id><gtr:title>High heritability is compatible with the broad distribution of set point viral load in HIV carriers.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78031c45c4819385754c81a8c0bcab45"><gtr:id>78031c45c4819385754c81a8c0bcab45</gtr:id><gtr:otherNames>Bonhoeffer S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56d41e7f213fb6.78885924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6D3C659-8C51-4A9B-A4E7-F8AA133C29E3</gtr:id><gtr:title>Phylodynamic inference for structured epidemiological models.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4dbd20029500a4687d6f828f5c6a2e9"><gtr:id>a4dbd20029500a4687d6f828f5c6a2e9</gtr:id><gtr:otherNames>Rasmussen DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>546223a0344c45.70832625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92945C63-0642-4E45-AB5B-E43BD6D6745F</gtr:id><gtr:title>Historical zoonoses and other changes in host tropism of Staphylococcus aureus, identified by phylogenetic analysis of a population dataset.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de2ae629721f1d63d5e9046feb25552f"><gtr:id>de2ae629721f1d63d5e9046feb25552f</gtr:id><gtr:otherNames>Shepheard MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23667472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59BB4E5A-261B-4A90-9E3D-D034AC689C68</gtr:id><gtr:title>Respiratory co-morbidities in people with HIV.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/869b1b9088a192a10571e20539225f70"><gtr:id>869b1b9088a192a10571e20539225f70</gtr:id><gtr:otherNames>Smit M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>585d5a8340c012.53822911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>339809AA-FC61-4468-87DA-6BCB39927993</gtr:id><gtr:title>A latent Markov modelling approach to the evaluation of circulating cathodic antigen strips for schistosomiasis diagnosis pre- and post-praziquantel treatment in Uganda.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1481951921c8df5f8f0ab0e8e5d84458"><gtr:id>1481951921c8df5f8f0ab0e8e5d84458</gtr:id><gtr:otherNames>Koukounari A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>5462239cc04a35.57165121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E021F008-DC47-4DB5-92A3-2FB2E5E58225</gtr:id><gtr:title>Within-host evolution of bacterial pathogens.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4561cf01b513731abf1179209f974d"><gtr:id>3b4561cf01b513731abf1179209f974d</gtr:id><gtr:otherNames>Didelot X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>56d41e92025f33.84535656</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98E81194-5313-440E-BA06-3841924FFC7F</gtr:id><gtr:title>Estimating the range of potential epidemiological impact of pre-exposure prophylaxis: run-away success or run-away failure?</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/991eb326f9097c61f435a7b3c0288b21"><gtr:id>991eb326f9097c61f435a7b3c0288b21</gtr:id><gtr:otherNames>Cremin ?</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>56d41e8e25cac2.14376141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC02B01F-9A65-43C8-A69A-5AD590026624</gtr:id><gtr:title>The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c139da6e5680a1450192925d0a9e9142"><gtr:id>c139da6e5680a1450192925d0a9e9142</gtr:id><gtr:otherNames>Cremin I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_13908_28_23296196</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9C7BAFA-1C7C-444B-9213-3849E1728A36</gtr:id><gtr:title>Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c48dd2b3b5c3d10dff7a6a1f13f8a3b"><gtr:id>2c48dd2b3b5c3d10dff7a6a1f13f8a3b</gtr:id><gtr:otherNames>GBD 2015 SDG Collaborators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>588b58e9c23f49.35221881</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5D18843-97D6-4F3C-BE77-0C544E5405A3</gtr:id><gtr:title>Multiannual patterns of influenza A transmission in Chinese live bird market systems.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4d60becc2050e924dc5302e034b97bc"><gtr:id>c4d60becc2050e924dc5302e034b97bc</gtr:id><gtr:otherNames>Pepin KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn><gtr:outcomeId>pm_13908_28_22458429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A893A97E-D57C-49A3-A4A9-F76AA556DB2E</gtr:id><gtr:title>Regular treatments of praziquantel do not impact on the genetic make-up of Schistosoma mansoni in Northern Senegal.</gtr:title><gtr:parentPublicationTitle>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0385ec0b8d95aaa468fdfc5be1bdf60e"><gtr:id>0385ec0b8d95aaa468fdfc5be1bdf60e</gtr:id><gtr:otherNames>Huyse T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1567-1348</gtr:issn><gtr:outcomeId>585d59dba0c186.10481638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64A8C4CF-28D0-4B03-A138-C1381188035E</gtr:id><gtr:title>A barrier to homologous recombination between sympatric strains of the cooperative soil bacterium Myxococcus xanthus.</gtr:title><gtr:parentPublicationTitle>The ISME journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78c2cd64992ff5aa0a2a1fa1d365e29d"><gtr:id>78c2cd64992ff5aa0a2a1fa1d365e29d</gtr:id><gtr:otherNames>Wielgoss S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1751-7362</gtr:issn><gtr:outcomeId>585d5b264827b3.64519729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCCCC661-CD8A-45B2-B9A3-467CBEF747B4</gtr:id><gtr:title>Development and future directions for the Joint United Nations Programme on HIV/AIDS estimates.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d66814e63753d82ca16869a696b2ed"><gtr:id>05d66814e63753d82ca16869a696b2ed</gtr:id><gtr:otherNames>Case KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>56d41e8d3f9a82.04775814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66B6E52F-3031-4A33-BD9E-9BD4829D42D8</gtr:id><gtr:title>New vaccine strategies to finish polio eradication.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad477705d4c8966434296d200f476ba2"><gtr:id>ad477705d4c8966434296d200f476ba2</gtr:id><gtr:otherNames>Grassly NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>56d41e84129073.86906252</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35A4E82F-E380-4DC5-9491-14FFE5433271</gtr:id><gtr:title>The relative clinical effectiveness and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections: a cluster randomised trial in primary care.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a04d981248aea7538648102550fcbd5"><gtr:id>9a04d981248aea7538648102550fcbd5</gtr:id><gtr:otherNames>Cassell JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>56d41e8629bfc1.08396407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32D867CE-EC00-4079-8BA5-720FCCDFD365</gtr:id><gtr:title>HIV-1 prevention with ART and PrEP: mathematical modeling insights into resistance, effectiveness, and public health impact.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47f29e652513a3e975b258aeca579f1c"><gtr:id>47f29e652513a3e975b258aeca579f1c</gtr:id><gtr:otherNames>Celum C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_13908_28_23570851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEBE9B33-BCAF-4AAE-9353-1170613AB8EC</gtr:id><gtr:title>The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29c8c2e55290f83c8645b954dd2ca494"><gtr:id>29c8c2e55290f83c8645b954dd2ca494</gtr:id><gtr:otherNames>Pretorius C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>5462239de22ac1.54712923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB1A18F0-0BA7-4244-B9DD-ADFDED85EBBB</gtr:id><gtr:title>Modelling Virus and Antibody Dynamics during Dengue Virus Infection Suggests a Role for Antibody in Virus Clearance.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c68817f93f554455e0f053b256b98c28"><gtr:id>c68817f93f554455e0f053b256b98c28</gtr:id><gtr:otherNames>Clapham HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>585d6270670dc8.23035414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98FC0C24-0E40-4B1F-9F34-7F6FB3069069</gtr:id><gtr:title>Co-circulation of influenza A virus strains and emergence of pandemic via reassortment: the role of cross-immunity.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a1ffb256ea1f8a75f52592d7011a432"><gtr:id>2a1ffb256ea1f8a75f52592d7011a432</gtr:id><gtr:otherNames>Zhang XS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>pm_13908_28_23438428</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>977D8248-FE1A-42F5-8684-84C33B0EB0D8</gtr:id><gtr:title>Developing and testing accelerated partner therapy for partner notification for people with genital Chlamydia trachomatis diagnosed in primary care: a pilot randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb172f98c3b3cae2335f97846123cefe"><gtr:id>cb172f98c3b3cae2335f97846123cefe</gtr:id><gtr:otherNames>Estcourt CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>585d587f843309.77674392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE82DAC4-981A-4FA2-BA5D-BF730D605CCA</gtr:id><gtr:title>The role of rapid diagnostics in managing Ebola epidemics.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdf299f55c5901d10bccacda54118ce6"><gtr:id>cdf299f55c5901d10bccacda54118ce6</gtr:id><gtr:otherNames>Nouvellet P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d41e7e746616.47598023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>255B3ABF-CFB2-4A16-99F8-C739B1206F3D</gtr:id><gtr:title>The design and statistical power of treatment re-infection studies of the association between pre-erythrocytic immunity and infection with Plasmodium falciparum.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f56584c638d4ce39ec15347d619b6f1"><gtr:id>8f56584c638d4ce39ec15347d619b6f1</gtr:id><gtr:otherNames>White MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_13908_28_23927576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4842BAF9-0B5D-4271-A0DF-20E1DB0A3CFB</gtr:id><gtr:title>Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modelling.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/033bdaf4c6cee76248b48b169f74c528"><gtr:id>033bdaf4c6cee76248b48b169f74c528</gtr:id><gtr:otherNames>Althaus CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>546223a7760bc6.14662045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>791A5A61-18EA-40AC-B4EF-3B260B242BBF</gtr:id><gtr:title>A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d36464595188fb3b03419b7352c84f4"><gtr:id>1d36464595188fb3b03419b7352c84f4</gtr:id><gtr:otherNames>Ruecker A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>546223a6034368.70574938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED43008A-26A6-4256-8CBF-80366A8D2F28</gtr:id><gtr:title>Estimating air temperature and its influence on malaria transmission across Africa.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d6e8ce16ad2fecd2f2f0b681fb82e91"><gtr:id>0d6e8ce16ad2fecd2f2f0b681fb82e91</gtr:id><gtr:otherNames>Garske T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23437143</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83B1C9CE-F54D-4EC4-969F-B949BAD01DE6</gtr:id><gtr:title>Inferring patterns of influenza transmission in swine from multiple streams of surveillance data.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d018dc6827a2df8bcfa9556d138a31f3"><gtr:id>d018dc6827a2df8bcfa9556d138a31f3</gtr:id><gtr:otherNames>Strelioff CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn><gtr:outcomeId>pm_13908_28_23658205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3A4293A-B7E4-4860-8FC0-8E715251C946</gtr:id><gtr:title>A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making.</gtr:title><gtr:parentPublicationTitle>Scientific data</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f919f6ab9ec769ab2d5c25bd7250cf7c"><gtr:id>f919f6ab9ec769ab2d5c25bd7250cf7c</gtr:id><gtr:otherNames>Van Kerkhove MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2052-4463</gtr:issn><gtr:outcomeId>56d41e7d123e13.54886182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7FDB1B1-6DF3-485D-9E85-ECE872E56FCB</gtr:id><gtr:title>Contact heterogeneity, rather than transmission efficiency, limits the emergence and spread of canine influenza virus.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4af449838a4924589ccfa8f068c17112"><gtr:id>4af449838a4924589ccfa8f068c17112</gtr:id><gtr:otherNames>Dalziel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>546223a6d0fc47.32376031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F62C4225-3A2E-4948-9A64-AEFFF8BB6C44</gtr:id><gtr:title>Departures from Cost-Effectiveness Recommendations: The Impact of Health System Constraints on Priority Setting</gtr:title><gtr:parentPublicationTitle>Health Systems &amp; Reform</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f44b1ce1958f5cdf22d383b94fe9337"><gtr:id>6f44b1ce1958f5cdf22d383b94fe9337</gtr:id><gtr:otherNames>Hauck K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d69c4d239f7.08408546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEE4F051-DADF-4BEF-BE76-2D47439AAC98</gtr:id><gtr:title>Key traveller groups of relevance to spatial malaria transmission: a survey of movement patterns in four sub-Saharan African countries.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f768e77bdb0f6ed61e52b8b25a383b"><gtr:id>c4f768e77bdb0f6ed61e52b8b25a383b</gtr:id><gtr:otherNames>Marshall JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>585d61d55b72a1.37165342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>861215EE-B54C-429F-BDA9-3788198B93B5</gtr:id><gtr:title>The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0041f4a356302586c7b023eb29481d03"><gtr:id>0041f4a356302586c7b023eb29481d03</gtr:id><gtr:otherNames>Flasche S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>588b5dba2a0833.43232581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8090F836-B807-4C37-9C42-FC86A7AD6E7B</gtr:id><gtr:title>Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study.</gtr:title><gtr:parentPublicationTitle>The lancet. HIV</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77e137722f01541e76220708b6f962e5"><gtr:id>77e137722f01541e76220708b6f962e5</gtr:id><gtr:otherNames>McGillen JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2352-3018</gtr:issn><gtr:outcomeId>585d5aafea76b1.60812262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0B0932C-A763-4A1B-B09B-E38E49756F2B</gtr:id><gtr:title>Epidemic Clones, Oceanic Gene Pools, and Eco-LD in the Free Living Marine Pathogen Vibrio parahaemolyticus.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0104f5eff142ccc0a3d38fde990ef71"><gtr:id>b0104f5eff142ccc0a3d38fde990ef71</gtr:id><gtr:otherNames>Cui Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>56d41e90bcab77.38797023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE2B201F-352E-4DA9-B40C-30060C39FCBC</gtr:id><gtr:title>The Global Drug Facility as an intervention in the market for tuberculosis drugs.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27982b3efb61f19f3555dc13dc24d6b9"><gtr:id>27982b3efb61f19f3555dc13dc24d6b9</gtr:id><gtr:otherNames>Arinaminpathy N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn><gtr:outcomeId>56d41e8536ceb4.18264295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1120AD7B-92FA-4D22-A188-F6D3ABCAA592</gtr:id><gtr:title>Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07eefe038ecfe88e29511c4d747f13cc"><gtr:id>07eefe038ecfe88e29511c4d747f13cc</gtr:id><gtr:otherNames>Turner HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>54622398441961.18923892</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAB8A810-2DA9-4866-A47A-AB095CF5A3D5</gtr:id><gtr:title>Mathematical modeling of the West Africa Ebola epidemic.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3347d5bf9d3b6c2865347b73ca9eed6"><gtr:id>c3347d5bf9d3b6c2865347b73ca9eed6</gtr:id><gtr:otherNames>Chretien JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>56d41e87cd7038.13035215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF9D7648-18D0-4288-A264-CF54A626205C</gtr:id><gtr:title>Ebola virus disease among children in West Africa.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9080986dd2c4c98653e05a77311da9"><gtr:id>cf9080986dd2c4c98653e05a77311da9</gtr:id><gtr:otherNames>WHO Ebola Response Team</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5675e14d2e775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>929BAD4A-0B7B-4BF1-834B-F800D17C2E5F</gtr:id><gtr:title>ClonalFrameML: efficient inference of recombination in whole bacterial genomes.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4561cf01b513731abf1179209f974d"><gtr:id>3b4561cf01b513731abf1179209f974d</gtr:id><gtr:otherNames>Didelot X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>56d41e8f9ccc23.22337579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72E129DD-92C8-41E2-8A39-F4B7105F8575</gtr:id><gtr:title>Assessing the global threat from Zika virus.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fd203c4935e89040e4c79986f1bdbcd"><gtr:id>1fd203c4935e89040e4c79986f1bdbcd</gtr:id><gtr:otherNames>Lessler J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>585d60ad7393a1.15887836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC88FDBC-46A9-419A-91EE-45403382D803</gtr:id><gtr:title>Phylodynamic analysis of ebola virus in the 2014 sierra leone epidemic.</gtr:title><gtr:parentPublicationTitle>PLoS currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d444279f286a49767168a388a92189e0"><gtr:id>d444279f286a49767168a388a92189e0</gtr:id><gtr:otherNames>Volz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-3999</gtr:issn><gtr:outcomeId>585d625b4a8f24.83880182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>967B6124-E49D-409D-B8A4-BE30EA748FD1</gtr:id><gtr:title>Priorities for action on the social determinants of health: Empirical evidence on the strongest associations with life expectancy in 54 low-income countries, 1990-2012.</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f44b1ce1958f5cdf22d383b94fe9337"><gtr:id>6f44b1ce1958f5cdf22d383b94fe9337</gtr:id><gtr:otherNames>Hauck K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>585d5a23b6a9b4.20712532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>087326C2-D055-4015-860E-A49B4984F4DB</gtr:id><gtr:title>The Incidence Patterns Model to Estimate the Distribution of New HIV Infections in Sub-Saharan Africa: Development and Validation of a Mathematical Model.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aefe390a9026dd555662fa9a988db3ad"><gtr:id>aefe390a9026dd555662fa9a988db3ad</gtr:id><gtr:otherNames>B?rquez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>585d6280434c62.38110149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AEB8E69-EA4B-405F-8977-4B62DDF57641</gtr:id><gtr:title>Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05292009361ad17b2c8c65722bc5cf4a"><gtr:id>05292009361ad17b2c8c65722bc5cf4a</gtr:id><gtr:otherNames>Eldholm V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>585d645f926225.98874569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>452A5376-FC57-428B-9E79-CCD3890D2D81</gtr:id><gtr:title>Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4b613d29afebcecaee6f1650e5734c6"><gtr:id>b4b613d29afebcecaee6f1650e5734c6</gtr:id><gtr:otherNames>Subramanian R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>588b5da9ee56a8.40606404</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7CA07A4-1FE7-4C6B-B421-B43EB8D6C361</gtr:id><gtr:title>Statistical algorithms for early detection of the annual influenza peak season in Hong Kong using sentinel surveillance data.</gtr:title><gtr:parentPublicationTitle>Hong Kong medical journal = Xianggang yi xue za zhi</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1eab34052d6e07d2c8b4adbc71386dd8"><gtr:id>1eab34052d6e07d2c8b4adbc71386dd8</gtr:id><gtr:otherNames>Cowling BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1024-2708</gtr:issn><gtr:outcomeId>pm_13908_28_23775178</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40221712-EC77-4B5E-AF8A-3D82BD68AAA8</gtr:id><gtr:title>Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f51342f6c7c83db2e5ba87a366a48f4a"><gtr:id>f51342f6c7c83db2e5ba87a366a48f4a</gtr:id><gtr:otherNames>Cairns ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56d41e7be46df0.79897105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E2FB140-EB1C-436F-8644-94081D5956A5</gtr:id><gtr:title>Policy: Badger-cull statistics carry uncertainty.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7c5cc40712da27e4422531c60624f4a"><gtr:id>b7c5cc40712da27e4422531c60624f4a</gtr:id><gtr:otherNames>Donnelly C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>546223991518f4.48414757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A947CB2E-1EA9-42C9-8852-47D91A429C3E</gtr:id><gtr:title>Contact diaries versus wearable proximity sensors in measuring contact patterns at a conference: method comparison and participants' attitudes.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c31d9740bcc0e01f94e6df1eaba962b"><gtr:id>7c31d9740bcc0e01f94e6df1eaba962b</gtr:id><gtr:otherNames>Smieszek T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>585d3bc9b45105.34102217</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F6BA01C-D5DC-489E-8E1A-160C3472BD30</gtr:id><gtr:title>Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3de28e6626628d1ba178bed34daf818"><gtr:id>a3de28e6626628d1ba178bed34daf818</gtr:id><gtr:otherNames>Pons-Salort M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>585d3e0fce7ab0.01609795</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B748CAB-EF74-464D-BD1A-731C5FD147CF</gtr:id><gtr:title>Embracing different approaches to estimating HIV incidence, prevalence and mortality.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47920c0acbc786b9526f10999fa6b48c"><gtr:id>47920c0acbc786b9526f10999fa6b48c</gtr:id><gtr:otherNames>Hallett TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>56d41e8d7a8495.48466750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>551679A5-174A-43BA-8D99-FD28C8A78343</gtr:id><gtr:title>Overcoming health systems barriers to successful malaria treatment.</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b08b4eee2ddf705ac85a1e9c3666af9f"><gtr:id>b08b4eee2ddf705ac85a1e9c3666af9f</gtr:id><gtr:otherNames>Rao VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn><gtr:outcomeId>pm_13908_28_23415933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BD07114-19BA-4106-B44A-6FF2630FAE54</gtr:id><gtr:title>The RooPfs study to assess whether improved housing provides additional protection against clinical malaria over current best practice in The Gambia: study protocol for a randomized controlled study and ancillary studies.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1241935f5c04a80d4ca1fc5ffc5bc53a"><gtr:id>1241935f5c04a80d4ca1fc5ffc5bc53a</gtr:id><gtr:otherNames>Pinder M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>585d61f6704c83.83891185</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31F2B5A2-C3A0-46E2-8C23-689736E7941B</gtr:id><gtr:title>A novel multiple-stage antimalarial agent that inhibits protein synthesis.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bddd27fab3c92cfdde83c801a3bc1ce1"><gtr:id>bddd27fab3c92cfdde83c801a3bc1ce1</gtr:id><gtr:otherNames>Baraga?a B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d41e8ab065f1.73747566</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8211498-E8EA-4681-9968-0F1C7290FA2A</gtr:id><gtr:title>A high-resolution genomic analysis of multidrug-resistant hospital outbreaks of Klebsiella pneumoniae.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa98d2c61ca79763afee57f247a20ba1"><gtr:id>fa98d2c61ca79763afee57f247a20ba1</gtr:id><gtr:otherNames>Chung The H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>585d63372c7713.89205435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAACBCA4-7FCD-4402-BC71-4872ABDE0287</gtr:id><gtr:title>Improving pandemic influenza risk assessment.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0b8e1725c014c1320e991217b4813eb"><gtr:id>b0b8e1725c014c1320e991217b4813eb</gtr:id><gtr:otherNames>Russell CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>546223a6aa6745.50800223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDC16E1E-9A75-40B2-964C-B2BCB7916A6C</gtr:id><gtr:title>Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9080986dd2c4c98653e05a77311da9"><gtr:id>cf9080986dd2c4c98653e05a77311da9</gtr:id><gtr:otherNames>WHO Ebola Response Team</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>546223a5a21f71.67193588</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36812938-A1A7-4D41-83BD-7C114CF0E2DE</gtr:id><gtr:title>Assessing the impact of next-generation rapid diagnostic tests on Plasmodium falciparum malaria elimination strategies.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/730ae9ad8c71b39ddf56c92de27a5308"><gtr:id>730ae9ad8c71b39ddf56c92de27a5308</gtr:id><gtr:otherNames>Slater HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d41e7a6f0fc9.55848187</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06DB2D14-A111-44CB-8561-20B84F95A012</gtr:id><gtr:title>Estimating Potential Incidence of MERS-CoV Associated with Hajj Pilgrims to Saudi Arabia, 2014.</gtr:title><gtr:parentPublicationTitle>PLoS currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fd203c4935e89040e4c79986f1bdbcd"><gtr:id>1fd203c4935e89040e4c79986f1bdbcd</gtr:id><gtr:otherNames>Lessler J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-3999</gtr:issn><gtr:outcomeId>56d41e7ccf8c61.87556494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED6DD1D8-58DE-4112-9733-86654F8CA0C3</gtr:id><gtr:title>A model of parity-dependent immunity to placental malaria.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/256159da0b605caed5f2456efb37ed15"><gtr:id>256159da0b605caed5f2456efb37ed15</gtr:id><gtr:otherNames>Walker PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_13908_28_23511473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E378DFF-68FC-4B74-AB32-B7C11887BA12</gtr:id><gtr:title>A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f56584c638d4ce39ec15347d619b6f1"><gtr:id>8f56584c638d4ce39ec15347d619b6f1</gtr:id><gtr:otherNames>White MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>546223a2c354d4.68429891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD4D2961-88FE-4FC5-A49A-88DB2A9C16C9</gtr:id><gtr:title>Editorial Commentary: Pediatric Norovirus in Developing Countries: A Picture Slowly Comes Into Focus.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2220da6152370f5e21a31e22ab4863f9"><gtr:id>2220da6152370f5e21a31e22ab4863f9</gtr:id><gtr:otherNames>Lopman BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>585d5d6178dd90.15193028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4F4F8A4-C6DB-457D-993E-0AF2F5BEEF95</gtr:id><gtr:title>Models for measuring anthelmintic drug efficacy for parasitologists.</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/387c0c1157f05fb17c3c673ecd50d8fa"><gtr:id>387c0c1157f05fb17c3c673ecd50d8fa</gtr:id><gtr:otherNames>Walker M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn><gtr:outcomeId>546223a523d812.14682607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24D58887-58F6-4F76-9814-EE2E66A95FCB</gtr:id><gtr:title>Genetic control of Aedes aegypti: data-driven modelling to assess the effect of releasing different life stages and the potential for long-term suppression.</gtr:title><gtr:parentPublicationTitle>Parasites &amp; vectors</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/345af6961b3dbf1d96b57a132e3e61f3"><gtr:id>345af6961b3dbf1d96b57a132e3e61f3</gtr:id><gtr:otherNames>Winskill P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1756-3305</gtr:issn><gtr:outcomeId>5462239eaf6ec9.19412160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD15E3ED-41F0-49BA-A3E6-DD29FC482A75</gtr:id><gtr:title>Effects of influenza antivirals on individual and population immunity over many epidemic waves.</gtr:title><gtr:parentPublicationTitle>Epidemiology and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4d60becc2050e924dc5302e034b97bc"><gtr:id>c4d60becc2050e924dc5302e034b97bc</gtr:id><gtr:otherNames>Pepin KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-2688</gtr:issn><gtr:outcomeId>pm_13908_28_22459665</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63CAEBEC-A916-4AA0-B44B-DB3849A85A82</gtr:id><gtr:title>Sampling through time and phylodynamic inference with coalescent and birth-death models.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a65aa60d956f1da3c46cfe9f95a31f"><gtr:id>29a65aa60d956f1da3c46cfe9f95a31f</gtr:id><gtr:otherNames>Volz EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>585d5ddb36d1d5.06405220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>095C5FE6-A94B-4326-A1EE-946C21BF201E</gtr:id><gtr:title>Transmission blocking activity of Azadirachta indica and Guiera senegalensis extracts on the sporogonic development of Plasmodium falciparum field isolates in Anopheles coluzzii mosquitoes.</gtr:title><gtr:parentPublicationTitle>Parasites &amp; vectors</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ee670e5baf486d78288ec10c2838c0f"><gtr:id>4ee670e5baf486d78288ec10c2838c0f</gtr:id><gtr:otherNames>Yerbanga RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1756-3305</gtr:issn><gtr:outcomeId>546223a00bbb64.62784185</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CE115D0-75C1-4DF2-B4D7-63F7E9C3C077</gtr:id><gtr:title>A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different Methods.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87279cc947cd5daa0ce52070fe322229"><gtr:id>87279cc947cd5daa0ce52070fe322229</gtr:id><gtr:otherNames>Rehle T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d41e8eef06b6.72969437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C17DDBDD-5A4B-4D56-AB96-4BD88E80E56F</gtr:id><gtr:title>Bayesian inference of infectious disease transmission from whole-genome sequence data.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4561cf01b513731abf1179209f974d"><gtr:id>3b4561cf01b513731abf1179209f974d</gtr:id><gtr:otherNames>Didelot X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>5462239f7e1945.51565697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>808B2531-D853-4477-BCB8-21C289EA82D8</gtr:id><gtr:title>Expanding the role of diagnostic and prognostic tools for infectious diseases in resource-poor settings.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc18eece58bea84cbf83a459378d6998"><gtr:id>bc18eece58bea84cbf83a459378d6998</gtr:id><gtr:otherNames>Ghani AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d41e7b0729b8.03085357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E3E7388-AB50-4D3C-A3AC-9D26BE393BED</gtr:id><gtr:title>The price of sex: condom use and the determinants of the price of sex among female sex workers in eastern Zimbabwe.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f33bf420e48650785cc0c40bda401b1"><gtr:id>9f33bf420e48650785cc0c40bda401b1</gtr:id><gtr:otherNames>Elmes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>doi_55f98698676384b5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>622D8456-95EE-4F91-A82E-3E95A63EE37C</gtr:id><gtr:title>The Landscape of Realized Homologous Recombination in Pathogenic Bacteria.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c76ac3809caae85c8a46d64cb3e4ff5"><gtr:id>4c76ac3809caae85c8a46d64cb3e4ff5</gtr:id><gtr:otherNames>Yahara K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>56d41e91cc2103.51167793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24672843-8C9D-4FE3-9D11-B5B7B95A98EB</gtr:id><gtr:title>Heterogeneity in the Effect of Common Shocks on Healthcare Expenditure Growth.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f44b1ce1958f5cdf22d383b94fe9337"><gtr:id>6f44b1ce1958f5cdf22d383b94fe9337</gtr:id><gtr:otherNames>Hauck K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>585d5876c20c72.87256703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>938AF8A2-8B61-4595-9806-FFAD99467B70</gtr:id><gtr:title>Polio vaccination: preparing for a change of routine.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7533d199dc05be90709dffd1cf0467"><gtr:id>6d7533d199dc05be90709dffd1cf0467</gtr:id><gtr:otherNames>Parker EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>585d5a6da0ffb2.58764494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DC3CE4C-5BB7-4886-8890-F0C423271215</gtr:id><gtr:title>Pre-entry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bb6149dd56f801d75cf1d49c110c647"><gtr:id>1bb6149dd56f801d75cf1d49c110c647</gtr:id><gtr:otherNames>Aldridge RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>5675dd4e733cc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>780F4A1F-1F1D-4314-811E-AF6101B935E4</gtr:id><gtr:title>Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88e7426a1b6368e2daa58e8e58834d34"><gtr:id>88e7426a1b6368e2daa58e8e58834d34</gtr:id><gtr:otherNames>van de Vijver DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>54622399965582.22659903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D13160C-F089-4540-B4FB-8D8971DAAE5D</gtr:id><gtr:title>Estimating malaria transmission intensity from Plasmodium falciparum serological data using antibody density models.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05257974d75e3f0396454c53ea05f34b"><gtr:id>05257974d75e3f0396454c53ea05f34b</gtr:id><gtr:otherNames>Pothin E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56d41e78d7d160.78052231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>770AE7F1-8A19-4FAD-9DB4-C54C1619075B</gtr:id><gtr:title>Genome sequencing of an extended series of NDM-producing Klebsiella pneumoniae isolates from neonatal infections in a Nepali hospital characterizes the extent of community- versus hospital-associated transmission in an endemic setting.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d73baf845cafdc73ad61e92bec2ca251"><gtr:id>d73baf845cafdc73ad61e92bec2ca251</gtr:id><gtr:otherNames>Stoesser N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>546223a62ae150.09253591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76E84000-BA74-48D6-AE3B-6116B73F5FEA</gtr:id><gtr:title>Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae at a single institution: insights into endemicity from whole-genome sequencing.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e79fcf2077daa4320474aa60e5e21028"><gtr:id>e79fcf2077daa4320474aa60e5e21028</gtr:id><gtr:otherNames>Mathers AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>56d41e9057feb1.54709882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6A994F6-5FAD-4E23-A561-E9D5D8724F76</gtr:id><gtr:title>Integration, community engagement, and polio eradication in Nigeria - authors' reply.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdaf6f773b6a94d33c43e43a06821d61"><gtr:id>cdaf6f773b6a94d33c43e43a06821d61</gtr:id><gtr:otherNames>Mangal TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>546223a46cf1e8.39864929</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37EAB52E-211C-4F99-A6C4-9E241E1D9FC4</gtr:id><gtr:title>High Transmissibility During Early HIV Infection Among Men Who Have Sex With Men-San Francisco, California.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5cde144981c580faa98f0466e66e6b5"><gtr:id>d5cde144981c580faa98f0466e66e6b5</gtr:id><gtr:otherNames>Hollingsworth TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>56d41e7fe19229.34248133</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20467D49-9465-4152-9F42-8ABA2EB964EA</gtr:id><gtr:title>Climate forcing of an emerging pathogenic fungus across a montane multi-host community.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8ed7bd628c30a8a802f5e7f92b89014"><gtr:id>c8ed7bd628c30a8a802f5e7f92b89014</gtr:id><gtr:otherNames>Clare FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>585d6a618ed1b4.55531657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E9F4D6D-7259-42E1-8E5E-457606BCA544</gtr:id><gtr:title>Erratum: Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/464a69d208034edf889526a6f84cdb83"><gtr:id>464a69d208034edf889526a6f84cdb83</gtr:id><gtr:otherNames>Weinert LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d5b71f01d47.68795834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94DBEF0D-EB54-45B7-B75D-FFDDA6A55232</gtr:id><gtr:title>How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact</gtr:title><gtr:parentPublicationTitle>AIDS Research and Human Retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8250c8021b845b0a46cd7eb10dabcb30"><gtr:id>8250c8021b845b0a46cd7eb10dabcb30</gtr:id><gtr:otherNames>Dimitrov D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546223a70556e1.05826651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>168A0A40-DA4C-4713-A7A3-944C11400569</gtr:id><gtr:title>How Many HIV infections may be averted by targeting primary infection in men who have sex with men? Quantification of changes in transmission-risk behavior, using an individual-based model.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1628bbc612be5aa351a2d0309c866300"><gtr:id>1628bbc612be5aa351a2d0309c866300</gtr:id><gtr:otherNames>White PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>doi_55faa2aa24f13421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A89B3CA1-4188-4580-9FD8-264CDACBDBE4</gtr:id><gtr:title>The final stages of the global eradication of poliomyelitis.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad477705d4c8966434296d200f476ba2"><gtr:id>ad477705d4c8966434296d200f476ba2</gtr:id><gtr:otherNames>Grassly NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>pm_13908_28_23798688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D445F31-B308-4640-BFBB-761E91418E18</gtr:id><gtr:title>Revealing the Micro-scale Signature of Endemic Zoonotic Disease Transmission in an African Urban Setting.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58669549da2f4045c7ac56fc34ffa668"><gtr:id>58669549da2f4045c7ac56fc34ffa668</gtr:id><gtr:otherNames>Bourhy H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>585d630642f437.02394268</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>172D62A3-10DC-4639-BB63-59A2978C7804</gtr:id><gtr:title>Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3de28e6626628d1ba178bed34daf818"><gtr:id>a3de28e6626628d1ba178bed34daf818</gtr:id><gtr:otherNames>Pons-Salort M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>585d630bae9997.05069517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA074211-713D-46FD-8F39-7C488231E6D4</gtr:id><gtr:title>The global burden of women's cancers: a grand challenge in global health</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/077d5ddf6576263fbef3240407cf0890"><gtr:id>077d5ddf6576263fbef3240407cf0890</gtr:id><gtr:otherNames>Ginsburg O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>588b58e4072515.22401453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F15B237-9683-412E-BEEB-B69213387E21</gtr:id><gtr:title>Horizontal DNA Transfer Mechanisms of Bacteria as Weapons of Intragenomic Conflict.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e8ad1fc53d4c06210e00afb647eb318"><gtr:id>6e8ad1fc53d4c06210e00afb647eb318</gtr:id><gtr:otherNames>Croucher NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>585d6261660855.96710655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBC031D8-D66D-4A1E-A4A2-7D5F859A4835</gtr:id><gtr:title>Developing a conceptual framework of seroadaptive behaviors in HIV-diagnosed men who have sex with men.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adbe3ffb2cbf3812dbc1bbe1e09b62f0"><gtr:id>adbe3ffb2cbf3812dbc1bbe1e09b62f0</gtr:id><gtr:otherNames>R?nn M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>doi_55f98698675a7370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99FCEF1A-036B-416C-9ED2-813DA29E393D</gtr:id><gtr:title>Apparently-Different Clearance Rates from Cohort Studies of Mycoplasma genitalium Are Consistent after Accounting for Incidence of Infection, Recurrent Infection, and Study Design.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c31d9740bcc0e01f94e6df1eaba962b"><gtr:id>7c31d9740bcc0e01f94e6df1eaba962b</gtr:id><gtr:otherNames>Smieszek T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d52b52a7421.77212773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13245113-E4BE-4C60-B8E4-49FFD76F34BD</gtr:id><gtr:title>Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd41c47ef0bc9fb86f02bf108d0615a1"><gtr:id>dd41c47ef0bc9fb86f02bf108d0615a1</gtr:id><gtr:otherNames>Estill J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23469035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E396C463-6F3B-4824-BBB8-D933D989E779</gtr:id><gtr:title>Introducing optimism to models of resource allocation to reduce HIV incidence - Authors' reply</gtr:title><gtr:parentPublicationTitle>The Lancet HIV</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba671c4c44f3b4e74f47be987964f863"><gtr:id>ba671c4c44f3b4e74f47be987964f863</gtr:id><gtr:otherNames>McGillen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>588b5920cf6039.30955966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42193246-F0B5-4A93-9A7B-175A49D1C9E1</gtr:id><gtr:title>Experimental study of the relationship between Plasmodium gametocyte density and infection success in mosquitoes; implications for the evaluation of malaria transmission-reducing interventions.</gtr:title><gtr:parentPublicationTitle>Experimental parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6e3c6ce2ec40a5ffe6f5377aaeb569c"><gtr:id>d6e3c6ce2ec40a5ffe6f5377aaeb569c</gtr:id><gtr:otherNames>Da DF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-4894</gtr:issn><gtr:outcomeId>56d41e8b821f87.84044560</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47E03472-57E2-498F-810A-07CBA9A8A655</gtr:id><gtr:title>The Burden of Typhoid and Paratyphoid in India: Systematic Review and Meta-analysis.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfd5dc2f22e7902f8275914f53086c75"><gtr:id>bfd5dc2f22e7902f8275914f53086c75</gtr:id><gtr:otherNames>John J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>585d6291583d51.15781078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05778EEE-5D42-40F1-85FB-5999F958262C</gtr:id><gtr:title>The ubiquitous nature of Listeria monocytogenes clones: a large-scale Multilocus Sequence Typing study.</gtr:title><gtr:parentPublicationTitle>Environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31152c028caf2dcb8e8b869a051e5e0c"><gtr:id>31152c028caf2dcb8e8b869a051e5e0c</gtr:id><gtr:otherNames>Haase JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1462-2912</gtr:issn><gtr:outcomeId>5462239bc55cd4.06849306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48A8338F-1932-4587-8B74-88408CE514B2</gtr:id><gtr:title>Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38bdeaa71df425665fb03a0331c8d987"><gtr:id>38bdeaa71df425665fb03a0331c8d987</gtr:id><gtr:otherNames>Churcher TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>546223986a31c7.68221032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>075BA36C-FA44-4F17-8C96-81EA214995C3</gtr:id><gtr:title>Towards an integrated ecosystem of R packages for the analysis of population genetic data.</gtr:title><gtr:parentPublicationTitle>Molecular ecology resources</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/907d0e7e2bfd661244e841aa595ce644"><gtr:id>907d0e7e2bfd661244e841aa595ce644</gtr:id><gtr:otherNames>Paradis E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1755-098X</gtr:issn><gtr:outcomeId>588b5bf06c0f33.01743181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC9CD537-CF57-4C50-84C4-2AD8AAFABF81</gtr:id><gtr:title>Transmission modeling and health systems: the case of TB in India.</gtr:title><gtr:parentPublicationTitle>International health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31bb62acbb1937b26f86f26143206ed7"><gtr:id>31bb62acbb1937b26f86f26143206ed7</gtr:id><gtr:otherNames>Mandal S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1876-3405</gtr:issn><gtr:outcomeId>56d41e85666865.31837564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA1CCA9C-C147-4EBF-83B6-B0C320FDC236</gtr:id><gtr:title>Anticipating the prevalence of avian influenza subtypes H9 and H5 in live-bird markets.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4d60becc2050e924dc5302e034b97bc"><gtr:id>c4d60becc2050e924dc5302e034b97bc</gtr:id><gtr:otherNames>Pepin KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23409145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B874CD46-4DB6-4976-9833-AA2275A7E40E</gtr:id><gtr:title>Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c09949b52b81a62d75b0ca5b0178b50"><gtr:id>6c09949b52b81a62d75b0ca5b0178b50</gtr:id><gtr:otherNames>Dorigatti I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5675e605e6e82</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A79B1AE-3D5C-43B3-8541-1B22BAECA797</gtr:id><gtr:title>Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcf87374f92387f9506905446404477a"><gtr:id>fcf87374f92387f9506905446404477a</gtr:id><gtr:otherNames>Sachdeva KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d41e8506d596.84635717</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9E2FF60-CF54-404F-8AEC-58810C04B1E3</gtr:id><gtr:title>Beware of using invalid transmission models to guide HIV health policy - authors' reply.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47920c0acbc786b9526f10999fa6b48c"><gtr:id>47920c0acbc786b9526f10999fa6b48c</gtr:id><gtr:otherNames>Hallett TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>546223a3e104a9.72257172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADC12D9D-6762-4A9E-A229-AE6A4071369B</gtr:id><gtr:title>Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0242d6d1156507f390e16a3eddb937bf"><gtr:id>0242d6d1156507f390e16a3eddb937bf</gtr:id><gtr:otherNames>Beshir KB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_13908_28_23945376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45D05E52-70E4-4252-ABB8-DAF7A4E1FE6A</gtr:id><gtr:title>Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13378166d22af7a7ca5b1f192611863"><gtr:id>b13378166d22af7a7ca5b1f192611863</gtr:id><gtr:otherNames>Cauchemez S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>5462239b490451.20284287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB9E360B-D83C-4E63-B005-D3C662409E7B</gtr:id><gtr:title>Interventions for avian influenza A (H5N1) risk management in live bird market networks.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4dd3bd1d8d7856fae7f35cc00d82e50"><gtr:id>a4dd3bd1d8d7856fae7f35cc00d82e50</gtr:id><gtr:otherNames>Fourni? G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13908_28_23650388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>953C64AB-C796-492C-8718-B6DBA42CC4B3</gtr:id><gtr:title>Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/256159da0b605caed5f2456efb37ed15"><gtr:id>256159da0b605caed5f2456efb37ed15</gtr:id><gtr:otherNames>Walker PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>546223a44796c8.17533809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>146CBD5E-7A62-4310-953A-2F38E658A535</gtr:id><gtr:title>Five challenges for stochastic epidemic models involving global transmission.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83a1f2f4aab80e7e78ee2e09ffc84192"><gtr:id>83a1f2f4aab80e7e78ee2e09ffc84192</gtr:id><gtr:otherNames>Britton T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>56d41e899e30e7.15640282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5C7E0B7-3398-4D59-9030-1FD2ED18BE87</gtr:id><gtr:title>The distribution of sex acts and condom use within partnerships in a rural sub-Saharan African population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d46dc28a53e3e7dbb98c412f1ff766a2"><gtr:id>d46dc28a53e3e7dbb98c412f1ff766a2</gtr:id><gtr:otherNames>Smith J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d62b95e2a49.34907617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>554B35AC-754F-4411-8B83-515C307BD3D0</gtr:id><gtr:title>Worldwide transmission and seasonal variation of pandemic influenza A(H1N1)2009 virus activity during the 2009-2010 pandemic.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bcd1ce78765e2c650b5be3947f52e48"><gtr:id>5bcd1ce78765e2c650b5be3947f52e48</gtr:id><gtr:otherNames>Storms AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn><gtr:outcomeId>pm_13908_28_23551904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81C4E7CA-F313-458B-BF6E-50BD6ECC26BC</gtr:id><gtr:title>Viral factors in influenza pandemic risk assessment.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc51a3c09ef13191fe709f2d522129fc"><gtr:id>fc51a3c09ef13191fe709f2d522129fc</gtr:id><gtr:otherNames>Lipsitch M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>588b5ed09efc89.92273668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E711CE6C-D07F-44A5-84E7-1208E7C6D710</gtr:id><gtr:title>Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/461530027901dfbfff6a85eae6abca81"><gtr:id>461530027901dfbfff6a85eae6abca81</gtr:id><gtr:otherNames>Butler AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_13908_28_23014519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82026526-CD90-45D6-9AE0-C0853C4A2CE9</gtr:id><gtr:title>Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/730ae9ad8c71b39ddf56c92de27a5308"><gtr:id>730ae9ad8c71b39ddf56c92de27a5308</gtr:id><gtr:otherNames>Slater HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56d41e79626521.18382690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>159E5AA6-5665-424A-874A-0215972DC1A6</gtr:id><gtr:title>How would a decision to leave the European Union affect medical research and health in the United Kingdom?</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society of Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4cdbda5ba40f14b6cd98628a410bc65"><gtr:id>c4cdbda5ba40f14b6cd98628a410bc65</gtr:id><gtr:otherNames>Majeed A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0141-0768</gtr:issn><gtr:outcomeId>585d5804a1bd50.54000714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E389E398-969B-4E7F-86DE-5183711B29A3</gtr:id><gtr:title>Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bb6149dd56f801d75cf1d49c110c647"><gtr:id>1bb6149dd56f801d75cf1d49c110c647</gtr:id><gtr:otherNames>Aldridge RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>585d5a707588c5.26093878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B92B7C6-C702-4547-ACBA-BC07E65C44F6</gtr:id><gtr:title>Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/256159da0b605caed5f2456efb37ed15"><gtr:id>256159da0b605caed5f2456efb37ed15</gtr:id><gtr:otherNames>Walker PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>5675e366770ed</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B77B9B0E-2A3D-47B2-AB92-B0017D4EE1F2</gtr:id><gtr:title>Genome-wide association study identifies vitamin B5 biosynthesis as a host specificity factor in Campylobacter.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f01ece8f3ec3b3c9e4b86067499a4026"><gtr:id>f01ece8f3ec3b3c9e4b86067499a4026</gtr:id><gtr:otherNames>Sheppard SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13908_28_23818615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AC472FD-0C0B-4918-8F3E-AF2E5A59C26E</gtr:id><gtr:title>Human-to-mosquito transmission efficiency increases as malaria is controlled.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38bdeaa71df425665fb03a0331c8d987"><gtr:id>38bdeaa71df425665fb03a0331c8d987</gtr:id><gtr:otherNames>Churcher TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56d41e8c4038f0.81993276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69CDD2BD-0441-43F7-879B-BA8290818457</gtr:id><gtr:title>How the dynamics and structure of sexual contact networks shape pathogen phylogenies.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8daea59cb2444c40ecae21e2ae9d204b"><gtr:id>8daea59cb2444c40ecae21e2ae9d204b</gtr:id><gtr:otherNames>Robinson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>pm_13908_28_23818840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C977860F-1831-4B37-938E-D2F68BCBA2F3</gtr:id><gtr:title>Genomic Analysis and Comparison of Two Gonorrhea Outbreaks.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4561cf01b513731abf1179209f974d"><gtr:id>3b4561cf01b513731abf1179209f974d</gtr:id><gtr:otherNames>Didelot X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d6ff61b8901.30341304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07947B8A-068F-4431-B5FA-59BD7231DAC7</gtr:id><gtr:title>Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/759ea59350160bfe2f4ff46945690745"><gtr:id>759ea59350160bfe2f4ff46945690745</gtr:id><gtr:otherNames>Griffin JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>56d41e79363a60.87358031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4FCB6BA-31C4-4C54-A7DC-D30D00AFFD45</gtr:id><gtr:title>Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f56584c638d4ce39ec15347d619b6f1"><gtr:id>8f56584c638d4ce39ec15347d619b6f1</gtr:id><gtr:otherNames>White MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>56d41e7c9a78a4.20975830</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BBDA114-B81D-426B-B8DF-FDB5D1912746</gtr:id><gtr:title>HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd4b424460e03e5dc9b6ba07e301546f"><gtr:id>cd4b424460e03e5dc9b6ba07e301546f</gtr:id><gtr:otherNames>Cori A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d62b4b97be4.99205938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DEC6BD9-ABF8-4588-8304-75F6D888469B</gtr:id><gtr:title>Social mixing patterns in rural and urban areas of southern China.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84337833d8b63ad1be8a59ca8f98e55c"><gtr:id>84337833d8b63ad1be8a59ca8f98e55c</gtr:id><gtr:otherNames>Read JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn><gtr:outcomeId>546223a05a3632.76652506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>365EC040-524C-4CA1-97C9-48B5EB42D5A6</gtr:id><gtr:title>Complex disease dynamics and the design of influenza vaccination programs.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfb5062b3b74deb6e922dc6a4250846e"><gtr:id>bfb5062b3b74deb6e922dc6a4250846e</gtr:id><gtr:otherNames>Riley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5462239b6f1206.89255724</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D695BB04-BB66-404E-9AC4-2EA527484812</gtr:id><gtr:title>Estimating the most efficient allocation of interventions to achieve reductions in Plasmodium falciparum malaria burden and transmission in Africa: a modelling study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/256159da0b605caed5f2456efb37ed15"><gtr:id>256159da0b605caed5f2456efb37ed15</gtr:id><gtr:otherNames>Walker PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>585d5a9a667ae3.97261466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EF70D3C-8BEB-4E17-96F9-EA183BF7FAE2</gtr:id><gtr:title>Improving Control of Tuberculosis in Low-Burden Countries: Insights from Mathematical Modeling.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1628bbc612be5aa351a2d0309c866300"><gtr:id>1628bbc612be5aa351a2d0309c866300</gtr:id><gtr:otherNames>White PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>585d402f73c2e2.71917941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4EC9515-A573-470C-8343-1B3305836305</gtr:id><gtr:title>Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/183477fd03e755ffd093359907ffb43e"><gtr:id>183477fd03e755ffd093359907ffb43e</gtr:id><gtr:otherNames>Phillips AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>585d5d7f510fc6.87620358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F191806-9B2C-46F6-97A9-666157EE3D53</gtr:id><gtr:title>Progressive genome-wide introgression in agricultural Campylobacter coli.</gtr:title><gtr:parentPublicationTitle>Molecular ecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f01ece8f3ec3b3c9e4b86067499a4026"><gtr:id>f01ece8f3ec3b3c9e4b86067499a4026</gtr:id><gtr:otherNames>Sheppard SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-1083</gtr:issn><gtr:outcomeId>pm_13908_28_23279096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE71510E-3098-4519-A438-9E1D6AD13A5B</gtr:id><gtr:title>Neglected tools for neglected diseases: mathematical models in economic evaluations.</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07eefe038ecfe88e29511c4d747f13cc"><gtr:id>07eefe038ecfe88e29511c4d747f13cc</gtr:id><gtr:otherNames>Turner HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn><gtr:outcomeId>56d41e8c76f0f5.27722372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76EEB6CD-C299-4422-A3C6-73246FD6B638</gtr:id><gtr:title>Unravelling mucosal immunity to poliovirus</gtr:title><gtr:parentPublicationTitle>The Lancet Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/184ec42c0ffd0cfe6535de233852a42e"><gtr:id>184ec42c0ffd0cfe6535de233852a42e</gtr:id><gtr:otherNames>Parker E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>588b59073751f4.08257400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7502E1D-0B1C-4AA5-906F-73B9B0314D42</gtr:id><gtr:title>Bovine tuberculosis: Badger-cull targets unlikely to reduce TB.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79868534e48f6997fa2239eae60f7e26"><gtr:id>79868534e48f6997fa2239eae60f7e26</gtr:id><gtr:otherNames>Donnelly CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d41e7e494aa7.98974351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78B0E58D-69F5-47C8-8E44-14736712D8E3</gtr:id><gtr:title>Seven challenges in modeling pathogen dynamics within-host and across scales.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f387dc3e7f93d87fd55b6a14687d547"><gtr:id>5f387dc3e7f93d87fd55b6a14687d547</gtr:id><gtr:otherNames>Gog JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>56d41e859f3190.79981058</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA5BE3F4-C0E9-406C-B3AD-1465C6825318</gtr:id><gtr:title>Simulation-guided design of serological surveys of the cumulative incidence of influenza infection.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fd3052f675ab3b1cce65819ff641463"><gtr:id>0fd3052f675ab3b1cce65819ff641463</gtr:id><gtr:otherNames>Wu KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>546223a54b9a98.61676437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D441DBBC-91B7-4EEB-BA2F-C5FC68EA839B</gtr:id><gtr:title>Whole genome sequencing in the prevention and control of Staphylococcus aureus infection.</gtr:title><gtr:parentPublicationTitle>The Journal of hospital infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba749585359b6d8b0a4c769e7880a6c3"><gtr:id>ba749585359b6d8b0a4c769e7880a6c3</gtr:id><gtr:otherNames>Price JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-6701</gtr:issn><gtr:outcomeId>pm_13908_28_23164609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C617408-2E46-4ECF-9915-E52CCCA2150F</gtr:id><gtr:title>Early Characterization of the Severity and Transmissibility of Pandemic Influenza Using Clinical Episode Data from Multiple Populations.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08eaa1b927bdf88d6c82651d9afc97a1"><gtr:id>08eaa1b927bdf88d6c82651d9afc97a1</gtr:id><gtr:otherNames>Riley P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>56d41e8834bcd9.96844277</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0865D5EF-604E-449E-BE09-087FE7AA74A5</gtr:id><gtr:title>Within-host evolution of Staphylococcus aureus during asymptomatic carriage.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cda315f140fbde098a2e2078c5a904e6"><gtr:id>cda315f140fbde098a2e2078c5a904e6</gtr:id><gtr:otherNames>Golubchik T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13908_28_23658690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E29BCB29-B65E-44A5-82AF-AFC04DE14D23</gtr:id><gtr:title>Risk factors for severe outcomes among members of the United States military hospitalized with pneumonia and influenza, 2000-2012.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f919f6ab9ec769ab2d5c25bd7250cf7c"><gtr:id>f919f6ab9ec769ab2d5c25bd7250cf7c</gtr:id><gtr:otherNames>Van Kerkhove MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56d41e8782dcc1.76587349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90279418-41A5-44B8-B69A-1AB1521DD201</gtr:id><gtr:title>Immunisation against a serine protease inhibitor reduces intensity of Plasmodium berghei infection in mosquitoes.</gtr:title><gtr:parentPublicationTitle>International journal for parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60f32e856c91f8719ed1862e0d189adf"><gtr:id>60f32e856c91f8719ed1862e0d189adf</gtr:id><gtr:otherNames>Williams AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0020-7519</gtr:issn><gtr:outcomeId>546223993f22f7.41106397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEFBD5B6-CA23-4B12-9748-AEA6774CA90D</gtr:id><gtr:title>The application of genomics to tracing bacterial pathogen transmission.</gtr:title><gtr:parentPublicationTitle>Current opinion in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e8ad1fc53d4c06210e00afb647eb318"><gtr:id>6e8ad1fc53d4c06210e00afb647eb318</gtr:id><gtr:otherNames>Croucher NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1369-5274</gtr:issn><gtr:outcomeId>56d41e90040322.49067649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06950A65-1DA2-4A11-AC05-C3BC9608DB35</gtr:id><gtr:title>Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7533d199dc05be90709dffd1cf0467"><gtr:id>6d7533d199dc05be90709dffd1cf0467</gtr:id><gtr:otherNames>Parker EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5462239f574e84.09468738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97E825F3-1329-4969-AFD5-F19E0682DFFD</gtr:id><gtr:title>Declaring a tuberculosis outbreak over with genomic epidemiology.</gtr:title><gtr:parentPublicationTitle>Microbial genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07450588469aaf238563d8497a02c44f"><gtr:id>07450588469aaf238563d8497a02c44f</gtr:id><gtr:otherNames>Hatherell HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2057-5858</gtr:issn><gtr:outcomeId>585d6a64ed3809.66048898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23EF1103-1005-4DC2-A9AB-EF39E32E54EE</gtr:id><gtr:title>Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a89abe3bbb378fda0bae27997ab36b2"><gtr:id>1a89abe3bbb378fda0bae27997ab36b2</gtr:id><gtr:otherNames>Ferguson NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>585d60b0132cb0.89506146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6D080A8-8651-45D6-9FB3-19011C95675F</gtr:id><gtr:title>Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data.</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ceae74dd0c122b07c393c7ea3163fba"><gtr:id>1ceae74dd0c122b07c393c7ea3163fba</gtr:id><gtr:otherNames>van Sighem A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn><gtr:outcomeId>56d41e80272576.29896454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0098382C-0E02-4E45-B1B0-A73910B6CBD3</gtr:id><gtr:title>Bidirectional genomic exchange between Helicobacter pylori strains from a family in Coventry, United Kingdom.</gtr:title><gtr:parentPublicationTitle>International journal of medical microbiology : IJMM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4d3aef5de398bc5f62146680fe68b8f"><gtr:id>e4d3aef5de398bc5f62146680fe68b8f</gtr:id><gtr:otherNames>Krebes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1438-4221</gtr:issn><gtr:outcomeId>546223a4e35970.55275140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F09D5BFA-20AD-4652-A3B1-19AA67425691</gtr:id><gtr:title>Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a027ec610bf5b7024664daa61a4ccc12"><gtr:id>a027ec610bf5b7024664daa61a4ccc12</gtr:id><gtr:otherNames>Menzies NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>585d5aa218f745.84419228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8909B7C-5D63-44D9-96B1-6C755C945ABF</gtr:id><gtr:title>Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df45bbde2fa354f91b34a4853de41aac"><gtr:id>df45bbde2fa354f91b34a4853de41aac</gtr:id><gtr:otherNames>Eaton JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>56d41e80611033.75903259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7E3E67D-2C41-407D-B9E6-9606D9FF57F7</gtr:id><gtr:title>Population-based cohort study of the management and survival of patients with early-stage oesophageal adenocarcinoma in England.</gtr:title><gtr:parentPublicationTitle>The British journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98657f7bd359406fadc42d40564097f3"><gtr:id>98657f7bd359406fadc42d40564097f3</gtr:id><gtr:otherNames>Chadwick G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn><gtr:outcomeId>56d41e872712f5.30095746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F697EEB-6756-4C2E-9F74-6E76CCD6D903</gtr:id><gtr:title>Genome-wide analysis of chromosomal import patterns after natural transformation of Helicobacter pylori.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/596907c4d7d7cd9221cbfbedfdd5369d"><gtr:id>596907c4d7d7cd9221cbfbedfdd5369d</gtr:id><gtr:otherNames>Bubendorfer S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d5b47746612.85493596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36133D05-81AC-4554-9AFE-6F097981C7D1</gtr:id><gtr:title>Generating the evidence base for malaria elimination: the situation in Haiti</gtr:title><gtr:parentPublicationTitle>The Lancet Global Health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f25ec9d0b1ef978069481d8474cd009"><gtr:id>3f25ec9d0b1ef978069481d8474cd009</gtr:id><gtr:otherNames>Okell L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>588b591a6c42e9.09987103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03465E3A-48C3-4D14-BAAC-2D19698A7376</gtr:id><gtr:title>Infectious disease: tough choices to reduce Ebola transmission.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5dc59c1ed4946aa81ee43cfd9c257bf"><gtr:id>e5dc59c1ed4946aa81ee43cfd9c257bf</gtr:id><gtr:otherNames>Whitty CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d41e8323d9d6.54681704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90C848BE-BFCC-44F5-A171-FE3EC9FC21C3</gtr:id><gtr:title>Factors determining anti-poliovirus type 3 antibodies among orally immunised Indian infants.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15f75daf7f1a57d3acef4cab00259c05"><gtr:id>15f75daf7f1a57d3acef4cab00259c05</gtr:id><gtr:otherNames>Kaliappan SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>588b58d4474346.24418217</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2EEB25E-81A5-4B26-A88C-B67DF128E8C1</gtr:id><gtr:title>Estimating Geographical Variation in the Risk of Zoonotic Plasmodium knowlesi Infection in Countries Eliminating Malaria.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4292d66428dbcf120f62062aca55cee2"><gtr:id>4292d66428dbcf120f62062aca55cee2</gtr:id><gtr:otherNames>Shearer FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>585d6299e80903.97580290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BEB7ADD-A4AD-4BA9-B002-158C6607346C</gtr:id><gtr:title>Localised Badger Culling Increases Risk of Herd Breakdown on Nearby, Not Focal, Land.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18506ab07d82c9ee62584cc125c82bbc"><gtr:id>18506ab07d82c9ee62584cc125c82bbc</gtr:id><gtr:otherNames>Bielby J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d62fb41a751.32511363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>195E2841-2AB2-491B-A22A-B1EE254803C2</gtr:id><gtr:title>Viral shedding, clinical history and transmission of influenza.</gtr:title><gtr:parentPublicationTitle>Hong Kong medical journal = Xianggang yi xue za zhi</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1eab34052d6e07d2c8b4adbc71386dd8"><gtr:id>1eab34052d6e07d2c8b4adbc71386dd8</gtr:id><gtr:otherNames>Cowling BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1024-2708</gtr:issn><gtr:outcomeId>pm_13908_28_23775182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7414DE4E-7D61-4B09-BAAE-73E6CA04006D</gtr:id><gtr:title>The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07eefe038ecfe88e29511c4d747f13cc"><gtr:id>07eefe038ecfe88e29511c4d747f13cc</gtr:id><gtr:otherNames>Turner HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>5462239a141451.04518637</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49090D83-9224-4083-945B-74D67137480B</gtr:id><gtr:title>Community-based screening and treatment for chronic hepatitis B in sub-Saharan Africa - Authors' reply</gtr:title><gtr:parentPublicationTitle>The Lancet Global Health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1c15b36e0d1274b3f9425d9ffea506f"><gtr:id>c1c15b36e0d1274b3f9425d9ffea506f</gtr:id><gtr:otherNames>Nayagam S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>588b591cf0c5f7.04830721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5A45A7F-D5B8-418F-A7D9-14EC5CC2DA05</gtr:id><gtr:title>The spatial resolution of epidemic peaks.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/531e490605bdca10c1b955f966b3cfd1"><gtr:id>531e490605bdca10c1b955f966b3cfd1</gtr:id><gtr:otherNames>Mills HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>5462239fd00035.09188402</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8D78F2E-EA93-4FB5-AD1A-FE6339962999</gtr:id><gtr:title>Inferring influenza dynamics and control in households.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e85c8c567beb1393c1fa53490e2fd8b5"><gtr:id>e85c8c567beb1393c1fa53490e2fd8b5</gtr:id><gtr:otherNames>Lau MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56d41e88640d34.34053747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4882C470-BF4C-4ED1-9135-7F2EC8917064</gtr:id><gtr:title>The Ecological Dynamics of Fecal Contamination and Salmonella Typhi and Salmonella Paratyphi A in Municipal Kathmandu Drinking Water.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7dc5204a6a5f780dfcd1867c7392b377"><gtr:id>7dc5204a6a5f780dfcd1867c7392b377</gtr:id><gtr:otherNames>Karkey A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>56d5aa5ca38799.03037188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>404F69AA-056E-4B02-BC8B-F29BBE7F5CA9</gtr:id><gtr:title>Costs of crowding for the transmission of malaria parasites.</gtr:title><gtr:parentPublicationTitle>Evolutionary applications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c1d049fffe9d74f850f8942e6301c94"><gtr:id>8c1d049fffe9d74f850f8942e6301c94</gtr:id><gtr:otherNames>Pollitt LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1752-4571</gtr:issn><gtr:outcomeId>54622398e2b971.96910449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>072685FF-0518-4FF3-AE1F-C6EC59AFCDCB</gtr:id><gtr:title>Identification of MERS-CoV in dromedary camels.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a89abe3bbb378fda0bae27997ab36b2"><gtr:id>1a89abe3bbb378fda0bae27997ab36b2</gtr:id><gtr:otherNames>Ferguson NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>585d5a804bb349.39506031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FA68E6D-3313-4836-BDBF-6A13C23155AF</gtr:id><gtr:title>Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindness.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/387c0c1157f05fb17c3c673ecd50d8fa"><gtr:id>387c0c1157f05fb17c3c673ecd50d8fa</gtr:id><gtr:otherNames>Walker M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56d41e8b258821.75658434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80406B1D-929F-4F12-B0EB-E05CB34AF103</gtr:id><gtr:title>Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d76303f19265c282fc765d04ce2d33ed"><gtr:id>d76303f19265c282fc765d04ce2d33ed</gtr:id><gtr:otherNames>Jones A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>585d5a5e046896.85721431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D23C23C-2977-473C-B5FE-CAD645674090</gtr:id><gtr:title>Urogenital schistosomiasis in women of reproductive age and pregnant mothers in Kwale County, Kenya.</gtr:title><gtr:parentPublicationTitle>Journal of helminthology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e7409bf8751f40311b1d4b683cfc059"><gtr:id>6e7409bf8751f40311b1d4b683cfc059</gtr:id><gtr:otherNames>Kihara JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-149X</gtr:issn><gtr:outcomeId>5462239a747ea3.21151466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61E1DFC3-9BCF-4539-B3DE-F8460C46B29E</gtr:id><gtr:title>Estimation of changes in the force of infection for intestinal and urogenital schistosomiasis in countries with schistosomiasis control initiative-assisted programmes.</gtr:title><gtr:parentPublicationTitle>Parasites &amp; vectors</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe9b3847b46b91cd77a0db2e20b27cb0"><gtr:id>fe9b3847b46b91cd77a0db2e20b27cb0</gtr:id><gtr:otherNames>French MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1756-3305</gtr:issn><gtr:outcomeId>56d41e8a747832.74232812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0215981-B9A7-4A23-AC07-FD6F0E6557CA</gtr:id><gtr:title>School closures during the 2009 influenza pandemic: national and local experiences.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13378166d22af7a7ca5b1f192611863"><gtr:id>b13378166d22af7a7ca5b1f192611863</gtr:id><gtr:otherNames>Cauchemez S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>585d61a3d9c801.69716778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90645421-3467-48D9-9E08-CAC8AD147644</gtr:id><gtr:title>Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e8ad1fc53d4c06210e00afb647eb318"><gtr:id>6e8ad1fc53d4c06210e00afb647eb318</gtr:id><gtr:otherNames>Croucher NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56d5aa5e94c612.69413952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>115B96E4-EB09-4016-B736-5978D3AE9038</gtr:id><gtr:title>Genomic analysis of emerging pathogens: methods, application and future trends.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff83f67f51e2506d928ee5dabbd4d3f"><gtr:id>9ff83f67f51e2506d928ee5dabbd4d3f</gtr:id><gtr:otherNames>Li LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>585d61f34e7505.42273020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4873AA17-5AEA-4F58-BD73-93A360367176</gtr:id><gtr:title>Characteristics of LGV repeaters: analysis of LGV surveillance data.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adbe3ffb2cbf3812dbc1bbe1e09b62f0"><gtr:id>adbe3ffb2cbf3812dbc1bbe1e09b62f0</gtr:id><gtr:otherNames>R?nn M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>546223a79b06a7.18050924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D616768B-27FA-42CF-8EF7-D9A165C4D74B</gtr:id><gtr:title>Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/705b323896cb1d14799e7afcdb2f125e"><gtr:id>705b323896cb1d14799e7afcdb2f125e</gtr:id><gtr:otherNames>Kassebaum N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>588b58e68672e4.72899209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41C73A6B-AAD7-4BA0-9075-1F4BF0F28033</gtr:id><gtr:title>A Meta-Analysis of Serological Response Associated with Yellow Fever Vaccination.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9608d56862750d064cba2ed712335877"><gtr:id>9608d56862750d064cba2ed712335877</gtr:id><gtr:otherNames>Jean K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>585d6cb848f956.54915440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E491C72-4CAF-4540-AF22-E08F543E5F24</gtr:id><gtr:title>Deciphering the complex: methodological overview of statistical models to derive OMICS-based biomarkers.</gtr:title><gtr:parentPublicationTitle>Environmental and molecular mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18ee1f29ad6e3a3300f0e1484f3da14a"><gtr:id>18ee1f29ad6e3a3300f0e1484f3da14a</gtr:id><gtr:otherNames>Chadeau-Hyam M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0893-6692</gtr:issn><gtr:outcomeId>585d58709708e3.97374436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B93CD023-DD97-448D-AC66-62124A2C17C0</gtr:id><gtr:title>Dynamics of the antibody response to Plasmodium falciparum infection in African children.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f56584c638d4ce39ec15347d619b6f1"><gtr:id>8f56584c638d4ce39ec15347d619b6f1</gtr:id><gtr:otherNames>White MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5462239fa954a7.52448133</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD83A6DB-DF70-4860-A50C-A8C12A834F13</gtr:id><gtr:title>Increases in gonorrhoea incidence and GUM clinic waiting times: are we in a vicious circle like the late 1990s and early 2000s, but now exacerbated by drug resistance?</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1628bbc612be5aa351a2d0309c866300"><gtr:id>1628bbc612be5aa351a2d0309c866300</gtr:id><gtr:otherNames>White PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>5a35e1ee0d2f00.07488126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>124BA456-1E10-42E9-A8E1-31CDB5C9040B</gtr:id><gtr:title>Recombination shapes genome architecture in an organism from the archaeal domain.</gtr:title><gtr:parentPublicationTitle>Genome biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f665fc11f927683bb3e50b5bae758ca"><gtr:id>1f665fc11f927683bb3e50b5bae758ca</gtr:id><gtr:otherNames>Krause DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-6653</gtr:issn><gtr:outcomeId>5462239d470bd6.72247756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C551599-5C9B-4B13-9F7B-AA4E4DD40A9A</gtr:id><gtr:title>Exploration of the power of routine surveillance data to assess the impacts of industry-led badger culling on bovine tuberculosis incidence in cattle herds.</gtr:title><gtr:parentPublicationTitle>The Veterinary record</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79868534e48f6997fa2239eae60f7e26"><gtr:id>79868534e48f6997fa2239eae60f7e26</gtr:id><gtr:otherNames>Donnelly CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0042-4900</gtr:issn><gtr:outcomeId>56d41e7dd2ffe0.78460245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E44683AA-7873-4E35-BCFB-69ABA7E38655</gtr:id><gtr:title>Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional Study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65cbd9d842ba99e94f69ec7e2078218c"><gtr:id>65cbd9d842ba99e94f69ec7e2078218c</gtr:id><gtr:otherNames>Stagg HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d41e86662441.32135065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FFFF658-0965-4304-9E20-E3150EA564C9</gtr:id><gtr:title>The spatiotemporal association of non-prescription retail sales with cases during the 2009 influenza pandemic in Great Britain.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a27eb54f4f37665d86f6ed58739c3d8"><gtr:id>1a27eb54f4f37665d86f6ed58739c3d8</gtr:id><gtr:otherNames>Todd S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>54622396684774.74172555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91744564-2767-4856-81C3-6C22B1F96F7A</gtr:id><gtr:title>Evaluating strategies to improve HIV care outcomes in Kenya: a modelling study.</gtr:title><gtr:parentPublicationTitle>The lancet. HIV</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4447bdce9355067a32815062b2193fcd"><gtr:id>4447bdce9355067a32815062b2193fcd</gtr:id><gtr:otherNames>Olney JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2352-3018</gtr:issn><gtr:outcomeId>585d5ab37f92a1.45149622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A68179E9-BEFA-438C-88E2-10E2FB9D240A</gtr:id><gtr:title>Heroic sacrifice or tragic mistake? Revisiting the Eyam plague, 350 years on</gtr:title><gtr:parentPublicationTitle>Significance</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4561cf01b513731abf1179209f974d"><gtr:id>3b4561cf01b513731abf1179209f974d</gtr:id><gtr:otherNames>Didelot X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d6bd1eb1fb2.22460866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B485B94-1CF9-4578-B3A1-4D2AE399B7BB</gtr:id><gtr:title>Future challenges for clinical care of an ageing population infected with HIV: a modelling study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/869b1b9088a192a10571e20539225f70"><gtr:id>869b1b9088a192a10571e20539225f70</gtr:id><gtr:otherNames>Smit M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>56d41e8e8d2749.62106786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABF43B1F-0922-4E6B-A040-EF6D8330A113</gtr:id><gtr:title>Minimizing the threat of pandemic emergence from avian influenza in poultry systems.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4d60becc2050e924dc5302e034b97bc"><gtr:id>c4d60becc2050e924dc5302e034b97bc</gtr:id><gtr:otherNames>Pepin KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>5462239c9553e8.37042623</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F23E512-48CC-4ACF-AFA3-45AC248E1CE0</gtr:id><gtr:title>Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk?</gtr:title><gtr:parentPublicationTitle>Contraception</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740b47608c2a17faae775070e5702f3"><gtr:id>5740b47608c2a17faae775070e5702f3</gtr:id><gtr:otherNames>Smith JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0010-7824</gtr:issn><gtr:outcomeId>588b586782a955.02719281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19CE6B71-A5E5-4535-8085-CE4E3C7EFABB</gtr:id><gtr:title>Use of serological surveys to generate key insights into the changing global landscape of infectious disease.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81226642a0a56d2d5871f640dfb1bfc1"><gtr:id>81226642a0a56d2d5871f640dfb1bfc1</gtr:id><gtr:otherNames>Metcalf CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>585d5a68c180c2.21893286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2803EC5-C4CD-49CF-A45C-0EBD3D165793</gtr:id><gtr:title>The path of least resistance: aggressive or moderate treatment?</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e7c7eb6721cd1656000e3e63d331c7f"><gtr:id>1e7c7eb6721cd1656000e3e63d331c7f</gtr:id><gtr:otherNames>Kouyos RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn><gtr:outcomeId>546223a5c89296.36295473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34F76938-32FD-44D8-9938-D87FAEFDA53A</gtr:id><gtr:title>Incorporating disease and population structure into models of SIR disease in contact networks.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86318df6cb4a0bac5c20c4ed3e64f84c"><gtr:id>86318df6cb4a0bac5c20c4ed3e64f84c</gtr:id><gtr:otherNames>Miller JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54622399b98503.70768146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19476248-35E6-4A5B-9122-0DEA2ED750B2</gtr:id><gtr:title>Genomic evolution and transmission of Helicobacter pylori in two South African families.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4561cf01b513731abf1179209f974d"><gtr:id>3b4561cf01b513731abf1179209f974d</gtr:id><gtr:otherNames>Didelot X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13908_28_23898187</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9461083A-5EF3-4E7D-96F6-F2F4CB9B833C</gtr:id><gtr:title>Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c4aa2aec517e6bc829e37e77ca0f66e"><gtr:id>2c4aa2aec517e6bc829e37e77ca0f66e</gtr:id><gtr:otherNames>Whittles LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5a2fd74ac93649.12915174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3721F28-AD01-4AAB-81DA-51B15261E5E6</gtr:id><gtr:title>Estimating the Future Impact of a Multi-Pronged Intervention Strategy on Ocular Disease Sequelae Caused by Trachoma: A Modeling Study.</gtr:title><gtr:parentPublicationTitle>Ophthalmic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2be76609c50fe26b2f0751299f933ef4"><gtr:id>2be76609c50fe26b2f0751299f933ef4</gtr:id><gtr:otherNames>Gambhir M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0928-6586</gtr:issn><gtr:outcomeId>56d41e83a5f165.74712982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82FCF792-CA23-4DCF-A94B-19AB1565621E</gtr:id><gtr:title>How reliable are morphological and anatomical characters to distinguish European wildcats, domestic cats and their hybrids in France?</gtr:title><gtr:parentPublicationTitle>Journal of Zoological Systematics and Evolutionary Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83893f04b8ad8af33eb0e8d436d7c77b"><gtr:id>83893f04b8ad8af33eb0e8d436d7c77b</gtr:id><gtr:otherNames>Devillard S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>585d6bd69e5020.47119609</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K010174/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>